# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
11	11	3.31763856008	-	9.97e-12	GO:0060968	regulation of gene silencing	BP
5	5	3.31763856008	-	1.01e-05	GO:0060850	regulation of transcription involved in cell fate commitment	BP
5	5	3.31763856008	-	1.01e-05	GO:0055012	ventricular cardiac muscle cell differentiation	BP
5	5	3.31763856008	-	1.01e-05	GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly	BP
4	4	3.31763856008	-	1.01e-04	GO:0030578	PML body organization	BP
4	4	3.31763856008	-	1.01e-04	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
4	4	3.31763856008	-	1.01e-04	GO:1904637	cellular response to ionomycin	BP
4	4	3.31763856008	-	1.01e-04	GO:0060534	trachea cartilage development	BP
4	4	3.31763856008	-	1.01e-04	GO:0003219	cardiac right ventricle formation	BP
4	4	3.31763856008	-	1.01e-04	GO:0046886	positive regulation of hormone biosynthetic process	BP
4	4	3.31763856008	-	1.01e-04	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
3	3	3.31763856008	-	1.01e-03	GO:0034770	histone H4-K20 methylation	BP
3	3	3.31763856008	-	1.01e-03	GO:0055005	ventricular cardiac myofibril assembly	BP
3	3	3.31763856008	-	1.01e-03	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
3	3	3.31763856008	-	1.01e-03	GO:0090230	regulation of centromere complex assembly	BP
3	3	3.31763856008	-	1.01e-03	GO:0055098	response to low-density lipoprotein particle	BP
3	3	3.31763856008	-	1.01e-03	GO:0060745	mammary gland branching involved in pregnancy	BP
3	3	3.31763856008	-	1.01e-03	GO:0045604	regulation of epidermal cell differentiation	BP
3	3	3.31763856008	-	1.01e-03	GO:0072539	T-helper 17 cell differentiation	BP
3	3	3.31763856008	-	1.01e-03	GO:0070537	histone H2A K63-linked deubiquitination	BP
3	3	3.31763856008	-	1.01e-03	GO:0010725	regulation of primitive erythrocyte differentiation	BP
3	3	3.31763856008	-	1.01e-03	GO:0035986	senescence-associated heterochromatin focus assembly	BP
3	3	3.31763856008	-	1.01e-03	GO:0070141	response to UV-A	BP
3	3	3.31763856008	-	1.01e-03	GO:0010871	negative regulation of receptor biosynthetic process	BP
3	3	3.31763856008	-	1.01e-03	GO:0097039	protein linear polyubiquitination	BP
3	3	3.31763856008	-	1.01e-03	GO:1990785	response to water-immersion restraint stress	BP
3	3	3.31763856008	-	1.01e-03	GO:0061198	fungiform papilla formation	BP
3	3	3.31763856008	-	1.01e-03	GO:2001141	regulation of RNA biosynthetic process	BP
3	3	3.31763856008	-	1.01e-03	GO:0003256	regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
3	3	3.31763856008	-	1.01e-03	GO:2000111	positive regulation of macrophage apoptotic process	BP
3	3	3.31763856008	-	1.01e-03	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
3	3	3.31763856008	-	1.01e-03	GO:0002068	glandular epithelial cell development	BP
3	3	3.31763856008	-	1.01e-03	GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose	BP
3	3	3.31763856008	-	1.01e-03	GO:0031281	positive regulation of cyclase activity	BP
3	3	3.31763856008	-	1.01e-03	GO:0090116	C-5 methylation of cytosine	BP
2	2	3.31763856008	-	1.01e-02	GO:0060260	regulation of transcription initiation from RNA polymerase II promoter	BP
2	2	3.31763856008	-	1.01e-02	GO:0003207	cardiac chamber formation	BP
2	2	3.31763856008	-	1.01e-02	GO:0031509	telomeric heterochromatin assembly	BP
2	2	3.31763856008	-	1.01e-02	GO:0060928	atrioventricular node cell development	BP
2	2	3.31763856008	-	1.01e-02	GO:0090402	oncogene-induced cell senescence	BP
2	2	3.31763856008	-	1.01e-02	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
2	2	3.31763856008	-	1.01e-02	GO:0014740	negative regulation of muscle hyperplasia	BP
2	2	3.31763856008	-	1.01e-02	GO:0097252	oligodendrocyte apoptotic process	BP
2	2	3.31763856008	-	1.01e-02	GO:2001055	positive regulation of mesenchymal cell apoptotic process	BP
2	2	3.31763856008	-	1.01e-02	GO:0008050	female courtship behavior	BP
2	2	3.31763856008	-	1.01e-02	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
2	2	3.31763856008	-	1.01e-02	GO:0038156	interleukin-3-mediated signaling pathway	BP
2	2	3.31763856008	-	1.01e-02	GO:0032071	regulation of endodeoxyribonuclease activity	BP
2	2	3.31763856008	-	1.01e-02	GO:2000077	negative regulation of type B pancreatic cell development	BP
2	2	3.31763856008	-	1.01e-02	GO:0055092	sterol homeostasis	BP
2	2	3.31763856008	-	1.01e-02	GO:0036315	cellular response to sterol	BP
2	2	3.31763856008	-	1.01e-02	GO:0023035	CD40 signaling pathway	BP
2	2	3.31763856008	-	1.01e-02	GO:0034971	histone H3-R17 methylation	BP
2	2	3.31763856008	-	1.01e-02	GO:0032916	positive regulation of transforming growth factor beta3 production	BP
2	2	3.31763856008	-	1.01e-02	GO:2000327	positive regulation of ligand-dependent nuclear receptor transcription coactivator activity	BP
2	2	3.31763856008	-	1.01e-02	GO:0071174	mitotic spindle checkpoint	BP
2	2	3.31763856008	-	1.01e-02	GO:0046605	regulation of centrosome cycle	BP
2	2	3.31763856008	-	1.01e-02	GO:0061145	lung smooth muscle development	BP
2	2	3.31763856008	-	1.01e-02	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose	BP
2	2	3.31763856008	-	1.01e-02	GO:0090042	tubulin deacetylation	BP
2	2	3.31763856008	-	1.01e-02	GO:1902340	negative regulation of chromosome condensation	BP
2	2	3.31763856008	-	1.01e-02	GO:1903758	negative regulation of transcription from RNA polymerase II promoter by histone modification	BP
2	2	3.31763856008	-	1.01e-02	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
2	2	3.31763856008	-	1.01e-02	GO:0035408	histone H3-T6 phosphorylation	BP
2	2	3.31763856008	-	1.01e-02	GO:0048145	regulation of fibroblast proliferation	BP
2	2	3.31763856008	-	1.01e-02	GO:1901558	response to metformin	BP
2	2	3.31763856008	-	1.01e-02	GO:0036369	transcription factor catabolic process	BP
2	2	3.31763856008	-	1.01e-02	GO:2000824	negative regulation of androgen receptor activity	BP
2	2	3.31763856008	-	1.01e-02	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
2	2	3.31763856008	-	1.01e-02	GO:0090427	activation of meiosis	BP
2	2	3.31763856008	-	1.01e-02	GO:2001038	regulation of cellular response to drug	BP
2	2	3.31763856008	-	1.01e-02	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
2	2	3.31763856008	-	1.01e-02	GO:0090241	negative regulation of histone H4 acetylation	BP
2	2	3.31763856008	-	1.01e-02	GO:0048513	animal organ development	BP
2	2	3.31763856008	-	1.01e-02	GO:0033127	regulation of histone phosphorylation	BP
2	2	3.31763856008	-	1.01e-02	GO:0061308	cardiac neural crest cell development involved in heart development	BP
2	2	3.31763856008	-	1.01e-02	GO:0090035	positive regulation of chaperone-mediated protein complex assembly	BP
2	2	3.31763856008	-	1.01e-02	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
2	2	3.31763856008	-	1.01e-02	GO:1902170	cellular response to reactive nitrogen species	BP
2	2	3.31763856008	-	1.01e-02	GO:0048340	paraxial mesoderm morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0044839	cell cycle G2/M phase transition	BP
2	2	3.31763856008	-	1.01e-02	GO:0007521	muscle cell fate determination	BP
2	2	3.31763856008	-	1.01e-02	GO:2000017	positive regulation of determination of dorsal identity	BP
2	2	3.31763856008	-	1.01e-02	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
2	2	3.31763856008	-	1.01e-02	GO:0030221	basophil differentiation	BP
2	2	3.31763856008	-	1.01e-02	GO:1900112	regulation of histone H3-K9 trimethylation	BP
2	2	3.31763856008	-	1.01e-02	GO:0072709	cellular response to sorbitol	BP
2	2	3.31763856008	-	1.01e-02	GO:0060577	pulmonary vein morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
2	2	3.31763856008	-	1.01e-02	GO:0002268	follicular dendritic cell differentiation	BP
2	2	3.31763856008	-	1.01e-02	GO:0038183	bile acid signaling pathway	BP
2	2	3.31763856008	-	1.01e-02	GO:0060532	bronchus cartilage development	BP
2	2	3.31763856008	-	1.01e-02	GO:0060251	regulation of glial cell proliferation	BP
2	2	3.31763856008	-	1.01e-02	GO:1900195	positive regulation of oocyte maturation	BP
2	2	3.31763856008	-	1.01e-02	GO:0021514	ventral spinal cord interneuron differentiation	BP
2	2	3.31763856008	-	1.01e-02	GO:0003218	cardiac left ventricle formation	BP
2	2	3.31763856008	-	1.01e-02	GO:0014733	regulation of skeletal muscle adaptation	BP
2	2	3.31763856008	-	1.01e-02	GO:1990791	dorsal root ganglion development	BP
2	2	3.31763856008	-	1.01e-02	GO:0010949	negative regulation of intestinal phytosterol absorption	BP
2	2	3.31763856008	-	1.01e-02	GO:0060977	coronary vasculature morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0003160	endocardium morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0003162	atrioventricular node development	BP
2	2	3.31763856008	-	1.01e-02	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
2	2	3.31763856008	-	1.01e-02	GO:0003290	atrial septum secundum morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:2000779	regulation of double-strand break repair	BP
2	2	3.31763856008	-	1.01e-02	GO:0060849	regulation of transcription involved in lymphatic endothelial cell fate commitment	BP
2	2	3.31763856008	-	1.01e-02	GO:0044027	hypermethylation of CpG island	BP
2	2	3.31763856008	-	1.01e-02	GO:0035854	eosinophil fate commitment	BP
2	2	3.31763856008	-	1.01e-02	GO:0045796	negative regulation of intestinal cholesterol absorption	BP
2	2	3.31763856008	-	1.01e-02	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
2	2	3.31763856008	-	1.01e-02	GO:0003221	right ventricular cardiac muscle tissue morphogenesis	BP
2	2	3.31763856008	-	1.01e-02	GO:0090308	regulation of methylation-dependent chromatin silencing	BP
2	2	3.31763856008	-	1.01e-02	GO:0071888	macrophage apoptotic process	BP
2	2	3.31763856008	-	1.01e-02	GO:0060713	labyrinthine layer morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0090340	positive regulation of secretion of lysosomal enzymes	BP
1	1	3.31763856008	-	1.00e-01	GO:0006591	ornithine metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0002458	peripheral T cell tolerance induction	BP
1	1	3.31763856008	-	1.00e-01	GO:0090341	negative regulation of secretion of lysosomal enzymes	BP
1	1	3.31763856008	-	1.00e-01	GO:2000108	positive regulation of leukocyte apoptotic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1901582	positive regulation of telomeric RNA transcription from RNA pol II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:1901581	negative regulation of telomeric RNA transcription from RNA pol II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0061085	regulation of histone H3-K27 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1903988	ferrous iron export across plasma membrane	BP
1	1	3.31763856008	-	1.00e-01	GO:0007344	pronuclear fusion	BP
1	1	3.31763856008	-	1.00e-01	GO:0071351	cellular response to interleukin-18	BP
1	1	3.31763856008	-	1.00e-01	GO:0086018	SA node cell to atrial cardiac muscle cell signalling	BP
1	1	3.31763856008	-	1.00e-01	GO:1904899	positive regulation of hepatic stellate cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0072073	kidney epithelium development	BP
1	1	3.31763856008	-	1.00e-01	GO:1902396	protein localization to bicellular tight junction	BP
1	1	3.31763856008	-	1.00e-01	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	1	3.31763856008	-	1.00e-01	GO:1902251	negative regulation of erythrocyte apoptotic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0060929	atrioventricular node cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0051238	sequestering of metal ion	BP
1	1	3.31763856008	-	1.00e-01	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	3.31763856008	-	1.00e-01	GO:0019676	ammonia assimilation cycle	BP
1	1	3.31763856008	-	1.00e-01	GO:1901135	carbohydrate derivative metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0061326	renal tubule development	BP
1	1	3.31763856008	-	1.00e-01	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0072615	interleukin-17 secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0000423	macromitophagy	BP
1	1	3.31763856008	-	1.00e-01	GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle	BP
1	1	3.31763856008	-	1.00e-01	GO:2001229	negative regulation of response to gamma radiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0043990	histone H2A-S1 phosphorylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1904762	positive regulation of myofibroblast differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0086052	membrane repolarization during SA node cell action potential	BP
1	1	3.31763856008	-	1.00e-01	GO:0034670	chemotaxis to arachidonic acid	BP
1	1	3.31763856008	-	1.00e-01	GO:0090198	negative regulation of chemokine secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0090195	chemokine secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0071387	cellular response to cortisol stimulus	BP
1	1	3.31763856008	-	1.00e-01	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	3.31763856008	-	1.00e-01	GO:0042265	peptidyl-asparagine hydroxylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0003171	atrioventricular valve development	BP
1	1	3.31763856008	-	1.00e-01	GO:0003175	tricuspid valve development	BP
1	1	3.31763856008	-	1.00e-01	GO:0002333	transitional one stage B cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0031935	regulation of chromatin silencing	BP
1	1	3.31763856008	-	1.00e-01	GO:2000723	negative regulation of cardiac vascular smooth muscle cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0038097	positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0045898	regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0070446	negative regulation of oligodendrocyte progenitor proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901994	negative regulation of meiotic cell cycle phase transition	BP
1	1	3.31763856008	-	1.00e-01	GO:0060345	spleen trabecula formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0003285	septum secundum development	BP
1	1	3.31763856008	-	1.00e-01	GO:2000564	regulation of CD8-positive, alpha-beta T cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0033184	positive regulation of histone ubiquitination	BP
1	1	3.31763856008	-	1.00e-01	GO:0031052	chromosome breakage	BP
1	1	3.31763856008	-	1.00e-01	GO:0031056	regulation of histone modification	BP
1	1	3.31763856008	-	1.00e-01	GO:1903788	positive regulation of glutathione biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0010021	amylopectin biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0032776	DNA methylation on cytosine	BP
1	1	3.31763856008	-	1.00e-01	GO:1901208	negative regulation of heart looping	BP
1	1	3.31763856008	-	1.00e-01	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	3.31763856008	-	1.00e-01	GO:0003131	mesodermal-endodermal cell signaling	BP
1	1	3.31763856008	-	1.00e-01	GO:0003138	primary heart field specification	BP
1	1	3.31763856008	-	1.00e-01	GO:1904071	presynaptic active zone assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:2000764	positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:2000761	positive regulation of N-terminal peptidyl-lysine acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000763	positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell	BP
1	1	3.31763856008	-	1.00e-01	GO:1904992	positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	3.31763856008	-	1.00e-01	GO:0035711	T-helper 1 cell activation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060594	mammary gland specification	BP
1	1	3.31763856008	-	1.00e-01	GO:0032730	positive regulation of interleukin-1 alpha production	BP
1	1	3.31763856008	-	1.00e-01	GO:0035037	sperm entry	BP
1	1	3.31763856008	-	1.00e-01	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1904404	response to formaldehyde	BP
1	1	3.31763856008	-	1.00e-01	GO:1900239	regulation of phenotypic switching	BP
1	1	3.31763856008	-	1.00e-01	GO:0090096	positive regulation of metanephric cap mesenchymal cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0098989	NMDA selective glutamate receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0060558	regulation of calcidiol 1-monooxygenase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0043697	cell dedifferentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0061548	ganglion development	BP
1	1	3.31763856008	-	1.00e-01	GO:0072141	renal interstitial fibroblast development	BP
1	1	3.31763856008	-	1.00e-01	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1990774	tumor necrosis factor secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	3.31763856008	-	1.00e-01	GO:0051695	actin filament uncapping	BP
1	1	3.31763856008	-	1.00e-01	GO:1904793	regulation of euchromatin binding	BP
1	1	3.31763856008	-	1.00e-01	GO:0060517	epithelial cell proliferation involved in prostatic bud elongation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902748	positive regulation of lens fiber cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0014813	skeletal muscle satellite cell commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0097343	ripoptosome assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0021881	Wnt-activated signaling pathway involved in forebrain neuron fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0051249	regulation of lymphocyte activation	BP
1	1	3.31763856008	-	1.00e-01	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	3.31763856008	-	1.00e-01	GO:0010481	epidermal cell division	BP
1	1	3.31763856008	-	1.00e-01	GO:2000173	negative regulation of branching morphogenesis of a nerve	BP
1	1	3.31763856008	-	1.00e-01	GO:2000826	regulation of heart morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0097101	blood vessel endothelial cell fate specification	BP
1	1	3.31763856008	-	1.00e-01	GO:0051799	negative regulation of hair follicle development	BP
1	1	3.31763856008	-	1.00e-01	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	3.31763856008	-	1.00e-01	GO:0051866	general adaptation syndrome	BP
1	1	3.31763856008	-	1.00e-01	GO:0051867	general adaptation syndrome, behavioral process	BP
1	1	3.31763856008	-	1.00e-01	GO:1903376	regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:1905000	regulation of membrane repolarization during atrial cardiac muscle cell action potential	BP
1	1	3.31763856008	-	1.00e-01	GO:2000612	regulation of thyroid-stimulating hormone secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:2000616	negative regulation of histone H3-K9 acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0021572	rhombomere 6 development	BP
1	1	3.31763856008	-	1.00e-01	GO:0071301	cellular response to vitamin B1	BP
1	1	3.31763856008	-	1.00e-01	GO:0033233	regulation of protein sumoylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0048561	establishment of animal organ orientation	BP
1	1	3.31763856008	-	1.00e-01	GO:0086027	AV node cell to bundle of His cell signaling	BP
1	1	3.31763856008	-	1.00e-01	GO:0006117	acetaldehyde metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0003270	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0000296	spermine transport	BP
1	1	3.31763856008	-	1.00e-01	GO:0035622	intrahepatic bile duct development	BP
1	1	3.31763856008	-	1.00e-01	GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress	BP
1	1	3.31763856008	-	1.00e-01	GO:0035627	ceramide transport	BP
1	1	3.31763856008	-	1.00e-01	GO:0035624	receptor transactivation	BP
1	1	3.31763856008	-	1.00e-01	GO:0001743	optic placode formation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000798	negative regulation of amniotic stem cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000794	regulation of epithelial cell proliferation involved in lung morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:2000793	cell proliferation involved in heart valve development	BP
1	1	3.31763856008	-	1.00e-01	GO:0043954	cellular component maintenance	BP
1	1	3.31763856008	-	1.00e-01	GO:0019089	transmission of virus	BP
1	1	3.31763856008	-	1.00e-01	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	3.31763856008	-	1.00e-01	GO:2000657	negative regulation of apolipoprotein binding	BP
1	1	3.31763856008	-	1.00e-01	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0061144	alveolar secondary septum development	BP
1	1	3.31763856008	-	1.00e-01	GO:0003144	embryonic heart tube formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	BP
1	1	3.31763856008	-	1.00e-01	GO:0003433	chondrocyte development involved in endochondral bone morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0002362	CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0036211	protein modification process	BP
1	1	3.31763856008	-	1.00e-01	GO:0019478	D-amino acid catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0072608	interleukin-10 secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0000433	negative regulation of transcription from RNA polymerase II promoter by glucose	BP
1	1	3.31763856008	-	1.00e-01	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	3.31763856008	-	1.00e-01	GO:0060784	regulation of cell proliferation involved in tissue homeostasis	BP
1	1	3.31763856008	-	1.00e-01	GO:0072386	plus-end-directed organelle transport along microtubule	BP
1	1	3.31763856008	-	1.00e-01	GO:2001250	positive regulation of ammonia assimilation cycle	BP
1	1	3.31763856008	-	1.00e-01	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0007440	foregut morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0060375	regulation of mast cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0001080	nitrogen catabolite activation of transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0002509	central tolerance induction to self antigen	BP
1	1	3.31763856008	-	1.00e-01	GO:0061106	negative regulation of stomach neuroendocrine cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0061107	seminal vesicle development	BP
1	1	3.31763856008	-	1.00e-01	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0044337	canonical Wnt signaling pathway involved in positive regulation of apoptotic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1901189	positive regulation of ephrin receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:1901186	positive regulation of ERBB signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0070105	positive regulation of interleukin-6-mediated signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0061373	mammillary axonal complex development	BP
1	1	3.31763856008	-	1.00e-01	GO:2001040	positive regulation of cellular response to drug	BP
1	1	3.31763856008	-	1.00e-01	GO:0014038	regulation of Schwann cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0035239	tube morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	3.31763856008	-	1.00e-01	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0086050	membrane repolarization during bundle of His cell action potential	BP
1	1	3.31763856008	-	1.00e-01	GO:0045844	positive regulation of striated muscle tissue development	BP
1	1	3.31763856008	-	1.00e-01	GO:0072303	positive regulation of glomerular metanephric mesangial cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060823	canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0002851	positive regulation of peripheral T cell tolerance induction	BP
1	1	3.31763856008	-	1.00e-01	GO:0036088	D-serine catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0002637	regulation of immunoglobulin production	BP
1	1	3.31763856008	-	1.00e-01	GO:0035042	fertilization, exchange of chromosomal proteins	BP
1	1	3.31763856008	-	1.00e-01	GO:0042766	nucleosome mobilization	BP
1	1	3.31763856008	-	1.00e-01	GO:0072110	glomerular mesangial cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0090085	regulation of protein deubiquitination	BP
1	1	3.31763856008	-	1.00e-01	GO:0070963	positive regulation of neutrophil mediated killing of gram-negative bacterium	BP
1	1	3.31763856008	-	1.00e-01	GO:2000213	positive regulation of glutamate metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1904353	regulation of telomere capping	BP
1	1	3.31763856008	-	1.00e-01	GO:0050703	interleukin-1 alpha secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0001543	ovarian follicle rupture	BP
1	1	3.31763856008	-	1.00e-01	GO:1904168	negative regulation of thyroid hormone receptor activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1905281	positive regulation of retrograde transport, endosome to Golgi	BP
1	1	3.31763856008	-	1.00e-01	GO:1903815	negative regulation of collecting lymphatic vessel constriction	BP
1	1	3.31763856008	-	1.00e-01	GO:0061550	cranial ganglion development	BP
1	1	3.31763856008	-	1.00e-01	GO:0009956	radial pattern formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060980	cell migration involved in coronary vasculogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0070926	regulation of ATP:ADP antiporter activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0031441	negative regulation of mRNA 3'-end processing	BP
1	1	3.31763856008	-	1.00e-01	GO:0051595	response to methylglyoxal	BP
1	1	3.31763856008	-	1.00e-01	GO:1903691	positive regulation of wound healing, spreading of epidermal cells	BP
1	1	3.31763856008	-	1.00e-01	GO:0060735	regulation of eIF2 alpha phosphorylation by dsRNA	BP
1	1	3.31763856008	-	1.00e-01	GO:0060730	regulation of intestinal epithelial structure maintenance	BP
1	1	3.31763856008	-	1.00e-01	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	3.31763856008	-	1.00e-01	GO:1905695	positive regulation of phosphatidic acid biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1905031	regulation of membrane repolarization during cardiac muscle cell action potential	BP
1	1	3.31763856008	-	1.00e-01	GO:0045407	positive regulation of interleukin-5 biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0034255	regulation of urea metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0070845	polyubiquitinated misfolded protein transport	BP
1	1	3.31763856008	-	1.00e-01	GO:0070846	Hsp90 deacetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1905206	positive regulation of hydrogen peroxide-induced cell death	BP
1	1	3.31763856008	-	1.00e-01	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0098749	cerebellar neuron development	BP
1	1	3.31763856008	-	1.00e-01	GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter	BP
1	1	3.31763856008	-	1.00e-01	GO:2000410	regulation of thymocyte migration	BP
1	1	3.31763856008	-	1.00e-01	GO:0003205	cardiac chamber development	BP
1	1	3.31763856008	-	1.00e-01	GO:0035978	histone H2A-S139 phosphorylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060248	detection of cell density by contact stimulus involved in contact inhibition	BP
1	1	3.31763856008	-	1.00e-01	GO:0001923	B-1 B cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	3.31763856008	-	1.00e-01	GO:0030421	defecation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060367	sagittal suture morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0003409	optic cup structural organization	BP
1	1	3.31763856008	-	1.00e-01	GO:0001710	mesodermal cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0036138	peptidyl-histidine hydroxylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0010905	negative regulation of UDP-glucose catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1903305	regulation of regulated secretory pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:2001178	positive regulation of mediator complex assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0070060	'de novo' actin filament nucleation	BP
1	1	3.31763856008	-	1.00e-01	GO:0090132	epithelium migration	BP
1	1	3.31763856008	-	1.00e-01	GO:1905244	regulation of modification of synaptic structure	BP
1	1	3.31763856008	-	1.00e-01	GO:0043380	regulation of memory T cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0046098	guanine metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0045014	negative regulation of transcription by glucose	BP
1	1	3.31763856008	-	1.00e-01	GO:0090425	acinar cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0006343	establishment of chromatin silencing	BP
1	1	3.31763856008	-	1.00e-01	GO:0060123	regulation of growth hormone secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0060127	prolactin secreting cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:2001031	positive regulation of cellular glucuronidation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902073	positive regulation of hypoxia-inducible factor-1alpha signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0043969	histone H2B acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0045932	negative regulation of muscle contraction	BP
1	1	3.31763856008	-	1.00e-01	GO:0086072	AV node cell-bundle of His cell adhesion involved in cell communication	BP
1	1	3.31763856008	-	1.00e-01	GO:0003226	right ventricular compact myocardium morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0002572	pro-T cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0021877	forebrain neuron fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0021872	forebrain generation of neurons	BP
1	1	3.31763856008	-	1.00e-01	GO:0002683	negative regulation of immune system process	BP
1	1	3.31763856008	-	1.00e-01	GO:0007499	ectoderm and mesoderm interaction	BP
1	1	3.31763856008	-	1.00e-01	GO:0044091	membrane biogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0043012	regulation of fusion of sperm to egg plasma membrane	BP
1	1	3.31763856008	-	1.00e-01	GO:1902038	positive regulation of hematopoietic stem cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0042659	regulation of cell fate specification	BP
1	1	3.31763856008	-	1.00e-01	GO:0060366	lambdoid suture morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0045977	positive regulation of mitotic cell cycle, embryonic	BP
1	1	3.31763856008	-	1.00e-01	GO:2000097	regulation of smooth muscle cell-matrix adhesion	BP
1	1	3.31763856008	-	1.00e-01	GO:0001840	neural plate development	BP
1	1	3.31763856008	-	1.00e-01	GO:0046016	positive regulation of transcription by glucose	BP
1	1	3.31763856008	-	1.00e-01	GO:0071678	olfactory bulb axon guidance	BP
1	1	3.31763856008	-	1.00e-01	GO:1904268	positive regulation of Schwann cell chemotaxis	BP
1	1	3.31763856008	-	1.00e-01	GO:0061114	branching involved in pancreas morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:1903766	positive regulation of potassium ion export across plasma membrane	BP
1	1	3.31763856008	-	1.00e-01	GO:0010045	response to nickel cation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902415	regulation of mRNA binding	BP
1	1	3.31763856008	-	1.00e-01	GO:0055130	D-alanine catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:2000979	positive regulation of forebrain neuron differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000977	regulation of forebrain neuron differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000971	negative regulation of detection of glucose	BP
1	1	3.31763856008	-	1.00e-01	GO:0099509	regulation of presynaptic cytosolic calcium ion concentration	BP
1	1	3.31763856008	-	1.00e-01	GO:1905337	positive regulation of aggrephagy	BP
1	1	3.31763856008	-	1.00e-01	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	3.31763856008	-	1.00e-01	GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000706	negative regulation of dense core granule biogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0072355	histone H3-T3 phosphorylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0031279	regulation of cyclase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1905524	negative regulation of protein autoubiquitination	BP
1	1	3.31763856008	-	1.00e-01	GO:0003185	sinoatrial valve morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0060873	anterior semicircular canal development	BP
1	1	3.31763856008	-	1.00e-01	GO:0060872	semicircular canal development	BP
1	1	3.31763856008	-	1.00e-01	GO:0060875	lateral semicircular canal development	BP
1	1	3.31763856008	-	1.00e-01	GO:0035898	parathyroid hormone secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:0048621	post-embryonic digestive tract morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:1905643	positive regulation of DNA methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1905642	negative regulation of DNA methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0001806	type IV hypersensitivity	BP
1	1	3.31763856008	-	1.00e-01	GO:1904227	negative regulation of glycogen synthase activity, transferring glucose-1-phosphate	BP
1	1	3.31763856008	-	1.00e-01	GO:0070661	leukocyte proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0071206	establishment of protein localization to juxtaparanode region of axon	BP
1	1	3.31763856008	-	1.00e-01	GO:0060479	lung cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000740	negative regulation of mesenchymal stem cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0046521	sphingoid catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0045870	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
1	1	3.31763856008	-	1.00e-01	GO:0040034	regulation of development, heterochronic	BP
1	1	3.31763856008	-	1.00e-01	GO:1901978	positive regulation of cell cycle checkpoint	BP
1	1	3.31763856008	-	1.00e-01	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	3.31763856008	-	1.00e-01	GO:2000016	negative regulation of determination of dorsal identity	BP
1	1	3.31763856008	-	1.00e-01	GO:0070194	synaptonemal complex disassembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0035883	enteroendocrine cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060004	reflex	BP
1	1	3.31763856008	-	1.00e-01	GO:0051541	elastin metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0010464	regulation of mesenchymal cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0019101	female somatic sex determination	BP
1	1	3.31763856008	-	1.00e-01	GO:0019102	male somatic sex determination	BP
1	1	3.31763856008	-	1.00e-01	GO:2000227	negative regulation of pancreatic A cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1900117	regulation of execution phase of apoptosis	BP
1	1	3.31763856008	-	1.00e-01	GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	BP
1	1	3.31763856008	-	1.00e-01	GO:0002194	hepatocyte cell migration	BP
1	1	3.31763856008	-	1.00e-01	GO:0036337	Fas signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:2000050	regulation of non-canonical Wnt signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0060578	superior vena cava morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:1904800	negative regulation of neuron remodeling	BP
1	1	3.31763856008	-	1.00e-01	GO:0044648	histone H3-K4 dimethylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
1	1	3.31763856008	-	1.00e-01	GO:0016479	negative regulation of transcription from RNA polymerase I promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:1904639	cellular response to resveratrol	BP
1	1	3.31763856008	-	1.00e-01	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0060217	hemangioblast cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901297	positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0036306	embryonic heart tube elongation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901291	negative regulation of double-strand break repair via single-strand annealing	BP
1	1	3.31763856008	-	1.00e-01	GO:0090494	dopamine uptake	BP
1	1	3.31763856008	-	1.00e-01	GO:0051582	positive regulation of neurotransmitter uptake	BP
1	1	3.31763856008	-	1.00e-01	GO:0045624	positive regulation of T-helper cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1905689	positive regulation of diacylglycerol kinase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0038185	intracellular bile acid receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0035112	genitalia morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0098759	cellular response to interleukin-8	BP
1	1	3.31763856008	-	1.00e-01	GO:0090108	positive regulation of high-density lipoprotein particle assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0044111	development involved in symbiotic interaction	BP
1	1	3.31763856008	-	1.00e-01	GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0035967	cellular response to topologically incorrect protein	BP
1	1	3.31763856008	-	1.00e-01	GO:1904531	positive regulation of actin filament binding	BP
1	1	3.31763856008	-	1.00e-01	GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	3.31763856008	-	1.00e-01	GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	3.31763856008	-	1.00e-01	GO:0007403	glial cell fate determination	BP
1	1	3.31763856008	-	1.00e-01	GO:2000806	positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled	BP
1	1	3.31763856008	-	1.00e-01	GO:2000807	regulation of synaptic vesicle clustering	BP
1	1	3.31763856008	-	1.00e-01	GO:2000802	positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0030844	positive regulation of intermediate filament depolymerization	BP
1	1	3.31763856008	-	1.00e-01	GO:0021515	cell differentiation in spinal cord	BP
1	1	3.31763856008	-	1.00e-01	GO:0007371	ventral midline determination	BP
1	1	3.31763856008	-	1.00e-01	GO:2000639	negative regulation of SREBP signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:1905274	regulation of modification of postsynaptic actin cytoskeleton	BP
1	1	3.31763856008	-	1.00e-01	GO:0003213	cardiac right atrium morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1990654	sebum secreting cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	3.31763856008	-	1.00e-01	GO:0000415	negative regulation of histone H3-K36 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0000414	regulation of histone H3-K36 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0000416	positive regulation of histone H3-K36 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0072599	establishment of protein localization to endoplasmic reticulum	BP
1	1	3.31763856008	-	1.00e-01	GO:0050865	regulation of cell activation	BP
1	1	3.31763856008	-	1.00e-01	GO:0002154	thyroid hormone mediated signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0061445	endocardial cushion cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:1903010	regulation of bone development	BP
1	1	3.31763856008	-	1.00e-01	GO:0097090	presynaptic membrane organization	BP
1	1	3.31763856008	-	1.00e-01	GO:1903489	positive regulation of lactation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902283	negative regulation of primary amine oxidase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1901258	positive regulation of macrophage colony-stimulating factor production	BP
1	1	3.31763856008	-	1.00e-01	GO:0003168	Purkinje myocyte differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0052547	regulation of peptidase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0071440	regulation of histone H3-K14 acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0061767	negative regulation of lung blood pressure	BP
1	1	3.31763856008	-	1.00e-01	GO:0010990	regulation of SMAD protein complex assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0072363	regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0072366	regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.31763856008	-	1.00e-01	GO:0032831	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902988	neurofibrillary tangle assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0006711	estrogen catabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0098974	postsynaptic actin cytoskeleton organization	BP
1	1	3.31763856008	-	1.00e-01	GO:1904274	tricellular tight junction assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0035128	post-embryonic forelimb morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0045083	negative regulation of interleukin-12 biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0010034	response to acetate	BP
1	1	3.31763856008	-	1.00e-01	GO:0071873	response to norepinephrine	BP
1	1	3.31763856008	-	1.00e-01	GO:1901211	negative regulation of cardiac chamber formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0071250	cellular response to nitrite	BP
1	1	3.31763856008	-	1.00e-01	GO:0061358	negative regulation of Wnt protein secretion	BP
1	1	3.31763856008	-	1.00e-01	GO:1904685	positive regulation of metalloendopeptidase activity	BP
1	1	3.31763856008	-	1.00e-01	GO:1905305	negative regulation of cardiac myofibril assembly	BP
1	1	3.31763856008	-	1.00e-01	GO:1901534	positive regulation of hematopoietic progenitor cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0043049	otic placode formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0048370	lateral mesoderm formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0032298	positive regulation of DNA-dependent DNA replication initiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060844	arterial endothelial cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:0060843	venous endothelial cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0098930	axonal transport	BP
1	1	3.31763856008	-	1.00e-01	GO:0032350	regulation of hormone metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate	BP
1	1	3.31763856008	-	1.00e-01	GO:1905477	positive regulation of protein localization to membrane	BP
1	1	3.31763856008	-	1.00e-01	GO:0042703	menstruation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902870	negative regulation of amacrine cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:1902691	respiratory basal cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0003322	pancreatic A cell development	BP
1	1	3.31763856008	-	1.00e-01	GO:0060717	chorion development	BP
1	1	3.31763856008	-	1.00e-01	GO:1990869	cellular response to chemokine	BP
1	1	3.31763856008	-	1.00e-01	GO:0060806	negative regulation of cell differentiation involved in embryonic placenta development	BP
1	1	3.31763856008	-	1.00e-01	GO:0097198	histone H3-K36 trimethylation	BP
1	1	3.31763856008	-	1.00e-01	GO:0061040	female gonad morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0061046	regulation of branching involved in lung morphogenesis	BP
1	1	3.31763856008	-	1.00e-01	GO:0007538	primary sex determination	BP
1	1	3.31763856008	-	1.00e-01	GO:2000683	regulation of cellular response to X-ray	BP
1	1	3.31763856008	-	1.00e-01	GO:2000685	positive regulation of cellular response to X-ray	BP
1	1	3.31763856008	-	1.00e-01	GO:0070377	negative regulation of ERK5 cascade	BP
1	1	3.31763856008	-	1.00e-01	GO:0072285	mesenchymal to epithelial transition involved in metanephric renal vesicle formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0072286	metanephric connecting tubule development	BP
1	1	3.31763856008	-	1.00e-01	GO:0032048	cardiolipin metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0060014	granulosa cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0060010	Sertoli cell fate commitment	BP
1	1	3.31763856008	-	1.00e-01	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	3.31763856008	-	1.00e-01	GO:0021910	smoothened signaling pathway involved in ventral spinal cord patterning	BP
1	1	3.31763856008	-	1.00e-01	GO:0051570	regulation of histone H3-K9 methylation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901674	regulation of histone H3-K27 acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1901675	negative regulation of histone H3-K27 acetylation	BP
1	1	3.31763856008	-	1.00e-01	GO:1900100	positive regulation of plasma cell differentiation	BP
1	1	3.31763856008	-	1.00e-01	GO:0045799	positive regulation of chromatin assembly or disassembly	BP
1	1	3.31763856008	-	1.00e-01	GO:0060566	positive regulation of DNA-templated transcription, termination	BP
1	1	3.31763856008	-	1.00e-01	GO:0060699	regulation of endoribonuclease activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	3.31763856008	-	1.00e-01	GO:0060691	epithelial cell maturation involved in salivary gland development	BP
1	1	3.31763856008	-	1.00e-01	GO:1902751	positive regulation of cell cycle G2/M phase transition	BP
1	1	3.31763856008	-	1.00e-01	GO:0022018	lateral ganglionic eminence cell proliferation	BP
1	1	3.31763856008	-	1.00e-01	GO:0071529	cementum mineralization	BP
1	1	3.31763856008	-	1.00e-01	GO:1901475	pyruvate transmembrane transport	BP
1	1	3.31763856008	-	1.00e-01	GO:1903839	positive regulation of mRNA 3'-UTR binding	BP
1	1	3.31763856008	-	1.00e-01	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	3.31763856008	-	1.00e-01	GO:1901863	positive regulation of muscle tissue development	BP
1	1	3.31763856008	-	1.00e-01	GO:0021763	subthalamic nucleus development	BP
1	1	3.31763856008	-	1.00e-01	GO:0042501	serine phosphorylation of STAT protein	BP
1	1	3.31763856008	-	1.00e-01	GO:0033567	DNA replication, Okazaki fragment processing	BP
1	1	3.31763856008	-	1.00e-01	GO:0031129	inductive cell-cell signaling	BP
1	1	3.31763856008	-	1.00e-01	GO:0031128	developmental induction	BP
1	1	3.31763856008	-	1.00e-01	GO:0009444	pyruvate oxidation	BP
1	1	3.31763856008	-	1.00e-01	GO:2000607	negative regulation of cell proliferation involved in mesonephros development	BP
1	1	3.31763856008	-	1.00e-01	GO:0007388	posterior compartment specification	BP
1	1	3.31763856008	-	1.00e-01	GO:0007387	anterior compartment pattern formation	BP
1	1	3.31763856008	-	1.00e-01	GO:0061433	cellular response to caloric restriction	BP
1	1	3.31763856008	-	1.00e-01	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	3.31763856008	-	1.00e-01	GO:0045992	negative regulation of embryonic development	BP
1	1	3.31763856008	-	1.00e-01	GO:0045990	carbon catabolite regulation of transcription	BP
1	1	3.31763856008	-	1.00e-01	GO:1905224	clathrin-coated pit assembly	BP
7	7	3.31763856008	-	1.01e-07	GO:0004887	thyroid hormone receptor activity	MF
5	5	3.31763856008	-	1.01e-05	GO:0003708	retinoic acid receptor activity	MF
5	5	3.31763856008	-	1.01e-05	GO:0000975	regulatory region DNA binding	MF
5	5	3.31763856008	-	1.01e-05	GO:0051525	NFAT protein binding	MF
5	5	3.31763856008	-	1.01e-05	GO:0042799	histone methyltransferase activity (H4-K20 specific)	MF
4	4	3.31763856008	-	1.01e-04	GO:0009008	DNA-methyltransferase activity	MF
4	4	3.31763856008	-	1.01e-04	GO:0030375	thyroid hormone receptor coactivator activity	MF
3	3	3.31763856008	-	1.01e-03	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
3	3	3.31763856008	-	1.01e-03	GO:0070644	vitamin D response element binding	MF
3	3	3.31763856008	-	1.01e-03	GO:0061628	H3K27me3 modified histone binding	MF
3	3	3.31763856008	-	1.01e-03	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	MF
3	3	3.31763856008	-	1.01e-03	GO:0008384	IkappaB kinase activity	MF
3	3	3.31763856008	-	1.01e-03	GO:0003886	DNA (cytosine-5-)-methyltransferase activity	MF
3	3	3.31763856008	-	1.01e-03	GO:0004886	9-cis retinoic acid receptor activity	MF
3	3	3.31763856008	-	1.01e-03	GO:0031493	nucleosomal histone binding	MF
3	3	3.31763856008	-	1.01e-03	GO:0004699	calcium-independent protein kinase C activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0004912	interleukin-3 receptor activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0031701	angiotensin receptor binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0032810	sterol response element binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0010736	serum response element binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0004874	aryl hydrocarbon receptor activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0035403	histone kinase activity (H3-T6 specific)	MF
2	2	3.31763856008	-	1.01e-02	GO:0016890	site-specific endodeoxyribonuclease activity, specific for altered base	MF
2	2	3.31763856008	-	1.01e-02	GO:0034988	Fc-gamma receptor I complex binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0001071	nucleic acid binding transcription factor activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0045322	unmethylated CpG binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0042903	tubulin deacetylase activity	MF
2	2	3.31763856008	-	1.01e-02	GO:0050682	AF-2 domain binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0031762	follicle-stimulating hormone receptor binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0001025	RNA polymerase III transcription factor binding	MF
2	2	3.31763856008	-	1.01e-02	GO:0031691	alpha-1A adrenergic receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:1990450	linear polyubiquitin binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0050649	testosterone 6-beta-hydroxylase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0043924	suramin binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0005477	pyruvate secondary active transmembrane transporter activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0008545	JUN kinase kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0043035	chromatin insulator sequence binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0052725	inositol-1,3,4-trisphosphate 6-kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0000016	lactase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0004955	prostaglandin receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001010	transcription factor activity, sequence-specific DNA binding transcription factor recruiting	MF
1	1	3.31763856008	-	1.00e-01	GO:0035033	histone deacetylase regulator activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0035501	MH1 domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0035500	MH2 domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0043997	histone acetyltransferase activity (H4-K12 specific)	MF
1	1	3.31763856008	-	1.00e-01	GO:0008434	calcitriol receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0008116	prostaglandin-I synthase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0061629	RNA polymerase II sequence-specific DNA binding transcription factor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0036468	L-dopa decarboxylase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0035175	histone kinase activity (H3-S10 specific)	MF
1	1	3.31763856008	-	1.00e-01	GO:0038047	morphine receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001069	regulatory region RNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0070539	linoleic acid binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0001128	RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly	MF
1	1	3.31763856008	-	1.00e-01	GO:0031531	thyrotropin-releasing hormone receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0001165	RNA polymerase I upstream control element sequence-specific DNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	3.31763856008	-	1.00e-01	GO:0060175	brain-derived neurotrophic factor-activated receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	MF
1	1	3.31763856008	-	1.00e-01	GO:0044213	intronic transcription regulatory region DNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0030549	acetylcholine receptor activator activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0008267	poly-glutamine tract binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0097655	serpin family protein binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0071855	neuropeptide receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0033780	taurochenodeoxycholate 6alpha-hydroxylase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0000250	lanosterol synthase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0004058	aromatic-L-amino-acid decarboxylase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0030273	melanin-concentrating hormone receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0008445	D-aspartate oxidase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:1990188	euchromatin binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0050429	calcium-dependent phospholipase C activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0031859	platelet activating factor receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0046970	NAD-dependent histone deacetylase activity (H4-K16 specific)	MF
1	1	3.31763856008	-	1.00e-01	GO:0052726	inositol-1,3,4-trisphosphate 5-kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0030616	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0036139	peptidyl-histidine dioxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0003884	D-amino-acid oxidase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001133	RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0004876	complement component C3a receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0050591	quinine 3-monooxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0071820	N-box binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0031896	V2 vasopressin receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0004979	beta-endorphin receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:1990444	F-box domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0004729	oxygen-dependent protoporphyrinogen oxidase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0047638	albendazole monooxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001225	RNA polymerase II transcription coactivator binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0001226	RNA polymerase II transcription corepressor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0004883	glucocorticoid receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001034	RNA polymerase III transcription factor activity, sequence-specific DNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0001595	angiotensin receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0051427	hormone receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0034593	phosphatidylinositol bisphosphate phosphatase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0034040	lipid-transporting ATPase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0070975	FHA domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0070974	POU domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0047323	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0047325	inositol tetrakisphosphate 1-kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0086087	voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization	MF
1	1	3.31763856008	-	1.00e-01	GO:0086082	cell adhesive protein binding involved in AV node cell-bundle of His cell communication	MF
1	1	3.31763856008	-	1.00e-01	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0050683	AF-1 domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0001187	transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting	MF
1	1	3.31763856008	-	1.00e-01	GO:0052835	inositol-3,4,6-trisphosphate 1-kinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0052830	inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0052831	inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0038186	lithocholic acid receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0008829	dCTP deaminase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0004611	phosphoenolpyruvate carboxykinase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0005133	interferon-gamma receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0036140	peptidyl-asparagine 3-dioxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0102320	1,8-cineole 2-exo-monooxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0032093	SAM domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	3.31763856008	-	1.00e-01	GO:0002153	steroid receptor RNA activator RNA binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0036403	arachidonate 8(S)-lipoxygenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0004925	prolactin receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0035642	histone methyltransferase activity (H3-R17 specific)	MF
1	1	3.31763856008	-	1.00e-01	GO:0010855	adenylate cyclase inhibitor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0003908	methylated-DNA-[protein]-cysteine S-methyltransferase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0032448	DNA hairpin binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0035258	steroid hormone receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0071884	vitamin D receptor activator activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0098973	structural constituent of postsynaptic actin cytoskeleton	MF
1	1	3.31763856008	-	1.00e-01	GO:0050692	DBD domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0099530	G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential	MF
1	1	3.31763856008	-	1.00e-01	GO:0017168	5-oxoprolinase (ATP-hydrolyzing) activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0001642	group III metabotropic glutamate receptor activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0050104	L-gulonate 3-dehydrogenase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:1902121	lithocholic acid binding	MF
1	1	3.31763856008	-	1.00e-01	GO:1902122	chenodeoxycholic acid binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0035851	Krueppel-associated box domain binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0034039	8-oxo-7,8-dihydroguanine DNA N-glycosylase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0070615	nucleosome-dependent ATPase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:1990763	arrestin family protein binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0086090	voltage-gated potassium channel activity involved in SA node cell action potential repolarization	MF
1	1	3.31763856008	-	1.00e-01	GO:0097689	iron channel activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0052825	inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity	MF
1	1	3.31763856008	-	1.00e-01	GO:0005140	interleukin-9 receptor binding	MF
1	1	3.31763856008	-	1.00e-01	GO:0035594	ganglioside binding	MF
1	1	3.31763856008	-	1.00e-01	GO:1902098	calcitriol binding	MF
26	27	3.26319077606	-	3.04e-11	GO:0032200	telomere organization	BP
33	35	3.23274966249	-	7.92e-11	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
14	15	3.21810288653	-	8.54e-12	GO:0046965	retinoid X receptor binding	MF
9	10	3.16563546663	-	9.13e-09	GO:0000338	protein deneddylation	BP
35	39	3.16151935816	-	9.87e-11	GO:0030522	intracellular receptor signaling pathway	BP
32	37	3.10818519445	-	1.41e-11	GO:0000183	chromatin silencing at rDNA	BP
6	7	3.09524613874	-	6.45e-06	GO:0010870	positive regulation of receptor biosynthetic process	BP
6	7	3.09524613874	-	6.45e-06	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
27	32	3.07252606224	-	9.11e-12	GO:0006335	DNA replication-dependent nucleosome assembly	BP
15	18	3.05460415424	-	4.99e-12	GO:0045653	negative regulation of megakaryocyte differentiation	BP
5	6	3.05460415424	-	1.01e-05	GO:0010887	negative regulation of cholesterol storage	BP
5	6	3.05460415424	-	5.55e-05	GO:0099565	chemical synaptic transmission, postsynaptic	BP
5	6	3.05460415424	-	5.55e-05	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
5	6	3.05460415424	-	5.55e-05	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
5	6	3.05460415424	-	5.55e-05	GO:0010216	maintenance of DNA methylation	BP
5	6	3.05460415424	-	5.55e-05	GO:0060536	cartilage morphogenesis	BP
5	6	3.05460415424	-	5.55e-05	GO:0006333	chromatin assembly or disassembly	BP
5	6	3.05460415424	-	5.55e-05	GO:0051573	negative regulation of histone H3-K9 methylation	BP
44	53	3.04914972415	-	4.00e-11	GO:0003707	steroid hormone receptor activity	MF
21	26	3.00951626472	-	1.24e-11	GO:0006336	DNA replication-independent nucleosome assembly	BP
12	15	2.99571046519	-	3.38e-10	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
12	15	2.99571046519	-	3.38e-10	GO:0042809	vitamin D receptor binding	MF
8	10	2.99571046519	-	3.76e-07	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
4	5	2.99571046519	-	1.01e-04	GO:0060509	Type I pneumocyte differentiation	BP
4	5	2.99571046519	-	1.01e-04	GO:0043045	DNA methylation involved in embryo development	BP
4	5	2.99571046519	-	4.64e-04	GO:0051891	positive regulation of cardioblast differentiation	BP
4	5	2.99571046519	-	4.64e-04	GO:0036016	cellular response to interleukin-3	BP
4	5	2.99571046519	-	4.64e-04	GO:0003289	atrial septum primum morphogenesis	BP
4	5	2.99571046519	-	4.64e-04	GO:0070345	negative regulation of fat cell proliferation	BP
4	5	2.99571046519	-	4.64e-04	GO:0014031	mesenchymal cell development	BP
4	5	2.99571046519	-	4.64e-04	GO:0060430	lung saccule development	BP
4	5	2.99571046519	-	4.64e-04	GO:0043550	regulation of lipid kinase activity	BP
16	20	2.99571046519	-	9.29e-12	GO:0016922	ligand-dependent nuclear receptor binding	MF
8	10	2.99571046519	-	3.76e-07	GO:0033558	protein deacetylase activity	MF
8	10	2.99571046519	-	3.76e-07	GO:0042975	peroxisome proliferator activated receptor binding	MF
4	5	2.99571046519	-	1.01e-04	GO:0061665	SUMO ligase activity	MF
4	5	2.99571046519	-	4.64e-04	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
4	5	2.99571046519	-	4.64e-04	GO:0043426	MRF binding	MF
4	5	2.99571046519	-	4.64e-04	GO:0000988	transcription factor activity, protein binding	MF
26	33	2.97368415886	-	9.11e-12	GO:0001104	RNA polymerase II transcription cofactor activity	MF
18	23	2.96400160546	-	1.20e-11	GO:0043044	ATP-dependent chromatin remodeling	BP
42	54	2.95506848069	-	6.71e-11	GO:0043401	steroid hormone mediated signaling pathway	BP
7	9	2.95506848069	-	3.02e-06	GO:2000188	regulation of cholesterol homeostasis	BP
20	26	2.93912693682	-	1.24e-11	GO:0035035	histone acetyltransferase binding	MF
37	49	2.91238208159	-	4.00e-11	GO:0045814	negative regulation of gene expression, epigenetic	BP
12	16	2.9026010608	-	7.45e-11	GO:0048384	retinoic acid receptor signaling pathway	BP
9	12	2.9026010608	-	1.67e-07	GO:2000273	positive regulation of receptor activity	BP
6	8	2.9026010608	-	2.36e-05	GO:0042753	positive regulation of circadian rhythm	BP
3	4	2.9026010608	-	1.01e-03	GO:0031936	negative regulation of chromatin silencing	BP
3	4	2.9026010608	-	1.01e-03	GO:0048550	negative regulation of pinocytosis	BP
3	4	2.9026010608	-	1.01e-03	GO:0060486	Clara cell differentiation	BP
3	4	2.9026010608	-	1.01e-03	GO:0090309	positive regulation of methylation-dependent chromatin silencing	BP
3	4	2.9026010608	-	3.73e-03	GO:0090400	stress-induced premature senescence	BP
3	4	2.9026010608	-	3.73e-03	GO:0043201	response to leucine	BP
3	4	2.9026010608	-	3.73e-03	GO:0019919	peptidyl-arginine methylation, to asymmetrical-dimethyl arginine	BP
3	4	2.9026010608	-	3.73e-03	GO:0097300	programmed necrotic cell death	BP
3	4	2.9026010608	-	3.73e-03	GO:0051567	histone H3-K9 methylation	BP
3	4	2.9026010608	-	3.73e-03	GO:2001168	positive regulation of histone H2B ubiquitination	BP
3	4	2.9026010608	-	3.73e-03	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
3	4	2.9026010608	-	3.73e-03	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
3	4	2.9026010608	-	3.73e-03	GO:0010724	regulation of definitive erythrocyte differentiation	BP
3	4	2.9026010608	-	3.73e-03	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
3	4	2.9026010608	-	3.73e-03	GO:0033136	serine phosphorylation of STAT3 protein	BP
3	4	2.9026010608	-	3.73e-03	GO:0090170	regulation of Golgi inheritance	BP
3	4	2.9026010608	-	3.73e-03	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
3	4	2.9026010608	-	3.73e-03	GO:0006344	maintenance of chromatin silencing	BP
3	4	2.9026010608	-	3.73e-03	GO:0090240	positive regulation of histone H4 acetylation	BP
3	4	2.9026010608	-	3.73e-03	GO:0045064	T-helper 2 cell differentiation	BP
3	4	2.9026010608	-	3.73e-03	GO:0018216	peptidyl-arginine methylation	BP
3	4	2.9026010608	-	3.73e-03	GO:0051098	regulation of binding	BP
3	4	2.9026010608	-	3.73e-03	GO:0060574	intestinal epithelial cell maturation	BP
3	4	2.9026010608	-	3.73e-03	GO:0010957	negative regulation of vitamin D biosynthetic process	BP
3	4	2.9026010608	-	3.73e-03	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
3	4	2.9026010608	-	3.73e-03	GO:0034121	regulation of toll-like receptor signaling pathway	BP
3	4	2.9026010608	-	3.73e-03	GO:0033158	regulation of protein import into nucleus, translocation	BP
3	4	2.9026010608	-	3.73e-03	GO:0021861	forebrain radial glial cell differentiation	BP
3	4	2.9026010608	-	3.73e-03	GO:0060018	astrocyte fate commitment	BP
3	4	2.9026010608	-	3.73e-03	GO:0051572	negative regulation of histone H3-K4 methylation	BP
3	4	2.9026010608	-	3.73e-03	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
3	4	2.9026010608	-	3.73e-03	GO:0035910	ascending aorta morphogenesis	BP
3	4	2.9026010608	-	3.73e-03	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	BP
3	4	2.9026010608	-	3.73e-03	GO:0032909	regulation of transforming growth factor beta2 production	BP
9	12	2.9026010608	-	1.67e-07	GO:0042974	retinoic acid receptor binding	MF
9	12	2.9026010608	-	1.67e-07	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
3	4	2.9026010608	-	1.01e-03	GO:0044323	retinoic acid-responsive element binding	MF
3	4	2.9026010608	-	3.73e-03	GO:0035173	histone kinase activity	MF
3	4	2.9026010608	-	3.73e-03	GO:0034056	estrogen response element binding	MF
3	4	2.9026010608	-	3.73e-03	GO:0035242	protein-arginine omega-N asymmetric methyltransferase activity	MF
3	4	2.9026010608	-	3.73e-03	GO:0004971	AMPA glutamate receptor activity	MF
3	4	2.9026010608	-	3.73e-03	GO:0071535	RING-like zinc finger domain binding	MF
3	4	2.9026010608	-	3.73e-03	GO:0050693	LBD domain binding	MF
32	43	2.89137380538	-	1.11e-10	GO:1904837	beta-catenin-TCF complex assembly	BP
23	31	2.88700420575	-	2.53e-11	GO:0006352	DNA-templated transcription, initiation	BP
11	15	2.87017958311	-	2.72e-09	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
8	11	2.85820694144	-	3.76e-07	GO:0006476	protein deacetylation	BP
16	22	2.85820694144	-	8.41e-11	GO:0035257	nuclear hormone receptor binding	MF
8	11	2.85820694144	-	1.26e-06	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
13	18	2.84815327678	-	5.22e-10	GO:0006337	nucleosome disassembly	BP
10	14	2.83221173291	-	6.85e-08	GO:0043923	positive regulation by host of viral transcription	BP
5	7	2.83221173291	-	1.78e-04	GO:0071499	cellular response to laminar fluid shear stress	BP
12	17	2.81513821955	-	3.38e-10	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
7	10	2.80306538725	-	9.19e-06	GO:0031065	positive regulation of histone deacetylation	BP
43	62	2.78970700439	-	5.08e-11	GO:0045815	positive regulation of gene expression, epigenetic	BP
9	13	2.78712384338	-	1.67e-07	GO:0035326	enhancer binding	MF
13	19	2.77015076478	-	1.50e-09	GO:0051568	histone H3-K4 methylation	BP
28	41	2.76744147752	-	1.86e-11	GO:0030521	androgen receptor signaling pathway	BP
102	150	2.76124521155	-	6.65e-11	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
16	24	2.73267605936	-	3.26e-11	GO:0016233	telomere capping	BP
10	15	2.73267605936	-	1.87e-07	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
10	15	2.73267605936	-	1.87e-07	GO:0051571	positive regulation of histone H3-K4 methylation	BP
8	12	2.73267605936	-	3.44e-06	GO:0001829	trophectodermal cell differentiation	BP
6	9	2.73267605936	-	6.45e-06	GO:0003143	embryonic heart tube morphogenesis	BP
6	9	2.73267605936	-	2.36e-05	GO:0003208	cardiac ventricle morphogenesis	BP
6	9	2.73267605936	-	2.36e-05	GO:0030857	negative regulation of epithelial cell differentiation	BP
6	9	2.73267605936	-	6.48e-05	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
6	9	2.73267605936	-	6.48e-05	GO:0035067	negative regulation of histone acetylation	BP
4	6	2.73267605936	-	1.01e-04	GO:0009913	epidermal cell differentiation	BP
4	6	2.73267605936	-	4.64e-04	GO:0007098	centrosome cycle	BP
4	6	2.73267605936	-	4.64e-04	GO:0061469	regulation of type B pancreatic cell proliferation	BP
4	6	2.73267605936	-	1.28e-03	GO:0098532	histone H3-K27 trimethylation	BP
4	6	2.73267605936	-	1.28e-03	GO:0046321	positive regulation of fatty acid oxidation	BP
4	6	2.73267605936	-	1.28e-03	GO:2000288	positive regulation of myoblast proliferation	BP
4	6	2.73267605936	-	1.28e-03	GO:0003180	aortic valve morphogenesis	BP
4	6	2.73267605936	-	1.28e-03	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
4	6	2.73267605936	-	1.28e-03	GO:0003309	type B pancreatic cell differentiation	BP
4	6	2.73267605936	-	1.28e-03	GO:0035897	proteolysis in other organism	BP
4	6	2.73267605936	-	1.28e-03	GO:0071156	regulation of cell cycle arrest	BP
4	6	2.73267605936	-	1.28e-03	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
4	6	2.73267605936	-	1.28e-03	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
4	6	2.73267605936	-	1.28e-03	GO:0060440	trachea formation	BP
4	6	2.73267605936	-	1.28e-03	GO:0035065	regulation of histone acetylation	BP
2	3	2.73267605936	-	1.01e-02	GO:0021524	visceral motor neuron differentiation	BP
2	3	2.73267605936	-	1.01e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
2	3	2.73267605936	-	1.01e-02	GO:0003278	apoptotic process involved in heart morphogenesis	BP
2	3	2.73267605936	-	1.01e-02	GO:0055014	atrial cardiac muscle cell development	BP
2	3	2.73267605936	-	1.01e-02	GO:0010956	negative regulation of calcidiol 1-monooxygenase activity	BP
2	3	2.73267605936	-	1.01e-02	GO:0001547	antral ovarian follicle growth	BP
2	3	2.73267605936	-	1.01e-02	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
2	3	2.73267605936	-	1.01e-02	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
2	3	2.73267605936	-	1.01e-02	GO:2001032	regulation of double-strand break repair via nonhomologous end joining	BP
2	3	2.73267605936	-	1.01e-02	GO:0060947	cardiac vascular smooth muscle cell differentiation	BP
2	3	2.73267605936	-	1.01e-02	GO:0060164	regulation of timing of neuron differentiation	BP
2	3	2.73267605936	-	1.01e-02	GO:0061113	pancreas morphogenesis	BP
2	3	2.73267605936	-	1.01e-02	GO:0043585	nose morphogenesis	BP
2	3	2.73267605936	-	1.01e-02	GO:1900114	positive regulation of histone H3-K9 trimethylation	BP
2	3	2.73267605936	-	1.01e-02	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	2.73267605936	-	1.01e-02	GO:0003350	pulmonary myocardium development	BP
2	3	2.73267605936	-	1.01e-02	GO:2000381	negative regulation of mesoderm development	BP
2	3	2.73267605936	-	1.01e-02	GO:1901536	negative regulation of DNA demethylation	BP
2	3	2.73267605936	-	1.01e-02	GO:0071930	negative regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
2	3	2.73267605936	-	2.81e-02	GO:1902661	positive regulation of glucose mediated signaling pathway	BP
2	3	2.73267605936	-	2.81e-02	GO:0045652	regulation of megakaryocyte differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
2	3	2.73267605936	-	2.81e-02	GO:0006499	N-terminal protein myristoylation	BP
2	3	2.73267605936	-	2.81e-02	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0031937	positive regulation of chromatin silencing	BP
2	3	2.73267605936	-	2.81e-02	GO:0098904	regulation of AV node cell action potential	BP
2	3	2.73267605936	-	2.81e-02	GO:0098903	regulation of membrane repolarization during action potential	BP
2	3	2.73267605936	-	2.81e-02	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
2	3	2.73267605936	-	2.81e-02	GO:0061138	morphogenesis of a branching epithelium	BP
2	3	2.73267605936	-	2.81e-02	GO:0002669	positive regulation of T cell anergy	BP
2	3	2.73267605936	-	2.81e-02	GO:1905426	positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0033590	response to cobalamin	BP
2	3	2.73267605936	-	2.81e-02	GO:2000074	regulation of type B pancreatic cell development	BP
2	3	2.73267605936	-	2.81e-02	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
2	3	2.73267605936	-	2.81e-02	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
2	3	2.73267605936	-	2.81e-02	GO:0089700	protein kinase D signaling	BP
2	3	2.73267605936	-	2.81e-02	GO:0072574	hepatocyte proliferation	BP
2	3	2.73267605936	-	2.81e-02	GO:0000320	re-entry into mitotic cell cycle	BP
2	3	2.73267605936	-	2.81e-02	GO:1904798	positive regulation of core promoter binding	BP
2	3	2.73267605936	-	2.81e-02	GO:0021775	smoothened signaling pathway involved in ventral spinal cord interneuron specification	BP
2	3	2.73267605936	-	2.81e-02	GO:0021776	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	BP
2	3	2.73267605936	-	2.81e-02	GO:0071895	odontoblast differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0045608	negative regulation of auditory receptor cell differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:2000820	negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
2	3	2.73267605936	-	2.81e-02	GO:2000611	positive regulation of thyroid hormone generation	BP
2	3	2.73267605936	-	2.81e-02	GO:0032911	negative regulation of transforming growth factor beta1 production	BP
2	3	2.73267605936	-	2.81e-02	GO:0045061	thymic T cell selection	BP
2	3	2.73267605936	-	2.81e-02	GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis	BP
2	3	2.73267605936	-	2.81e-02	GO:0033273	response to vitamin	BP
2	3	2.73267605936	-	2.81e-02	GO:0045925	positive regulation of female receptivity	BP
2	3	2.73267605936	-	2.81e-02	GO:0090258	negative regulation of mitochondrial fission	BP
2	3	2.73267605936	-	2.81e-02	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
2	3	2.73267605936	-	2.81e-02	GO:0090043	regulation of tubulin deacetylation	BP
2	3	2.73267605936	-	2.81e-02	GO:0038161	prolactin signaling pathway	BP
2	3	2.73267605936	-	2.81e-02	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	BP
2	3	2.73267605936	-	2.81e-02	GO:0060379	cardiac muscle cell myoblast differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
2	3	2.73267605936	-	2.81e-02	GO:0044778	meiotic DNA integrity checkpoint	BP
2	3	2.73267605936	-	2.81e-02	GO:1901026	ripoptosome assembly involved in necroptotic process	BP
2	3	2.73267605936	-	2.81e-02	GO:0031063	regulation of histone deacetylation	BP
2	3	2.73267605936	-	2.81e-02	GO:0019218	regulation of steroid metabolic process	BP
2	3	2.73267605936	-	2.81e-02	GO:0060633	negative regulation of transcription initiation from RNA polymerase II promoter	BP
2	3	2.73267605936	-	2.81e-02	GO:0009912	auditory receptor cell fate commitment	BP
2	3	2.73267605936	-	2.81e-02	GO:0018394	peptidyl-lysine acetylation	BP
2	3	2.73267605936	-	2.81e-02	GO:0072092	ureteric bud invasion	BP
2	3	2.73267605936	-	2.81e-02	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	2.73267605936	-	2.81e-02	GO:0001922	B-1 B cell homeostasis	BP
2	3	2.73267605936	-	2.81e-02	GO:1901798	positive regulation of signal transduction by p53 class mediator	BP
2	3	2.73267605936	-	2.81e-02	GO:2000297	negative regulation of synapse maturation	BP
2	3	2.73267605936	-	2.81e-02	GO:1901797	negative regulation of signal transduction by p53 class mediator	BP
2	3	2.73267605936	-	2.81e-02	GO:0072014	proximal tubule development	BP
2	3	2.73267605936	-	2.81e-02	GO:0003199	endocardial cushion to mesenchymal transition involved in heart valve formation	BP
2	3	2.73267605936	-	2.81e-02	GO:0000189	MAPK import into nucleus	BP
2	3	2.73267605936	-	2.81e-02	GO:0060948	cardiac vascular smooth muscle cell development	BP
2	3	2.73267605936	-	2.81e-02	GO:0061309	cardiac neural crest cell development involved in outflow tract morphogenesis	BP
2	3	2.73267605936	-	2.81e-02	GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	3	2.73267605936	-	2.81e-02	GO:2000974	negative regulation of pro-B cell differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:1904468	negative regulation of tumor necrosis factor secretion	BP
2	3	2.73267605936	-	2.81e-02	GO:0048625	myoblast fate commitment	BP
2	3	2.73267605936	-	2.81e-02	GO:0016577	histone demethylation	BP
2	3	2.73267605936	-	2.81e-02	GO:2000466	negative regulation of glycogen (starch) synthase activity	BP
2	3	2.73267605936	-	2.81e-02	GO:0035054	embryonic heart tube anterior/posterior pattern specification	BP
2	3	2.73267605936	-	2.81e-02	GO:0035880	embryonic nail plate morphogenesis	BP
2	3	2.73267605936	-	2.81e-02	GO:0035886	vascular smooth muscle cell differentiation	BP
2	3	2.73267605936	-	2.81e-02	GO:0043504	mitochondrial DNA repair	BP
2	3	2.73267605936	-	2.81e-02	GO:2000195	negative regulation of female gonad development	BP
2	3	2.73267605936	-	2.81e-02	GO:0051097	negative regulation of helicase activity	BP
2	3	2.73267605936	-	2.81e-02	GO:0001555	oocyte growth	BP
2	3	2.73267605936	-	2.81e-02	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	BP
2	3	2.73267605936	-	2.81e-02	GO:0021553	olfactory nerve development	BP
2	3	2.73267605936	-	2.81e-02	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
2	3	2.73267605936	-	2.81e-02	GO:2000345	regulation of hepatocyte proliferation	BP
2	3	2.73267605936	-	2.81e-02	GO:2000116	regulation of cysteine-type endopeptidase activity	BP
2	3	2.73267605936	-	2.81e-02	GO:0002118	aggressive behavior	BP
2	3	2.73267605936	-	2.81e-02	GO:2001184	positive regulation of interleukin-12 secretion	BP
2	3	2.73267605936	-	2.81e-02	GO:2000630	positive regulation of miRNA metabolic process	BP
2	3	2.73267605936	-	2.81e-02	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
2	3	2.73267605936	-	2.81e-02	GO:0033152	immunoglobulin V(D)J recombination	BP
2	3	2.73267605936	-	2.81e-02	GO:0003166	bundle of His development	BP
2	3	2.73267605936	-	2.81e-02	GO:0002520	immune system development	BP
2	3	2.73267605936	-	2.81e-02	GO:0071871	response to epinephrine	BP
2	3	2.73267605936	-	2.81e-02	GO:0071409	cellular response to cycloheximide	BP
2	3	2.73267605936	-	2.81e-02	GO:0021697	cerebellar cortex formation	BP
2	3	2.73267605936	-	2.81e-02	GO:1900222	negative regulation of beta-amyloid clearance	BP
2	3	2.73267605936	-	2.81e-02	GO:0043987	histone H3-S10 phosphorylation	BP
2	3	2.73267605936	-	2.81e-02	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
2	3	2.73267605936	-	2.81e-02	GO:1904646	cellular response to beta-amyloid	BP
20	30	2.73267605936	-	1.12e-11	GO:0031492	nucleosomal DNA binding	MF
18	27	2.73267605936	-	3.04e-11	GO:0046966	thyroid hormone receptor binding	MF
4	6	2.73267605936	-	1.28e-03	GO:0001221	transcription cofactor binding	MF
2	3	2.73267605936	-	1.01e-02	GO:0030369	ICAM-3 receptor activity	MF
2	3	2.73267605936	-	1.01e-02	GO:0050473	arachidonate 15-lipoxygenase activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0050816	phosphothreonine binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0045309	protein phosphorylated amino acid binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0004705	JUN kinase activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0019166	trans-2-enoyl-CoA reductase (NADPH) activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0034979	NAD-dependent protein deacetylase activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0044729	hemi-methylated DNA-binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0035939	microsatellite binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0046976	histone methyltransferase activity (H3-K27 specific)	MF
2	3	2.73267605936	-	2.81e-02	GO:0097472	cyclin-dependent protein kinase activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0017136	NAD-dependent histone deacetylase activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0070095	fructose-6-phosphate binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0004882	androgen receptor activity	MF
2	3	2.73267605936	-	2.81e-02	GO:0043398	HLH domain binding	MF
2	3	2.73267605936	-	2.81e-02	GO:0031692	alpha-1B adrenergic receptor binding	MF
13	20	2.69615018333	-	1.50e-09	GO:0033613	activating transcription factor binding	MF
11	17	2.68960733747	-	6.95e-08	GO:0042800	histone methyltransferase activity (H3-K4 specific)	MF
7	11	2.6655618635	-	9.19e-06	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
7	11	2.6655618635	-	9.19e-06	GO:0006473	protein acetylation	BP
42	66	2.6655618635	-	7.83e-11	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
7	11	2.6655618635	-	2.31e-05	GO:0004707	MAP kinase activity	MF
7	11	2.6655618635	-	2.31e-05	GO:0035259	glucocorticoid receptor binding	MF
7	11	2.6655618635	-	2.31e-05	GO:0070411	I-SMAD binding	MF
12	19	2.65467354736	-	2.55e-08	GO:0070932	histone H3 deacetylation	BP
41	65	2.65282275167	-	2.06e-11	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
10	16	2.63956665497	-	4.54e-07	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
5	8	2.63956665497	-	1.78e-04	GO:0003139	secondary heart field specification	BP
5	8	2.63956665497	-	1.78e-04	GO:0030850	prostate gland development	BP
5	8	2.63956665497	-	1.78e-04	GO:0016584	nucleosome positioning	BP
5	8	2.63956665497	-	4.35e-04	GO:0018026	peptidyl-lysine monomethylation	BP
5	8	2.63956665497	-	4.35e-04	GO:0033598	mammary gland epithelial cell proliferation	BP
5	8	2.63956665497	-	4.35e-04	GO:0085020	protein K6-linked ubiquitination	BP
5	8	2.63956665497	-	4.35e-04	GO:2000020	positive regulation of male gonad development	BP
15	24	2.63956665497	-	5.30e-10	GO:0043425	bHLH transcription factor binding	MF
5	8	2.63956665497	-	4.35e-04	GO:0003680	AT DNA binding	MF
26	42	2.62576085544	-	9.87e-11	GO:0051290	protein heterotetramerization	BP
13	21	2.62576085544	-	3.89e-09	GO:0070412	R-SMAD binding	MF
8	13	2.61719884194	-	1.26e-06	GO:0051145	smooth muscle cell differentiation	BP
8	13	2.61719884194	-	1.26e-06	GO:0061029	eyelid development in camera-type eye	BP
8	13	2.61719884194	-	3.44e-06	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
8	13	2.61719884194	-	3.44e-06	GO:0004535	poly(A)-specific ribonuclease activity	MF
25	41	2.60394274523	-	3.44e-11	GO:0050681	androgen receptor binding	MF
14	23	2.60143152608	-	3.35e-09	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
26	43	2.59181352352	-	3.44e-11	GO:0001046	core promoter sequence-specific DNA binding	MF
12	20	2.58067296591	-	1.03e-08	GO:0030520	intracellular estrogen receptor signaling pathway	BP
6	10	2.58067296591	-	2.36e-05	GO:0048096	chromatin-mediated maintenance of transcription	BP
6	10	2.58067296591	-	6.48e-05	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
6	10	2.58067296591	-	1.48e-04	GO:0033235	positive regulation of protein sumoylation	BP
6	10	2.58067296591	-	1.48e-04	GO:2000773	negative regulation of cellular senescence	BP
3	5	2.58067296591	-	1.01e-03	GO:0003211	cardiac ventricle formation	BP
3	5	2.58067296591	-	3.73e-03	GO:0071557	histone H3-K27 demethylation	BP
3	5	2.58067296591	-	3.73e-03	GO:0072602	interleukin-4 secretion	BP
3	5	2.58067296591	-	3.73e-03	GO:1904628	cellular response to phorbol 13-acetate 12-myristate	BP
3	5	2.58067296591	-	3.73e-03	GO:0048752	semicircular canal morphogenesis	BP
3	5	2.58067296591	-	3.73e-03	GO:0003406	retinal pigment epithelium development	BP
3	5	2.58067296591	-	3.73e-03	GO:0086045	membrane depolarization during AV node cell action potential	BP
3	5	2.58067296591	-	8.62e-03	GO:0018027	peptidyl-lysine dimethylation	BP
3	5	2.58067296591	-	8.62e-03	GO:0002074	extraocular skeletal muscle development	BP
3	5	2.58067296591	-	8.62e-03	GO:0071599	otic vesicle development	BP
3	5	2.58067296591	-	8.62e-03	GO:1902749	regulation of cell cycle G2/M phase transition	BP
3	5	2.58067296591	-	8.62e-03	GO:0045063	T-helper 1 cell differentiation	BP
3	5	2.58067296591	-	8.62e-03	GO:0033132	negative regulation of glucokinase activity	BP
3	5	2.58067296591	-	8.62e-03	GO:0048143	astrocyte activation	BP
3	5	2.58067296591	-	8.62e-03	GO:0002634	regulation of germinal center formation	BP
3	5	2.58067296591	-	8.62e-03	GO:0030854	positive regulation of granulocyte differentiation	BP
3	5	2.58067296591	-	8.62e-03	GO:0072584	caveolin-mediated endocytosis	BP
3	5	2.58067296591	-	8.62e-03	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
3	5	2.58067296591	-	8.62e-03	GO:0035246	peptidyl-arginine N-methylation	BP
3	5	2.58067296591	-	8.62e-03	GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
3	5	2.58067296591	-	8.62e-03	GO:0010828	positive regulation of glucose transport	BP
3	5	2.58067296591	-	8.62e-03	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
3	5	2.58067296591	-	8.62e-03	GO:0043353	enucleate erythrocyte differentiation	BP
3	5	2.58067296591	-	8.62e-03	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	5	2.58067296591	-	8.62e-03	GO:0033153	T cell receptor V(D)J recombination	BP
3	5	2.58067296591	-	8.62e-03	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
21	35	2.58067296591	-	1.95e-11	GO:0001105	RNA polymerase II transcription coactivator activity	MF
9	15	2.58067296591	-	4.93e-07	GO:0019789	SUMO transferase activity	MF
9	15	2.58067296591	-	1.26e-06	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
9	15	2.58067296591	-	2.86e-06	GO:0004697	protein kinase C activity	MF
6	10	2.58067296591	-	1.48e-04	GO:0070016	armadillo repeat domain binding	MF
3	5	2.58067296591	-	3.73e-03	GO:0071558	histone demethylase activity (H3-K27 specific)	MF
3	5	2.58067296591	-	8.62e-03	GO:0030284	estrogen receptor activity	MF
3	5	2.58067296591	-	8.62e-03	GO:0010385	double-stranded methylated DNA binding	MF
3	5	2.58067296591	-	8.62e-03	GO:0004532	exoribonuclease activity	MF
3	5	2.58067296591	-	8.62e-03	GO:0048273	mitogen-activated protein kinase p38 binding	MF
3	5	2.58067296591	-	8.62e-03	GO:0005231	excitatory extracellular ligand-gated ion channel activity	MF
16	27	2.56275105791	-	1.93e-10	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
13	22	2.55864665958	-	2.06e-08	GO:0006306	DNA methylation	BP
13	22	2.55864665958	-	1.50e-09	GO:1990841	promoter-specific chromatin binding	MF
10	17	2.55210381372	-	1.87e-07	GO:0021542	dentate gyrus development	BP
10	17	2.55210381372	-	4.54e-07	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
7	12	2.54003098141	-	2.31e-05	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
7	12	2.54003098141	-	2.31e-05	GO:0003215	cardiac right ventricle morphogenesis	BP
7	12	2.54003098141	-	5.06e-05	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
29	50	2.53176336543	-	6.70e-11	GO:0001085	RNA polymerase II transcription factor binding	MF
22	38	2.52914266527	-	1.41e-11	GO:0001102	RNA polymerase II activating transcription factor binding	MF
11	19	2.52914266527	-	9.28e-09	GO:0001158	enhancer sequence-specific DNA binding	MF
59	102	2.52785626747	-	6.04e-11	GO:0042826	histone deacetylase binding	MF
23	40	2.51927242125	-	2.78e-11	GO:0018024	histone-lysine N-methyltransferase activity	MF
12	21	2.51028363802	-	1.23e-07	GO:0051403	stress-activated MAPK cascade	BP
8	14	2.51028363802	-	3.44e-06	GO:0010832	negative regulation of myotube differentiation	BP
4	7	2.51028363802	-	4.64e-04	GO:0060740	prostate gland epithelium morphogenesis	BP
4	7	2.51028363802	-	4.64e-04	GO:0036302	atrioventricular canal development	BP
4	7	2.51028363802	-	1.28e-03	GO:0071455	cellular response to hyperoxia	BP
4	7	2.51028363802	-	1.28e-03	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
4	7	2.51028363802	-	1.28e-03	GO:0034983	peptidyl-lysine deacetylation	BP
4	7	2.51028363802	-	1.28e-03	GO:0051574	positive regulation of histone H3-K9 methylation	BP
4	7	2.51028363802	-	2.75e-03	GO:2000641	regulation of early endosome to late endosome transport	BP
4	7	2.51028363802	-	2.75e-03	GO:0007221	positive regulation of transcription of Notch receptor target	BP
4	7	2.51028363802	-	2.75e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
4	7	2.51028363802	-	2.75e-03	GO:0016458	gene silencing	BP
4	7	2.51028363802	-	2.75e-03	GO:0034351	negative regulation of glial cell apoptotic process	BP
4	7	2.51028363802	-	2.75e-03	GO:1900364	negative regulation of mRNA polyadenylation	BP
4	7	2.51028363802	-	2.75e-03	GO:0060290	transdifferentiation	BP
4	7	2.51028363802	-	2.75e-03	GO:0044321	response to leptin	BP
4	7	2.51028363802	-	2.75e-03	GO:0043983	histone H4-K12 acetylation	BP
28	49	2.51028363802	-	6.70e-11	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
20	35	2.51028363802	-	7.92e-11	GO:0070888	E-box binding	MF
8	14	2.51028363802	-	3.44e-06	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
4	7	2.51028363802	-	1.28e-03	GO:0001222	transcription corepressor binding	MF
34	60	2.49821080572	-	3.64e-11	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
22	39	2.49166795985	-	2.78e-11	GO:0030331	estrogen receptor binding	MF
9	16	2.48756356152	-	2.86e-06	GO:0035162	embryonic hemopoiesis	BP
9	16	2.48756356152	-	5.95e-06	GO:0003203	endocardial cushion morphogenesis	BP
18	32	2.48756356152	-	1.13e-10	GO:0070491	repressing transcription factor binding	MF
32	57	2.48474854591	-	2.36e-11	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
33	59	2.47938963007	-	5.79e-11	GO:0001047	core promoter binding	MF
10	18	2.46964165352	-	1.00e-06	GO:0001892	embryonic placenta development	BP
10	18	2.46964165352	-	1.00e-06	GO:0035066	positive regulation of histone acetylation	BP
5	9	2.46964165352	-	1.78e-04	GO:0061072	iris morphogenesis	BP
5	9	2.46964165352	-	4.35e-04	GO:0048660	regulation of smooth muscle cell proliferation	BP
5	9	2.46964165352	-	8.98e-04	GO:0016572	histone phosphorylation	BP
5	9	2.46964165352	-	8.98e-04	GO:0070933	histone H4 deacetylation	BP
5	9	2.46964165352	-	8.98e-04	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
135	243	2.46964165352	-	7.56e-11	GO:0003713	transcription coactivator activity	MF
5	9	2.46964165352	-	4.35e-04	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
5	9	2.46964165352	-	8.98e-04	GO:0016274	protein-arginine N-methyltransferase activity	MF
154	278	2.46548402805	-	7.43e-11	GO:0008134	transcription factor binding	MF
26	47	2.46348942654	-	6.24e-11	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
32	58	2.45965756495	-	3.91e-11	GO:0031490	chromatin DNA binding	MF
6	11	2.44316944216	-	1.48e-04	GO:2000036	regulation of stem cell population maintenance	BP
6	11	2.44316944216	-	2.98e-04	GO:0010390	histone monoubiquitination	BP
6	11	2.44316944216	-	2.98e-04	GO:0060544	regulation of necroptotic process	BP
6	11	2.44316944216	-	1.48e-04	GO:0016407	acetyltransferase activity	MF
6	11	2.44316944216	-	2.98e-04	GO:0070410	co-SMAD binding	MF
13	24	2.4331157775	-	8.52e-08	GO:0043388	positive regulation of DNA binding	BP
20	37	2.43011328934	-	2.78e-11	GO:0004407	histone deacetylase activity	MF
7	13	2.42455376399	-	5.06e-05	GO:0060413	atrial septum morphogenesis	BP
7	13	2.42455376399	-	5.06e-05	GO:0044030	regulation of DNA methylation	BP
29	54	2.42073205304	-	6.71e-11	GO:0006325	chromatin organization	BP
22	41	2.4195181741	-	2.78e-11	GO:0004402	histone acetyltransferase activity	MF
15	28	2.41717423363	-	1.03e-08	GO:0051059	NF-kappaB binding	MF
8	15	2.41074796447	-	3.39e-05	GO:0051123	RNA polymerase II transcriptional preinitiation complex assembly	BP
8	15	2.41074796447	-	3.39e-05	GO:0070742	C2H2 zinc finger domain binding	MF
9	17	2.40010072027	-	2.86e-06	GO:0071375	cellular response to peptide hormone stimulus	BP
9	17	2.40010072027	-	5.95e-06	GO:0016571	histone methylation	BP
54	102	2.40010072027	-	1.08e-10	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
22	42	2.38475275594	-	6.24e-11	GO:0034080	CENP-A containing nucleosome assembly	BP
11	21	2.38475275594	-	1.35e-06	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
12	23	2.37903910474	-	2.46e-07	GO:0045648	positive regulation of erythrocyte differentiation	BP
13	25	2.37422208844	-	9.27e-09	GO:0016573	histone acetylation	BP
30	59	2.34188610632	-	5.79e-11	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
41	81	2.33534056181	-	2.34e-11	GO:0006338	chromatin remodeling	BP
11	22	2.31763856008	-	7.09e-07	GO:0046329	negative regulation of JNK cascade	BP
7	14	2.31763856008	-	5.06e-05	GO:0060065	uterus development	BP
7	14	2.31763856008	-	1.00e-04	GO:0040029	regulation of gene expression, epigenetic	BP
7	14	2.31763856008	-	1.00e-04	GO:0042692	muscle cell differentiation	BP
6	12	2.31763856008	-	2.98e-04	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
6	12	2.31763856008	-	5.46e-04	GO:0043149	stress fiber assembly	BP
6	12	2.31763856008	-	5.46e-04	GO:0060644	mammary gland epithelial cell differentiation	BP
3	6	2.31763856008	-	3.73e-03	GO:0010694	positive regulation of alkaline phosphatase activity	BP
3	6	2.31763856008	-	3.73e-03	GO:0021930	cerebellar granule cell precursor proliferation	BP
3	6	2.31763856008	-	8.62e-03	GO:0038092	nodal signaling pathway	BP
3	6	2.31763856008	-	8.62e-03	GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
3	6	2.31763856008	-	8.62e-03	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
3	6	2.31763856008	-	8.62e-03	GO:0032792	negative regulation of CREB transcription factor activity	BP
3	6	2.31763856008	-	8.62e-03	GO:0032808	lacrimal gland development	BP
3	6	2.31763856008	-	8.62e-03	GO:0051150	regulation of smooth muscle cell differentiation	BP
3	6	2.31763856008	-	1.60e-02	GO:0051271	negative regulation of cellular component movement	BP
3	6	2.31763856008	-	1.60e-02	GO:0046632	alpha-beta T cell differentiation	BP
3	6	2.31763856008	-	1.60e-02	GO:0051101	regulation of DNA binding	BP
3	6	2.31763856008	-	1.60e-02	GO:0014033	neural crest cell differentiation	BP
3	6	2.31763856008	-	1.60e-02	GO:0001711	endodermal cell fate commitment	BP
3	6	2.31763856008	-	1.60e-02	GO:0061154	endothelial tube morphogenesis	BP
3	6	2.31763856008	-	1.60e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
3	6	2.31763856008	-	1.60e-02	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
3	6	2.31763856008	-	1.60e-02	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
3	6	2.31763856008	-	1.60e-02	GO:0048668	collateral sprouting	BP
3	6	2.31763856008	-	1.60e-02	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
3	6	2.31763856008	-	1.60e-02	GO:0010742	macrophage derived foam cell differentiation	BP
3	6	2.31763856008	-	1.60e-02	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
3	6	2.31763856008	-	1.60e-02	GO:2000675	negative regulation of type B pancreatic cell apoptotic process	BP
3	6	2.31763856008	-	1.60e-02	GO:0061312	BMP signaling pathway involved in heart development	BP
3	6	2.31763856008	-	1.60e-02	GO:0051346	negative regulation of hydrolase activity	BP
3	6	2.31763856008	-	1.60e-02	GO:0060789	hair follicle placode formation	BP
62	124	2.31763856008	-	8.95e-11	GO:0042393	histone binding	MF
9	18	2.31763856008	-	1.15e-05	GO:0070577	lysine-acetylated histone binding	MF
6	12	2.31763856008	-	5.46e-04	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
6	12	2.31763856008	-	5.46e-04	GO:0000989	transcription factor activity, transcription factor binding	MF
3	6	2.31763856008	-	1.60e-02	GO:0019870	potassium channel inhibitor activity	MF
3	6	2.31763856008	-	1.60e-02	GO:0008469	histone-arginine N-methyltransferase activity	MF
16	32	2.31763856008	-	1.22e-08	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
10	20	2.31763856008	-	7.18e-06	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
8	16	2.31763856008	-	6.18e-05	GO:0035994	response to muscle stretch	BP
5	10	2.31763856008	-	1.78e-04	GO:0048935	peripheral nervous system neuron development	BP
5	10	2.31763856008	-	4.35e-04	GO:0060411	cardiac septum morphogenesis	BP
5	10	2.31763856008	-	8.98e-04	GO:0003181	atrioventricular valve morphogenesis	BP
5	10	2.31763856008	-	8.98e-04	GO:0048596	embryonic camera-type eye morphogenesis	BP
4	8	2.31763856008	-	1.28e-03	GO:0048646	anatomical structure formation involved in morphogenesis	BP
5	10	2.31763856008	-	1.65e-03	GO:0031571	mitotic G1 DNA damage checkpoint	BP
5	10	2.31763856008	-	1.65e-03	GO:0042416	dopamine biosynthetic process	BP
5	10	2.31763856008	-	1.65e-03	GO:0051775	response to redox state	BP
4	8	2.31763856008	-	2.75e-03	GO:0060020	Bergmann glial cell differentiation	BP
4	8	2.31763856008	-	2.75e-03	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
4	8	2.31763856008	-	2.75e-03	GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
4	8	2.31763856008	-	2.75e-03	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
4	8	2.31763856008	-	2.75e-03	GO:1903351	cellular response to dopamine	BP
4	8	2.31763856008	-	2.75e-03	GO:0007183	SMAD protein complex assembly	BP
4	8	2.31763856008	-	5.06e-03	GO:0033523	histone H2B ubiquitination	BP
4	8	2.31763856008	-	5.06e-03	GO:0071550	death-inducing signaling complex assembly	BP
4	8	2.31763856008	-	5.06e-03	GO:0051569	regulation of histone H3-K4 methylation	BP
4	8	2.31763856008	-	5.06e-03	GO:0002467	germinal center formation	BP
4	8	2.31763856008	-	5.06e-03	GO:0003300	cardiac muscle hypertrophy	BP
4	8	2.31763856008	-	5.06e-03	GO:1900119	positive regulation of execution phase of apoptosis	BP
4	8	2.31763856008	-	5.06e-03	GO:2000774	positive regulation of cellular senescence	BP
2	4	2.31763856008	-	1.01e-02	GO:0090403	oxidative stress-induced premature senescence	BP
2	4	2.31763856008	-	1.01e-02	GO:0042481	regulation of odontogenesis	BP
2	4	2.31763856008	-	1.01e-02	GO:0050994	regulation of lipid catabolic process	BP
2	4	2.31763856008	-	2.81e-02	GO:0048368	lateral mesoderm development	BP
2	4	2.31763856008	-	2.81e-02	GO:1902806	regulation of cell cycle G1/S phase transition	BP
2	4	2.31763856008	-	2.81e-02	GO:0070384	Harderian gland development	BP
2	4	2.31763856008	-	2.81e-02	GO:1904179	positive regulation of adipose tissue development	BP
2	4	2.31763856008	-	2.81e-02	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	2.31763856008	-	2.81e-02	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	2.31763856008	-	2.81e-02	GO:0070858	negative regulation of bile acid biosynthetic process	BP
2	4	2.31763856008	-	2.81e-02	GO:0045607	regulation of auditory receptor cell differentiation	BP
2	4	2.31763856008	-	2.81e-02	GO:0031113	regulation of microtubule polymerization	BP
2	4	2.31763856008	-	2.81e-02	GO:2000653	regulation of genetic imprinting	BP
2	4	2.31763856008	-	2.81e-02	GO:0034103	regulation of tissue remodeling	BP
2	4	2.31763856008	-	2.81e-02	GO:0007290	spermatid nucleus elongation	BP
2	4	2.31763856008	-	2.81e-02	GO:0071466	cellular response to xenobiotic stimulus	BP
2	4	2.31763856008	-	2.81e-02	GO:0072221	metanephric distal convoluted tubule development	BP
2	4	2.31763856008	-	2.81e-02	GO:0031064	negative regulation of histone deacetylation	BP
2	4	2.31763856008	-	2.81e-02	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
2	4	2.31763856008	-	2.81e-02	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
2	4	2.31763856008	-	2.81e-02	GO:0021782	glial cell development	BP
2	4	2.31763856008	-	2.81e-02	GO:0032348	negative regulation of aldosterone biosynthetic process	BP
2	4	2.31763856008	-	2.81e-02	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	2.31763856008	-	2.81e-02	GO:0021559	trigeminal nerve development	BP
2	4	2.31763856008	-	2.81e-02	GO:0003257	positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	4	2.31763856008	-	2.81e-02	GO:0060971	embryonic heart tube left/right pattern formation	BP
2	4	2.31763856008	-	2.81e-02	GO:2000065	negative regulation of cortisol biosynthetic process	BP
2	4	2.31763856008	-	2.81e-02	GO:0021953	central nervous system neuron differentiation	BP
2	4	2.31763856008	-	5.26e-02	GO:0071359	cellular response to dsRNA	BP
2	4	2.31763856008	-	5.26e-02	GO:0031508	pericentric heterochromatin assembly	BP
2	4	2.31763856008	-	5.26e-02	GO:0003170	heart valve development	BP
2	4	2.31763856008	-	5.26e-02	GO:0071459	protein localization to chromosome, centromeric region	BP
2	4	2.31763856008	-	5.26e-02	GO:0046545	development of primary female sexual characteristics	BP
2	4	2.31763856008	-	5.26e-02	GO:0032369	negative regulation of lipid transport	BP
2	4	2.31763856008	-	5.26e-02	GO:0060669	embryonic placenta morphogenesis	BP
2	4	2.31763856008	-	5.26e-02	GO:1901203	positive regulation of extracellular matrix assembly	BP
2	4	2.31763856008	-	5.26e-02	GO:0010883	regulation of lipid storage	BP
2	4	2.31763856008	-	5.26e-02	GO:0071922	regulation of cohesin loading	BP
2	4	2.31763856008	-	5.26e-02	GO:0014044	Schwann cell development	BP
2	4	2.31763856008	-	5.26e-02	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	2.31763856008	-	5.26e-02	GO:0042345	regulation of NF-kappaB import into nucleus	BP
2	4	2.31763856008	-	5.26e-02	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
2	4	2.31763856008	-	5.26e-02	GO:0060235	lens induction in camera-type eye	BP
2	4	2.31763856008	-	5.26e-02	GO:0060708	spongiotrophoblast differentiation	BP
2	4	2.31763856008	-	5.26e-02	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
2	4	2.31763856008	-	5.26e-02	GO:0002328	pro-B cell differentiation	BP
2	4	2.31763856008	-	5.26e-02	GO:0002326	B cell lineage commitment	BP
2	4	2.31763856008	-	5.26e-02	GO:0019086	late viral transcription	BP
2	4	2.31763856008	-	5.26e-02	GO:0007258	JUN phosphorylation	BP
2	4	2.31763856008	-	5.26e-02	GO:0050847	progesterone receptor signaling pathway	BP
2	4	2.31763856008	-	5.26e-02	GO:0007296	vitellogenesis	BP
2	4	2.31763856008	-	5.26e-02	GO:0042063	gliogenesis	BP
2	4	2.31763856008	-	5.26e-02	GO:0070734	histone H3-K27 methylation	BP
2	4	2.31763856008	-	5.26e-02	GO:0031670	cellular response to nutrient	BP
2	4	2.31763856008	-	5.26e-02	GO:0032376	positive regulation of cholesterol transport	BP
2	4	2.31763856008	-	5.26e-02	GO:0009750	response to fructose	BP
2	4	2.31763856008	-	5.26e-02	GO:0030035	microspike assembly	BP
2	4	2.31763856008	-	5.26e-02	GO:0060033	anatomical structure regression	BP
2	4	2.31763856008	-	5.26e-02	GO:0018393	internal peptidyl-lysine acetylation	BP
2	4	2.31763856008	-	5.26e-02	GO:0030910	olfactory placode formation	BP
2	4	2.31763856008	-	5.26e-02	GO:1990182	exosomal secretion	BP
2	4	2.31763856008	-	5.26e-02	GO:0070849	response to epidermal growth factor	BP
2	4	2.31763856008	-	5.26e-02	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
2	4	2.31763856008	-	5.26e-02	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
2	4	2.31763856008	-	5.26e-02	GO:0032925	regulation of activin receptor signaling pathway	BP
2	4	2.31763856008	-	5.26e-02	GO:0006642	triglyceride mobilization	BP
2	4	2.31763856008	-	5.26e-02	GO:0010735	positive regulation of transcription via serum response element binding	BP
2	4	2.31763856008	-	5.26e-02	GO:2000664	positive regulation of interleukin-5 secretion	BP
2	4	2.31763856008	-	5.26e-02	GO:0060364	frontal suture morphogenesis	BP
2	4	2.31763856008	-	5.26e-02	GO:0010822	positive regulation of mitochondrion organization	BP
2	4	2.31763856008	-	5.26e-02	GO:0031077	post-embryonic camera-type eye development	BP
2	4	2.31763856008	-	5.26e-02	GO:0002051	osteoblast fate commitment	BP
2	4	2.31763856008	-	5.26e-02	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
2	4	2.31763856008	-	5.26e-02	GO:0010463	mesenchymal cell proliferation	BP
2	4	2.31763856008	-	5.26e-02	GO:0070836	caveola assembly	BP
2	4	2.31763856008	-	5.26e-02	GO:0021943	formation of radial glial scaffolds	BP
2	4	2.31763856008	-	5.26e-02	GO:0033686	positive regulation of luteinizing hormone secretion	BP
2	4	2.31763856008	-	5.26e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
2	4	2.31763856008	-	5.26e-02	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	2.31763856008	-	5.26e-02	GO:0050798	activated T cell proliferation	BP
2	4	2.31763856008	-	5.26e-02	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
2	4	2.31763856008	-	5.26e-02	GO:0007100	mitotic centrosome separation	BP
2	4	2.31763856008	-	5.26e-02	GO:1903936	cellular response to sodium arsenite	BP
2	4	2.31763856008	-	5.26e-02	GO:0014904	myotube cell development	BP
2	4	2.31763856008	-	5.26e-02	GO:0060842	arterial endothelial cell differentiation	BP
2	4	2.31763856008	-	5.26e-02	GO:0071218	cellular response to misfolded protein	BP
2	4	2.31763856008	-	5.26e-02	GO:0048679	regulation of axon regeneration	BP
2	4	2.31763856008	-	5.26e-02	GO:0010626	negative regulation of Schwann cell proliferation	BP
2	4	2.31763856008	-	5.26e-02	GO:0072289	metanephric nephron tubule formation	BP
2	4	2.31763856008	-	5.26e-02	GO:1902714	negative regulation of interferon-gamma secretion	BP
2	4	2.31763856008	-	5.26e-02	GO:2000189	positive regulation of cholesterol homeostasis	BP
2	4	2.31763856008	-	5.26e-02	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
1	2	2.31763856008	-	1.00e-01	GO:0097152	mesenchymal cell apoptotic process	BP
1	2	2.31763856008	-	1.00e-01	GO:0072079	nephron tubule formation	BP
1	2	2.31763856008	-	1.00e-01	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	2.31763856008	-	1.00e-01	GO:0070171	negative regulation of tooth mineralization	BP
1	2	2.31763856008	-	1.00e-01	GO:0032823	regulation of natural killer cell differentiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	2.31763856008	-	1.00e-01	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	2.31763856008	-	1.00e-01	GO:0033594	response to hydroxyisoflavone	BP
1	2	2.31763856008	-	1.00e-01	GO:0009786	regulation of asymmetric cell division	BP
1	2	2.31763856008	-	1.00e-01	GO:1903860	negative regulation of dendrite extension	BP
1	2	2.31763856008	-	1.00e-01	GO:1900135	positive regulation of renin secretion into blood stream	BP
1	2	2.31763856008	-	1.00e-01	GO:1901857	positive regulation of cellular respiration	BP
1	2	2.31763856008	-	1.00e-01	GO:0021882	regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment	BP
1	2	2.31763856008	-	1.00e-01	GO:0003415	chondrocyte hypertrophy	BP
1	2	2.31763856008	-	1.00e-01	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	BP
1	2	2.31763856008	-	1.00e-01	GO:1900425	negative regulation of defense response to bacterium	BP
1	2	2.31763856008	-	1.00e-01	GO:0048520	positive regulation of behavior	BP
1	2	2.31763856008	-	1.00e-01	GO:0099558	maintenance of synapse structure	BP
1	2	2.31763856008	-	1.00e-01	GO:0072190	ureter urothelium development	BP
1	2	2.31763856008	-	1.00e-01	GO:0035574	histone H4-K20 demethylation	BP
1	2	2.31763856008	-	1.00e-01	GO:0051136	regulation of NK T cell differentiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0060465	pharynx development	BP
1	2	2.31763856008	-	1.00e-01	GO:0060460	left lung morphogenesis	BP
1	2	2.31763856008	-	1.00e-01	GO:0007423	sensory organ development	BP
1	2	2.31763856008	-	1.00e-01	GO:0060738	epithelial-mesenchymal signaling involved in prostate gland development	BP
1	2	2.31763856008	-	1.00e-01	GO:0071393	cellular response to progesterone stimulus	BP
1	2	2.31763856008	-	1.00e-01	GO:0060900	embryonic camera-type eye formation	BP
1	2	2.31763856008	-	1.00e-01	GO:0010730	negative regulation of hydrogen peroxide biosynthetic process	BP
1	2	2.31763856008	-	1.00e-01	GO:0002684	positive regulation of immune system process	BP
1	2	2.31763856008	-	1.00e-01	GO:0007493	endodermal cell fate determination	BP
1	2	2.31763856008	-	1.00e-01	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	2.31763856008	-	1.00e-01	GO:0021623	oculomotor nerve formation	BP
1	2	2.31763856008	-	1.00e-01	GO:0009063	cellular amino acid catabolic process	BP
1	2	2.31763856008	-	1.00e-01	GO:0021985	neurohypophysis development	BP
1	2	2.31763856008	-	1.00e-01	GO:0042942	D-serine transport	BP
1	2	2.31763856008	-	1.00e-01	GO:0033082	regulation of extrathymic T cell differentiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0097536	thymus epithelium morphogenesis	BP
1	2	2.31763856008	-	1.00e-01	GO:1901979	regulation of inward rectifier potassium channel activity	BP
1	2	2.31763856008	-	1.00e-01	GO:0030222	eosinophil differentiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0072554	blood vessel lumenization	BP
1	2	2.31763856008	-	1.00e-01	GO:1900111	positive regulation of histone H3-K9 dimethylation	BP
1	2	2.31763856008	-	1.00e-01	GO:0001554	luteolysis	BP
1	2	2.31763856008	-	1.00e-01	GO:0014835	myoblast differentiation involved in skeletal muscle regeneration	BP
1	2	2.31763856008	-	1.00e-01	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	2.31763856008	-	1.00e-01	GO:0021557	oculomotor nerve development	BP
1	2	2.31763856008	-	1.00e-01	GO:0021558	trochlear nerve development	BP
1	2	2.31763856008	-	1.00e-01	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	2.31763856008	-	1.00e-01	GO:1903053	regulation of extracellular matrix organization	BP
1	2	2.31763856008	-	1.00e-01	GO:0030641	regulation of cellular pH	BP
1	2	2.31763856008	-	1.00e-01	GO:0042595	behavioral response to starvation	BP
1	2	2.31763856008	-	1.00e-01	GO:0090187	positive regulation of pancreatic juice secretion	BP
1	2	2.31763856008	-	1.00e-01	GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway	BP
1	2	2.31763856008	-	1.00e-01	GO:0033092	positive regulation of immature T cell proliferation in thymus	BP
1	2	2.31763856008	-	1.00e-01	GO:1902871	positive regulation of amacrine cell differentiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0090657	telomeric loop disassembly	BP
1	2	2.31763856008	-	1.00e-01	GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	2	2.31763856008	-	1.00e-01	GO:0090362	positive regulation of platelet-derived growth factor production	BP
1	2	2.31763856008	-	1.00e-01	GO:0072560	type B pancreatic cell maturation	BP
1	2	2.31763856008	-	1.00e-01	GO:0009405	pathogenesis	BP
1	2	2.31763856008	-	1.00e-01	GO:0097681	double-strand break repair via alternative nonhomologous end joining	BP
1	2	2.31763856008	-	1.00e-01	GO:0021893	cerebral cortex GABAergic interneuron fate commitment	BP
1	2	2.31763856008	-	1.00e-01	GO:2000143	negative regulation of DNA-templated transcription, initiation	BP
1	2	2.31763856008	-	1.00e-01	GO:0002017	regulation of blood volume by renal aldosterone	BP
1	2	2.31763856008	-	1.00e-01	GO:0003241	growth involved in heart morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:1904528	positive regulation of microtubule binding	BP
1	2	2.31763856008	-	1.91e-01	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0071109	superior temporal gyrus development	BP
1	2	2.31763856008	-	1.91e-01	GO:2000818	negative regulation of myoblast proliferation	BP
1	2	2.31763856008	-	1.91e-01	GO:0097154	GABAergic neuron differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:1902257	negative regulation of apoptotic process involved in outflow tract morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	2	2.31763856008	-	1.91e-01	GO:2000628	regulation of miRNA metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0001776	leukocyte homeostasis	BP
1	2	2.31763856008	-	1.91e-01	GO:0071140	resolution of mitotic recombination intermediates	BP
1	2	2.31763856008	-	1.91e-01	GO:1903003	positive regulation of protein deubiquitination	BP
1	2	2.31763856008	-	1.91e-01	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0042264	peptidyl-aspartic acid hydroxylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0021855	hypothalamus cell migration	BP
1	2	2.31763856008	-	1.91e-01	GO:0099566	regulation of postsynaptic cytosolic calcium ion concentration	BP
1	2	2.31763856008	-	1.91e-01	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0071453	cellular response to oxygen levels	BP
1	2	2.31763856008	-	1.91e-01	GO:0048320	axial mesoderm formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0043241	protein complex disassembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0098907	regulation of SA node cell action potential	BP
1	2	2.31763856008	-	1.91e-01	GO:0032368	regulation of lipid transport	BP
1	2	2.31763856008	-	1.91e-01	GO:0010565	regulation of cellular ketone metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0071657	positive regulation of granulocyte colony-stimulating factor production	BP
1	2	2.31763856008	-	1.91e-01	GO:0034402	recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex	BP
1	2	2.31763856008	-	1.91e-01	GO:1901201	regulation of extracellular matrix assembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0071417	cellular response to organonitrogen compound	BP
1	2	2.31763856008	-	1.91e-01	GO:0071929	alpha-tubulin acetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0021681	cerebellar granular layer development	BP
1	2	2.31763856008	-	1.91e-01	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0097026	dendritic cell dendrite assembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0002032	desensitization of G-protein coupled receptor protein signaling pathway by arrestin	BP
1	2	2.31763856008	-	1.91e-01	GO:0051445	regulation of meiotic cell cycle	BP
1	2	2.31763856008	-	1.91e-01	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0060025	regulation of synaptic activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0061034	olfactory bulb mitral cell layer development	BP
1	2	2.31763856008	-	1.91e-01	GO:0061032	visceral serous pericardium development	BP
1	2	2.31763856008	-	1.91e-01	GO:1902530	positive regulation of protein linear polyubiquitination	BP
1	2	2.31763856008	-	1.91e-01	GO:0036353	histone H2A-K119 monoubiquitination	BP
1	2	2.31763856008	-	1.91e-01	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0065001	specification of axis polarity	BP
1	2	2.31763856008	-	1.91e-01	GO:0048259	regulation of receptor-mediated endocytosis	BP
1	2	2.31763856008	-	1.91e-01	GO:0043335	protein unfolding	BP
1	2	2.31763856008	-	1.91e-01	GO:0043331	response to dsRNA	BP
1	2	2.31763856008	-	1.91e-01	GO:0010260	animal organ senescence	BP
1	2	2.31763856008	-	1.91e-01	GO:0050432	catecholamine secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:1900275	negative regulation of phospholipase C activity	BP
1	2	2.31763856008	-	1.91e-01	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0048210	Golgi vesicle fusion to target membrane	BP
1	2	2.31763856008	-	1.91e-01	GO:1902746	regulation of lens fiber cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0090169	regulation of spindle assembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0032957	inositol trisphosphate metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0010767	regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	2	2.31763856008	-	1.91e-01	GO:0010157	response to chlorate	BP
1	2	2.31763856008	-	1.91e-01	GO:0036294	cellular response to decreased oxygen levels	BP
1	2	2.31763856008	-	1.91e-01	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	2.31763856008	-	1.91e-01	GO:0046642	negative regulation of alpha-beta T cell proliferation	BP
1	2	2.31763856008	-	1.91e-01	GO:0007638	mechanosensory behavior	BP
1	2	2.31763856008	-	1.91e-01	GO:2001162	positive regulation of histone H3-K79 methylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0034970	histone H3-R2 methylation	BP
1	2	2.31763856008	-	1.91e-01	GO:2000615	regulation of histone H3-K9 acetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0021571	rhombomere 5 development	BP
1	2	2.31763856008	-	1.91e-01	GO:0072160	nephron tubule epithelial cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0071306	cellular response to vitamin E	BP
1	2	2.31763856008	-	1.91e-01	GO:0051650	establishment of vesicle localization	BP
1	2	2.31763856008	-	1.91e-01	GO:0006116	NADH oxidation	BP
1	2	2.31763856008	-	1.91e-01	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	2.31763856008	-	1.91e-01	GO:0032912	negative regulation of transforming growth factor beta2 production	BP
1	2	2.31763856008	-	1.91e-01	GO:0070178	D-serine metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0070535	histone H2A K63-linked ubiquitination	BP
1	2	2.31763856008	-	1.91e-01	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0000294	nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay	BP
1	2	2.31763856008	-	1.91e-01	GO:2000320	negative regulation of T-helper 17 cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0010727	negative regulation of hydrogen peroxide metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0003188	heart valve formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0034395	regulation of transcription from RNA polymerase II promoter in response to iron	BP
1	2	2.31763856008	-	1.91e-01	GO:0032425	positive regulation of mismatch repair	BP
1	2	2.31763856008	-	1.91e-01	GO:0045645	positive regulation of eosinophil differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0010934	macrophage cytokine production	BP
1	2	2.31763856008	-	1.91e-01	GO:0048069	eye pigmentation	BP
1	2	2.31763856008	-	1.91e-01	GO:0072053	renal inner medulla development	BP
1	2	2.31763856008	-	1.91e-01	GO:0072054	renal outer medulla development	BP
1	2	2.31763856008	-	1.91e-01	GO:0086067	AV node cell to bundle of His cell communication	BP
1	2	2.31763856008	-	1.91e-01	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	2.31763856008	-	1.91e-01	GO:0035470	positive regulation of vascular wound healing	BP
1	2	2.31763856008	-	1.91e-01	GO:0045023	G0 to G1 transition	BP
1	2	2.31763856008	-	1.91e-01	GO:0046831	regulation of RNA export from nucleus	BP
1	2	2.31763856008	-	1.91e-01	GO:0046833	positive regulation of RNA export from nucleus	BP
1	2	2.31763856008	-	1.91e-01	GO:0035669	TRAM-dependent toll-like receptor 4 signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	2.31763856008	-	1.91e-01	GO:0010874	regulation of cholesterol efflux	BP
1	2	2.31763856008	-	1.91e-01	GO:1905366	negative regulation of intralumenal vesicle formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0045684	positive regulation of epidermis development	BP
1	2	2.31763856008	-	1.91e-01	GO:0030821	negative regulation of cAMP catabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:1904908	negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric	BP
1	2	2.31763856008	-	1.91e-01	GO:0090045	positive regulation of deacetylase activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0019046	release from viral latency	BP
1	2	2.31763856008	-	1.91e-01	GO:0019049	evasion or tolerance of host defenses by virus	BP
1	2	2.31763856008	-	1.91e-01	GO:1900078	positive regulation of cellular response to insulin stimulus	BP
1	2	2.31763856008	-	1.91e-01	GO:1903038	negative regulation of leukocyte cell-cell adhesion	BP
1	2	2.31763856008	-	1.91e-01	GO:0007057	spindle assembly involved in female meiosis I	BP
1	2	2.31763856008	-	1.91e-01	GO:0051284	positive regulation of sequestering of calcium ion	BP
1	2	2.31763856008	-	1.91e-01	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0072197	ureter morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0044869	negative regulation by host of viral exo-alpha-sialidase activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0044860	protein localization to plasma membrane raft	BP
1	2	2.31763856008	-	1.91e-01	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	2.31763856008	-	1.91e-01	GO:0006542	glutamine biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0031061	negative regulation of histone methylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0035026	leading edge cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:1904049	negative regulation of spontaneous neurotransmitter secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
1	2	2.31763856008	-	1.91e-01	GO:0038043	interleukin-5-mediated signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0086100	endothelin receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0031635	adenylate cyclase-inhibiting opioid receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0039535	regulation of RIG-I signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0007518	myoblast fate determination	BP
1	2	2.31763856008	-	1.91e-01	GO:0003062	regulation of heart rate by chemical signal	BP
1	2	2.31763856008	-	1.91e-01	GO:0061188	negative regulation of chromatin silencing at rDNA	BP
1	2	2.31763856008	-	1.91e-01	GO:0060632	regulation of microtubule-based movement	BP
1	2	2.31763856008	-	1.91e-01	GO:0002638	negative regulation of immunoglobulin production	BP
1	2	2.31763856008	-	1.91e-01	GO:0060032	notochord regression	BP
1	2	2.31763856008	-	1.91e-01	GO:1903382	negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0072738	cellular response to diamide	BP
1	2	2.31763856008	-	1.91e-01	GO:0060545	positive regulation of necroptotic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0003342	proepicardium development	BP
1	2	2.31763856008	-	1.91e-01	GO:0060988	lipid tube assembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0098815	modulation of excitatory postsynaptic potential	BP
1	2	2.31763856008	-	1.91e-01	GO:0031444	slow-twitch skeletal muscle fiber contraction	BP
1	2	2.31763856008	-	1.91e-01	GO:2001288	positive regulation of caveolin-mediated endocytosis	BP
1	2	2.31763856008	-	1.91e-01	GO:1904879	positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	2	2.31763856008	-	1.91e-01	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:1902952	positive regulation of dendritic spine maintenance	BP
1	2	2.31763856008	-	1.91e-01	GO:0022037	metencephalon development	BP
1	2	2.31763856008	-	1.91e-01	GO:0014806	smooth muscle hyperplasia	BP
1	2	2.31763856008	-	1.91e-01	GO:0071506	cellular response to mycophenolic acid	BP
1	2	2.31763856008	-	1.91e-01	GO:0032615	interleukin-12 production	BP
1	2	2.31763856008	-	1.91e-01	GO:0055025	positive regulation of cardiac muscle tissue development	BP
1	2	2.31763856008	-	1.91e-01	GO:0051252	regulation of RNA metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0003404	optic vesicle morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0048710	regulation of astrocyte differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0001712	ectodermal cell fate commitment	BP
1	2	2.31763856008	-	1.91e-01	GO:2000291	regulation of myoblast proliferation	BP
1	2	2.31763856008	-	1.91e-01	GO:0002296	T-helper 1 cell lineage commitment	BP
1	2	2.31763856008	-	1.91e-01	GO:2000627	positive regulation of miRNA catabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0052314	phytoalexin metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0035441	cell migration involved in vasculogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:1902275	regulation of chromatin organization	BP
1	2	2.31763856008	-	1.91e-01	GO:0007206	phospholipase C-activating G-protein coupled glutamate receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0035633	maintenance of permeability of blood-brain barrier	BP
1	2	2.31763856008	-	1.91e-01	GO:0003195	tricuspid valve formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0003193	pulmonary valve formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	2.31763856008	-	1.91e-01	GO:2001202	negative regulation of transforming growth factor-beta secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:2000663	negative regulation of interleukin-5 secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:2000666	negative regulation of interleukin-13 secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0001172	transcription, RNA-templated	BP
1	2	2.31763856008	-	1.91e-01	GO:0035407	histone H3-T11 phosphorylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0061153	trachea gland development	BP
1	2	2.31763856008	-	1.91e-01	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0021873	forebrain neuroblast division	BP
1	2	2.31763856008	-	1.91e-01	GO:0003156	regulation of animal organ formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0044324	regulation of transcription involved in anterior/posterior axis specification	BP
1	2	2.31763856008	-	1.91e-01	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0051702	interaction with symbiont	BP
1	2	2.31763856008	-	1.91e-01	GO:1902036	regulation of hematopoietic stem cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0038179	neurotrophin signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
1	2	2.31763856008	-	1.91e-01	GO:2000978	negative regulation of forebrain neuron differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0060435	bronchiole development	BP
1	2	2.31763856008	-	1.91e-01	GO:0060434	bronchus morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0002643	regulation of tolerance induction	BP
1	2	2.31763856008	-	1.91e-01	GO:0071478	cellular response to radiation	BP
1	2	2.31763856008	-	1.91e-01	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0035802	adrenal cortex formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0033363	secretory granule organization	BP
1	2	2.31763856008	-	1.91e-01	GO:0044871	negative regulation by host of viral glycoprotein metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0021986	habenula development	BP
1	2	2.31763856008	-	1.91e-01	GO:1990051	activation of protein kinase C activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0060297	regulation of sarcomere organization	BP
1	2	2.31763856008	-	1.91e-01	GO:0045872	positive regulation of rhodopsin gene expression	BP
1	2	2.31763856008	-	1.91e-01	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	2.31763856008	-	1.91e-01	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	2.31763856008	-	1.91e-01	GO:0072318	clathrin coat disassembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0097531	mast cell migration	BP
1	2	2.31763856008	-	1.91e-01	GO:0040030	regulation of molecular function, epigenetic	BP
1	2	2.31763856008	-	1.91e-01	GO:0070427	nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	2.31763856008	-	1.91e-01	GO:0060086	circadian temperature homeostasis	BP
1	2	2.31763856008	-	1.91e-01	GO:1903849	positive regulation of aorta morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0035051	cardiocyte differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0031990	mRNA export from nucleus in response to heat stress	BP
1	2	2.31763856008	-	1.91e-01	GO:0043503	skeletal muscle fiber adaptation	BP
1	2	2.31763856008	-	1.91e-01	GO:0061833	protein localization to tricellular tight junction	BP
1	2	2.31763856008	-	1.91e-01	GO:0045161	neuronal ion channel clustering	BP
1	2	2.31763856008	-	1.91e-01	GO:2000191	regulation of fatty acid transport	BP
1	2	2.31763856008	-	1.91e-01	GO:0019100	male germ-line sex determination	BP
1	2	2.31763856008	-	1.91e-01	GO:1900110	negative regulation of histone H3-K9 dimethylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0060760	positive regulation of response to cytokine stimulus	BP
1	2	2.31763856008	-	1.91e-01	GO:0060764	cell-cell signaling involved in mammary gland development	BP
1	2	2.31763856008	-	1.91e-01	GO:0050716	positive regulation of interleukin-1 secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0021599	abducens nerve formation	BP
1	2	2.31763856008	-	1.91e-01	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
1	2	2.31763856008	-	1.91e-01	GO:1902722	positive regulation of prolactin secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0090149	mitochondrial membrane fission	BP
1	2	2.31763856008	-	1.91e-01	GO:0044154	histone H3-K14 acetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0035922	foramen ovale closure	BP
1	2	2.31763856008	-	1.91e-01	GO:0035926	chemokine (C-C motif) ligand 2 secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0043311	positive regulation of eosinophil degranulation	BP
1	2	2.31763856008	-	1.91e-01	GO:0001189	RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript	BP
1	2	2.31763856008	-	1.91e-01	GO:0097324	melanocyte migration	BP
1	2	2.31763856008	-	1.91e-01	GO:0032227	negative regulation of synaptic transmission, dopaminergic	BP
1	2	2.31763856008	-	1.91e-01	GO:0031134	sister chromatid biorientation	BP
1	2	2.31763856008	-	1.91e-01	GO:0034243	regulation of transcription elongation from RNA polymerase II promoter	BP
1	2	2.31763856008	-	1.91e-01	GO:0090107	regulation of high-density lipoprotein particle assembly	BP
1	2	2.31763856008	-	1.91e-01	GO:0032972	regulation of muscle filament sliding speed	BP
1	2	2.31763856008	-	1.91e-01	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	2.31763856008	-	1.91e-01	GO:0035397	helper T cell enhancement of adaptive immune response	BP
1	2	2.31763856008	-	1.91e-01	GO:0061647	histone H3-K9 modification	BP
1	2	2.31763856008	-	1.91e-01	GO:0086097	phospholipase C-activating angiotensin-activated signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0051012	microtubule sliding	BP
1	2	2.31763856008	-	1.91e-01	GO:0071322	cellular response to carbohydrate stimulus	BP
1	2	2.31763856008	-	1.91e-01	GO:1903056	regulation of melanosome organization	BP
1	2	2.31763856008	-	1.91e-01	GO:0051598	meiotic recombination checkpoint	BP
1	2	2.31763856008	-	1.91e-01	GO:0034728	nucleosome organization	BP
1	2	2.31763856008	-	1.91e-01	GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	BP
1	2	2.31763856008	-	1.91e-01	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	2.31763856008	-	1.91e-01	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	2.31763856008	-	1.91e-01	GO:2001023	regulation of response to drug	BP
1	2	2.31763856008	-	1.91e-01	GO:0034124	regulation of MyD88-dependent toll-like receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:2000845	positive regulation of testosterone secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0043970	histone H3-K9 acetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0046456	icosanoid biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:1903016	negative regulation of exo-alpha-sialidase activity	BP
1	2	2.31763856008	-	1.91e-01	GO:1903019	negative regulation of glycoprotein metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0033484	nitric oxide homeostasis	BP
1	2	2.31763856008	-	1.91e-01	GO:1990619	histone H3-K9 deacetylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0035411	catenin import into nucleus	BP
1	2	2.31763856008	-	1.91e-01	GO:0061162	establishment of monopolar cell polarity	BP
1	2	2.31763856008	-	1.91e-01	GO:0060979	vasculogenesis involved in coronary vascular morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0070124	mitochondrial translational initiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0003169	coronary vein morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0031943	regulation of glucocorticoid metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	2.31763856008	-	1.91e-01	GO:0048332	mesoderm morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
1	2	2.31763856008	-	1.91e-01	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	2.31763856008	-	1.91e-01	GO:0010559	regulation of glycoprotein biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development	BP
1	2	2.31763856008	-	1.91e-01	GO:0045082	positive regulation of interleukin-10 biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0018205	peptidyl-lysine modification	BP
1	2	2.31763856008	-	1.91e-01	GO:0032764	negative regulation of mast cell cytokine production	BP
1	2	2.31763856008	-	1.91e-01	GO:0071879	positive regulation of adrenergic receptor signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0014015	positive regulation of gliogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0014908	myotube differentiation involved in skeletal muscle regeneration	BP
1	2	2.31763856008	-	1.91e-01	GO:2000777	positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia	BP
1	2	2.31763856008	-	1.91e-01	GO:1901532	regulation of hematopoietic progenitor cell differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0039003	pronephric field specification	BP
1	2	2.31763856008	-	1.91e-01	GO:0006286	base-excision repair, base-free sugar-phosphate removal	BP
1	2	2.31763856008	-	1.91e-01	GO:0006285	base-excision repair, AP site formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0048638	regulation of developmental growth	BP
1	2	2.31763856008	-	1.91e-01	GO:0021691	cerebellar Purkinje cell layer maturation	BP
1	2	2.31763856008	-	1.91e-01	GO:0048822	enucleate erythrocyte development	BP
1	2	2.31763856008	-	1.91e-01	GO:0043368	positive T cell selection	BP
1	2	2.31763856008	-	1.91e-01	GO:0060443	mammary gland morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0003329	pancreatic PP cell fate commitment	BP
1	2	2.31763856008	-	1.91e-01	GO:0003326	pancreatic A cell fate commitment	BP
1	2	2.31763856008	-	1.91e-01	GO:2000276	negative regulation of oxidative phosphorylation uncoupler activity	BP
1	2	2.31763856008	-	1.91e-01	GO:2000278	regulation of DNA biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0051531	NFAT protein import into nucleus	BP
1	2	2.31763856008	-	1.91e-01	GO:0035511	oxidative DNA demethylation	BP
1	2	2.31763856008	-	1.91e-01	GO:0050725	positive regulation of interleukin-1 beta biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0036344	platelet morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0070375	ERK5 cascade	BP
1	2	2.31763856008	-	1.91e-01	GO:0002790	peptide secretion	BP
1	2	2.31763856008	-	1.91e-01	GO:0097050	type B pancreatic cell apoptotic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0010899	regulation of phosphatidylcholine catabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0072134	nephrogenic mesenchyme morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	BP
1	2	2.31763856008	-	1.91e-01	GO:0046331	lateral inhibition	BP
1	2	2.31763856008	-	1.91e-01	GO:2000182	regulation of progesterone biosynthetic process	BP
1	2	2.31763856008	-	1.91e-01	GO:1904338	regulation of dopaminergic neuron differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0036304	umbilical cord morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0003006	developmental process involved in reproduction	BP
1	2	2.31763856008	-	1.91e-01	GO:0060560	developmental growth involved in morphogenesis	BP
1	2	2.31763856008	-	1.91e-01	GO:0070828	heterochromatin organization	BP
1	2	2.31763856008	-	1.91e-01	GO:1902750	negative regulation of cell cycle G2/M phase transition	BP
1	2	2.31763856008	-	1.91e-01	GO:0072179	nephric duct formation	BP
1	2	2.31763856008	-	1.91e-01	GO:0021894	cerebral cortex GABAergic interneuron development	BP
1	2	2.31763856008	-	1.91e-01	GO:0021892	cerebral cortex GABAergic interneuron differentiation	BP
1	2	2.31763856008	-	1.91e-01	GO:0003420	regulation of growth plate cartilage chondrocyte proliferation	BP
1	2	2.31763856008	-	1.91e-01	GO:0039692	single stranded viral RNA replication via double stranded DNA intermediate	BP
1	2	2.31763856008	-	1.91e-01	GO:0033561	regulation of water loss via skin	BP
1	2	2.31763856008	-	1.91e-01	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	2.31763856008	-	1.91e-01	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	BP
1	2	2.31763856008	-	1.91e-01	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	2.31763856008	-	1.91e-01	GO:0006163	purine nucleotide metabolic process	BP
1	2	2.31763856008	-	1.91e-01	GO:0072033	renal vesicle formation	BP
4	8	2.31763856008	-	4.64e-04	GO:0019213	deacetylase activity	MF
5	10	2.31763856008	-	8.98e-04	GO:0032454	histone demethylase activity (H3-K9 specific)	MF
4	8	2.31763856008	-	5.06e-03	GO:0001164	RNA polymerase I CORE element sequence-specific DNA binding	MF
4	8	2.31763856008	-	5.06e-03	GO:0030235	nitric-oxide synthase regulator activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0016361	activin receptor activity, type I	MF
2	4	2.31763856008	-	5.26e-02	GO:0031014	troponin T binding	MF
2	4	2.31763856008	-	5.26e-02	GO:0004677	DNA-dependent protein kinase activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0030546	receptor activator activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0008349	MAP kinase kinase kinase kinase activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0034191	apolipoprotein A-I receptor binding	MF
2	4	2.31763856008	-	5.26e-02	GO:0008853	exodeoxyribonuclease III activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0043125	ErbB-3 class receptor binding	MF
2	4	2.31763856008	-	5.26e-02	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
2	4	2.31763856008	-	5.26e-02	GO:0004698	calcium-dependent protein kinase C activity	MF
2	4	2.31763856008	-	5.26e-02	GO:0017162	aryl hydrocarbon receptor binding	MF
2	4	2.31763856008	-	5.26e-02	GO:0044020	histone methyltransferase activity (H4-R3 specific)	MF
1	2	2.31763856008	-	1.00e-01	GO:0017050	D-erythro-sphingosine kinase activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0034188	apolipoprotein A-I receptor activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0035575	histone demethylase activity (H4-K20 specific)	MF
1	2	2.31763856008	-	1.00e-01	GO:0008481	sphinganine kinase activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0030343	vitamin D3 25-hydroxylase activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0090556	phosphatidylserine-translocating ATPase activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0038181	bile acid receptor activity	MF
1	2	2.31763856008	-	1.00e-01	GO:0016151	nickel cation binding	MF
1	2	2.31763856008	-	1.00e-01	GO:0046811	histone deacetylase inhibitor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0004666	prostaglandin-endoperoxide synthase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0086059	voltage-gated calcium channel activity involved SA node cell action potential	MF
1	2	2.31763856008	-	1.91e-01	GO:0019912	cyclin-dependent protein kinase activating kinase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0033142	progesterone receptor binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0001632	leukotriene B4 receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0016165	linoleate 13S-lipoxygenase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0035034	histone acetyltransferase regulator activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0008311	double-stranded DNA 3'-5' exodeoxyribonuclease activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0036505	prosaposin receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0019828	aspartic-type endopeptidase inhibitor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0098770	FBXO family protein binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0008534	oxidized purine nucleobase lesion DNA N-glycosylase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0032422	purine-rich negative regulatory element binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0047710	bis(5'-adenosyl)-triphosphatase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0070576	vitamin D 24-hydroxylase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0003968	RNA-directed 5'-3' RNA polymerase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0008263	pyrimidine-specific mismatch base pair DNA N-glycosylase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0004906	interferon-gamma receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0008670	2,4-dienoyl-CoA reductase (NADPH) activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0003845	11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity	MF
1	2	2.31763856008	-	1.91e-01	GO:1990269	RNA polymerase II C-terminal domain phosphoserine binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0008309	double-stranded DNA exodeoxyribonuclease activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005055	laminin receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0004914	interleukin-5 receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0033549	MAP kinase phosphatase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0030617	transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005128	erythropoietin receptor binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0042610	CD8 receptor binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0035402	histone kinase activity (H3-T11 specific)	MF
1	2	2.31763856008	-	1.91e-01	GO:0005330	dopamine:sodium symporter activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0061752	telomeric repeat-containing RNA binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0072354	histone kinase activity (H3-T3 specific)	MF
1	2	2.31763856008	-	1.91e-01	GO:0004723	calcium-dependent protein serine/threonine phosphatase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0000995	transcription factor activity, core RNA polymerase III binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0008170	N-methyltransferase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0099583	neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration	MF
1	2	2.31763856008	-	1.91e-01	GO:0004105	choline-phosphate cytidylyltransferase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005174	CD40 receptor binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	2.31763856008	-	1.91e-01	GO:0004613	phosphoenolpyruvate carboxykinase (GTP) activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0017002	activin-activated receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005135	interleukin-3 receptor binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0017042	glycosylceramidase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0001147	transcription termination site sequence-specific DNA binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0004692	cGMP-dependent protein kinase activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0017129	triglyceride binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0004962	endothelin receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0070080	titin Z domain binding	MF
1	2	2.31763856008	-	1.91e-01	GO:0001640	adenylate cyclase inhibiting G-protein coupled glutamate receptor activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0008160	protein tyrosine phosphatase activator activity	MF
1	2	2.31763856008	-	1.91e-01	GO:0008124	4-alpha-hydroxytetrahydrobiopterin dehydratase activity	MF
102	208	2.28962418391	-	1.02e-10	GO:0044212	transcription regulatory region DNA binding	MF
14	29	2.26701248701	-	1.78e-07	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
123	255	2.26579962856	-	1.32e-10	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
11	23	2.25350822266	-	3.51e-07	GO:0055088	lipid homeostasis	BP
11	23	2.25350822266	-	4.29e-06	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
32	67	2.25154936962	-	1.82e-11	GO:0002039	p53 binding	MF
30	63	2.24724923219	-	5.08e-11	GO:0006303	double-strand break repair via nonhomologous end joining	BP
19	40	2.24363797863	-	4.00e-11	GO:0044255	cellular lipid metabolic process	BP
26	55	2.23671856469	-	1.11e-10	GO:0003712	transcription cofactor activity	MF
155	329	2.23181919162	-	1.08e-10	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
8	17	2.23017571883	-	6.18e-05	GO:0033189	response to vitamin A	BP
7	15	2.21810288653	-	5.06e-05	GO:0034968	histone lysine methylation	BP
7	15	2.21810288653	-	1.83e-04	GO:0080182	histone H3-K4 trimethylation	BP
54	116	2.21454506711	-	3.22e-11	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
26	56	2.21072335616	-	1.02e-10	GO:0032922	circadian regulation of gene expression	BP
6	13	2.20216134266	-	1.48e-04	GO:0045618	positive regulation of keratinocyte differentiation	BP
6	13	2.20216134266	-	2.98e-04	GO:0031641	regulation of myelination	BP
6	13	2.20216134266	-	9.28e-04	GO:0001784	phosphotyrosine binding	MF
6	13	2.20216134266	-	9.28e-04	GO:0035497	cAMP response element binding	MF
11	24	2.19210767799	-	7.21e-06	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
81	177	2.18988301288	-	1.36e-10	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
20	44	2.18013503633	-	5.48e-10	GO:0016575	histone deacetylation	BP
10	22	2.18013503633	-	3.94e-06	GO:0007492	endoderm development	BP
10	22	2.18013503633	-	1.25e-05	GO:0003148	outflow tract septum morphogenesis	BP
5	11	2.18013503633	-	8.98e-04	GO:0032703	negative regulation of interleukin-2 production	BP
5	11	2.18013503633	-	1.65e-03	GO:0071498	cellular response to fluid shear stress	BP
5	11	2.18013503633	-	1.65e-03	GO:0042770	signal transduction in response to DNA damage	BP
5	11	2.18013503633	-	1.65e-03	GO:0055015	ventricular cardiac muscle cell development	BP
5	11	2.18013503633	-	1.65e-03	GO:0033169	histone H3-K9 demethylation	BP
5	11	2.18013503633	-	2.77e-03	GO:0032495	response to muramyl dipeptide	BP
5	11	2.18013503633	-	2.77e-03	GO:0000185	activation of MAPKKK activity	BP
5	11	2.18013503633	-	2.77e-03	GO:0035195	gene silencing by miRNA	BP
5	11	2.18013503633	-	2.77e-03	GO:0045667	regulation of osteoblast differentiation	BP
5	11	2.18013503633	-	1.65e-03	GO:0001223	transcription coactivator binding	MF
13	29	2.16009728309	-	5.13e-07	GO:0060412	ventricular septum morphogenesis	BP
13	29	2.16009728309	-	8.69e-07	GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	BP
12	27	2.14771355864	-	1.48e-06	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
12	27	2.14771355864	-	2.50e-06	GO:0043392	negative regulation of DNA binding	BP
8	18	2.14771355864	-	3.39e-05	GO:0060324	face development	BP
4	9	2.14771355864	-	1.28e-03	GO:0048617	embryonic foregut morphogenesis	BP
4	9	2.14771355864	-	2.75e-03	GO:0030903	notochord development	BP
4	9	2.14771355864	-	2.75e-03	GO:0060039	pericardium development	BP
4	9	2.14771355864	-	2.75e-03	GO:0061314	Notch signaling involved in heart development	BP
4	9	2.14771355864	-	5.06e-03	GO:0036500	ATF6-mediated unfolded protein response	BP
4	9	2.14771355864	-	5.06e-03	GO:0042473	outer ear morphogenesis	BP
4	9	2.14771355864	-	5.06e-03	GO:0060674	placenta blood vessel development	BP
4	9	2.14771355864	-	5.06e-03	GO:0003197	endocardial cushion development	BP
4	9	2.14771355864	-	5.06e-03	GO:0002726	positive regulation of T cell cytokine production	BP
4	9	2.14771355864	-	8.40e-03	GO:0060261	positive regulation of transcription initiation from RNA polymerase II promoter	BP
4	9	2.14771355864	-	8.40e-03	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
4	9	2.14771355864	-	8.40e-03	GO:0051146	striated muscle cell differentiation	BP
4	9	2.14771355864	-	8.40e-03	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
4	9	2.14771355864	-	8.40e-03	GO:0010831	positive regulation of myotube differentiation	BP
4	9	2.14771355864	-	8.40e-03	GO:0043068	positive regulation of programmed cell death	BP
4	9	2.14771355864	-	8.40e-03	GO:0030851	granulocyte differentiation	BP
4	9	2.14771355864	-	8.40e-03	GO:0033762	response to glucagon	BP
4	9	2.14771355864	-	8.40e-03	GO:0021895	cerebral cortex neuron differentiation	BP
4	9	2.14771355864	-	8.40e-03	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
4	9	2.14771355864	-	8.40e-03	GO:0030957	Tat protein binding	MF
4	9	2.14771355864	-	8.40e-03	GO:0001075	transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly	MF
88	199	2.14044555817	-	6.63e-11	GO:0003714	transcription corepressor activity	MF
19	43	2.13930131882	-	4.38e-09	GO:0043966	histone H3 acetylation	BP
55	125	2.13321398894	-	1.17e-10	GO:1901796	regulation of signal transduction by p53 class mediator	BP
7	16	2.12499348214	-	1.83e-04	GO:1900745	positive regulation of p38MAPK cascade	BP
7	16	2.12499348214	-	1.83e-04	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
7	16	2.12499348214	-	3.13e-04	GO:0009416	response to light stimulus	BP
7	16	2.12499348214	-	5.09e-04	GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	MF
10	23	2.11600469891	-	3.94e-06	GO:0009954	proximal/distal pattern formation	BP
10	23	2.11600469891	-	2.08e-05	GO:0030332	cyclin binding	MF
21	49	2.09524613874	-	5.42e-10	GO:0042752	regulation of circadian rhythm	BP
12	28	2.09524613874	-	4.66e-07	GO:0035116	embryonic hindlimb morphogenesis	BP
6	14	2.09524613874	-	2.98e-04	GO:0010875	positive regulation of cholesterol efflux	BP
6	14	2.09524613874	-	5.46e-04	GO:0060038	cardiac muscle cell proliferation	BP
6	14	2.09524613874	-	5.46e-04	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
6	14	2.09524613874	-	9.28e-04	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
6	14	2.09524613874	-	9.28e-04	GO:0032743	positive regulation of interleukin-2 production	BP
3	7	2.09524613874	-	3.73e-03	GO:0035356	cellular triglyceride homeostasis	BP
3	7	2.09524613874	-	8.62e-03	GO:0043031	negative regulation of macrophage activation	BP
3	7	2.09524613874	-	8.62e-03	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
3	7	2.09524613874	-	1.60e-02	GO:0045656	negative regulation of monocyte differentiation	BP
3	7	2.09524613874	-	1.60e-02	GO:0045722	positive regulation of gluconeogenesis	BP
3	7	2.09524613874	-	1.60e-02	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
3	7	2.09524613874	-	1.60e-02	GO:0010837	regulation of keratinocyte proliferation	BP
3	7	2.09524613874	-	1.60e-02	GO:0001542	ovulation from ovarian follicle	BP
3	7	2.09524613874	-	1.60e-02	GO:1903214	regulation of protein targeting to mitochondrion	BP
3	7	2.09524613874	-	1.60e-02	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
3	7	2.09524613874	-	1.60e-02	GO:0060563	neuroepithelial cell differentiation	BP
3	7	2.09524613874	-	1.60e-02	GO:0045617	negative regulation of keratinocyte differentiation	BP
3	7	2.09524613874	-	2.59e-02	GO:0046826	negative regulation of protein export from nucleus	BP
3	7	2.09524613874	-	2.59e-02	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
3	7	2.09524613874	-	2.59e-02	GO:1901385	regulation of voltage-gated calcium channel activity	BP
3	7	2.09524613874	-	2.59e-02	GO:1902231	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
3	7	2.09524613874	-	2.59e-02	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
3	7	2.09524613874	-	2.59e-02	GO:0003183	mitral valve morphogenesis	BP
3	7	2.09524613874	-	2.59e-02	GO:0034616	response to laminar fluid shear stress	BP
3	7	2.09524613874	-	2.59e-02	GO:0060575	intestinal epithelial cell differentiation	BP
3	7	2.09524613874	-	2.59e-02	GO:0021795	cerebral cortex cell migration	BP
3	7	2.09524613874	-	2.59e-02	GO:0032872	regulation of stress-activated MAPK cascade	BP
3	7	2.09524613874	-	2.59e-02	GO:0038066	p38MAPK cascade	BP
3	7	2.09524613874	-	2.59e-02	GO:0061049	cell growth involved in cardiac muscle cell development	BP
3	7	2.09524613874	-	2.59e-02	GO:0030219	megakaryocyte differentiation	BP
3	7	2.09524613874	-	2.59e-02	GO:0050891	multicellular organismal water homeostasis	BP
12	28	2.09524613874	-	1.48e-06	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
6	14	2.09524613874	-	9.28e-04	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
3	7	2.09524613874	-	1.60e-02	GO:0015280	ligand-gated sodium channel activity	MF
3	7	2.09524613874	-	2.59e-02	GO:0004970	ionotropic glutamate receptor activity	MF
3	7	2.09524613874	-	2.59e-02	GO:0097322	7SK snRNA binding	MF
212	496	2.09136270425	-	2.10e-10	GO:0045893	positive regulation of transcription, DNA-templated	BP
47	110	2.09086769823	-	1.12e-10	GO:0006334	nucleosome assembly	BP
25	59	2.07885170049	-	3.64e-11	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
11	26	2.07663046057	-	4.29e-06	GO:0021983	pituitary gland development	BP
8	19	2.06971104663	-	2.75e-04	GO:0043393	regulation of protein binding	BP
33	79	2.05825193126	-	2.93e-11	GO:0008013	beta-catenin binding	MF
10	24	2.05460415424	-	2.05e-06	GO:0030878	thyroid gland development	BP
5	12	2.05460415424	-	1.65e-03	GO:0030278	regulation of ossification	BP
5	12	2.05460415424	-	1.65e-03	GO:0042592	homeostatic process	BP
5	12	2.05460415424	-	2.77e-03	GO:0060707	trophoblast giant cell differentiation	BP
5	12	2.05460415424	-	2.77e-03	GO:0043922	negative regulation by host of viral transcription	BP
5	12	2.05460415424	-	2.77e-03	GO:0030212	hyaluronan metabolic process	BP
5	12	2.05460415424	-	4.37e-03	GO:0055093	response to hyperoxia	BP
5	12	2.05460415424	-	4.37e-03	GO:0051457	maintenance of protein location in nucleus	BP
5	12	2.05460415424	-	4.37e-03	GO:0035635	entry of bacterium into host cell	BP
5	12	2.05460415424	-	4.37e-03	GO:0016578	histone deubiquitination	BP
5	12	2.05460415424	-	4.37e-03	GO:0061014	positive regulation of mRNA catabolic process	BP
5	12	2.05460415424	-	4.37e-03	GO:0042994	cytoplasmic sequestering of transcription factor	BP
5	12	2.05460415424	-	4.37e-03	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
5	12	2.05460415424	-	4.37e-03	GO:0035518	histone H2A monoubiquitination	BP
5	12	2.05460415424	-	4.37e-03	GO:0004708	MAP kinase kinase activity	MF
7	17	2.03753064089	-	5.09e-04	GO:0045638	negative regulation of myeloid cell differentiation	BP
7	17	2.03753064089	-	1.00e-04	GO:0008301	DNA binding, bending	MF
11	27	2.02218267655	-	4.29e-06	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
11	27	2.02218267655	-	7.21e-06	GO:0001106	RNA polymerase II transcription corepressor activity	MF
6	15	1.99571046519	-	5.46e-04	GO:0035050	embryonic heart tube development	BP
6	15	1.99571046519	-	9.28e-04	GO:0007548	sex differentiation	BP
6	15	1.99571046519	-	1.49e-03	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
6	15	1.99571046519	-	1.49e-03	GO:0070498	interleukin-1-mediated signaling pathway	BP
6	15	1.99571046519	-	2.27e-03	GO:0043981	histone H4-K5 acetylation	BP
6	15	1.99571046519	-	2.27e-03	GO:0043982	histone H4-K8 acetylation	BP
8	20	1.99571046519	-	3.39e-05	GO:0002052	positive regulation of neuroblast proliferation	BP
4	10	1.99571046519	-	2.75e-03	GO:0045598	regulation of fat cell differentiation	BP
4	10	1.99571046519	-	2.75e-03	GO:0043586	tongue development	BP
4	10	1.99571046519	-	5.06e-03	GO:0043267	negative regulation of potassium ion transport	BP
4	10	1.99571046519	-	5.06e-03	GO:0048048	embryonic eye morphogenesis	BP
4	10	1.99571046519	-	8.40e-03	GO:0006307	DNA dealkylation involved in DNA repair	BP
4	10	1.99571046519	-	8.40e-03	GO:0003214	cardiac left ventricle morphogenesis	BP
4	10	1.99571046519	-	8.40e-03	GO:2001022	positive regulation of response to DNA damage stimulus	BP
4	10	1.99571046519	-	8.40e-03	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
2	5	1.99571046519	-	1.01e-02	GO:0003357	noradrenergic neuron differentiation	BP
4	10	1.99571046519	-	1.29e-02	GO:1903827	regulation of cellular protein localization	BP
4	10	1.99571046519	-	1.29e-02	GO:0051247	positive regulation of protein metabolic process	BP
4	10	1.99571046519	-	1.29e-02	GO:0043276	anoikis	BP
4	10	1.99571046519	-	1.29e-02	GO:0033327	Leydig cell differentiation	BP
4	10	1.99571046519	-	1.29e-02	GO:0032930	positive regulation of superoxide anion generation	BP
4	10	1.99571046519	-	1.29e-02	GO:2001020	regulation of response to DNA damage stimulus	BP
4	10	1.99571046519	-	1.29e-02	GO:0031000	response to caffeine	BP
2	5	1.99571046519	-	2.81e-02	GO:0048645	animal organ formation	BP
2	5	1.99571046519	-	2.81e-02	GO:0061743	motor learning	BP
2	5	1.99571046519	-	2.81e-02	GO:0032714	negative regulation of interleukin-5 production	BP
2	5	1.99571046519	-	5.26e-02	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
2	5	1.99571046519	-	5.26e-02	GO:0048733	sebaceous gland development	BP
2	5	1.99571046519	-	5.26e-02	GO:0009299	mRNA transcription	BP
2	5	1.99571046519	-	5.26e-02	GO:0010793	regulation of mRNA export from nucleus	BP
2	5	1.99571046519	-	5.26e-02	GO:0043374	CD8-positive, alpha-beta T cell differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:0060510	Type II pneumocyte differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:0003417	growth plate cartilage development	BP
2	5	1.99571046519	-	5.26e-02	GO:0060136	embryonic process involved in female pregnancy	BP
2	5	1.99571046519	-	5.26e-02	GO:0060956	endocardial cell differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:0048311	mitochondrion distribution	BP
2	5	1.99571046519	-	5.26e-02	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	1.99571046519	-	5.26e-02	GO:2000987	positive regulation of behavioral fear response	BP
2	5	1.99571046519	-	5.26e-02	GO:0010632	regulation of epithelial cell migration	BP
2	5	1.99571046519	-	5.26e-02	GO:0035881	amacrine cell differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
2	5	1.99571046519	-	5.26e-02	GO:1901727	positive regulation of histone deacetylase activity	BP
2	5	1.99571046519	-	5.26e-02	GO:0021696	cerebellar cortex morphogenesis	BP
2	5	1.99571046519	-	5.26e-02	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:0060019	radial glial cell differentiation	BP
2	5	1.99571046519	-	5.26e-02	GO:0045823	positive regulation of heart contraction	BP
2	5	1.99571046519	-	8.19e-02	GO:0006360	transcription from RNA polymerase I promoter	BP
2	5	1.99571046519	-	8.19e-02	GO:0042541	hemoglobin biosynthetic process	BP
2	5	1.99571046519	-	8.19e-02	GO:0072655	establishment of protein localization to mitochondrion	BP
2	5	1.99571046519	-	8.19e-02	GO:0042634	regulation of hair cycle	BP
2	5	1.99571046519	-	8.19e-02	GO:0034349	glial cell apoptotic process	BP
2	5	1.99571046519	-	8.19e-02	GO:0061734	parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization	BP
2	5	1.99571046519	-	8.19e-02	GO:0036091	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
2	5	1.99571046519	-	8.19e-02	GO:1902808	positive regulation of cell cycle G1/S phase transition	BP
2	5	1.99571046519	-	8.19e-02	GO:0065004	protein-DNA complex assembly	BP
2	5	1.99571046519	-	8.19e-02	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	1.99571046519	-	8.19e-02	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
2	5	1.99571046519	-	8.19e-02	GO:0031536	positive regulation of exit from mitosis	BP
2	5	1.99571046519	-	8.19e-02	GO:0045646	regulation of erythrocyte differentiation	BP
2	5	1.99571046519	-	8.19e-02	GO:0034620	cellular response to unfolded protein	BP
2	5	1.99571046519	-	8.19e-02	GO:0045843	negative regulation of striated muscle tissue development	BP
2	5	1.99571046519	-	8.19e-02	GO:0044828	negative regulation by host of viral genome replication	BP
2	5	1.99571046519	-	8.19e-02	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	5	1.99571046519	-	8.19e-02	GO:0051081	nuclear envelope disassembly	BP
2	5	1.99571046519	-	8.19e-02	GO:0016202	regulation of striated muscle tissue development	BP
2	5	1.99571046519	-	8.19e-02	GO:0048755	branching morphogenesis of a nerve	BP
2	5	1.99571046519	-	8.19e-02	GO:0042699	follicle-stimulating hormone signaling pathway	BP
2	5	1.99571046519	-	8.19e-02	GO:0070842	aggresome assembly	BP
2	5	1.99571046519	-	8.19e-02	GO:0071504	cellular response to heparin	BP
2	5	1.99571046519	-	8.19e-02	GO:2001171	positive regulation of ATP biosynthetic process	BP
2	5	1.99571046519	-	8.19e-02	GO:0071332	cellular response to fructose stimulus	BP
2	5	1.99571046519	-	8.19e-02	GO:2000780	negative regulation of double-strand break repair	BP
2	5	1.99571046519	-	8.19e-02	GO:1902035	positive regulation of hematopoietic stem cell proliferation	BP
2	5	1.99571046519	-	8.19e-02	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
2	5	1.99571046519	-	8.19e-02	GO:0048341	paraxial mesoderm formation	BP
2	5	1.99571046519	-	8.19e-02	GO:0030262	apoptotic nuclear changes	BP
2	5	1.99571046519	-	8.19e-02	GO:0061052	negative regulation of cell growth involved in cardiac muscle cell development	BP
2	5	1.99571046519	-	8.19e-02	GO:0032713	negative regulation of interleukin-4 production	BP
2	5	1.99571046519	-	8.19e-02	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
2	5	1.99571046519	-	8.19e-02	GO:0051546	keratinocyte migration	BP
2	5	1.99571046519	-	8.19e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
2	5	1.99571046519	-	8.19e-02	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
2	5	1.99571046519	-	8.19e-02	GO:0051583	dopamine uptake involved in synaptic transmission	BP
2	5	1.99571046519	-	8.19e-02	GO:0070201	regulation of establishment of protein localization	BP
2	5	1.99571046519	-	8.19e-02	GO:0021942	radial glia guided migration of Purkinje cell	BP
2	5	1.99571046519	-	8.19e-02	GO:0002260	lymphocyte homeostasis	BP
2	5	1.99571046519	-	8.19e-02	GO:1904885	beta-catenin destruction complex assembly	BP
2	5	1.99571046519	-	8.19e-02	GO:0060157	urinary bladder development	BP
2	5	1.99571046519	-	8.19e-02	GO:0044314	protein K27-linked ubiquitination	BP
2	5	1.99571046519	-	8.19e-02	GO:0010991	negative regulation of SMAD protein complex assembly	BP
2	5	1.99571046519	-	8.19e-02	GO:0071681	cellular response to indole-3-methanol	BP
2	5	1.99571046519	-	8.19e-02	GO:0035519	protein K29-linked ubiquitination	BP
2	5	1.99571046519	-	8.19e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
2	5	1.99571046519	-	8.19e-02	GO:0010452	histone H3-K36 methylation	BP
2	5	1.99571046519	-	8.19e-02	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
2	5	1.99571046519	-	8.19e-02	GO:0030098	lymphocyte differentiation	BP
2	5	1.99571046519	-	8.19e-02	GO:0051023	regulation of immunoglobulin secretion	BP
2	5	1.99571046519	-	5.26e-02	GO:0019871	sodium channel inhibitor activity	MF
2	5	1.99571046519	-	5.26e-02	GO:0070513	death domain binding	MF
2	5	1.99571046519	-	5.26e-02	GO:0051575	5'-deoxyribose-5-phosphate lyase activity	MF
2	5	1.99571046519	-	8.19e-02	GO:0032184	SUMO polymer binding	MF
2	5	1.99571046519	-	8.19e-02	GO:0030911	TPR domain binding	MF
2	5	1.99571046519	-	8.19e-02	GO:0008142	oxysterol binding	MF
2	5	1.99571046519	-	8.19e-02	GO:0071532	ankyrin repeat binding	MF
2	5	1.99571046519	-	8.19e-02	GO:0070878	primary miRNA binding	MF
2	5	1.99571046519	-	8.19e-02	GO:0004844	uracil DNA N-glycosylase activity	MF
2	5	1.99571046519	-	8.19e-02	GO:0046974	histone methyltransferase activity (H3-K9 specific)	MF
147	368	1.99374894886	-	1.73e-10	GO:0003682	chromatin binding	MF
216	545	1.98241364258	-	2.09e-10	GO:0006366	transcription from RNA polymerase II promoter	BP
21	53	1.98203552829	-	1.43e-09	GO:0048511	rhythmic process	BP
11	28	1.96971525666	-	7.21e-06	GO:0048863	stem cell differentiation	BP
11	28	1.96971525666	-	4.25e-05	GO:0045739	positive regulation of DNA repair	BP
7	18	1.95506848069	-	9.19e-06	GO:0023019	signal transduction involved in regulation of gene expression	BP
7	18	1.95506848069	-	5.09e-04	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
43	111	1.94948744843	-	4.39e-11	GO:0016569	covalent chromatin modification	BP
380	981	1.94938484219	-	2.46e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
5	13	1.93912693682	-	1.65e-03	GO:0031076	embryonic camera-type eye development	BP
5	13	1.93912693682	-	2.77e-03	GO:0050872	white fat cell differentiation	BP
5	13	1.93912693682	-	6.51e-03	GO:0001678	cellular glucose homeostasis	BP
5	13	1.93912693682	-	6.51e-03	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
5	13	1.93912693682	-	6.51e-03	GO:0006379	mRNA cleavage	BP
42	110	1.92859626933	-	4.39e-11	GO:0031047	gene silencing by RNA	BP
16	42	1.9253211373	-	3.68e-08	GO:0045599	negative regulation of fat cell differentiation	BP
8	21	1.9253211373	-	1.75e-04	GO:0008327	methyl-CpG binding	MF
11	29	1.91908918359	-	2.83e-05	GO:1903146	regulation of mitophagy	BP
11	29	1.91908918359	-	6.22e-05	GO:0008094	DNA-dependent ATPase activity	MF
17	45	1.913248305	-	2.15e-08	GO:0035914	skeletal muscle cell differentiation	BP
18	48	1.9026010608	-	3.66e-07	GO:0007254	JNK cascade	BP
12	32	1.9026010608	-	1.01e-05	GO:0071479	cellular response to ionizing radiation	BP
12	32	1.9026010608	-	1.53e-05	GO:0043967	histone H4 acetylation	BP
9	24	1.9026010608	-	1.48e-04	GO:0071158	positive regulation of cell cycle arrest	BP
6	16	1.9026010608	-	1.49e-03	GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	BP
6	16	1.9026010608	-	1.49e-03	GO:0042307	positive regulation of protein import into nucleus	BP
6	16	1.9026010608	-	1.49e-03	GO:0060216	definitive hemopoiesis	BP
6	16	1.9026010608	-	1.49e-03	GO:0035855	megakaryocyte development	BP
6	16	1.9026010608	-	2.27e-03	GO:0006349	regulation of gene expression by genetic imprinting	BP
6	16	1.9026010608	-	2.27e-03	GO:0043968	histone H2A acetylation	BP
6	16	1.9026010608	-	3.33e-03	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
6	16	1.9026010608	-	3.33e-03	GO:0032270	positive regulation of cellular protein metabolic process	BP
3	8	1.9026010608	-	8.62e-03	GO:0048512	circadian behavior	BP
3	8	1.9026010608	-	1.60e-02	GO:0071374	cellular response to parathyroid hormone stimulus	BP
3	8	1.9026010608	-	1.60e-02	GO:0001763	morphogenesis of a branching structure	BP
3	8	1.9026010608	-	2.59e-02	GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
3	8	1.9026010608	-	2.59e-02	GO:0055001	muscle cell development	BP
3	8	1.9026010608	-	2.59e-02	GO:0045654	positive regulation of megakaryocyte differentiation	BP
3	8	1.9026010608	-	2.59e-02	GO:0071168	protein localization to chromatin	BP
3	8	1.9026010608	-	2.59e-02	GO:0032330	regulation of chondrocyte differentiation	BP
3	8	1.9026010608	-	2.59e-02	GO:0060982	coronary artery morphogenesis	BP
3	8	1.9026010608	-	2.59e-02	GO:0000076	DNA replication checkpoint	BP
3	8	1.9026010608	-	2.59e-02	GO:0010954	positive regulation of protein processing	BP
3	8	1.9026010608	-	2.59e-02	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
3	8	1.9026010608	-	2.59e-02	GO:0035912	dorsal aorta morphogenesis	BP
3	8	1.9026010608	-	2.59e-02	GO:0071316	cellular response to nicotine	BP
3	8	1.9026010608	-	3.83e-02	GO:0060100	positive regulation of phagocytosis, engulfment	BP
3	8	1.9026010608	-	3.83e-02	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
3	8	1.9026010608	-	3.83e-02	GO:0045647	negative regulation of erythrocyte differentiation	BP
3	8	1.9026010608	-	3.83e-02	GO:0033173	calcineurin-NFAT signaling cascade	BP
3	8	1.9026010608	-	3.83e-02	GO:0070102	interleukin-6-mediated signaling pathway	BP
3	8	1.9026010608	-	3.83e-02	GO:0071548	response to dexamethasone	BP
3	8	1.9026010608	-	3.83e-02	GO:0010941	regulation of cell death	BP
3	8	1.9026010608	-	3.83e-02	GO:0006975	DNA damage induced protein phosphorylation	BP
3	8	1.9026010608	-	3.83e-02	GO:0090073	positive regulation of protein homodimerization activity	BP
3	8	1.9026010608	-	3.83e-02	GO:0033129	positive regulation of histone phosphorylation	BP
3	8	1.9026010608	-	3.83e-02	GO:1903599	positive regulation of mitophagy	BP
3	8	1.9026010608	-	3.83e-02	GO:0010498	proteasomal protein catabolic process	BP
6	16	1.9026010608	-	2.27e-03	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
3	8	1.9026010608	-	3.83e-02	GO:0008140	cAMP response element binding protein binding	MF
3	8	1.9026010608	-	3.83e-02	GO:0001135	transcription factor activity, RNA polymerase II transcription factor recruiting	MF
265	711	1.89378135991	-	1.60e-10	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
16	43	1.89137380538	-	2.51e-07	GO:0048538	thymus development	BP
16	43	1.89137380538	-	1.84e-06	GO:0034644	cellular response to UV	BP
16	43	1.89137380538	-	3.86e-07	GO:0046332	SMAD binding	MF
10	27	1.8846791528	-	1.25e-05	GO:0005496	steroid binding	MF
174	471	1.88099880631	-	1.80e-10	GO:0045892	negative regulation of transcription, DNA-templated	BP
7	19	1.87706596869	-	5.09e-04	GO:0030220	platelet formation	BP
7	19	1.87706596869	-	1.18e-03	GO:0010906	regulation of glucose metabolic process	BP
7	19	1.87706596869	-	1.18e-03	GO:0030099	myeloid cell differentiation	BP
7	19	1.87706596869	-	1.71e-03	GO:0043011	myeloid dendritic cell differentiation	BP
7	19	1.87706596869	-	1.71e-03	GO:0004709	MAP kinase kinase kinase activity	MF
22	60	1.87017958311	-	9.99e-09	GO:0070301	cellular response to hydrogen peroxide	BP
11	30	1.87017958311	-	8.94e-05	GO:0006362	transcription elongation from RNA polymerase I promoter	BP
28	77	1.85820694144	-	6.56e-11	GO:0009952	anterior/posterior pattern specification	BP
16	44	1.85820694144	-	2.63e-06	GO:0043525	positive regulation of neuron apoptotic process	BP
12	33	1.85820694144	-	3.30e-05	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
12	33	1.85820694144	-	4.71e-05	GO:0006361	transcription initiation from RNA polymerase I promoter	BP
4	11	1.85820694144	-	2.75e-03	GO:0042551	neuron maturation	BP
4	11	1.85820694144	-	5.06e-03	GO:0006346	methylation-dependent chromatin silencing	BP
4	11	1.85820694144	-	8.40e-03	GO:0001893	maternal placenta development	BP
4	11	1.85820694144	-	8.40e-03	GO:0042445	hormone metabolic process	BP
4	11	1.85820694144	-	8.40e-03	GO:0010867	positive regulation of triglyceride biosynthetic process	BP
4	11	1.85820694144	-	8.40e-03	GO:2000737	negative regulation of stem cell differentiation	BP
4	11	1.85820694144	-	1.29e-02	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
4	11	1.85820694144	-	1.29e-02	GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	BP
4	11	1.85820694144	-	1.29e-02	GO:0060272	embryonic skeletal joint morphogenesis	BP
4	11	1.85820694144	-	1.29e-02	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
4	11	1.85820694144	-	1.87e-02	GO:0010884	positive regulation of lipid storage	BP
4	11	1.85820694144	-	1.87e-02	GO:0003279	cardiac septum development	BP
4	11	1.85820694144	-	1.87e-02	GO:1901653	cellular response to peptide	BP
4	11	1.85820694144	-	1.87e-02	GO:0060765	regulation of androgen receptor signaling pathway	BP
4	11	1.85820694144	-	1.87e-02	GO:0060487	lung epithelial cell differentiation	BP
4	11	1.85820694144	-	1.87e-02	GO:0043560	insulin receptor substrate binding	MF
4	11	1.85820694144	-	1.87e-02	GO:0008066	glutamate receptor activity	MF
13	36	1.84815327678	-	1.21e-05	GO:0048536	spleen development	BP
9	25	1.84370737175	-	3.23e-04	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
23	64	1.84120051614	-	2.48e-09	GO:0035019	somatic stem cell population maintenance	BP
5	14	1.83221173291	-	4.37e-03	GO:0001708	cell fate specification	BP
5	14	1.83221173291	-	4.37e-03	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
5	14	1.83221173291	-	4.37e-03	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
5	14	1.83221173291	-	6.51e-03	GO:0014912	negative regulation of smooth muscle cell migration	BP
5	14	1.83221173291	-	6.51e-03	GO:0060749	mammary gland alveolus development	BP
5	14	1.83221173291	-	6.51e-03	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
5	14	1.83221173291	-	9.31e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
5	14	1.83221173291	-	9.31e-03	GO:0098586	cellular response to virus	BP
5	14	1.83221173291	-	9.31e-03	GO:0042993	positive regulation of transcription factor import into nucleus	BP
5	14	1.83221173291	-	9.31e-03	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
5	14	1.83221173291	-	9.31e-03	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
11	31	1.82287386833	-	7.21e-06	GO:0035115	embryonic forelimb morphogenesis	BP
11	31	1.82287386833	-	1.26e-04	GO:0006363	termination of RNA polymerase I transcription	BP
6	17	1.81513821955	-	9.28e-04	GO:0009948	anterior/posterior axis specification	BP
6	17	1.81513821955	-	3.33e-03	GO:0030325	adrenal gland development	BP
6	17	1.81513821955	-	3.33e-03	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
6	17	1.81513821955	-	3.33e-03	GO:0030225	macrophage differentiation	BP
6	17	1.81513821955	-	4.71e-03	GO:0031491	nucleosome binding	MF
13	37	1.80862491259	-	1.21e-05	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
42	120	1.80306538725	-	3.18e-11	GO:0044267	cellular protein metabolic process	BP
7	20	1.80306538725	-	3.13e-04	GO:0031016	pancreas development	BP
7	20	1.80306538725	-	2.41e-03	GO:0045663	positive regulation of myoblast differentiation	BP
7	20	1.80306538725	-	2.41e-03	GO:1901216	positive regulation of neuron death	BP
8	23	1.79407660402	-	4.19e-04	GO:0031018	endocrine pancreas development	BP
8	23	1.79407660402	-	8.86e-04	GO:0090398	cellular senescence	BP
9	26	1.78712384338	-	6.43e-04	GO:0045931	positive regulation of mitotic cell cycle	BP
10	29	1.78158565984	-	5.23e-05	GO:0001569	branching involved in blood vessel morphogenesis	BP
26	76	1.77015076478	-	7.83e-11	GO:0007623	circadian rhythm	BP
134	398	1.74710312999	-	1.55e-10	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
13	39	1.73267605936	-	3.49e-05	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
9	27	1.73267605936	-	6.02e-05	GO:0001755	neural crest cell migration	BP
10	30	1.73267605936	-	7.94e-05	GO:0001707	mesoderm formation	BP
9	27	1.73267605936	-	1.48e-04	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
8	24	1.73267605936	-	8.86e-04	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
6	18	1.73267605936	-	2.27e-03	GO:0002076	osteoblast development	BP
6	18	1.73267605936	-	3.33e-03	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
6	18	1.73267605936	-	4.71e-03	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
5	15	1.73267605936	-	6.51e-03	GO:0001953	negative regulation of cell-matrix adhesion	BP
5	15	1.73267605936	-	9.31e-03	GO:0031573	intra-S DNA damage checkpoint	BP
5	15	1.73267605936	-	9.31e-03	GO:0070848	response to growth factor	BP
5	15	1.73267605936	-	9.31e-03	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
4	12	1.73267605936	-	1.29e-02	GO:0043616	keratinocyte proliferation	BP
4	12	1.73267605936	-	1.29e-02	GO:0009888	tissue development	BP
4	12	1.73267605936	-	1.29e-02	GO:0071391	cellular response to estrogen stimulus	BP
3	9	1.73267605936	-	1.60e-02	GO:0055091	phospholipid homeostasis	BP
4	12	1.73267605936	-	1.87e-02	GO:0060425	lung morphogenesis	BP
4	12	1.73267605936	-	1.87e-02	GO:0007512	adult heart development	BP
4	12	1.73267605936	-	2.58e-02	GO:0021819	layer formation in cerebral cortex	BP
4	12	1.73267605936	-	2.58e-02	GO:0007252	I-kappaB phosphorylation	BP
4	12	1.73267605936	-	2.58e-02	GO:0048712	negative regulation of astrocyte differentiation	BP
4	12	1.73267605936	-	2.58e-02	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
4	12	1.73267605936	-	2.58e-02	GO:0036499	PERK-mediated unfolded protein response	BP
4	12	1.73267605936	-	2.58e-02	GO:0045820	negative regulation of glycolytic process	BP
4	12	1.73267605936	-	2.58e-02	GO:0021954	central nervous system neuron development	BP
3	9	1.73267605936	-	2.59e-02	GO:0046548	retinal rod cell development	BP
3	9	1.73267605936	-	2.59e-02	GO:0010907	positive regulation of glucose metabolic process	BP
3	9	1.73267605936	-	2.59e-02	GO:0072358	cardiovascular system development	BP
3	9	1.73267605936	-	3.83e-02	GO:2000810	regulation of bicellular tight junction assembly	BP
3	9	1.73267605936	-	3.83e-02	GO:0019953	sexual reproduction	BP
3	9	1.73267605936	-	3.83e-02	GO:1990403	embryonic brain development	BP
3	9	1.73267605936	-	3.83e-02	GO:0006353	DNA-templated transcription, termination	BP
3	9	1.73267605936	-	3.83e-02	GO:0010469	regulation of receptor activity	BP
3	9	1.73267605936	-	3.83e-02	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
3	9	1.73267605936	-	3.83e-02	GO:0030299	intestinal cholesterol absorption	BP
2	6	1.73267605936	-	5.26e-02	GO:2001054	negative regulation of mesenchymal cell apoptotic process	BP
2	6	1.73267605936	-	5.26e-02	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
3	9	1.73267605936	-	5.33e-02	GO:0034405	response to fluid shear stress	BP
3	9	1.73267605936	-	5.33e-02	GO:0031053	primary miRNA processing	BP
3	9	1.73267605936	-	5.33e-02	GO:2000178	negative regulation of neural precursor cell proliferation	BP
3	9	1.73267605936	-	5.33e-02	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
3	9	1.73267605936	-	5.33e-02	GO:0006265	DNA topological change	BP
3	9	1.73267605936	-	5.33e-02	GO:0034333	adherens junction assembly	BP
2	6	1.73267605936	-	8.19e-02	GO:0030579	ubiquitin-dependent SMAD protein catabolic process	BP
2	6	1.73267605936	-	8.19e-02	GO:0031017	exocrine pancreas development	BP
2	6	1.73267605936	-	8.19e-02	GO:0060992	response to fungicide	BP
2	6	1.73267605936	-	8.19e-02	GO:0032204	regulation of telomere maintenance	BP
2	6	1.73267605936	-	8.19e-02	GO:0002320	lymphoid progenitor cell differentiation	BP
2	6	1.73267605936	-	8.19e-02	GO:0048525	negative regulation of viral process	BP
2	6	1.73267605936	-	8.19e-02	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
2	6	1.73267605936	-	8.19e-02	GO:2000553	positive regulation of T-helper 2 cell cytokine production	BP
2	6	1.73267605936	-	8.19e-02	GO:0031062	positive regulation of histone methylation	BP
2	6	1.73267605936	-	8.19e-02	GO:0072540	T-helper 17 cell lineage commitment	BP
2	6	1.73267605936	-	8.19e-02	GO:0021984	adenohypophysis development	BP
2	6	1.73267605936	-	8.19e-02	GO:0010631	epithelial cell migration	BP
2	6	1.73267605936	-	8.19e-02	GO:0035315	hair cell differentiation	BP
2	6	1.73267605936	-	8.19e-02	GO:0051099	positive regulation of binding	BP
2	6	1.73267605936	-	8.19e-02	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
2	6	1.73267605936	-	8.19e-02	GO:0033211	adiponectin-activated signaling pathway	BP
2	6	1.73267605936	-	8.19e-02	GO:0042415	norepinephrine metabolic process	BP
2	6	1.73267605936	-	8.19e-02	GO:0021798	forebrain dorsal/ventral pattern formation	BP
2	6	1.73267605936	-	8.19e-02	GO:0021796	cerebral cortex regionalization	BP
2	6	1.73267605936	-	8.19e-02	GO:0045719	negative regulation of glycogen biosynthetic process	BP
1	3	1.73267605936	-	1.00e-01	GO:0070172	positive regulation of tooth mineralization	BP
1	3	1.73267605936	-	1.00e-01	GO:2000721	positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
1	3	1.73267605936	-	1.00e-01	GO:1902807	negative regulation of cell cycle G1/S phase transition	BP
1	3	1.73267605936	-	1.00e-01	GO:0060913	cardiac cell fate determination	BP
1	3	1.73267605936	-	1.00e-01	GO:0002138	retinoic acid biosynthetic process	BP
1	3	1.73267605936	-	1.00e-01	GO:0006670	sphingosine metabolic process	BP
1	3	1.73267605936	-	1.00e-01	GO:0030858	positive regulation of epithelial cell differentiation	BP
1	3	1.73267605936	-	1.00e-01	GO:0036378	calcitriol biosynthetic process from calciol	BP
1	3	1.73267605936	-	1.00e-01	GO:0060005	vestibular reflex	BP
1	3	1.73267605936	-	1.00e-01	GO:0015917	aminophospholipid transport	BP
1	3	1.73267605936	-	1.00e-01	GO:0003140	determination of left/right asymmetry in lateral mesoderm	BP
2	6	1.73267605936	-	1.15e-01	GO:0034773	histone H4-K20 trimethylation	BP
2	6	1.73267605936	-	1.15e-01	GO:2001014	regulation of skeletal muscle cell differentiation	BP
2	6	1.73267605936	-	1.15e-01	GO:0010564	regulation of cell cycle process	BP
2	6	1.73267605936	-	1.15e-01	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
2	6	1.73267605936	-	1.15e-01	GO:0070816	phosphorylation of RNA polymerase II C-terminal domain	BP
2	6	1.73267605936	-	1.15e-01	GO:0071559	response to transforming growth factor beta	BP
2	6	1.73267605936	-	1.15e-01	GO:0010265	SCF complex assembly	BP
2	6	1.73267605936	-	1.15e-01	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	6	1.73267605936	-	1.15e-01	GO:0090166	Golgi disassembly	BP
2	6	1.73267605936	-	1.15e-01	GO:2000171	negative regulation of dendrite development	BP
2	6	1.73267605936	-	1.15e-01	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
2	6	1.73267605936	-	1.15e-01	GO:0007253	cytoplasmic sequestering of NF-kappaB	BP
2	6	1.73267605936	-	1.15e-01	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
2	6	1.73267605936	-	1.15e-01	GO:0001661	conditioned taste aversion	BP
2	6	1.73267605936	-	1.15e-01	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
2	6	1.73267605936	-	1.15e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
2	6	1.73267605936	-	1.15e-01	GO:1903140	regulation of establishment of endothelial barrier	BP
2	6	1.73267605936	-	1.15e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
2	6	1.73267605936	-	1.15e-01	GO:2000667	positive regulation of interleukin-13 secretion	BP
2	6	1.73267605936	-	1.15e-01	GO:0097084	vascular smooth muscle cell development	BP
2	6	1.73267605936	-	1.15e-01	GO:0003158	endothelium development	BP
2	6	1.73267605936	-	1.15e-01	GO:1903265	positive regulation of tumor necrosis factor-mediated signaling pathway	BP
2	6	1.73267605936	-	1.15e-01	GO:0060363	cranial suture morphogenesis	BP
2	6	1.73267605936	-	1.15e-01	GO:0071470	cellular response to osmotic stress	BP
2	6	1.73267605936	-	1.15e-01	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
2	6	1.73267605936	-	1.15e-01	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
2	6	1.73267605936	-	1.15e-01	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	BP
2	6	1.73267605936	-	1.15e-01	GO:0033210	leptin-mediated signaling pathway	BP
2	6	1.73267605936	-	1.15e-01	GO:0045661	regulation of myoblast differentiation	BP
2	6	1.73267605936	-	1.15e-01	GO:0070244	negative regulation of thymocyte apoptotic process	BP
2	6	1.73267605936	-	1.15e-01	GO:0007182	common-partner SMAD protein phosphorylation	BP
2	6	1.73267605936	-	1.15e-01	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
2	6	1.73267605936	-	1.15e-01	GO:0043985	histone H4-R3 methylation	BP
1	3	1.73267605936	-	1.91e-01	GO:0070561	vitamin D receptor signaling pathway	BP
1	3	1.73267605936	-	1.91e-01	GO:0007228	positive regulation of hh target transcription factor activity	BP
1	3	1.73267605936	-	1.91e-01	GO:0046639	negative regulation of alpha-beta T cell differentiation	BP
1	3	1.73267605936	-	1.91e-01	GO:0019918	peptidyl-arginine methylation, to symmetrical-dimethyl arginine	BP
1	3	1.73267605936	-	1.91e-01	GO:1900625	positive regulation of monocyte aggregation	BP
1	3	1.73267605936	-	1.91e-01	GO:0002667	regulation of T cell anergy	BP
1	3	1.73267605936	-	1.91e-01	GO:0060066	oviduct development	BP
1	3	1.73267605936	-	1.91e-01	GO:0060856	establishment of blood-brain barrier	BP
1	3	1.73267605936	-	1.91e-01	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:0060596	mammary placode formation	BP
1	3	1.73267605936	-	1.91e-01	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	1.73267605936	-	1.91e-01	GO:0072102	glomerulus morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:0010387	COP9 signalosome assembly	BP
1	3	1.73267605936	-	1.91e-01	GO:0001781	neutrophil apoptotic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	1.73267605936	-	1.91e-01	GO:0046167	glycerol-3-phosphate biosynthetic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0070859	positive regulation of bile acid biosynthetic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0010482	regulation of epidermal cell division	BP
1	3	1.73267605936	-	1.91e-01	GO:0051797	regulation of hair follicle development	BP
1	3	1.73267605936	-	1.91e-01	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
1	3	1.73267605936	-	1.91e-01	GO:0072050	S-shaped body morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:0021533	cell differentiation in hindbrain	BP
1	3	1.73267605936	-	1.91e-01	GO:0009822	alkaloid catabolic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0072600	establishment of protein localization to Golgi	BP
1	3	1.73267605936	-	1.91e-01	GO:0042278	purine nucleoside metabolic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0010573	vascular endothelial growth factor production	BP
1	3	1.73267605936	-	1.91e-01	GO:0051490	negative regulation of filopodium assembly	BP
1	3	1.73267605936	-	1.91e-01	GO:0019230	proprioception	BP
1	3	1.73267605936	-	1.91e-01	GO:0070633	transepithelial transport	BP
1	3	1.73267605936	-	1.91e-01	GO:0033076	isoquinoline alkaloid metabolic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0031344	regulation of cell projection organization	BP
1	3	1.73267605936	-	1.91e-01	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
1	3	1.73267605936	-	1.91e-01	GO:0009957	epidermal cell fate specification	BP
1	3	1.73267605936	-	1.91e-01	GO:0051594	detection of glucose	BP
1	3	1.73267605936	-	1.91e-01	GO:0021544	subpallium development	BP
1	3	1.73267605936	-	1.91e-01	GO:0003408	optic cup formation involved in camera-type eye development	BP
1	3	1.73267605936	-	1.91e-01	GO:0007418	ventral midline development	BP
1	3	1.73267605936	-	1.91e-01	GO:0044242	cellular lipid catabolic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0021502	neural fold elevation formation	BP
1	3	1.73267605936	-	1.91e-01	GO:0035873	lactate transmembrane transport	BP
1	3	1.73267605936	-	1.91e-01	GO:0003192	mitral valve formation	BP
1	3	1.73267605936	-	1.91e-01	GO:0072675	osteoclast fusion	BP
1	3	1.73267605936	-	1.91e-01	GO:0030104	water homeostasis	BP
1	3	1.73267605936	-	1.91e-01	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	1.73267605936	-	1.91e-01	GO:0048302	regulation of isotype switching to IgG isotypes	BP
1	3	1.73267605936	-	1.91e-01	GO:1900042	positive regulation of interleukin-2 secretion	BP
1	3	1.73267605936	-	1.91e-01	GO:1902990	mitotic telomere maintenance via semi-conservative replication	BP
1	3	1.73267605936	-	1.91e-01	GO:0006576	cellular biogenic amine metabolic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0002820	negative regulation of adaptive immune response	BP
1	3	1.73267605936	-	1.91e-01	GO:0010636	positive regulation of mitochondrial fusion	BP
1	3	1.73267605936	-	1.91e-01	GO:0070970	interleukin-2 secretion	BP
1	3	1.73267605936	-	1.91e-01	GO:0000305	response to oxygen radical	BP
1	3	1.73267605936	-	1.91e-01	GO:0034766	negative regulation of ion transmembrane transport	BP
1	3	1.73267605936	-	1.91e-01	GO:0046885	regulation of hormone biosynthetic process	BP
1	3	1.73267605936	-	1.91e-01	GO:0090271	positive regulation of fibroblast growth factor production	BP
1	3	1.73267605936	-	1.91e-01	GO:0072049	comma-shaped body morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:1902617	response to fluoride	BP
1	3	1.73267605936	-	1.91e-01	GO:0042668	auditory receptor cell fate determination	BP
1	3	1.73267605936	-	1.91e-01	GO:0072044	collecting duct development	BP
1	3	1.73267605936	-	1.91e-01	GO:0071219	cellular response to molecule of bacterial origin	BP
1	3	1.73267605936	-	1.91e-01	GO:0072133	metanephric mesenchyme morphogenesis	BP
1	3	1.73267605936	-	1.91e-01	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	1.73267605936	-	1.91e-01	GO:0021914	negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning	BP
1	3	1.73267605936	-	1.91e-01	GO:1904339	negative regulation of dopaminergic neuron differentiation	BP
1	3	1.73267605936	-	1.91e-01	GO:0061009	common bile duct development	BP
1	3	1.73267605936	-	1.91e-01	GO:1900106	positive regulation of hyaluranon cable assembly	BP
1	3	1.73267605936	-	1.91e-01	GO:0072718	response to cisplatin	BP
1	3	1.73267605936	-	1.91e-01	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	1.73267605936	-	1.91e-01	GO:0042461	photoreceptor cell development	BP
1	3	1.73267605936	-	1.91e-01	GO:0048713	regulation of oligodendrocyte differentiation	BP
1	3	1.73267605936	-	1.91e-01	GO:0048017	inositol lipid-mediated signaling	BP
1	3	1.73267605936	-	1.91e-01	GO:0051647	nucleus localization	BP
1	3	1.73267605936	-	1.91e-01	GO:0060523	prostate epithelial cord elongation	BP
1	3	1.73267605936	-	1.91e-01	GO:0042427	serotonin biosynthetic process	BP
1	3	1.73267605936	-	2.72e-01	GO:1902219	negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress	BP
1	3	1.73267605936	-	2.72e-01	GO:0002331	pre-B cell allelic exclusion	BP
1	3	1.73267605936	-	2.72e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0033262	regulation of nuclear cell cycle DNA replication	BP
1	3	1.73267605936	-	2.72e-01	GO:0035993	deltoid tuberosity development	BP
1	3	1.73267605936	-	2.72e-01	GO:0044346	fibroblast apoptotic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	1.73267605936	-	2.72e-01	GO:0060492	lung induction	BP
1	3	1.73267605936	-	2.72e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	1.73267605936	-	2.72e-01	GO:2001015	negative regulation of skeletal muscle cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0001773	myeloid dendritic cell activation	BP
1	3	1.73267605936	-	2.72e-01	GO:0009994	oocyte differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0071494	cellular response to UV-C	BP
1	3	1.73267605936	-	2.72e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0044774	mitotic DNA integrity checkpoint	BP
1	3	1.73267605936	-	2.72e-01	GO:0003310	pancreatic A cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0090261	positive regulation of inclusion body assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0002513	tolerance induction to self antigen	BP
1	3	1.73267605936	-	2.72e-01	GO:1903748	negative regulation of establishment of protein localization to mitochondrion	BP
1	3	1.73267605936	-	2.72e-01	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	BP
1	3	1.73267605936	-	2.72e-01	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
1	3	1.73267605936	-	2.72e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	1.73267605936	-	2.72e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	1.73267605936	-	2.72e-01	GO:0022602	ovulation cycle process	BP
1	3	1.73267605936	-	2.72e-01	GO:1903202	negative regulation of oxidative stress-induced cell death	BP
1	3	1.73267605936	-	2.72e-01	GO:1903208	negative regulation of hydrogen peroxide-induced neuron death	BP
1	3	1.73267605936	-	2.72e-01	GO:0060414	aorta smooth muscle tissue morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	BP
1	3	1.73267605936	-	2.72e-01	GO:0007500	mesodermal cell fate determination	BP
1	3	1.73267605936	-	2.72e-01	GO:0014043	negative regulation of neuron maturation	BP
1	3	1.73267605936	-	2.72e-01	GO:0014041	regulation of neuron maturation	BP
1	3	1.73267605936	-	2.72e-01	GO:1902803	regulation of synaptic vesicle transport	BP
1	3	1.73267605936	-	2.72e-01	GO:0016553	base conversion or substitution editing	BP
1	3	1.73267605936	-	2.72e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	1.73267605936	-	2.72e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	1.73267605936	-	2.72e-01	GO:0097061	dendritic spine organization	BP
1	3	1.73267605936	-	2.72e-01	GO:0045590	negative regulation of regulatory T cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:1901897	regulation of relaxation of cardiac muscle	BP
1	3	1.73267605936	-	2.72e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	1.73267605936	-	2.72e-01	GO:0060741	prostate gland stromal morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0048936	peripheral nervous system neuron axonogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0022028	tangential migration from the subventricular zone to the olfactory bulb	BP
1	3	1.73267605936	-	2.72e-01	GO:0035284	brain segmentation	BP
1	3	1.73267605936	-	2.72e-01	GO:0021885	forebrain cell migration	BP
1	3	1.73267605936	-	2.72e-01	GO:0010766	negative regulation of sodium ion transport	BP
1	3	1.73267605936	-	2.72e-01	GO:0021773	striatal medium spiny neuron differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	1.73267605936	-	2.72e-01	GO:1990737	response to manganese-induced endoplasmic reticulum stress	BP
1	3	1.73267605936	-	2.72e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:1903542	negative regulation of exosomal secretion	BP
1	3	1.73267605936	-	2.72e-01	GO:0001704	formation of primary germ layer	BP
1	3	1.73267605936	-	2.72e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:2000825	positive regulation of androgen receptor activity	BP
1	3	1.73267605936	-	2.72e-01	GO:0051795	positive regulation of timing of catagen	BP
1	3	1.73267605936	-	2.72e-01	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0003274	endocardial cushion fusion	BP
1	3	1.73267605936	-	2.72e-01	GO:0015722	canalicular bile acid transport	BP
1	3	1.73267605936	-	2.72e-01	GO:1902263	apoptotic process involved in embryonic digit morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0090435	protein localization to nuclear envelope	BP
1	3	1.73267605936	-	2.72e-01	GO:0034140	negative regulation of toll-like receptor 3 signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:2001212	regulation of vasculogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0007352	zygotic specification of dorsal/ventral axis	BP
1	3	1.73267605936	-	2.72e-01	GO:0090259	regulation of retinal ganglion cell axon guidance	BP
1	3	1.73267605936	-	2.72e-01	GO:0048295	positive regulation of isotype switching to IgE isotypes	BP
1	3	1.73267605936	-	2.72e-01	GO:0048298	positive regulation of isotype switching to IgA isotypes	BP
1	3	1.73267605936	-	2.72e-01	GO:0035984	cellular response to trichostatin A	BP
1	3	1.73267605936	-	2.72e-01	GO:0048880	sensory system development	BP
1	3	1.73267605936	-	2.72e-01	GO:0048742	regulation of skeletal muscle fiber development	BP
1	3	1.73267605936	-	2.72e-01	GO:0045351	type I interferon biosynthetic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0045682	regulation of epidermis development	BP
1	3	1.73267605936	-	2.72e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
1	3	1.73267605936	-	2.72e-01	GO:2001258	negative regulation of cation channel activity	BP
1	3	1.73267605936	-	2.72e-01	GO:0038163	thrombopoietin-mediated signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0032692	negative regulation of interleukin-1 production	BP
1	3	1.73267605936	-	2.72e-01	GO:0060374	mast cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0051365	cellular response to potassium ion starvation	BP
1	3	1.73267605936	-	2.72e-01	GO:0046890	regulation of lipid biosynthetic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0072193	ureter smooth muscle cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0090003	regulation of establishment of protein localization to plasma membrane	BP
1	3	1.73267605936	-	2.72e-01	GO:1902306	negative regulation of sodium ion transmembrane transport	BP
1	3	1.73267605936	-	2.72e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	1.73267605936	-	2.72e-01	GO:0006549	isoleucine metabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0000255	allantoin metabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0031060	regulation of histone methylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
1	3	1.73267605936	-	2.72e-01	GO:0060675	ureteric bud morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0048807	female genitalia morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:1901491	negative regulation of lymphangiogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:1904044	response to aldosterone	BP
1	3	1.73267605936	-	2.72e-01	GO:0003157	endocardium development	BP
1	3	1.73267605936	-	2.72e-01	GO:1902856	negative regulation of non-motile cilium assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0090204	protein localization to nuclear pore	BP
1	3	1.73267605936	-	2.72e-01	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	1.73267605936	-	2.72e-01	GO:0039530	MDA-5 signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0070358	actin polymerization-dependent cell motility	BP
1	3	1.73267605936	-	2.72e-01	GO:0060638	mesenchymal-epithelial cell signaling	BP
1	3	1.73267605936	-	2.72e-01	GO:1903421	regulation of synaptic vesicle recycling	BP
1	3	1.73267605936	-	2.72e-01	GO:0051987	positive regulation of attachment of spindle microtubules to kinetochore	BP
1	3	1.73267605936	-	2.72e-01	GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay	BP
1	3	1.73267605936	-	2.72e-01	GO:0090245	axis elongation involved in somitogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0021587	cerebellum morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0030917	midbrain-hindbrain boundary development	BP
1	3	1.73267605936	-	2.72e-01	GO:0070212	protein poly-ADP-ribosylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0045408	regulation of interleukin-6 biosynthetic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0021545	cranial nerve development	BP
1	3	1.73267605936	-	2.72e-01	GO:0048597	post-embryonic camera-type eye morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0032613	interleukin-10 production	BP
1	3	1.73267605936	-	2.72e-01	GO:0060242	contact inhibition	BP
1	3	1.73267605936	-	2.72e-01	GO:1902897	regulation of postsynaptic density protein 95 clustering	BP
1	3	1.73267605936	-	2.72e-01	GO:0023021	termination of signal transduction	BP
1	3	1.73267605936	-	2.72e-01	GO:0042524	negative regulation of tyrosine phosphorylation of Stat5 protein	BP
1	3	1.73267605936	-	2.72e-01	GO:1903551	regulation of extracellular exosome assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0030859	polarized epithelial cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0051788	response to misfolded protein	BP
1	3	1.73267605936	-	2.72e-01	GO:0002291	T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	BP
1	3	1.73267605936	-	2.72e-01	GO:2001170	negative regulation of ATP biosynthetic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0048388	endosomal lumen acidification	BP
1	3	1.73267605936	-	2.72e-01	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0035166	post-embryonic hemopoiesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0072017	distal tubule development	BP
1	3	1.73267605936	-	2.72e-01	GO:0072012	glomerulus vasculature development	BP
1	3	1.73267605936	-	2.72e-01	GO:0090135	actin filament branching	BP
1	3	1.73267605936	-	2.72e-01	GO:0099074	mitochondrion to lysosome transport	BP
1	3	1.73267605936	-	2.72e-01	GO:0032387	negative regulation of intracellular transport	BP
1	3	1.73267605936	-	2.72e-01	GO:0032651	regulation of interleukin-1 beta production	BP
1	3	1.73267605936	-	2.72e-01	GO:0003190	atrioventricular valve formation	BP
1	3	1.73267605936	-	2.72e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0002317	plasma cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:2001033	negative regulation of double-strand break repair via nonhomologous end joining	BP
1	3	1.73267605936	-	2.72e-01	GO:0001754	eye photoreceptor cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:2000504	positive regulation of blood vessel remodeling	BP
1	3	1.73267605936	-	2.72e-01	GO:0033128	negative regulation of histone phosphorylation	BP
1	3	1.73267605936	-	2.72e-01	GO:1902037	negative regulation of hematopoietic stem cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0051294	establishment of spindle orientation	BP
1	3	1.73267605936	-	2.72e-01	GO:0010829	negative regulation of glucose transport	BP
1	3	1.73267605936	-	2.72e-01	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
1	3	1.73267605936	-	2.72e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0071475	cellular hyperosmotic salinity response	BP
1	3	1.73267605936	-	2.72e-01	GO:0000819	sister chromatid segregation	BP
1	3	1.73267605936	-	2.72e-01	GO:1902459	positive regulation of stem cell population maintenance	BP
1	3	1.73267605936	-	2.72e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	1.73267605936	-	2.72e-01	GO:0045123	cellular extravasation	BP
1	3	1.73267605936	-	2.72e-01	GO:0070424	regulation of nucleotide-binding oligomerization domain containing signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:0048858	cell projection morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	1.73267605936	-	2.72e-01	GO:0045163	clustering of voltage-gated potassium channels	BP
1	3	1.73267605936	-	2.72e-01	GO:0071733	transcriptional activation by promoter-enhancer looping	BP
1	3	1.73267605936	-	2.72e-01	GO:0030223	neutrophil differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0034201	response to oleic acid	BP
1	3	1.73267605936	-	2.72e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	1.73267605936	-	2.72e-01	GO:0033687	osteoblast proliferation	BP
1	3	1.73267605936	-	2.72e-01	GO:0060729	intestinal epithelial structure maintenance	BP
1	3	1.73267605936	-	2.72e-01	GO:1905232	cellular response to L-glutamate	BP
1	3	1.73267605936	-	2.72e-01	GO:0032602	chemokine production	BP
1	3	1.73267605936	-	2.72e-01	GO:2000348	regulation of CD40 signaling pathway	BP
1	3	1.73267605936	-	2.72e-01	GO:1901165	positive regulation of trophoblast cell migration	BP
1	3	1.73267605936	-	2.72e-01	GO:0009648	photoperiodism	BP
1	3	1.73267605936	-	2.72e-01	GO:1901315	negative regulation of histone H2A K63-linked ubiquitination	BP
1	3	1.73267605936	-	2.72e-01	GO:2001180	negative regulation of interleukin-10 secretion	BP
1	3	1.73267605936	-	2.72e-01	GO:1902593	single-organism nuclear import	BP
1	3	1.73267605936	-	2.72e-01	GO:0046068	cGMP metabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0045007	depurination	BP
1	3	1.73267605936	-	2.72e-01	GO:0070168	negative regulation of biomineral tissue development	BP
1	3	1.73267605936	-	2.72e-01	GO:0061684	chaperone-mediated autophagy	BP
1	3	1.73267605936	-	2.72e-01	GO:0097286	iron ion import	BP
1	3	1.73267605936	-	2.72e-01	GO:0060480	lung goblet cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:2001027	negative regulation of endothelial cell chemotaxis	BP
1	3	1.73267605936	-	2.72e-01	GO:1900407	regulation of cellular response to oxidative stress	BP
1	3	1.73267605936	-	2.72e-01	GO:0051882	mitochondrial depolarization	BP
1	3	1.73267605936	-	2.72e-01	GO:0097676	histone H3-K36 dimethylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0051154	negative regulation of striated muscle cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0021869	forebrain ventricular zone progenitor cell division	BP
1	3	1.73267605936	-	2.72e-01	GO:0060197	cloacal septation	BP
1	3	1.73267605936	-	2.72e-01	GO:0043009	chordate embryonic development	BP
1	3	1.73267605936	-	2.72e-01	GO:0010992	ubiquitin homeostasis	BP
1	3	1.73267605936	-	2.72e-01	GO:2001271	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	BP
1	3	1.73267605936	-	2.72e-01	GO:0060350	endochondral bone morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0090234	regulation of kinetochore assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
1	3	1.73267605936	-	2.72e-01	GO:1903772	regulation of viral budding via host ESCRT complex	BP
1	3	1.73267605936	-	2.72e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	1.73267605936	-	2.72e-01	GO:0010817	regulation of hormone levels	BP
1	3	1.73267605936	-	2.72e-01	GO:0006562	proline catabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:0042977	activation of JAK2 kinase activity	BP
1	3	1.73267605936	-	2.72e-01	GO:1900226	negative regulation of NLRP3 inflammasome complex assembly	BP
1	3	1.73267605936	-	2.72e-01	GO:0060058	positive regulation of apoptotic process involved in mammary gland involution	BP
1	3	1.73267605936	-	2.72e-01	GO:0010621	negative regulation of transcription by transcription factor localization	BP
1	3	1.73267605936	-	2.72e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	1.73267605936	-	2.72e-01	GO:0043988	histone H3-S28 phosphorylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0070370	cellular heat acclimation	BP
1	3	1.73267605936	-	2.72e-01	GO:0072282	metanephric nephron tubule morphogenesis	BP
1	3	1.73267605936	-	2.72e-01	GO:0019858	cytosine metabolic process	BP
1	3	1.73267605936	-	2.72e-01	GO:1901843	positive regulation of high voltage-gated calcium channel activity	BP
1	3	1.73267605936	-	2.72e-01	GO:0061005	cell differentiation involved in kidney development	BP
1	3	1.73267605936	-	2.72e-01	GO:1904640	response to methionine	BP
1	3	1.73267605936	-	2.72e-01	GO:0097680	double-strand break repair via classical nonhomologous end joining	BP
1	3	1.73267605936	-	2.72e-01	GO:0060221	retinal rod cell differentiation	BP
1	3	1.73267605936	-	2.72e-01	GO:0034969	histone arginine methylation	BP
1	3	1.73267605936	-	2.72e-01	GO:0043137	DNA replication, removal of RNA primer	BP
1	3	1.73267605936	-	2.72e-01	GO:0072034	renal vesicle induction	BP
1	3	1.73267605936	-	2.72e-01	GO:0090118	receptor-mediated endocytosis involved in cholesterol transport	BP
120	360	1.73267605936	-	1.28e-10	GO:0043565	sequence-specific DNA binding	MF
17	51	1.73267605936	-	1.40e-06	GO:0035064	methylated histone binding	MF
8	24	1.73267605936	-	1.24e-03	GO:0032452	histone demethylase activity	MF
8	24	1.73267605936	-	1.70e-03	GO:0003899	DNA-directed 5'-3' RNA polymerase activity	MF
4	12	1.73267605936	-	1.29e-02	GO:0008331	high voltage-gated calcium channel activity	MF
4	12	1.73267605936	-	2.58e-02	GO:0043422	protein kinase B binding	MF
3	9	1.73267605936	-	2.59e-02	GO:0016176	superoxide-generating NADPH oxidase activator activity	MF
3	9	1.73267605936	-	2.59e-02	GO:0071933	Arp2/3 complex binding	MF
3	9	1.73267605936	-	3.83e-02	GO:0046790	virion binding	MF
3	9	1.73267605936	-	5.33e-02	GO:0043995	histone acetyltransferase activity (H4-K5 specific)	MF
3	9	1.73267605936	-	5.33e-02	GO:0043996	histone acetyltransferase activity (H4-K8 specific)	MF
3	9	1.73267605936	-	5.33e-02	GO:0046972	histone acetyltransferase activity (H4-K16 specific)	MF
2	6	1.73267605936	-	8.19e-02	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
2	6	1.73267605936	-	8.19e-02	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
2	6	1.73267605936	-	8.19e-02	GO:0008276	protein methyltransferase activity	MF
2	6	1.73267605936	-	8.19e-02	GO:0070324	thyroid hormone binding	MF
2	6	1.73267605936	-	8.19e-02	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
1	3	1.73267605936	-	1.00e-01	GO:0047844	deoxycytidine deaminase activity	MF
1	3	1.73267605936	-	1.00e-01	GO:0033218	amide binding	MF
2	6	1.73267605936	-	1.15e-01	GO:0004704	NF-kappaB-inducing kinase activity	MF
2	6	1.73267605936	-	1.15e-01	GO:0005168	neurotrophin TRKA receptor binding	MF
2	6	1.73267605936	-	1.15e-01	GO:0046975	histone methyltransferase activity (H3-K36 specific)	MF
2	6	1.73267605936	-	1.15e-01	GO:0032453	histone demethylase activity (H3-K4 specific)	MF
2	6	1.73267605936	-	1.15e-01	GO:0016929	SUMO-specific protease activity	MF
2	6	1.73267605936	-	1.15e-01	GO:0070087	chromo shadow domain binding	MF
2	6	1.73267605936	-	1.15e-01	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0003918	DNA topoisomerase type II (ATP-hydrolyzing) activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0019958	C-X-C chemokine binding	MF
1	3	1.73267605936	-	1.91e-01	GO:0102490	8-oxo-dGTP phosphohydrolase activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0048403	brain-derived neurotrophic factor binding	MF
1	3	1.73267605936	-	1.91e-01	GO:0004370	glycerol kinase activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0002046	opsin binding	MF
1	3	1.73267605936	-	1.91e-01	GO:0035276	ethanol binding	MF
1	3	1.73267605936	-	1.91e-01	GO:0035243	protein-arginine omega-N symmetric methyltransferase activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0016149	translation release factor activity, codon specific	MF
1	3	1.73267605936	-	1.91e-01	GO:0008332	low voltage-gated calcium channel activity	MF
1	3	1.73267605936	-	1.91e-01	GO:0046625	sphingolipid binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0016971	flavin-linked sulfhydryl oxidase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0070139	SUMO-specific endopeptidase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0004505	phenylalanine 4-monooxygenase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0019826	oxygen sensor activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0004351	glutamate decarboxylase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0032549	ribonucleoside binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0034186	apolipoprotein A-I binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0001129	RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly	MF
1	3	1.73267605936	-	2.72e-01	GO:0030172	troponin C binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0016278	lysine N-methyltransferase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0055106	ubiquitin-protein transferase regulator activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0043812	phosphatidylinositol-4-phosphate phosphatase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0050508	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0015616	DNA translocase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0046404	ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0030348	syntaxin-3 binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0044547	DNA topoisomerase binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0035241	protein-arginine omega-N monomethyltransferase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0008330	protein tyrosine/threonine phosphatase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0043120	tumor necrosis factor binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0031826	type 2A serotonin receptor binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0034648	histone demethylase activity (H3-dimethyl-K4 specific)	MF
1	3	1.73267605936	-	2.72e-01	GO:0004711	ribosomal protein S6 kinase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0060090	binding, bridging	MF
1	3	1.73267605936	-	2.72e-01	GO:0042978	ornithine decarboxylase activator activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0004517	nitric-oxide synthase activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0015093	ferrous iron transmembrane transporter activity	MF
1	3	1.73267605936	-	2.72e-01	GO:0070905	serine binding	MF
1	3	1.73267605936	-	2.72e-01	GO:0043139	5'-3' DNA helicase activity	MF
24	73	1.71277650192	-	6.07e-08	GO:0006283	transcription-coupled nucleotide-excision repair	BP
18	55	1.706203848	-	1.72e-07	GO:0042475	odontogenesis of dentin-containing tooth	BP
11	34	1.68960733747	-	1.75e-04	GO:0001837	epithelial to mesenchymal transition	BP
9	28	1.68020863946	-	2.22e-04	GO:0003281	ventricular septum development	BP
9	28	1.68020863946	-	1.18e-03	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
9	28	1.68020863946	-	1.18e-03	GO:0010332	response to gamma radiation	BP
18	56	1.68020863946	-	1.15e-07	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
8	25	1.6737823703	-	1.24e-03	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
8	25	1.6737823703	-	1.24e-03	GO:0060612	adipose tissue development	BP
8	25	1.6737823703	-	2.28e-03	GO:0071353	cellular response to interleukin-4	BP
8	25	1.6737823703	-	2.28e-03	GO:0051149	positive regulation of muscle cell differentiation	BP
14	44	1.6655618635	-	9.30e-06	GO:0003151	outflow tract morphogenesis	BP
7	22	1.6655618635	-	1.71e-03	GO:0071398	cellular response to fatty acid	BP
6	19	1.65467354736	-	3.33e-03	GO:0032332	positive regulation of chondrocyte differentiation	BP
6	19	1.65467354736	-	3.33e-03	GO:0045879	negative regulation of smoothened signaling pathway	BP
6	19	1.65467354736	-	6.47e-03	GO:0046827	positive regulation of protein export from nucleus	BP
10	32	1.63956665497	-	1.17e-04	GO:0030513	positive regulation of BMP signaling pathway	BP
10	32	1.63956665497	-	6.15e-04	GO:0045773	positive regulation of axon extension	BP
5	16	1.63956665497	-	6.51e-03	GO:0050767	regulation of neurogenesis	BP
5	16	1.63956665497	-	1.28e-02	GO:2000811	negative regulation of anoikis	BP
5	16	1.63956665497	-	1.28e-02	GO:2000179	positive regulation of neural precursor cell proliferation	BP
5	16	1.63956665497	-	1.71e-02	GO:0030224	monocyte differentiation	BP
256	824	1.63113803289	-	1.66e-10	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
4	13	1.61719884194	-	1.87e-02	GO:0048546	digestive tract morphogenesis	BP
4	13	1.61719884194	-	1.87e-02	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
4	13	1.61719884194	-	2.58e-02	GO:0045651	positive regulation of macrophage differentiation	BP
4	13	1.61719884194	-	2.58e-02	GO:0051974	negative regulation of telomerase activity	BP
4	13	1.61719884194	-	2.58e-02	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
4	13	1.61719884194	-	3.44e-02	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
4	13	1.61719884194	-	3.44e-02	GO:0048821	erythrocyte development	BP
4	13	1.61719884194	-	3.44e-02	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
4	13	1.61719884194	-	3.44e-02	GO:0042176	regulation of protein catabolic process	BP
4	13	1.61719884194	-	3.44e-02	GO:2000573	positive regulation of DNA biosynthetic process	BP
4	13	1.61719884194	-	3.44e-02	GO:0070986	left/right axis specification	BP
4	13	1.61719884194	-	3.44e-02	GO:0043984	histone H4-K16 acetylation	BP
14	46	1.60143152608	-	1.32e-05	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
14	46	1.60143152608	-	1.84e-05	GO:0051591	response to cAMP	BP
7	23	1.60143152608	-	4.43e-03	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
31	102	1.59940952849	-	7.38e-10	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
10	33	1.59517253561	-	6.15e-04	GO:0045787	positive regulation of cell cycle	BP
9	30	1.58067296591	-	4.61e-04	GO:0071773	cellular response to BMP stimulus	BP
9	30	1.58067296591	-	1.18e-03	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	BP
9	30	1.58067296591	-	1.56e-03	GO:0051879	Hsp90 protein binding	MF
15	50	1.58067296591	-	5.67e-05	GO:0032481	positive regulation of type I interferon production	BP
6	20	1.58067296591	-	3.33e-03	GO:0060716	labyrinthine layer blood vessel development	BP
3	10	1.58067296591	-	8.62e-03	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
6	20	1.58067296591	-	1.14e-02	GO:1900182	positive regulation of protein localization to nucleus	BP
3	10	1.58067296591	-	1.60e-02	GO:0060174	limb bud formation	BP
3	10	1.58067296591	-	2.59e-02	GO:0090009	primitive streak formation	BP
3	10	1.58067296591	-	3.83e-02	GO:2000648	positive regulation of stem cell proliferation	BP
3	10	1.58067296591	-	3.83e-02	GO:0021904	dorsal/ventral neural tube patterning	BP
3	10	1.58067296591	-	5.33e-02	GO:0050880	regulation of blood vessel size	BP
3	10	1.58067296591	-	5.33e-02	GO:1903078	positive regulation of protein localization to plasma membrane	BP
3	10	1.58067296591	-	5.33e-02	GO:0071236	cellular response to antibiotic	BP
3	10	1.58067296591	-	5.33e-02	GO:0033673	negative regulation of kinase activity	BP
3	10	1.58067296591	-	5.33e-02	GO:0003184	pulmonary valve morphogenesis	BP
3	10	1.58067296591	-	5.33e-02	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
3	10	1.58067296591	-	5.33e-02	GO:0007614	short-term memory	BP
3	10	1.58067296591	-	5.33e-02	GO:0046626	regulation of insulin receptor signaling pathway	BP
3	10	1.58067296591	-	5.33e-02	GO:0045793	positive regulation of cell size	BP
3	10	1.58067296591	-	7.06e-02	GO:0051272	positive regulation of cellular component movement	BP
3	10	1.58067296591	-	7.06e-02	GO:0006983	ER overload response	BP
3	10	1.58067296591	-	7.06e-02	GO:0010225	response to UV-C	BP
3	10	1.58067296591	-	7.06e-02	GO:0050678	regulation of epithelial cell proliferation	BP
3	10	1.58067296591	-	7.06e-02	GO:0060546	negative regulation of necroptotic process	BP
3	10	1.58067296591	-	7.06e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
3	10	1.58067296591	-	7.06e-02	GO:0042053	regulation of dopamine metabolic process	BP
6	20	1.58067296591	-	8.67e-03	GO:0030159	receptor signaling complex scaffold activity	MF
3	10	1.58067296591	-	3.83e-02	GO:0001055	RNA polymerase II activity	MF
3	10	1.58067296591	-	3.83e-02	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
50	168	1.56917732707	-	8.95e-11	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
11	37	1.56761681309	-	5.59e-04	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
61	206	1.56187537046	-	8.38e-11	GO:0019904	protein domain specific binding	MF
20	68	1.55210381372	-	4.10e-06	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
5	17	1.55210381372	-	1.28e-02	GO:0001702	gastrulation with mouth forming second	BP
5	17	1.55210381372	-	1.28e-02	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
5	17	1.55210381372	-	1.71e-02	GO:2000778	positive regulation of interleukin-6 secretion	BP
5	17	1.55210381372	-	1.28e-02	GO:0016279	protein-lysine N-methyltransferase activity	MF
5	17	1.55210381372	-	2.23e-02	GO:0071837	HMG box domain binding	MF
7	24	1.54003098141	-	4.43e-03	GO:0055007	cardiac muscle cell differentiation	BP
7	24	1.54003098141	-	4.43e-03	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
28	96	1.54003098141	-	9.94e-08	GO:0047485	protein N-terminus binding	MF
16	55	1.53627884655	-	7.08e-06	GO:0042733	embryonic digit morphogenesis	BP
9	31	1.53336725113	-	3.23e-04	GO:0048701	embryonic cranial skeleton morphogenesis	BP
9	31	1.53336725113	-	1.18e-03	GO:0042220	response to cocaine	BP
9	31	1.53336725113	-	1.18e-03	GO:0030217	T cell differentiation	BP
9	31	1.53336725113	-	2.62e-03	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
14	49	1.51028363802	-	2.26e-04	GO:0051865	protein autoubiquitination	BP
12	42	1.51028363802	-	3.82e-04	GO:1901215	negative regulation of neuron death	BP
6	21	1.51028363802	-	4.71e-03	GO:0001502	cartilage condensation	BP
6	21	1.51028363802	-	6.47e-03	GO:0045672	positive regulation of osteoclast differentiation	BP
6	21	1.51028363802	-	6.47e-03	GO:0046697	decidualization	BP
6	21	1.51028363802	-	1.14e-02	GO:0010165	response to X-ray	BP
4	14	1.51028363802	-	8.40e-03	GO:0021854	hypothalamus development	BP
4	14	1.51028363802	-	1.87e-02	GO:0003407	neural retina development	BP
4	14	1.51028363802	-	2.58e-02	GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
4	14	1.51028363802	-	2.58e-02	GO:0042325	regulation of phosphorylation	BP
2	7	1.51028363802	-	2.81e-02	GO:0006776	vitamin A metabolic process	BP
4	14	1.51028363802	-	3.44e-02	GO:0070528	protein kinase C signaling	BP
2	7	1.51028363802	-	5.26e-02	GO:0014807	regulation of somitogenesis	BP
2	7	1.51028363802	-	5.26e-02	GO:0060831	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
2	7	1.51028363802	-	5.26e-02	GO:0021516	dorsal spinal cord development	BP
2	7	1.51028363802	-	8.19e-02	GO:0072643	interferon-gamma secretion	BP
2	7	1.51028363802	-	8.19e-02	GO:0015844	monoamine transport	BP
2	7	1.51028363802	-	8.19e-02	GO:0006029	proteoglycan metabolic process	BP
2	7	1.51028363802	-	8.19e-02	GO:0003344	pericardium morphogenesis	BP
2	7	1.51028363802	-	8.19e-02	GO:0060736	prostate gland growth	BP
2	7	1.51028363802	-	8.19e-02	GO:0032927	positive regulation of activin receptor signaling pathway	BP
2	7	1.51028363802	-	8.19e-02	GO:0090336	positive regulation of brown fat cell differentiation	BP
2	7	1.51028363802	-	8.19e-02	GO:0051151	negative regulation of smooth muscle cell differentiation	BP
2	7	1.51028363802	-	8.19e-02	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
2	7	1.51028363802	-	1.15e-01	GO:0014009	glial cell proliferation	BP
2	7	1.51028363802	-	1.15e-01	GO:0060998	regulation of dendritic spine development	BP
2	7	1.51028363802	-	1.15e-01	GO:0009629	response to gravity	BP
2	7	1.51028363802	-	1.15e-01	GO:0019048	modulation by virus of host morphology or physiology	BP
2	7	1.51028363802	-	1.15e-01	GO:2000049	positive regulation of cell-cell adhesion mediated by cadherin	BP
2	7	1.51028363802	-	1.15e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
2	7	1.51028363802	-	1.15e-01	GO:0032411	positive regulation of transporter activity	BP
2	7	1.51028363802	-	1.15e-01	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
2	7	1.51028363802	-	1.15e-01	GO:0060576	intestinal epithelial cell development	BP
2	7	1.51028363802	-	1.15e-01	GO:0090140	regulation of mitochondrial fission	BP
2	7	1.51028363802	-	1.15e-01	GO:0050861	positive regulation of B cell receptor signaling pathway	BP
2	7	1.51028363802	-	1.15e-01	GO:1902004	positive regulation of beta-amyloid formation	BP
2	7	1.51028363802	-	1.15e-01	GO:0060972	left/right pattern formation	BP
2	7	1.51028363802	-	1.15e-01	GO:0014902	myotube differentiation	BP
2	7	1.51028363802	-	1.15e-01	GO:0008366	axon ensheathment	BP
2	7	1.51028363802	-	1.50e-01	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0019896	axonal transport of mitochondrion	BP
2	7	1.51028363802	-	1.50e-01	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0045955	negative regulation of calcium ion-dependent exocytosis	BP
2	7	1.51028363802	-	1.50e-01	GO:0034340	response to type I interferon	BP
2	7	1.51028363802	-	1.50e-01	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	BP
2	7	1.51028363802	-	1.50e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0001783	B cell apoptotic process	BP
2	7	1.51028363802	-	1.50e-01	GO:2000177	regulation of neural precursor cell proliferation	BP
2	7	1.51028363802	-	1.50e-01	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
2	7	1.51028363802	-	1.50e-01	GO:0043405	regulation of MAP kinase activity	BP
2	7	1.51028363802	-	1.50e-01	GO:0048102	autophagic cell death	BP
2	7	1.51028363802	-	1.50e-01	GO:0031340	positive regulation of vesicle fusion	BP
2	7	1.51028363802	-	1.50e-01	GO:0002438	acute inflammatory response to antigenic stimulus	BP
2	7	1.51028363802	-	1.50e-01	GO:0048699	generation of neurons	BP
2	7	1.51028363802	-	1.50e-01	GO:0032966	negative regulation of collagen biosynthetic process	BP
2	7	1.51028363802	-	1.50e-01	GO:0006348	chromatin silencing at telomere	BP
2	7	1.51028363802	-	1.50e-01	GO:0071636	positive regulation of transforming growth factor beta production	BP
2	7	1.51028363802	-	1.50e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0060008	Sertoli cell differentiation	BP
2	7	1.51028363802	-	1.50e-01	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0031642	negative regulation of myelination	BP
2	7	1.51028363802	-	1.50e-01	GO:2000347	positive regulation of hepatocyte proliferation	BP
2	7	1.51028363802	-	1.50e-01	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
2	7	1.51028363802	-	1.50e-01	GO:0048702	embryonic neurocranium morphogenesis	BP
2	7	1.51028363802	-	1.50e-01	GO:0048708	astrocyte differentiation	BP
2	7	1.51028363802	-	1.50e-01	GO:0031497	chromatin assembly	BP
2	7	1.51028363802	-	1.50e-01	GO:0016926	protein desumoylation	BP
2	7	1.51028363802	-	1.50e-01	GO:0071447	cellular response to hydroperoxide	BP
2	7	1.51028363802	-	1.50e-01	GO:0070417	cellular response to cold	BP
2	7	1.51028363802	-	1.50e-01	GO:1900016	negative regulation of cytokine production involved in inflammatory response	BP
2	7	1.51028363802	-	1.50e-01	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
2	7	1.51028363802	-	1.50e-01	GO:0010669	epithelial structure maintenance	BP
4	14	1.51028363802	-	4.45e-02	GO:0070063	RNA polymerase binding	MF
4	14	1.51028363802	-	4.45e-02	GO:0034236	protein kinase A catalytic subunit binding	MF
2	7	1.51028363802	-	8.19e-02	GO:0005501	retinoid binding	MF
2	7	1.51028363802	-	8.19e-02	GO:0015271	outward rectifier potassium channel activity	MF
2	7	1.51028363802	-	1.15e-01	GO:0001848	complement binding	MF
2	7	1.51028363802	-	1.50e-01	GO:0097157	pre-mRNA intronic binding	MF
2	7	1.51028363802	-	1.50e-01	GO:0044389	ubiquitin-like protein ligase binding	MF
2	7	1.51028363802	-	1.50e-01	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
2	7	1.51028363802	-	1.50e-01	GO:0019209	kinase activator activity	MF
2	7	1.51028363802	-	1.50e-01	GO:0004691	cAMP-dependent protein kinase activity	MF
9	32	1.48756356152	-	3.32e-03	GO:0070911	global genome nucleotide-excision repair	BP
9	32	1.48756356152	-	3.32e-03	GO:0097421	liver regeneration	BP
25	89	1.48576131889	-	3.01e-07	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
21	75	1.48113729236	-	3.65e-06	GO:0016925	protein sumoylation	BP
7	25	1.48113729236	-	7.52e-03	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
27	97	1.47261322005	-	6.65e-08	GO:0051726	regulation of cell cycle	BP
10	36	1.46964165352	-	4.57e-04	GO:0001568	blood vessel development	BP
5	18	1.46964165352	-	2.23e-02	GO:1990138	neuron projection extension	BP
5	18	1.46964165352	-	2.23e-02	GO:0001894	tissue homeostasis	BP
5	18	1.46964165352	-	2.23e-02	GO:0051412	response to corticosterone	BP
5	18	1.46964165352	-	2.23e-02	GO:0050870	positive regulation of T cell activation	BP
5	18	1.46964165352	-	2.84e-02	GO:0035904	aorta development	BP
5	18	1.46964165352	-	2.84e-02	GO:0003678	DNA helicase activity	MF
8	29	1.45965756495	-	3.01e-03	GO:0010033	response to organic substance	BP
8	29	1.45965756495	-	3.90e-03	GO:0000060	protein import into nucleus, translocation	BP
8	29	1.45965756495	-	3.90e-03	GO:0006284	base-excision repair	BP
8	29	1.45965756495	-	6.30e-03	GO:0006513	protein monoubiquitination	BP
8	29	1.45965756495	-	6.30e-03	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
8	29	1.45965756495	-	4.99e-03	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
11	40	1.45514208383	-	7.24e-04	GO:0045668	negative regulation of osteoblast differentiation	BP
17	62	1.45090509094	-	2.73e-06	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
20	73	1.44974209609	-	8.68e-06	GO:0001843	neural tube closure	BP
12	44	1.44316944216	-	1.68e-04	GO:0030178	negative regulation of Wnt signaling pathway	BP
6	22	1.44316944216	-	1.14e-02	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
6	22	1.44316944216	-	1.46e-02	GO:0071480	cellular response to gamma radiation	BP
3	11	1.44316944216	-	1.60e-02	GO:0070166	enamel mineralization	BP
6	22	1.44316944216	-	1.84e-02	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
3	11	1.44316944216	-	2.59e-02	GO:0002064	epithelial cell development	BP
3	11	1.44316944216	-	3.83e-02	GO:0002089	lens morphogenesis in camera-type eye	BP
3	11	1.44316944216	-	5.33e-02	GO:0010389	regulation of G2/M transition of mitotic cell cycle	BP
3	11	1.44316944216	-	5.33e-02	GO:0055078	sodium ion homeostasis	BP
3	11	1.44316944216	-	5.33e-02	GO:0022409	positive regulation of cell-cell adhesion	BP
3	11	1.44316944216	-	5.33e-02	GO:0072520	seminiferous tubule development	BP
3	11	1.44316944216	-	7.06e-02	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
3	11	1.44316944216	-	7.06e-02	GO:0051764	actin crosslink formation	BP
3	11	1.44316944216	-	7.06e-02	GO:0048484	enteric nervous system development	BP
3	11	1.44316944216	-	7.06e-02	GO:0001823	mesonephros development	BP
3	11	1.44316944216	-	7.06e-02	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
3	11	1.44316944216	-	7.06e-02	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
3	11	1.44316944216	-	7.06e-02	GO:0048711	positive regulation of astrocyte differentiation	BP
3	11	1.44316944216	-	7.06e-02	GO:0060218	hematopoietic stem cell differentiation	BP
3	11	1.44316944216	-	9.01e-02	GO:0043249	erythrocyte maturation	BP
3	11	1.44316944216	-	9.01e-02	GO:0002031	G-protein coupled receptor internalization	BP
3	11	1.44316944216	-	9.01e-02	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
3	11	1.44316944216	-	9.01e-02	GO:0006266	DNA ligation	BP
3	11	1.44316944216	-	9.01e-02	GO:0035970	peptidyl-threonine dephosphorylation	BP
3	11	1.44316944216	-	9.01e-02	GO:0033120	positive regulation of RNA splicing	BP
3	11	1.44316944216	-	3.83e-02	GO:0035925	mRNA 3'-UTR AU-rich region binding	MF
3	11	1.44316944216	-	5.33e-02	GO:0005548	phospholipid transporter activity	MF
3	11	1.44316944216	-	7.06e-02	GO:0050786	RAGE receptor binding	MF
9	33	1.44316944216	-	1.18e-03	GO:0003007	heart morphogenesis	BP
9	33	1.44316944216	-	3.32e-03	GO:0051973	positive regulation of telomerase activity	BP
21	77	1.44316944216	-	9.70e-07	GO:0016301	kinase activity	MF
19	70	1.43628305658	-	9.89e-06	GO:0001889	liver development	BP
13	48	1.4331157775	-	3.49e-05	GO:0045600	positive regulation of fat cell differentiation	BP
13	48	1.4331157775	-	2.02e-04	GO:0034097	response to cytokine	BP
10	37	1.43011328934	-	1.75e-03	GO:0048469	cell maturation	BP
10	37	1.43011328934	-	2.77e-03	GO:0007257	activation of JUN kinase activity	BP
55	204	1.42657293163	-	5.38e-11	GO:0006974	cellular response to DNA damage stimulus	BP
7	26	1.42455376399	-	4.43e-03	GO:0019216	regulation of lipid metabolic process	BP
7	26	1.42455376399	-	4.43e-03	GO:0070328	triglyceride homeostasis	BP
7	26	1.42455376399	-	5.82e-03	GO:0048709	oligodendrocyte differentiation	BP
7	26	1.42455376399	-	1.20e-02	GO:0051721	protein phosphatase 2A binding	MF
18	67	1.42147437106	-	1.85e-05	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
11	41	1.4195181741	-	5.59e-04	GO:0007566	embryo implantation	BP
11	41	1.4195181741	-	9.28e-04	GO:0007595	lactation	BP
11	41	1.4195181741	-	1.18e-03	GO:0045740	positive regulation of DNA replication	BP
11	41	1.4195181741	-	1.48e-03	GO:0030218	erythrocyte differentiation	BP
51	191	1.41263507401	-	5.19e-11	GO:0004672	protein kinase activity	MF
8	30	1.41074796447	-	1.70e-03	GO:0030901	midbrain development	BP
8	30	1.41074796447	-	2.28e-03	GO:0031667	response to nutrient levels	BP
8	30	1.41074796447	-	3.01e-03	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
4	15	1.41074796447	-	2.58e-02	GO:0048485	sympathetic nervous system development	BP
4	15	1.41074796447	-	2.58e-02	GO:0030279	negative regulation of ossification	BP
4	15	1.41074796447	-	3.44e-02	GO:0060347	heart trabecula formation	BP
4	15	1.41074796447	-	3.44e-02	GO:0044849	estrous cycle	BP
4	15	1.41074796447	-	4.45e-02	GO:0071850	mitotic cell cycle arrest	BP
4	15	1.41074796447	-	4.45e-02	GO:0030502	negative regulation of bone mineralization	BP
4	15	1.41074796447	-	4.45e-02	GO:0000729	DNA double-strand break processing	BP
4	15	1.41074796447	-	4.45e-02	GO:0050768	negative regulation of neurogenesis	BP
4	15	1.41074796447	-	5.60e-02	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
4	15	1.41074796447	-	5.60e-02	GO:0051393	alpha-actinin binding	MF
17	64	1.40510140133	-	4.41e-05	GO:0018107	peptidyl-threonine phosphorylation	BP
9	34	1.40010072027	-	4.17e-03	GO:0010634	positive regulation of epithelial cell migration	BP
10	38	1.39163914152	-	6.15e-04	GO:0001657	ureteric bud development	BP
5	19	1.39163914152	-	2.84e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
5	19	1.39163914152	-	9.31e-03	GO:0051213	dioxygenase activity	MF
121	460	1.39101174641	-	1.78e-10	GO:0046982	protein heterodimerization activity	MF
41	156	1.38978834583	-	4.62e-10	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
18	69	1.37903910474	-	1.85e-05	GO:0045444	fat cell differentiation	BP
6	23	1.37903910474	-	1.46e-02	GO:0070371	ERK1 and ERK2 cascade	BP
6	23	1.37903910474	-	1.84e-02	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
6	23	1.37903910474	-	1.84e-02	GO:0071889	14-3-3 protein binding	MF
13	50	1.37422208844	-	3.33e-04	GO:0048146	positive regulation of fibroblast proliferation	BP
20	77	1.37278011427	-	4.10e-06	GO:0060070	canonical Wnt signaling pathway	BP
7	27	1.37010597997	-	2.41e-03	GO:0045746	negative regulation of Notch signaling pathway	BP
8	31	1.36344224969	-	9.67e-03	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
9	35	1.35828054458	-	4.17e-03	GO:0045786	negative regulation of cell cycle	BP
9	35	1.35828054458	-	5.17e-03	GO:0031648	protein destabilization	BP
28	109	1.35680915736	-	9.69e-07	GO:0000082	G1/S transition of mitotic cell cycle	BP
29	113	1.35544059279	-	4.30e-07	GO:0071222	cellular response to lipopolysaccharide	BP
34	133	1.34981896583	-	1.72e-07	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
37	145	1.34718283569	-	2.38e-08	GO:0018105	peptidyl-serine phosphorylation	BP
14	55	1.34363376861	-	1.38e-04	GO:0001570	vasculogenesis	BP
15	59	1.34188610632	-	3.68e-04	GO:0031398	positive regulation of protein ubiquitination	BP
16	63	1.34035863658	-	3.91e-05	GO:0043627	response to estrogen	BP
16	63	1.34035863658	-	3.02e-04	GO:0019903	protein phosphatase binding	MF
28	111	1.33057761579	-	7.74e-08	GO:0007219	Notch signaling pathway	BP
35	139	1.3279805043	-	1.14e-08	GO:0007050	cell cycle arrest	BP
15	60	1.31763856008	-	1.93e-04	GO:0034599	cellular response to oxidative stress	BP
11	44	1.31763856008	-	3.21e-04	GO:0048666	neuron development	BP
14	56	1.31763856008	-	6.74e-04	GO:0032091	negative regulation of protein binding	BP
12	48	1.31763856008	-	1.23e-03	GO:0019827	stem cell population maintenance	BP
9	36	1.31763856008	-	3.32e-03	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
9	36	1.31763856008	-	4.17e-03	GO:0071392	cellular response to estradiol stimulus	BP
6	24	1.31763856008	-	8.67e-03	GO:0048589	developmental growth	BP
7	28	1.31763856008	-	1.48e-02	GO:0050434	positive regulation of viral transcription	BP
7	28	1.31763856008	-	1.81e-02	GO:0000077	DNA damage checkpoint	BP
6	24	1.31763856008	-	1.84e-02	GO:0071345	cellular response to cytokine stimulus	BP
6	24	1.31763856008	-	1.84e-02	GO:0007569	cell aging	BP
6	24	1.31763856008	-	2.79e-02	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
3	12	1.31763856008	-	7.06e-02	GO:0001706	endoderm formation	BP
3	12	1.31763856008	-	7.06e-02	GO:0002437	inflammatory response to antigenic stimulus	BP
3	12	1.31763856008	-	7.06e-02	GO:0045670	regulation of osteoclast differentiation	BP
3	12	1.31763856008	-	7.06e-02	GO:0050868	negative regulation of T cell activation	BP
3	12	1.31763856008	-	7.06e-02	GO:0046622	positive regulation of organ growth	BP
3	12	1.31763856008	-	7.06e-02	GO:0090399	replicative senescence	BP
3	12	1.31763856008	-	9.01e-02	GO:1900181	negative regulation of protein localization to nucleus	BP
3	12	1.31763856008	-	9.01e-02	GO:0010763	positive regulation of fibroblast migration	BP
3	12	1.31763856008	-	9.01e-02	GO:2000505	regulation of energy homeostasis	BP
3	12	1.31763856008	-	9.01e-02	GO:0071361	cellular response to ethanol	BP
3	12	1.31763856008	-	1.12e-01	GO:0055008	cardiac muscle tissue morphogenesis	BP
3	12	1.31763856008	-	1.12e-01	GO:0034329	cell junction assembly	BP
3	12	1.31763856008	-	7.06e-02	GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	MF
3	12	1.31763856008	-	9.01e-02	GO:0050321	tau-protein kinase activity	MF
3	12	1.31763856008	-	1.12e-01	GO:0048185	activin binding	MF
10	40	1.31763856008	-	2.77e-03	GO:0032024	positive regulation of insulin secretion	BP
8	32	1.31763856008	-	7.85e-03	GO:0070555	response to interleukin-1	BP
5	20	1.31763856008	-	1.71e-02	GO:0032753	positive regulation of interleukin-4 production	BP
5	20	1.31763856008	-	1.71e-02	GO:0007520	myoblast fusion	BP
4	16	1.31763856008	-	2.58e-02	GO:0032924	activin receptor signaling pathway	BP
5	20	1.31763856008	-	2.84e-02	GO:0097150	neuronal stem cell population maintenance	BP
5	20	1.31763856008	-	2.84e-02	GO:0043113	receptor clustering	BP
4	16	1.31763856008	-	3.44e-02	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
4	16	1.31763856008	-	3.44e-02	GO:0070509	calcium ion import	BP
5	20	1.31763856008	-	3.55e-02	GO:0045662	negative regulation of myoblast differentiation	BP
5	20	1.31763856008	-	4.35e-02	GO:0042326	negative regulation of phosphorylation	BP
5	20	1.31763856008	-	4.35e-02	GO:0008361	regulation of cell size	BP
2	8	1.31763856008	-	5.26e-02	GO:2000781	positive regulation of double-strand break repair	BP
2	8	1.31763856008	-	5.26e-02	GO:0006690	icosanoid metabolic process	BP
4	16	1.31763856008	-	6.89e-02	GO:0031396	regulation of protein ubiquitination	BP
2	8	1.31763856008	-	8.19e-02	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
2	8	1.31763856008	-	8.19e-02	GO:0003073	regulation of systemic arterial blood pressure	BP
2	8	1.31763856008	-	8.19e-02	GO:0071313	cellular response to caffeine	BP
1	4	1.31763856008	-	1.00e-01	GO:0048859	formation of anatomical boundary	BP
2	8	1.31763856008	-	1.15e-01	GO:0071800	podosome assembly	BP
2	8	1.31763856008	-	1.15e-01	GO:0060346	bone trabecula formation	BP
2	8	1.31763856008	-	1.15e-01	GO:0040016	embryonic cleavage	BP
2	8	1.31763856008	-	1.15e-01	GO:1904948	midbrain dopaminergic neuron differentiation	BP
2	8	1.31763856008	-	1.15e-01	GO:0007494	midgut development	BP
2	8	1.31763856008	-	1.15e-01	GO:0043129	surfactant homeostasis	BP
2	8	1.31763856008	-	1.15e-01	GO:0048339	paraxial mesoderm development	BP
2	8	1.31763856008	-	1.50e-01	GO:0000012	single strand break repair	BP
2	8	1.31763856008	-	1.50e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
2	8	1.31763856008	-	1.50e-01	GO:0051103	DNA ligation involved in DNA repair	BP
2	8	1.31763856008	-	1.50e-01	GO:0040019	positive regulation of embryonic development	BP
2	8	1.31763856008	-	1.50e-01	GO:0042119	neutrophil activation	BP
2	8	1.31763856008	-	1.50e-01	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
2	8	1.31763856008	-	1.50e-01	GO:0006356	regulation of transcription from RNA polymerase I promoter	BP
2	8	1.31763856008	-	1.50e-01	GO:0048312	intracellular distribution of mitochondria	BP
2	8	1.31763856008	-	1.50e-01	GO:0033993	response to lipid	BP
2	8	1.31763856008	-	1.50e-01	GO:0001818	negative regulation of cytokine production	BP
2	8	1.31763856008	-	1.50e-01	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
2	8	1.31763856008	-	1.50e-01	GO:0050702	interleukin-1 beta secretion	BP
2	8	1.31763856008	-	1.50e-01	GO:0050663	cytokine secretion	BP
2	8	1.31763856008	-	1.50e-01	GO:0070544	histone H3-K36 demethylation	BP
2	8	1.31763856008	-	1.50e-01	GO:0009062	fatty acid catabolic process	BP
2	8	1.31763856008	-	1.50e-01	GO:0060253	negative regulation of glial cell proliferation	BP
2	8	1.31763856008	-	1.50e-01	GO:0015908	fatty acid transport	BP
2	8	1.31763856008	-	1.88e-01	GO:0071493	cellular response to UV-B	BP
2	8	1.31763856008	-	1.88e-01	GO:0050687	negative regulation of defense response to virus	BP
2	8	1.31763856008	-	1.88e-01	GO:0032731	positive regulation of interleukin-1 beta production	BP
2	8	1.31763856008	-	1.88e-01	GO:0072577	endothelial cell apoptotic process	BP
2	8	1.31763856008	-	1.88e-01	GO:0075713	establishment of integrated proviral latency	BP
2	8	1.31763856008	-	1.88e-01	GO:0032463	negative regulation of protein homooligomerization	BP
2	8	1.31763856008	-	1.88e-01	GO:0035234	ectopic germ cell programmed cell death	BP
2	8	1.31763856008	-	1.88e-01	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
2	8	1.31763856008	-	1.88e-01	GO:0002674	negative regulation of acute inflammatory response	BP
2	8	1.31763856008	-	1.88e-01	GO:0048762	mesenchymal cell differentiation	BP
2	8	1.31763856008	-	1.88e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
2	8	1.31763856008	-	1.88e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
2	8	1.31763856008	-	1.88e-01	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
2	8	1.31763856008	-	1.88e-01	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
2	8	1.31763856008	-	1.88e-01	GO:0016574	histone ubiquitination	BP
2	8	1.31763856008	-	1.88e-01	GO:0060396	growth hormone receptor signaling pathway	BP
2	8	1.31763856008	-	1.88e-01	GO:0034720	histone H3-K4 demethylation	BP
2	8	1.31763856008	-	1.88e-01	GO:0045008	depyrimidination	BP
2	8	1.31763856008	-	1.88e-01	GO:0014732	skeletal muscle atrophy	BP
2	8	1.31763856008	-	1.88e-01	GO:0033151	V(D)J recombination	BP
2	8	1.31763856008	-	1.88e-01	GO:0071312	cellular response to alkaloid	BP
1	4	1.31763856008	-	1.91e-01	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	1.31763856008	-	1.91e-01	GO:0051725	protein de-ADP-ribosylation	BP
1	4	1.31763856008	-	1.91e-01	GO:0051447	negative regulation of meiotic cell cycle	BP
1	4	1.31763856008	-	1.91e-01	GO:0021575	hindbrain morphogenesis	BP
1	4	1.31763856008	-	1.91e-01	GO:0046684	response to pyrethroid	BP
1	4	1.31763856008	-	1.91e-01	GO:1901657	glycosyl compound metabolic process	BP
1	4	1.31763856008	-	1.91e-01	GO:0043587	tongue morphogenesis	BP
1	4	1.31763856008	-	1.91e-01	GO:0060214	endocardium formation	BP
1	4	1.31763856008	-	1.91e-01	GO:0021555	midbrain-hindbrain boundary morphogenesis	BP
1	4	1.31763856008	-	1.91e-01	GO:0021759	globus pallidus development	BP
1	4	1.31763856008	-	1.91e-01	GO:0007386	compartment pattern specification	BP
1	4	1.31763856008	-	2.72e-01	GO:0048731	system development	BP
1	4	1.31763856008	-	2.72e-01	GO:0036438	maintenance of lens transparency	BP
1	4	1.31763856008	-	2.72e-01	GO:0086016	AV node cell action potential	BP
1	4	1.31763856008	-	2.72e-01	GO:0006663	platelet activating factor biosynthetic process	BP
1	4	1.31763856008	-	2.72e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	1.31763856008	-	2.72e-01	GO:0008211	glucocorticoid metabolic process	BP
1	4	1.31763856008	-	2.72e-01	GO:0031547	brain-derived neurotrophic factor receptor signaling pathway	BP
1	4	1.31763856008	-	2.72e-01	GO:0060965	negative regulation of gene silencing by miRNA	BP
1	4	1.31763856008	-	2.72e-01	GO:0009987	cellular process	BP
1	4	1.31763856008	-	2.72e-01	GO:0007442	hindgut morphogenesis	BP
1	4	1.31763856008	-	2.72e-01	GO:0001826	inner cell mass cell differentiation	BP
1	4	1.31763856008	-	2.72e-01	GO:0003338	metanephros morphogenesis	BP
1	4	1.31763856008	-	2.72e-01	GO:0035502	metanephric part of ureteric bud development	BP
1	4	1.31763856008	-	2.72e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	1.31763856008	-	2.72e-01	GO:0072144	glomerular mesangial cell development	BP
1	4	1.31763856008	-	2.72e-01	GO:0072676	lymphocyte migration	BP
1	4	1.31763856008	-	2.72e-01	GO:0003272	endocardial cushion formation	BP
1	4	1.31763856008	-	2.72e-01	GO:0003273	cell migration involved in endocardial cushion formation	BP
1	4	1.31763856008	-	2.72e-01	GO:1902261	positive regulation of delayed rectifier potassium channel activity	BP
1	4	1.31763856008	-	2.72e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	4	1.31763856008	-	2.72e-01	GO:0003231	cardiac ventricle development	BP
1	4	1.31763856008	-	2.72e-01	GO:0002360	T cell lineage commitment	BP
1	4	1.31763856008	-	2.72e-01	GO:0060429	epithelium development	BP
1	4	1.31763856008	-	2.72e-01	GO:0032100	positive regulation of appetite	BP
1	4	1.31763856008	-	2.72e-01	GO:0006779	porphyrin-containing compound biosynthetic process	BP
1	4	1.31763856008	-	2.72e-01	GO:0070317	negative regulation of G0 to G1 transition	BP
1	4	1.31763856008	-	2.72e-01	GO:0048808	male genitalia morphogenesis	BP
1	4	1.31763856008	-	2.72e-01	GO:0015842	aminergic neurotransmitter loading into synaptic vesicle	BP
1	4	1.31763856008	-	2.72e-01	GO:0046726	positive regulation by virus of viral protein levels in host cell	BP
1	4	1.31763856008	-	2.72e-01	GO:0002677	negative regulation of chronic inflammatory response	BP
1	4	1.31763856008	-	2.72e-01	GO:1900127	positive regulation of hyaluronan biosynthetic process	BP
1	4	1.31763856008	-	2.72e-01	GO:0060244	negative regulation of cell proliferation involved in contact inhibition	BP
1	4	1.31763856008	-	2.72e-01	GO:0044245	polysaccharide digestion	BP
1	4	1.31763856008	-	2.72e-01	GO:0021979	hypothalamus cell differentiation	BP
1	4	1.31763856008	-	2.72e-01	GO:0035634	response to stilbenoid	BP
1	4	1.31763856008	-	2.72e-01	GO:0070741	response to interleukin-6	BP
1	4	1.31763856008	-	2.72e-01	GO:0007320	insemination	BP
1	4	1.31763856008	-	2.72e-01	GO:0061156	pulmonary artery morphogenesis	BP
1	4	1.31763856008	-	2.72e-01	GO:0048133	male germ-line stem cell asymmetric division	BP
1	4	1.31763856008	-	2.72e-01	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
1	4	1.31763856008	-	2.72e-01	GO:0014028	notochord formation	BP
1	4	1.31763856008	-	2.72e-01	GO:0060043	regulation of cardiac muscle cell proliferation	BP
1	4	1.31763856008	-	2.72e-01	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
1	4	1.31763856008	-	2.72e-01	GO:0060684	epithelial-mesenchymal cell signaling	BP
1	4	1.31763856008	-	2.72e-01	GO:0090370	negative regulation of cholesterol efflux	BP
1	4	1.31763856008	-	2.72e-01	GO:1904888	cranial skeletal system development	BP
1	4	1.31763856008	-	2.72e-01	GO:0032392	DNA geometric change	BP
1	4	1.31763856008	-	2.72e-01	GO:0046629	gamma-delta T cell activation	BP
1	4	1.31763856008	-	2.72e-01	GO:2000672	negative regulation of motor neuron apoptotic process	BP
1	4	1.31763856008	-	2.72e-01	GO:0090184	positive regulation of kidney development	BP
1	4	1.31763856008	-	2.72e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	1.31763856008	-	2.72e-01	GO:2000021	regulation of ion homeostasis	BP
1	4	1.31763856008	-	2.72e-01	GO:0060613	fat pad development	BP
1	4	1.31763856008	-	2.72e-01	GO:0045759	negative regulation of action potential	BP
1	4	1.31763856008	-	2.72e-01	GO:0010453	regulation of cell fate commitment	BP
1	4	1.31763856008	-	2.72e-01	GO:0014827	intestine smooth muscle contraction	BP
1	4	1.31763856008	-	2.72e-01	GO:0021891	olfactory bulb interneuron development	BP
1	4	1.31763856008	-	2.72e-01	GO:0016321	female meiosis chromosome segregation	BP
1	4	1.31763856008	-	3.45e-01	GO:0060263	regulation of respiratory burst	BP
1	4	1.31763856008	-	3.45e-01	GO:0002455	humoral immune response mediated by circulating immunoglobulin	BP
1	4	1.31763856008	-	3.45e-01	GO:0033522	histone H2A ubiquitination	BP
1	4	1.31763856008	-	3.45e-01	GO:0045077	negative regulation of interferon-gamma biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0031507	heterochromatin assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	4	1.31763856008	-	3.45e-01	GO:0071801	regulation of podosome assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0010523	negative regulation of calcium ion transport into cytosol	BP
1	4	1.31763856008	-	3.45e-01	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0035799	ureter maturation	BP
1	4	1.31763856008	-	3.45e-01	GO:0051147	regulation of muscle cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0055118	negative regulation of cardiac muscle contraction	BP
1	4	1.31763856008	-	3.45e-01	GO:0035655	interleukin-18-mediated signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:2001269	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	1.31763856008	-	3.45e-01	GO:0070445	regulation of oligodendrocyte progenitor proliferation	BP
1	4	1.31763856008	-	3.45e-01	GO:0043242	negative regulation of protein complex disassembly	BP
1	4	1.31763856008	-	3.45e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	4	1.31763856008	-	3.45e-01	GO:0051106	positive regulation of DNA ligation	BP
1	4	1.31763856008	-	3.45e-01	GO:0042159	lipoprotein catabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0097029	mature conventional dendritic cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
1	4	1.31763856008	-	3.45e-01	GO:0072107	positive regulation of ureteric bud formation	BP
1	4	1.31763856008	-	3.45e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	4	1.31763856008	-	3.45e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	1.31763856008	-	3.45e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	1.31763856008	-	3.45e-01	GO:2001137	positive regulation of endocytic recycling	BP
1	4	1.31763856008	-	3.45e-01	GO:0065002	intracellular protein transmembrane transport	BP
1	4	1.31763856008	-	3.45e-01	GO:1990966	ATP generation from poly-ADP-D-ribose	BP
1	4	1.31763856008	-	3.45e-01	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
1	4	1.31763856008	-	3.45e-01	GO:0002741	positive regulation of cytokine secretion involved in immune response	BP
1	4	1.31763856008	-	3.45e-01	GO:0060513	prostatic bud formation	BP
1	4	1.31763856008	-	3.45e-01	GO:0090168	Golgi reassembly	BP
1	4	1.31763856008	-	3.45e-01	GO:0010155	regulation of proton transport	BP
1	4	1.31763856008	-	3.45e-01	GO:0048023	positive regulation of melanin biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0031394	positive regulation of prostaglandin biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0003186	tricuspid valve morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0046602	regulation of mitotic centrosome separation	BP
1	4	1.31763856008	-	3.45e-01	GO:0038127	ERBB signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0061333	renal tubule morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0030174	regulation of DNA-dependent DNA replication initiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0048318	axial mesoderm development	BP
1	4	1.31763856008	-	3.45e-01	GO:0045964	positive regulation of dopamine metabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0003104	positive regulation of glomerular filtration	BP
1	4	1.31763856008	-	3.45e-01	GO:0060421	positive regulation of heart growth	BP
1	4	1.31763856008	-	3.45e-01	GO:0010835	regulation of protein ADP-ribosylation	BP
1	4	1.31763856008	-	3.45e-01	GO:2001044	regulation of integrin-mediated signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:1905323	telomerase holoenzyme complex assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:0032375	negative regulation of cholesterol transport	BP
1	4	1.31763856008	-	3.45e-01	GO:0070318	positive regulation of G0 to G1 transition	BP
1	4	1.31763856008	-	3.45e-01	GO:0060676	ureteric bud formation	BP
1	4	1.31763856008	-	3.45e-01	GO:0051138	positive regulation of NK T cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0007089	traversing start control point of mitotic cell cycle	BP
1	4	1.31763856008	-	3.45e-01	GO:0007161	calcium-independent cell-matrix adhesion	BP
1	4	1.31763856008	-	3.45e-01	GO:2000491	positive regulation of hepatic stellate cell activation	BP
1	4	1.31763856008	-	3.45e-01	GO:0043570	maintenance of DNA repeat elements	BP
1	4	1.31763856008	-	3.45e-01	GO:0044791	positive regulation by host of viral release from host cell	BP
1	4	1.31763856008	-	3.45e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:0021540	corpus callosum morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0042992	negative regulation of transcription factor import into nucleus	BP
1	4	1.31763856008	-	3.45e-01	GO:0007621	negative regulation of female receptivity	BP
1	4	1.31763856008	-	3.45e-01	GO:0051660	establishment of centrosome localization	BP
1	4	1.31763856008	-	3.45e-01	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	1.31763856008	-	3.45e-01	GO:2001200	positive regulation of dendritic cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0046449	creatinine metabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0035404	histone-serine phosphorylation	BP
1	4	1.31763856008	-	3.45e-01	GO:0042036	negative regulation of cytokine biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0060161	positive regulation of dopamine receptor signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0009301	snRNA transcription	BP
1	4	1.31763856008	-	3.45e-01	GO:0035093	spermatogenesis, exchange of chromosomal proteins	BP
1	4	1.31763856008	-	3.45e-01	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	1.31763856008	-	3.45e-01	GO:0006538	glutamate catabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0051169	nuclear transport	BP
1	4	1.31763856008	-	3.45e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	1.31763856008	-	3.45e-01	GO:0016071	mRNA metabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0010826	negative regulation of centrosome duplication	BP
1	4	1.31763856008	-	3.45e-01	GO:0035771	interleukin-4-mediated signaling pathway	BP
1	4	1.31763856008	-	3.45e-01	GO:0006573	valine metabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0048541	Peyer's patch development	BP
1	4	1.31763856008	-	3.45e-01	GO:0071205	protein localization to juxtaparanode region of axon	BP
1	4	1.31763856008	-	3.45e-01	GO:0060298	positive regulation of sarcomere organization	BP
1	4	1.31763856008	-	3.45e-01	GO:2000741	positive regulation of mesenchymal stem cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0045876	positive regulation of sister chromatid cohesion	BP
1	4	1.31763856008	-	3.45e-01	GO:0070192	chromosome organization involved in meiotic cell cycle	BP
1	4	1.31763856008	-	3.45e-01	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
1	4	1.31763856008	-	3.45e-01	GO:0045836	positive regulation of meiotic nuclear division	BP
1	4	1.31763856008	-	3.45e-01	GO:0034698	response to gonadotropin	BP
1	4	1.31763856008	-	3.45e-01	GO:0006273	lagging strand elongation	BP
1	4	1.31763856008	-	3.45e-01	GO:0072553	terminal button organization	BP
1	4	1.31763856008	-	3.45e-01	GO:0042490	mechanoreceptor differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0034088	maintenance of mitotic sister chromatid cohesion	BP
1	4	1.31763856008	-	3.45e-01	GO:0032226	positive regulation of synaptic transmission, dopaminergic	BP
1	4	1.31763856008	-	3.45e-01	GO:0045629	negative regulation of T-helper 2 cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0000492	box C/D snoRNP assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:0072513	positive regulation of secondary heart field cardioblast proliferation	BP
1	4	1.31763856008	-	3.45e-01	GO:0002725	negative regulation of T cell cytokine production	BP
1	4	1.31763856008	-	3.45e-01	GO:0060535	trachea cartilage morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0045986	negative regulation of smooth muscle contraction	BP
1	4	1.31763856008	-	3.45e-01	GO:2000346	negative regulation of hepatocyte proliferation	BP
1	4	1.31763856008	-	3.45e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:2001181	positive regulation of interleukin-10 secretion	BP
1	4	1.31763856008	-	3.45e-01	GO:0045472	response to ether	BP
1	4	1.31763856008	-	3.45e-01	GO:0033133	positive regulation of glucokinase activity	BP
1	4	1.31763856008	-	3.45e-01	GO:0048549	positive regulation of pinocytosis	BP
1	4	1.31763856008	-	3.45e-01	GO:0006482	protein demethylation	BP
1	4	1.31763856008	-	3.45e-01	GO:0060485	mesenchyme development	BP
1	4	1.31763856008	-	3.45e-01	GO:0002159	desmosome assembly	BP
1	4	1.31763856008	-	3.45e-01	GO:2000676	positive regulation of type B pancreatic cell apoptotic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0045901	positive regulation of translational elongation	BP
1	4	1.31763856008	-	3.45e-01	GO:0048505	regulation of timing of cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:0010513	positive regulation of phosphatidylinositol biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:2000736	regulation of stem cell differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:1901984	negative regulation of protein acetylation	BP
1	4	1.31763856008	-	3.45e-01	GO:1901985	positive regulation of protein acetylation	BP
1	4	1.31763856008	-	3.45e-01	GO:0060351	cartilage development involved in endochondral bone morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	1.31763856008	-	3.45e-01	GO:0051345	positive regulation of hydrolase activity	BP
1	4	1.31763856008	-	3.45e-01	GO:0045085	negative regulation of interleukin-2 biosynthetic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0030050	vesicle transport along actin filament	BP
1	4	1.31763856008	-	3.45e-01	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
1	4	1.31763856008	-	3.45e-01	GO:0061041	regulation of wound healing	BP
1	4	1.31763856008	-	3.45e-01	GO:1990086	lens fiber cell apoptotic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0032042	mitochondrial DNA metabolic process	BP
1	4	1.31763856008	-	3.45e-01	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
1	4	1.31763856008	-	3.45e-01	GO:0051385	response to mineralocorticoid	BP
1	4	1.31763856008	-	3.45e-01	GO:1904504	positive regulation of lipophagy	BP
1	4	1.31763856008	-	3.45e-01	GO:0097350	neutrophil clearance	BP
1	4	1.31763856008	-	3.45e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	1.31763856008	-	3.45e-01	GO:2000373	positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity	BP
1	4	1.31763856008	-	3.45e-01	GO:0021764	amygdala development	BP
1	4	1.31763856008	-	3.45e-01	GO:0021957	corticospinal tract morphogenesis	BP
1	4	1.31763856008	-	3.45e-01	GO:0071315	cellular response to morphine	BP
1	4	1.31763856008	-	3.45e-01	GO:0048570	notochord morphogenesis	BP
4	16	1.31763856008	-	6.89e-02	GO:0000400	four-way junction DNA binding	MF
2	8	1.31763856008	-	1.15e-01	GO:0032052	bile acid binding	MF
2	8	1.31763856008	-	1.50e-01	GO:0051864	histone demethylase activity (H3-K36 specific)	MF
2	8	1.31763856008	-	1.50e-01	GO:0005113	patched binding	MF
2	8	1.31763856008	-	1.50e-01	GO:0102391	decanoate--CoA ligase activity	MF
2	8	1.31763856008	-	1.88e-01	GO:0030983	mismatched DNA binding	MF
2	8	1.31763856008	-	1.88e-01	GO:0097027	ubiquitin-protein transferase activator activity	MF
2	8	1.31763856008	-	1.88e-01	GO:0000150	recombinase activity	MF
2	8	1.31763856008	-	1.88e-01	GO:0032183	SUMO binding	MF
2	8	1.31763856008	-	1.88e-01	GO:0031386	protein tag	MF
1	4	1.31763856008	-	1.91e-01	GO:0031628	opioid receptor binding	MF
1	4	1.31763856008	-	1.91e-01	GO:0050501	hyaluronan synthase activity	MF
1	4	1.31763856008	-	1.91e-01	GO:0004522	ribonuclease A activity	MF
1	4	1.31763856008	-	1.91e-01	GO:0015252	hydrogen ion channel activity	MF
1	4	1.31763856008	-	1.91e-01	GO:0004515	nicotinate-nucleotide adenylyltransferase activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0005219	ryanodine-sensitive calcium-release channel activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0017151	DEAD/H-box RNA helicase binding	MF
1	4	1.31763856008	-	2.72e-01	GO:0048763	calcium-induced calcium release activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0070891	lipoteichoic acid binding	MF
1	4	1.31763856008	-	2.72e-01	GO:0001515	opioid peptide activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0034875	caffeine oxidase activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0050833	pyruvate transmembrane transporter activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0042287	MHC protein binding	MF
1	4	1.31763856008	-	2.72e-01	GO:0030229	very-low-density lipoprotein particle receptor activity	MF
1	4	1.31763856008	-	2.72e-01	GO:0005176	ErbB-2 class receptor binding	MF
1	4	1.31763856008	-	2.72e-01	GO:0090554	phosphatidylcholine-translocating ATPase activity	MF
1	4	1.31763856008	-	2.72e-01	GO:1990405	protein antigen binding	MF
1	4	1.31763856008	-	2.72e-01	GO:0004035	alkaline phosphatase activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0050815	phosphoserine binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0036435	K48-linked polyubiquitin binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0043208	glycosphingolipid binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0004740	pyruvate dehydrogenase (acetyl-transferring) kinase activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0003917	DNA topoisomerase type I activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0004706	JUN kinase kinase kinase activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0005025	transforming growth factor beta receptor activity, type I	MF
1	4	1.31763856008	-	3.45e-01	GO:0048408	epidermal growth factor binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0070851	growth factor receptor binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0097100	supercoiled DNA binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0000213	tRNA-intron endonuclease activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0004945	angiotensin type II receptor activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0031852	mu-type opioid receptor binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0097371	MDM2/MDM4 family protein binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0000403	Y-form DNA binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0036033	mediator complex binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0004974	leukotriene receptor activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0034617	tetrahydrobiopterin binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0005497	androgen binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0035312	5'-3' exodeoxyribonuclease activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0001882	nucleoside binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0086089	voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	MF
1	4	1.31763856008	-	3.45e-01	GO:0005172	vascular endothelial growth factor receptor binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0043121	neurotrophin binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0033192	calmodulin-dependent protein phosphatase activity	MF
1	4	1.31763856008	-	3.45e-01	GO:0045503	dynein light chain binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0016505	peptidase activator activity involved in apoptotic process	MF
1	4	1.31763856008	-	3.45e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
1	4	1.31763856008	-	3.45e-01	GO:0019788	NEDD8 transferase activity	MF
19	77	1.29877953283	-	4.97e-05	GO:0032869	cellular response to insulin stimulus	BP
14	57	1.29210346797	-	1.07e-04	GO:0001947	heart looping	BP
14	57	1.29210346797	-	1.78e-04	GO:0045669	positive regulation of osteoblast differentiation	BP
14	57	1.29210346797	-	6.74e-04	GO:0003684	damaged DNA binding	MF
93	379	1.29074333302	-	1.39e-10	GO:0008285	negative regulation of cell proliferation	BP
13	53	1.29015782366	-	6.63e-04	GO:0071333	cellular response to glucose stimulus	BP
13	53	1.29015782366	-	1.01e-03	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
12	49	1.28789121668	-	1.51e-03	GO:0004386	helicase activity	MF
78	319	1.28562816518	-	2.07e-10	GO:0019899	enzyme binding	MF
11	45	1.28521708239	-	2.78e-03	GO:0031100	animal organ regeneration	BP
11	45	1.28521708239	-	1.84e-03	GO:0005080	protein kinase C binding	MF
32	131	1.28421555854	-	3.07e-07	GO:0010629	negative regulation of gene expression	BP
27	111	1.27811019589	-	3.79e-07	GO:0045766	positive regulation of angiogenesis	BP
17	70	1.27581838438	-	3.60e-04	GO:0042795	snRNA transcription from RNA polymerase II promoter	BP
8	33	1.27324444072	-	1.18e-02	GO:0043507	positive regulation of JUN kinase activity	BP
8	33	1.27324444072	-	1.18e-02	GO:0006370	7-methylguanosine mRNA capping	BP
8	33	1.27324444072	-	2.28e-03	GO:0016874	ligase activity	MF
30	124	1.2703328453	-	2.35e-07	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
44	182	1.26927553852	-	3.58e-10	GO:0007596	blood coagulation	BP
7	29	1.26701248701	-	9.56e-03	GO:0001654	eye development	BP
7	29	1.26701248701	-	1.81e-02	GO:0048147	negative regulation of fibroblast proliferation	BP
7	29	1.26701248701	-	1.81e-02	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
7	29	1.26701248701	-	2.18e-02	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
7	29	1.26701248701	-	2.18e-02	GO:0000278	mitotic cell cycle	BP
12	50	1.25874487102	-	1.51e-03	GO:0071407	cellular response to organic cyclic compound	BP
6	25	1.25874487102	-	1.14e-02	GO:0051899	membrane depolarization	BP
6	25	1.25874487102	-	1.84e-02	GO:0050772	positive regulation of axonogenesis	BP
10	42	1.24724923219	-	1.38e-03	GO:0032526	response to retinoic acid	BP
5	21	1.24724923219	-	1.71e-02	GO:0071542	dopaminergic neuron differentiation	BP
5	21	1.24724923219	-	2.23e-02	GO:0071157	negative regulation of cell cycle arrest	BP
5	21	1.24724923219	-	4.35e-02	GO:0030879	mammary gland development	BP
5	21	1.24724923219	-	4.35e-02	GO:0051443	positive regulation of ubiquitin-protein transferase activity	BP
5	21	1.24724923219	-	5.26e-02	GO:0017025	TBP-class protein binding	MF
23	97	1.24128767395	-	1.55e-05	GO:0071456	cellular response to hypoxia	BP
41	173	1.24056233706	-	6.15e-09	GO:0001701	in utero embryonic development	BP
18	76	1.23963604808	-	3.79e-05	GO:0060021	palate development	BP
9	38	1.23963604808	-	3.32e-03	GO:0045597	positive regulation of cell differentiation	BP
9	38	1.23963604808	-	7.74e-03	GO:0038128	ERBB2 signaling pathway	BP
4	17	1.23017571883	-	5.06e-03	GO:0050909	sensory perception of taste	BP
8	34	1.23017571883	-	1.70e-02	GO:1990090	cellular response to nerve growth factor stimulus	BP
4	17	1.23017571883	-	4.45e-02	GO:0032331	negative regulation of chondrocyte differentiation	BP
4	17	1.23017571883	-	4.45e-02	GO:0030193	regulation of blood coagulation	BP
4	17	1.23017571883	-	5.60e-02	GO:0071354	cellular response to interleukin-6	BP
4	17	1.23017571883	-	5.60e-02	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	BP
4	17	1.23017571883	-	5.60e-02	GO:0071380	cellular response to prostaglandin E stimulus	BP
4	17	1.23017571883	-	5.60e-02	GO:0045926	negative regulation of growth	BP
4	17	1.23017571883	-	5.60e-02	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
4	17	1.23017571883	-	6.89e-02	GO:0021772	olfactory bulb development	BP
4	17	1.23017571883	-	6.89e-02	GO:1904355	positive regulation of telomere capping	BP
4	17	1.23017571883	-	6.89e-02	GO:0048854	brain morphogenesis	BP
4	17	1.23017571883	-	8.32e-02	GO:0010039	response to iron ion	BP
4	17	1.23017571883	-	3.44e-02	GO:0017127	cholesterol transporter activity	MF
4	17	1.23017571883	-	6.89e-02	GO:0034237	protein kinase A regulatory subunit binding	MF
22	94	1.22248132704	-	7.10e-05	GO:0006368	transcription elongation from RNA polymerase II promoter	BP
18	77	1.22077702083	-	1.85e-05	GO:0030324	lung development	BP
7	30	1.21810288653	-	1.48e-02	GO:0007259	JAK-STAT cascade	BP
10	43	1.21330190026	-	8.15e-04	GO:0045165	cell fate commitment	BP
13	56	1.21072335616	-	4.23e-04	GO:0009612	response to mechanical stimulus	BP
6	26	1.20216134266	-	1.84e-02	GO:0001958	endochondral ossification	BP
6	26	1.20216134266	-	2.28e-02	GO:0033077	T cell differentiation in thymus	BP
6	26	1.20216134266	-	2.28e-02	GO:0032715	negative regulation of interleukin-6 production	BP
3	13	1.20216134266	-	2.59e-02	GO:0021527	spinal cord association neuron differentiation	BP
6	26	1.20216134266	-	2.79e-02	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
3	13	1.20216134266	-	3.83e-02	GO:0001964	startle response	BP
3	13	1.20216134266	-	5.33e-02	GO:0005513	detection of calcium ion	BP
3	13	1.20216134266	-	5.33e-02	GO:0060402	calcium ion transport into cytosol	BP
3	13	1.20216134266	-	7.06e-02	GO:0007398	ectoderm development	BP
3	13	1.20216134266	-	7.06e-02	GO:0014032	neural crest cell development	BP
3	13	1.20216134266	-	7.06e-02	GO:0002087	regulation of respiratory gaseous exchange by neurological system process	BP
3	13	1.20216134266	-	7.06e-02	GO:0048665	neuron fate specification	BP
3	13	1.20216134266	-	9.01e-02	GO:0071425	hematopoietic stem cell proliferation	BP
3	13	1.20216134266	-	9.01e-02	GO:0003016	respiratory system process	BP
3	13	1.20216134266	-	9.01e-02	GO:0055089	fatty acid homeostasis	BP
3	13	1.20216134266	-	1.12e-01	GO:0035909	aorta morphogenesis	BP
3	13	1.20216134266	-	1.12e-01	GO:0019395	fatty acid oxidation	BP
3	13	1.20216134266	-	1.12e-01	GO:0071285	cellular response to lithium ion	BP
3	13	1.20216134266	-	1.12e-01	GO:0060317	cardiac epithelial to mesenchymal transition	BP
3	13	1.20216134266	-	1.12e-01	GO:0071872	cellular response to epinephrine stimulus	BP
3	13	1.20216134266	-	1.35e-01	GO:0045088	regulation of innate immune response	BP
3	13	1.20216134266	-	1.35e-01	GO:0070306	lens fiber cell differentiation	BP
3	13	1.20216134266	-	1.35e-01	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
3	13	1.20216134266	-	1.35e-01	GO:0006809	nitric oxide biosynthetic process	BP
3	13	1.20216134266	-	1.35e-01	GO:2001234	negative regulation of apoptotic signaling pathway	BP
3	13	1.20216134266	-	1.35e-01	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
3	13	1.20216134266	-	5.33e-02	GO:0070403	NAD+ binding	MF
3	13	1.20216134266	-	1.12e-01	GO:0043024	ribosomal small subunit binding	MF
3	13	1.20216134266	-	1.35e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
17	74	1.1956480357	-	5.16e-04	GO:0071260	cellular response to mechanical stimulus	BP
57	249	1.19052664217	-	1.19e-10	GO:0010628	positive regulation of gene expression	BP
8	35	1.18835554313	-	2.02e-02	GO:0070534	protein K63-linked ubiquitination	BP
16	70	1.18835554313	-	4.46e-04	GO:0003690	double-stranded DNA binding	MF
10	44	1.18013503633	-	1.75e-03	GO:0032870	cellular response to hormone stimulus	BP
5	22	1.18013503633	-	2.84e-02	GO:0010842	retina layer formation	BP
5	22	1.18013503633	-	3.55e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
5	22	1.18013503633	-	4.35e-02	GO:0060173	limb development	BP
5	22	1.18013503633	-	4.35e-02	GO:0050699	WW domain binding	MF
17	75	1.17628271083	-	1.22e-05	GO:0045666	positive regulation of neuron differentiation	BP
17	75	1.17628271083	-	3.60e-04	GO:0019900	kinase binding	MF
7	31	1.17079717175	-	2.61e-02	GO:0006383	transcription from RNA polymerase III promoter	BP
7	31	1.17079717175	-	2.18e-02	GO:0030544	Hsp70 protein binding	MF
18	80	1.16563546663	-	1.12e-04	GO:0035264	multicellular organism growth	BP
9	40	1.16563546663	-	4.17e-03	GO:0048704	embryonic skeletal system morphogenesis	BP
9	40	1.16563546663	-	1.33e-02	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
14	63	1.14771355864	-	6.74e-04	GO:0031647	regulation of protein stability	BP
10	45	1.14771355864	-	4.20e-03	GO:0030900	forebrain development	BP
12	54	1.14771355864	-	5.38e-03	GO:0045732	positive regulation of protein catabolic process	BP
8	36	1.14771355864	-	1.42e-02	GO:0030177	positive regulation of Wnt signaling pathway	BP
6	27	1.14771355864	-	2.79e-02	GO:0010942	positive regulation of cell death	BP
4	18	1.14771355864	-	4.45e-02	GO:1903861	positive regulation of dendrite extension	BP
4	18	1.14771355864	-	4.45e-02	GO:0060037	pharyngeal system development	BP
6	27	1.14771355864	-	4.75e-02	GO:0009314	response to radiation	BP
4	18	1.14771355864	-	5.60e-02	GO:1903506	regulation of nucleic acid-templated transcription	BP
4	18	1.14771355864	-	5.60e-02	GO:0030318	melanocyte differentiation	BP
4	18	1.14771355864	-	6.89e-02	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
2	9	1.14771355864	-	8.19e-02	GO:0046549	retinal cone cell development	BP
4	18	1.14771355864	-	9.89e-02	GO:0031668	cellular response to extracellular stimulus	BP
2	9	1.14771355864	-	1.15e-01	GO:0002315	marginal zone B cell differentiation	BP
2	9	1.14771355864	-	1.15e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
2	9	1.14771355864	-	1.50e-01	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	1.14771355864	-	1.50e-01	GO:0042118	endothelial cell activation	BP
2	9	1.14771355864	-	1.50e-01	GO:0007599	hemostasis	BP
2	9	1.14771355864	-	1.88e-01	GO:0006515	misfolded or incompletely synthesized protein catabolic process	BP
2	9	1.14771355864	-	1.88e-01	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
2	9	1.14771355864	-	1.88e-01	GO:0000733	DNA strand renaturation	BP
2	9	1.14771355864	-	1.88e-01	GO:0032886	regulation of microtubule-based process	BP
2	9	1.14771355864	-	1.88e-01	GO:0098789	pre-mRNA cleavage required for polyadenylation	BP
2	9	1.14771355864	-	1.88e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
2	9	1.14771355864	-	1.88e-01	GO:0042754	negative regulation of circadian rhythm	BP
2	9	1.14771355864	-	1.88e-01	GO:0009410	response to xenobiotic stimulus	BP
2	9	1.14771355864	-	1.88e-01	GO:0035562	negative regulation of chromatin binding	BP
2	9	1.14771355864	-	1.88e-01	GO:0003254	regulation of membrane depolarization	BP
2	9	1.14771355864	-	1.88e-01	GO:0042088	T-helper 1 type immune response	BP
2	9	1.14771355864	-	1.88e-01	GO:0050795	regulation of behavior	BP
2	9	1.14771355864	-	1.88e-01	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
2	9	1.14771355864	-	1.88e-01	GO:0070493	thrombin-activated receptor signaling pathway	BP
2	9	1.14771355864	-	2.26e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
2	9	1.14771355864	-	2.26e-01	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
2	9	1.14771355864	-	2.26e-01	GO:0008354	germ cell migration	BP
2	9	1.14771355864	-	2.26e-01	GO:0050774	negative regulation of dendrite morphogenesis	BP
2	9	1.14771355864	-	2.26e-01	GO:0010224	response to UV-B	BP
2	9	1.14771355864	-	2.26e-01	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
2	9	1.14771355864	-	2.26e-01	GO:0050807	regulation of synapse organization	BP
2	9	1.14771355864	-	2.26e-01	GO:0051593	response to folic acid	BP
2	9	1.14771355864	-	2.26e-01	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
2	9	1.14771355864	-	2.26e-01	GO:0044320	cellular response to leptin stimulus	BP
2	9	1.14771355864	-	2.26e-01	GO:0043589	skin morphogenesis	BP
2	9	1.14771355864	-	2.26e-01	GO:0035563	positive regulation of chromatin binding	BP
2	9	1.14771355864	-	2.26e-01	GO:0007184	SMAD protein import into nucleus	BP
2	9	1.14771355864	-	2.26e-01	GO:0035456	response to interferon-beta	BP
2	9	1.14771355864	-	2.26e-01	GO:0033314	mitotic DNA replication checkpoint	BP
2	9	1.14771355864	-	2.26e-01	GO:0010614	negative regulation of cardiac muscle hypertrophy	BP
2	9	1.14771355864	-	2.26e-01	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	9	1.14771355864	-	2.26e-01	GO:0032688	negative regulation of interferon-beta production	BP
2	9	1.14771355864	-	2.26e-01	GO:0022407	regulation of cell-cell adhesion	BP
2	9	1.14771355864	-	2.26e-01	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
4	18	1.14771355864	-	9.89e-02	GO:0005234	extracellular-glutamate-gated ion channel activity	MF
4	18	1.14771355864	-	9.89e-02	GO:0051019	mitogen-activated protein kinase binding	MF
2	9	1.14771355864	-	1.50e-01	GO:0016918	retinal binding	MF
2	9	1.14771355864	-	2.26e-01	GO:0001054	RNA polymerase I activity	MF
2	9	1.14771355864	-	2.26e-01	GO:0003691	double-stranded telomeric DNA binding	MF
2	9	1.14771355864	-	2.26e-01	GO:0034713	type I transforming growth factor beta receptor binding	MF
2	9	1.14771355864	-	2.26e-01	GO:0031681	G-protein beta-subunit binding	MF
2	9	1.14771355864	-	2.26e-01	GO:0019887	protein kinase regulator activity	MF
63	284	1.14517136407	-	3.86e-10	GO:0031625	ubiquitin protein ligase binding	MF
15	68	1.13706631444	-	3.68e-04	GO:0006310	DNA recombination	BP
20	91	1.13177201477	-	2.71e-05	GO:0009653	anatomical structure morphogenesis	BP
20	91	1.13177201477	-	1.31e-04	GO:0032355	response to estradiol	BP
9	41	1.1300115569	-	5.17e-03	GO:0009725	response to hormone	BP
16	73	1.1278140012	-	3.02e-04	GO:0050728	negative regulation of inflammatory response	BP
7	32	1.12499348214	-	3.08e-02	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
7	32	1.12499348214	-	3.62e-02	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
75	344	1.12019249587	-	2.14e-10	GO:0004674	protein serine/threonine kinase activity	MF
8	37	1.10818519445	-	2.37e-02	GO:0030890	positive regulation of B cell proliferation	BP
378	1762	1.09688277538	-	3.88e-10	GO:0006351	transcription, DNA-templated	BP
9	42	1.09524613874	-	1.83e-02	GO:0031397	negative regulation of protein ubiquitination	BP
6	28	1.09524613874	-	2.79e-02	GO:0006378	mRNA polyadenylation	BP
3	14	1.09524613874	-	7.06e-02	GO:0010839	negative regulation of keratinocyte proliferation	BP
3	14	1.09524613874	-	7.06e-02	GO:0003382	epithelial cell morphogenesis	BP
3	14	1.09524613874	-	1.12e-01	GO:0019079	viral genome replication	BP
3	14	1.09524613874	-	1.12e-01	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
3	14	1.09524613874	-	1.12e-01	GO:0043409	negative regulation of MAPK cascade	BP
3	14	1.09524613874	-	1.12e-01	GO:2000310	regulation of NMDA receptor activity	BP
3	14	1.09524613874	-	1.12e-01	GO:0006309	apoptotic DNA fragmentation	BP
3	14	1.09524613874	-	1.12e-01	GO:0022011	myelination in peripheral nervous system	BP
3	14	1.09524613874	-	1.35e-01	GO:0007095	mitotic G2 DNA damage checkpoint	BP
3	14	1.09524613874	-	1.35e-01	GO:0030818	negative regulation of cAMP biosynthetic process	BP
3	14	1.09524613874	-	1.35e-01	GO:0007076	mitotic chromosome condensation	BP
3	14	1.09524613874	-	1.59e-01	GO:0007212	dopamine receptor signaling pathway	BP
3	14	1.09524613874	-	1.59e-01	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
3	14	1.09524613874	-	1.59e-01	GO:0032968	positive regulation of transcription elongation from RNA polymerase II promoter	BP
3	14	1.09524613874	-	1.59e-01	GO:0010243	response to organonitrogen compound	BP
3	14	1.09524613874	-	1.59e-01	GO:0043254	regulation of protein complex assembly	BP
3	14	1.09524613874	-	1.59e-01	GO:0045948	positive regulation of translational initiation	BP
3	14	1.09524613874	-	1.35e-01	GO:0005095	GTPase inhibitor activity	MF
3	14	1.09524613874	-	1.59e-01	GO:0001056	RNA polymerase III activity	MF
3	14	1.09524613874	-	1.59e-01	GO:0031434	mitogen-activated protein kinase kinase binding	MF
3	14	1.09524613874	-	1.59e-01	GO:0070182	DNA polymerase binding	MF
3	14	1.09524613874	-	1.59e-01	GO:0035198	miRNA binding	MF
34	159	1.09221844604	-	6.19e-06	GO:0001666	response to hypoxia	BP
324	1518	1.08953248755	-	3.85e-10	GO:0003677	DNA binding	MF
10	47	1.08497780329	-	2.33e-02	GO:0070936	protein K48-linked ubiquitination	BP
7	33	1.08059936278	-	2.61e-02	GO:0007585	respiratory gaseous exchange	BP
7	33	1.08059936278	-	3.08e-02	GO:0001974	blood vessel remodeling	BP
43	203	1.0785673976	-	7.16e-07	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
18	85	1.07817262538	-	1.12e-04	GO:0009887	animal organ morphogenesis	BP
22	104	1.07663046057	-	1.88e-05	GO:0010468	regulation of gene expression	BP
15	71	1.07478203618	-	1.36e-03	GO:0060333	interferon-gamma-mediated signaling pathway	BP
62	294	1.07216252563	-	4.72e-10	GO:0043065	positive regulation of apoptotic process	BP
31	147	1.07216252563	-	5.20e-08	GO:0046983	protein dimerization activity	MF
8	38	1.06971104663	-	2.02e-02	GO:0021549	cerebellum development	BP
4	19	1.06971104663	-	8.32e-02	GO:0014911	positive regulation of smooth muscle cell migration	BP
4	19	1.06971104663	-	8.32e-02	GO:0055117	regulation of cardiac muscle contraction	BP
4	19	1.06971104663	-	8.32e-02	GO:0042832	defense response to protozoan	BP
4	19	1.06971104663	-	9.89e-02	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
36	171	1.06971104663	-	1.18e-05	GO:0008022	protein C-terminus binding	MF
4	19	1.06971104663	-	1.16e-01	GO:0070064	proline-rich region binding	MF
13	62	1.06388196783	-	3.05e-03	GO:0006302	double-strand break repair	BP
9	43	1.06129880682	-	4.17e-03	GO:0001756	somitogenesis	BP
61	292	1.05855133876	-	9.16e-09	GO:0016032	viral process	BP
5	24	1.05460415424	-	7.37e-02	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
24	116	1.04462006567	-	1.33e-04	GO:0030308	negative regulation of cell growth	BP
12	58	1.04462006567	-	2.24e-03	GO:0051216	cartilage development	BP
6	29	1.04462006567	-	4.02e-02	GO:0007281	germ cell development	BP
6	29	1.04462006567	-	4.75e-02	GO:0042149	cellular response to glucose starvation	BP
6	29	1.04462006567	-	4.75e-02	GO:0034504	protein localization to nucleus	BP
6	29	1.04462006567	-	5.55e-02	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
78	377	1.04462006567	-	1.12e-10	GO:0019901	protein kinase binding	MF
21	102	1.03753064089	-	2.48e-04	GO:0001649	osteoblast differentiation	BP
7	34	1.03753064089	-	7.60e-02	GO:0000731	DNA synthesis involved in DNA repair	BP
7	34	1.03753064089	-	3.62e-02	GO:0031624	ubiquitin conjugating enzyme binding	MF
8	39	1.03223634122	-	9.67e-03	GO:0030326	embryonic limb morphogenesis	BP
8	39	1.03223634122	-	2.37e-02	GO:0009411	response to UV	BP
9	44	1.02813194288	-	1.56e-02	GO:0032508	DNA duplex unwinding	BP
9	44	1.02813194288	-	1.56e-02	GO:0007519	skeletal muscle tissue development	BP
10	49	1.02485681085	-	2.33e-02	GO:0010212	response to ionizing radiation	BP
10	49	1.02485681085	-	8.76e-03	GO:0097110	scaffold protein binding	MF
22	108	1.02218267655	-	2.57e-04	GO:0009615	response to virus	BP
11	54	1.02218267655	-	8.07e-03	GO:0030097	hemopoiesis	BP
12	59	1.01995801144	-	5.38e-03	GO:0032092	positive regulation of protein binding	BP
13	64	1.01807827822	-	9.02e-03	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
14	69	1.01646902536	-	6.74e-04	GO:0071300	cellular response to retinoic acid	BP
14	69	1.01646902536	-	4.23e-03	GO:0001938	positive regulation of endothelial cell proliferation	BP
14	69	1.01646902536	-	6.75e-03	GO:0007265	Ras protein signal transduction	BP
90	444	1.01507579006	-	1.25e-10	GO:0043066	negative regulation of apoptotic process	BP
30	148	1.01507579006	-	3.44e-05	GO:0050852	T cell receptor signaling pathway	BP
15	74	1.01507579006	-	2.63e-03	GO:0042060	wound healing	BP
6	30	0.995710465191	-	2.79e-02	GO:0048873	homeostasis of number of cells within a tissue	BP
6	30	0.995710465191	-	2.79e-02	GO:0050873	brown fat cell differentiation	BP
6	30	0.995710465191	-	5.55e-02	GO:0046326	positive regulation of glucose import	BP
6	30	0.995710465191	-	5.55e-02	GO:0001932	regulation of protein phosphorylation	BP
3	15	0.995710465191	-	1.12e-01	GO:0051276	chromosome organization	BP
6	30	0.995710465191	-	1.16e-01	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
3	15	0.995710465191	-	1.35e-01	GO:0001824	blastocyst development	BP
3	15	0.995710465191	-	1.35e-01	GO:0048593	camera-type eye morphogenesis	BP
3	15	0.995710465191	-	1.35e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
3	15	0.995710465191	-	1.59e-01	GO:0048872	homeostasis of number of cells	BP
3	15	0.995710465191	-	1.59e-01	GO:0043277	apoptotic cell clearance	BP
3	15	0.995710465191	-	1.59e-01	GO:0035024	negative regulation of Rho protein signal transduction	BP
3	15	0.995710465191	-	1.59e-01	GO:0010608	posttranscriptional regulation of gene expression	BP
3	15	0.995710465191	-	1.59e-01	GO:0045445	myoblast differentiation	BP
3	15	0.995710465191	-	1.59e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
3	15	0.995710465191	-	1.59e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
3	15	0.995710465191	-	1.85e-01	GO:0045725	positive regulation of glycogen biosynthetic process	BP
3	15	0.995710465191	-	1.85e-01	GO:0046328	regulation of JNK cascade	BP
3	15	0.995710465191	-	1.85e-01	GO:0031929	TOR signaling	BP
3	15	0.995710465191	-	1.85e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
3	15	0.995710465191	-	1.85e-01	GO:0006388	tRNA splicing, via endonucleolytic cleavage and ligation	BP
3	15	0.995710465191	-	1.85e-01	GO:0030889	negative regulation of B cell proliferation	BP
3	15	0.995710465191	-	1.85e-01	GO:0007215	glutamate receptor signaling pathway	BP
3	15	0.995710465191	-	1.35e-01	GO:0030676	Rac guanyl-nucleotide exchange factor activity	MF
3	15	0.995710465191	-	1.59e-01	GO:0048037	cofactor binding	MF
13	65	0.995710465191	-	1.80e-03	GO:0030183	B cell differentiation	BP
9	45	0.995710465191	-	1.48e-04	GO:0045596	negative regulation of cell differentiation	BP
11	55	0.995710465191	-	5.81e-03	GO:0045665	negative regulation of neuron differentiation	BP
5	25	0.995710465191	-	1.28e-02	GO:0015721	bile acid and bile salt transport	BP
9	45	0.995710465191	-	1.56e-02	GO:0071363	cellular response to growth factor stimulus	BP
5	25	0.995710465191	-	1.71e-02	GO:0006694	steroid biosynthetic process	BP
5	25	0.995710465191	-	3.55e-02	GO:0060349	bone morphogenesis	BP
5	25	0.995710465191	-	4.35e-02	GO:0007202	activation of phospholipase C activity	BP
5	25	0.995710465191	-	5.26e-02	GO:0045930	negative regulation of mitotic cell cycle	BP
5	25	0.995710465191	-	6.26e-02	GO:0034612	response to tumor necrosis factor	BP
5	25	0.995710465191	-	8.58e-02	GO:0060976	coronary vasculature development	BP
5	25	0.995710465191	-	9.88e-02	GO:0000188	inactivation of MAPK activity	BP
87	435	0.995710465191	-	2.08e-10	GO:0006468	protein phosphorylation	BP
8	40	0.995710465191	-	1.42e-02	GO:0032570	response to progesterone	BP
4	20	0.995710465191	-	2.58e-02	GO:0043046	DNA methylation involved in gamete generation	BP
2	10	0.995710465191	-	2.81e-02	GO:0002430	complement receptor mediated signaling pathway	BP
2	10	0.995710465191	-	5.26e-02	GO:0030728	ovulation	BP
4	20	0.995710465191	-	6.89e-02	GO:0031334	positive regulation of protein complex assembly	BP
4	20	0.995710465191	-	6.89e-02	GO:0045987	positive regulation of smooth muscle contraction	BP
2	10	0.995710465191	-	8.19e-02	GO:0046470	phosphatidylcholine metabolic process	BP
4	20	0.995710465191	-	8.32e-02	GO:0034614	cellular response to reactive oxygen species	BP
4	20	0.995710465191	-	9.89e-02	GO:0043623	cellular protein complex assembly	BP
2	10	0.995710465191	-	1.15e-01	GO:0002021	response to dietary excess	BP
4	20	0.995710465191	-	1.16e-01	GO:0031572	G2 DNA damage checkpoint	BP
4	20	0.995710465191	-	1.16e-01	GO:0045861	negative regulation of proteolysis	BP
2	10	0.995710465191	-	1.50e-01	GO:0051006	positive regulation of lipoprotein lipase activity	BP
2	10	0.995710465191	-	1.50e-01	GO:0030261	chromosome condensation	BP
2	10	0.995710465191	-	1.50e-01	GO:0032525	somite rostral/caudal axis specification	BP
2	10	0.995710465191	-	1.50e-01	GO:0015909	long-chain fatty acid transport	BP
2	10	0.995710465191	-	1.88e-01	GO:0045723	positive regulation of fatty acid biosynthetic process	BP
2	10	0.995710465191	-	1.88e-01	GO:0035136	forelimb morphogenesis	BP
2	10	0.995710465191	-	1.88e-01	GO:0007216	G-protein coupled glutamate receptor signaling pathway	BP
2	10	0.995710465191	-	1.88e-01	GO:0090501	RNA phosphodiester bond hydrolysis	BP
2	10	0.995710465191	-	1.88e-01	GO:0060055	angiogenesis involved in wound healing	BP
1	5	0.995710465191	-	1.91e-01	GO:0006706	steroid catabolic process	BP
1	5	0.995710465191	-	1.91e-01	GO:0070309	lens fiber cell morphogenesis	BP
1	5	0.995710465191	-	1.91e-01	GO:0097070	ductus arteriosus closure	BP
1	5	0.995710465191	-	1.91e-01	GO:0090207	regulation of triglyceride metabolic process	BP
1	5	0.995710465191	-	1.91e-01	GO:0021797	forebrain anterior/posterior pattern specification	BP
1	5	0.995710465191	-	1.91e-01	GO:0042743	hydrogen peroxide metabolic process	BP
2	10	0.995710465191	-	2.26e-01	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	BP
2	10	0.995710465191	-	2.26e-01	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
2	10	0.995710465191	-	2.26e-01	GO:0040015	negative regulation of multicellular organism growth	BP
2	10	0.995710465191	-	2.26e-01	GO:0010762	regulation of fibroblast migration	BP
2	10	0.995710465191	-	2.26e-01	GO:0016331	morphogenesis of embryonic epithelium	BP
2	10	0.995710465191	-	2.26e-01	GO:0033234	negative regulation of protein sumoylation	BP
2	10	0.995710465191	-	2.26e-01	GO:2000009	negative regulation of protein localization to cell surface	BP
2	10	0.995710465191	-	2.26e-01	GO:0002218	activation of innate immune response	BP
2	10	0.995710465191	-	2.26e-01	GO:0000290	deadenylation-dependent decapping of nuclear-transcribed mRNA	BP
2	10	0.995710465191	-	2.26e-01	GO:0043268	positive regulation of potassium ion transport	BP
2	10	0.995710465191	-	2.26e-01	GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter	BP
2	10	0.995710465191	-	2.26e-01	GO:0060484	lung-associated mesenchyme development	BP
2	10	0.995710465191	-	2.26e-01	GO:0003334	keratinocyte development	BP
2	10	0.995710465191	-	2.65e-01	GO:0071383	cellular response to steroid hormone stimulus	BP
2	10	0.995710465191	-	2.65e-01	GO:1902188	positive regulation of viral release from host cell	BP
2	10	0.995710465191	-	2.65e-01	GO:0043306	positive regulation of mast cell degranulation	BP
2	10	0.995710465191	-	2.65e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
2	10	0.995710465191	-	2.65e-01	GO:0051168	nuclear export	BP
2	10	0.995710465191	-	2.65e-01	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
2	10	0.995710465191	-	2.65e-01	GO:0060009	Sertoli cell development	BP
2	10	0.995710465191	-	2.65e-01	GO:0090331	negative regulation of platelet aggregation	BP
2	10	0.995710465191	-	2.65e-01	GO:0060252	positive regulation of glial cell proliferation	BP
2	10	0.995710465191	-	2.65e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
2	10	0.995710465191	-	2.65e-01	GO:0033197	response to vitamin E	BP
2	10	0.995710465191	-	2.65e-01	GO:0032727	positive regulation of interferon-alpha production	BP
1	5	0.995710465191	-	2.72e-01	GO:2000647	negative regulation of stem cell proliferation	BP
1	5	0.995710465191	-	2.72e-01	GO:0033554	cellular response to stress	BP
1	5	0.995710465191	-	2.72e-01	GO:0021889	olfactory bulb interneuron differentiation	BP
1	5	0.995710465191	-	2.72e-01	GO:0002322	B cell proliferation involved in immune response	BP
1	5	0.995710465191	-	2.72e-01	GO:0003100	regulation of systemic arterial blood pressure by endothelin	BP
1	5	0.995710465191	-	2.72e-01	GO:0046219	indolalkylamine biosynthetic process	BP
1	5	0.995710465191	-	2.72e-01	GO:1990845	adaptive thermogenesis	BP
1	5	0.995710465191	-	2.72e-01	GO:0055069	zinc ion homeostasis	BP
1	5	0.995710465191	-	2.72e-01	GO:0030856	regulation of epithelial cell differentiation	BP
1	5	0.995710465191	-	2.72e-01	GO:0046618	drug export	BP
1	5	0.995710465191	-	2.72e-01	GO:0021879	forebrain neuron differentiation	BP
1	5	0.995710465191	-	2.72e-01	GO:0002829	negative regulation of type 2 immune response	BP
1	5	0.995710465191	-	2.72e-01	GO:0030311	poly-N-acetyllactosamine biosynthetic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0048730	epidermis morphogenesis	BP
1	5	0.995710465191	-	3.45e-01	GO:0050856	regulation of T cell receptor signaling pathway	BP
1	5	0.995710465191	-	3.45e-01	GO:0003283	atrial septum development	BP
1	5	0.995710465191	-	3.45e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
1	5	0.995710465191	-	3.45e-01	GO:0060591	chondroblast differentiation	BP
1	5	0.995710465191	-	3.45e-01	GO:0021960	anterior commissure morphogenesis	BP
1	5	0.995710465191	-	3.45e-01	GO:0048562	embryonic organ morphogenesis	BP
1	5	0.995710465191	-	3.45e-01	GO:0046600	negative regulation of centriole replication	BP
1	5	0.995710465191	-	3.45e-01	GO:0032460	negative regulation of protein oligomerization	BP
1	5	0.995710465191	-	3.45e-01	GO:0090266	regulation of mitotic cell cycle spindle assembly checkpoint	BP
1	5	0.995710465191	-	3.45e-01	GO:0031346	positive regulation of cell projection organization	BP
1	5	0.995710465191	-	3.45e-01	GO:0097500	receptor localization to non-motile cilium	BP
1	5	0.995710465191	-	3.45e-01	GO:0045636	positive regulation of melanocyte differentiation	BP
1	5	0.995710465191	-	3.45e-01	GO:0071502	cellular response to temperature stimulus	BP
1	5	0.995710465191	-	3.45e-01	GO:0051005	negative regulation of lipoprotein lipase activity	BP
1	5	0.995710465191	-	3.45e-01	GO:0001302	replicative cell aging	BP
1	5	0.995710465191	-	3.45e-01	GO:0090036	regulation of protein kinase C signaling	BP
1	5	0.995710465191	-	3.45e-01	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	0.995710465191	-	3.45e-01	GO:0043584	nose development	BP
1	5	0.995710465191	-	3.45e-01	GO:0051122	hepoxilin biosynthetic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0019563	glycerol catabolic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0010637	negative regulation of mitochondrial fusion	BP
1	5	0.995710465191	-	3.45e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0009414	response to water deprivation	BP
1	5	0.995710465191	-	3.45e-01	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	0.995710465191	-	3.45e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	0.995710465191	-	3.45e-01	GO:0002933	lipid hydroxylation	BP
1	5	0.995710465191	-	3.45e-01	GO:0086046	membrane depolarization during SA node cell action potential	BP
1	5	0.995710465191	-	3.45e-01	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
1	5	0.995710465191	-	3.45e-01	GO:2000738	positive regulation of stem cell differentiation	BP
1	5	0.995710465191	-	3.45e-01	GO:0072207	metanephric epithelium development	BP
1	5	0.995710465191	-	3.45e-01	GO:0050996	positive regulation of lipid catabolic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0001832	blastocyst growth	BP
1	5	0.995710465191	-	3.45e-01	GO:0014050	negative regulation of glutamate secretion	BP
1	5	0.995710465191	-	3.45e-01	GO:0071394	cellular response to testosterone stimulus	BP
1	5	0.995710465191	-	3.45e-01	GO:0072284	metanephric S-shaped body morphogenesis	BP
1	5	0.995710465191	-	3.45e-01	GO:0048864	stem cell development	BP
1	5	0.995710465191	-	3.45e-01	GO:0038027	apolipoprotein A-I-mediated signaling pathway	BP
1	5	0.995710465191	-	3.45e-01	GO:0070231	T cell apoptotic process	BP
1	5	0.995710465191	-	3.45e-01	GO:0072178	nephric duct morphogenesis	BP
1	5	0.995710465191	-	4.11e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	0.995710465191	-	4.11e-01	GO:0016191	synaptic vesicle uncoating	BP
1	5	0.995710465191	-	4.11e-01	GO:0061087	positive regulation of histone H3-K27 methylation	BP
1	5	0.995710465191	-	4.11e-01	GO:0010715	regulation of extracellular matrix disassembly	BP
1	5	0.995710465191	-	4.11e-01	GO:0046822	regulation of nucleocytoplasmic transport	BP
1	5	0.995710465191	-	4.11e-01	GO:0034134	toll-like receptor 2 signaling pathway	BP
1	5	0.995710465191	-	4.11e-01	GO:0044772	mitotic cell cycle phase transition	BP
1	5	0.995710465191	-	4.11e-01	GO:0060964	regulation of gene silencing by miRNA	BP
1	5	0.995710465191	-	4.11e-01	GO:0007262	STAT protein import into nucleus	BP
1	5	0.995710465191	-	4.11e-01	GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	BP
1	5	0.995710465191	-	4.11e-01	GO:0032269	negative regulation of cellular protein metabolic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0061737	leukotriene signaling pathway	BP
1	5	0.995710465191	-	4.11e-01	GO:0031622	positive regulation of fever generation	BP
1	5	0.995710465191	-	4.11e-01	GO:1902474	positive regulation of protein localization to synapse	BP
1	5	0.995710465191	-	4.11e-01	GO:0060028	convergent extension involved in axis elongation	BP
1	5	0.995710465191	-	4.11e-01	GO:0033599	regulation of mammary gland epithelial cell proliferation	BP
1	5	0.995710465191	-	4.11e-01	GO:0030240	skeletal muscle thin filament assembly	BP
1	5	0.995710465191	-	4.11e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	0.995710465191	-	4.11e-01	GO:0010656	negative regulation of muscle cell apoptotic process	BP
1	5	0.995710465191	-	4.11e-01	GO:1900271	regulation of long-term synaptic potentiation	BP
1	5	0.995710465191	-	4.11e-01	GO:0050882	voluntary musculoskeletal movement	BP
1	5	0.995710465191	-	4.11e-01	GO:0051823	regulation of synapse structural plasticity	BP
1	5	0.995710465191	-	4.11e-01	GO:0000707	meiotic DNA recombinase assembly	BP
1	5	0.995710465191	-	4.11e-01	GO:0006398	mRNA 3'-end processing by stem-loop binding and cleavage	BP
1	5	0.995710465191	-	4.11e-01	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	5	0.995710465191	-	4.11e-01	GO:0098735	positive regulation of the force of heart contraction	BP
1	5	0.995710465191	-	4.11e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	0.995710465191	-	4.11e-01	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
1	5	0.995710465191	-	4.11e-01	GO:2000651	positive regulation of sodium ion transmembrane transporter activity	BP
1	5	0.995710465191	-	4.11e-01	GO:0061462	protein localization to lysosome	BP
1	5	0.995710465191	-	4.11e-01	GO:0045927	positive regulation of growth	BP
1	5	0.995710465191	-	4.11e-01	GO:0060179	male mating behavior	BP
1	5	0.995710465191	-	4.11e-01	GO:0021631	optic nerve morphogenesis	BP
1	5	0.995710465191	-	4.11e-01	GO:0000212	meiotic spindle organization	BP
1	5	0.995710465191	-	4.11e-01	GO:0034316	negative regulation of Arp2/3 complex-mediated actin nucleation	BP
1	5	0.995710465191	-	4.11e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	0.995710465191	-	4.11e-01	GO:0008063	Toll signaling pathway	BP
1	5	0.995710465191	-	4.11e-01	GO:0046578	regulation of Ras protein signal transduction	BP
1	5	0.995710465191	-	4.11e-01	GO:0038084	vascular endothelial growth factor signaling pathway	BP
1	5	0.995710465191	-	4.11e-01	GO:0010310	regulation of hydrogen peroxide metabolic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0098914	membrane repolarization during atrial cardiac muscle cell action potential	BP
1	5	0.995710465191	-	4.11e-01	GO:0010571	positive regulation of nuclear cell cycle DNA replication	BP
1	5	0.995710465191	-	4.11e-01	GO:0032747	positive regulation of interleukin-23 production	BP
1	5	0.995710465191	-	4.11e-01	GO:0003150	muscular septum morphogenesis	BP
1	5	0.995710465191	-	4.11e-01	GO:0006003	fructose 2,6-bisphosphate metabolic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0045842	positive regulation of mitotic metaphase/anaphase transition	BP
1	5	0.995710465191	-	4.11e-01	GO:0019530	taurine metabolic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0032232	negative regulation of actin filament bundle assembly	BP
1	5	0.995710465191	-	4.11e-01	GO:0032494	response to peptidoglycan	BP
1	5	0.995710465191	-	4.11e-01	GO:0045639	positive regulation of myeloid cell differentiation	BP
1	5	0.995710465191	-	4.11e-01	GO:0045637	regulation of myeloid cell differentiation	BP
1	5	0.995710465191	-	4.11e-01	GO:0010940	positive regulation of necrotic cell death	BP
1	5	0.995710465191	-	4.11e-01	GO:0001504	neurotransmitter uptake	BP
1	5	0.995710465191	-	4.11e-01	GO:0048598	embryonic morphogenesis	BP
1	5	0.995710465191	-	4.11e-01	GO:0001714	endodermal cell fate specification	BP
1	5	0.995710465191	-	4.11e-01	GO:0034197	triglyceride transport	BP
1	5	0.995710465191	-	4.11e-01	GO:0010739	positive regulation of protein kinase A signaling	BP
1	5	0.995710465191	-	4.11e-01	GO:0070296	sarcoplasmic reticulum calcium ion transport	BP
1	5	0.995710465191	-	4.11e-01	GO:0090074	negative regulation of protein homodimerization activity	BP
1	5	0.995710465191	-	4.11e-01	GO:0070242	thymocyte apoptotic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0036035	osteoclast development	BP
1	5	0.995710465191	-	4.11e-01	GO:0051354	negative regulation of oxidoreductase activity	BP
1	5	0.995710465191	-	4.11e-01	GO:0010040	response to iron(II) ion	BP
1	5	0.995710465191	-	4.11e-01	GO:0046755	viral budding	BP
1	5	0.995710465191	-	4.11e-01	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	5	0.995710465191	-	4.11e-01	GO:0033081	regulation of T cell differentiation in thymus	BP
1	5	0.995710465191	-	4.11e-01	GO:0030263	apoptotic chromosome condensation	BP
1	5	0.995710465191	-	4.11e-01	GO:0002821	positive regulation of adaptive immune response	BP
1	5	0.995710465191	-	4.11e-01	GO:2000467	positive regulation of glycogen (starch) synthase activity	BP
1	5	0.995710465191	-	4.11e-01	GO:0045838	positive regulation of membrane potential	BP
1	5	0.995710465191	-	4.11e-01	GO:0036336	dendritic cell migration	BP
1	5	0.995710465191	-	4.11e-01	GO:0001887	selenium compound metabolic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0090330	regulation of platelet aggregation	BP
1	5	0.995710465191	-	4.11e-01	GO:0090335	regulation of brown fat cell differentiation	BP
1	5	0.995710465191	-	4.11e-01	GO:0032489	regulation of Cdc42 protein signal transduction	BP
1	5	0.995710465191	-	4.11e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
1	5	0.995710465191	-	4.11e-01	GO:0031133	regulation of axon diameter	BP
1	5	0.995710465191	-	4.11e-01	GO:0007610	behavior	BP
1	5	0.995710465191	-	4.11e-01	GO:0045040	protein import into mitochondrial outer membrane	BP
1	5	0.995710465191	-	4.11e-01	GO:0070245	positive regulation of thymocyte apoptotic process	BP
1	5	0.995710465191	-	4.11e-01	GO:0051220	cytoplasmic sequestering of protein	BP
1	5	0.995710465191	-	4.11e-01	GO:0051223	regulation of protein transport	BP
1	5	0.995710465191	-	4.11e-01	GO:1904385	cellular response to angiotensin	BP
1	5	0.995710465191	-	4.11e-01	GO:0006924	activation-induced cell death of T cells	BP
1	5	0.995710465191	-	4.11e-01	GO:0032876	negative regulation of DNA endoreduplication	BP
1	5	0.995710465191	-	4.11e-01	GO:0090188	negative regulation of pancreatic juice secretion	BP
1	5	0.995710465191	-	4.11e-01	GO:2000535	regulation of entry of bacterium into host cell	BP
1	5	0.995710465191	-	4.11e-01	GO:0003161	cardiac conduction system development	BP
1	5	0.995710465191	-	4.11e-01	GO:0010994	free ubiquitin chain polymerization	BP
1	5	0.995710465191	-	4.11e-01	GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity	BP
1	5	0.995710465191	-	4.11e-01	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
1	5	0.995710465191	-	4.11e-01	GO:0048639	positive regulation of developmental growth	BP
1	5	0.995710465191	-	4.11e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
1	5	0.995710465191	-	4.11e-01	GO:0032534	regulation of microvillus assembly	BP
1	5	0.995710465191	-	4.11e-01	GO:0060561	apoptotic process involved in morphogenesis	BP
1	5	0.995710465191	-	4.11e-01	GO:0006089	lactate metabolic process	BP
4	20	0.995710465191	-	5.60e-02	GO:0005112	Notch binding	MF
2	10	0.995710465191	-	1.88e-01	GO:0019911	structural constituent of myelin sheath	MF
1	5	0.995710465191	-	1.91e-01	GO:0005499	vitamin D binding	MF
2	10	0.995710465191	-	2.26e-01	GO:0019104	DNA N-glycosylase activity	MF
2	10	0.995710465191	-	2.26e-01	GO:0008080	N-acetyltransferase activity	MF
2	10	0.995710465191	-	2.26e-01	GO:0016504	peptidase activator activity	MF
2	10	0.995710465191	-	2.65e-01	GO:0042805	actinin binding	MF
2	10	0.995710465191	-	2.65e-01	GO:0045295	gamma-catenin binding	MF
2	10	0.995710465191	-	2.65e-01	GO:0048156	tau protein binding	MF
2	10	0.995710465191	-	2.65e-01	GO:0034452	dynactin binding	MF
1	5	0.995710465191	-	2.72e-01	GO:0043141	ATP-dependent 5'-3' DNA helicase activity	MF
1	5	0.995710465191	-	2.72e-01	GO:0008532	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity	MF
1	5	0.995710465191	-	2.72e-01	GO:0004528	phosphodiesterase I activity	MF
1	5	0.995710465191	-	2.72e-01	GO:0032190	acrosin binding	MF
1	5	0.995710465191	-	2.72e-01	GO:0008422	beta-glucosidase activity	MF
1	5	0.995710465191	-	3.45e-01	GO:0101020	estrogen 16-alpha-hydroxylase activity	MF
1	5	0.995710465191	-	3.45e-01	GO:0046870	cadmium ion binding	MF
1	5	0.995710465191	-	3.45e-01	GO:0071813	lipoprotein particle binding	MF
1	5	0.995710465191	-	3.45e-01	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
1	5	0.995710465191	-	3.45e-01	GO:0032451	demethylase activity	MF
1	5	0.995710465191	-	3.45e-01	GO:1990254	keratin filament binding	MF
1	5	0.995710465191	-	3.45e-01	GO:0034596	phosphatidylinositol phosphate 4-phosphatase activity	MF
1	5	0.995710465191	-	3.45e-01	GO:0015129	lactate transmembrane transporter activity	MF
1	5	0.995710465191	-	3.45e-01	GO:0016462	pyrophosphatase activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0051373	FATZ binding	MF
1	5	0.995710465191	-	4.11e-01	GO:1990239	steroid hormone binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0031013	troponin I binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0004331	fructose-2,6-bisphosphate 2-phosphatase activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0035174	histone serine kinase activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	MF
1	5	0.995710465191	-	4.11e-01	GO:0042609	CD4 receptor binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0005324	long-chain fatty acid transporter activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0017069	snRNA binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0050544	arachidonic acid binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0015277	kainate selective glutamate receptor activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0048495	Roundabout binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0008186	RNA-dependent ATPase activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0034711	inhibin binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0005087	Ran guanyl-nucleotide exchange factor activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0044877	macromolecular complex binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0034046	poly(G) binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0071253	connexin binding	MF
1	5	0.995710465191	-	4.11e-01	GO:0015057	thrombin-activated receptor activity	MF
1	5	0.995710465191	-	4.11e-01	GO:0019966	interleukin-1 binding	MF
60	301	0.990909478927	-	3.73e-09	GO:0042493	response to drug	BP
18	91	0.979768921322	-	2.90e-04	GO:0009636	response to toxic substance	BP
12	61	0.971863723236	-	3.86e-03	GO:0042632	cholesterol homeostasis	BP
36	183	0.971863723236	-	1.87e-05	GO:0061630	ubiquitin protein ligase activity	MF
19	97	0.965653231335	-	2.77e-04	GO:0030182	neuron differentiation	BP
7	36	0.955068480693	-	2.18e-02	GO:0002062	chondrocyte differentiation	BP
7	36	0.955068480693	-	3.08e-02	GO:0032720	negative regulation of tumor necrosis factor production	BP
7	36	0.955068480693	-	8.55e-02	GO:0042769	DNA damage response, detection of DNA damage	BP
13	67	0.951989087761	-	2.06e-02	GO:0038061	NIK/NF-kappaB signaling	BP
6	31	0.948404750412	-	4.75e-02	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
11	57	0.944180164551	-	1.44e-02	GO:0060041	retina development in camera-type eye	BP
11	57	0.944180164551	-	2.00e-02	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
52	270	0.941262681168	-	8.95e-08	GO:0016579	protein deubiquitination	BP
5	26	0.939126936824	-	9.88e-02	GO:0000732	strand displacement	BP
5	26	0.939126936824	-	9.88e-02	GO:0050999	regulation of nitric-oxide synthase activity	BP
5	26	0.939126936824	-	1.77e-01	GO:0032728	positive regulation of interferon-beta production	BP
14	73	0.935168923256	-	4.98e-03	GO:0007005	mitochondrion organization	BP
18	94	0.932974709843	-	1.79e-03	GO:0008584	male gonad development	BP
8	42	0.925321137299	-	1.42e-02	GO:0001658	branching involved in ureteric bud morphogenesis	BP
4	21	0.925321137299	-	3.44e-02	GO:0032094	response to food	BP
4	21	0.925321137299	-	8.32e-02	GO:0045671	negative regulation of osteoclast differentiation	BP
4	21	0.925321137299	-	9.89e-02	GO:0035902	response to immobilization stress	BP
4	21	0.925321137299	-	9.89e-02	GO:0048844	artery morphogenesis	BP
4	21	0.925321137299	-	1.16e-01	GO:0001782	B cell homeostasis	BP
4	21	0.925321137299	-	1.16e-01	GO:0048870	cell motility	BP
4	21	0.925321137299	-	1.34e-01	GO:0050769	positive regulation of neurogenesis	BP
4	21	0.925321137299	-	1.53e-01	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	BP
4	21	0.925321137299	-	1.53e-01	GO:0006293	nucleotide-excision repair, preincision complex stabilization	BP
4	21	0.925321137299	-	1.53e-01	GO:0030316	osteoclast differentiation	BP
4	21	0.925321137299	-	1.53e-01	GO:0006997	nucleus organization	BP
34	179	0.921285624064	-	6.19e-06	GO:0016055	Wnt signaling pathway	BP
11	58	0.919089183588	-	8.07e-03	GO:0021766	hippocampus development	BP
25	132	0.917100630494	-	6.84e-04	GO:0050821	protein stabilization	BP
30	159	0.911646200402	-	1.21e-04	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
34	181	0.905255514245	-	6.20e-08	GO:0038095	Fc-epsilon receptor signaling pathway	BP
9	48	0.902601060799	-	3.77e-02	GO:0060548	negative regulation of cell death	BP
9	48	0.902601060799	-	3.77e-02	GO:0009267	cellular response to starvation	BP
3	16	0.902601060799	-	7.06e-02	GO:0008209	androgen metabolic process	BP
3	16	0.902601060799	-	9.01e-02	GO:0048566	embryonic digestive tract development	BP
6	32	0.902601060799	-	1.16e-01	GO:0010507	negative regulation of autophagy	BP
6	32	0.902601060799	-	1.22e-01	GO:0046677	response to antibiotic	BP
6	32	0.902601060799	-	1.22e-01	GO:0071549	cellular response to dexamethasone stimulus	BP
3	16	0.902601060799	-	1.35e-01	GO:0021522	spinal cord motor neuron differentiation	BP
3	16	0.902601060799	-	1.35e-01	GO:0014850	response to muscle activity	BP
3	16	0.902601060799	-	1.59e-01	GO:0031293	membrane protein intracellular domain proteolysis	BP
3	16	0.902601060799	-	1.59e-01	GO:0061036	positive regulation of cartilage development	BP
3	16	0.902601060799	-	1.59e-01	GO:0001709	cell fate determination	BP
3	16	0.902601060799	-	1.85e-01	GO:0032479	regulation of type I interferon production	BP
3	16	0.902601060799	-	1.85e-01	GO:0010259	multicellular organism aging	BP
3	16	0.902601060799	-	1.85e-01	GO:0071732	cellular response to nitric oxide	BP
3	16	0.902601060799	-	1.85e-01	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
3	16	0.902601060799	-	2.12e-01	GO:0034142	toll-like receptor 4 signaling pathway	BP
3	16	0.902601060799	-	3.83e-02	GO:0001972	retinoic acid binding	MF
3	16	0.902601060799	-	1.35e-01	GO:0004540	ribonuclease activity	MF
3	16	0.902601060799	-	1.59e-01	GO:0008408	3'-5' exonuclease activity	MF
3	16	0.902601060799	-	2.12e-01	GO:0050750	low-density lipoprotein particle receptor binding	MF
14	75	0.89617479164	-	1.67e-02	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
8	43	0.891373805376	-	4.99e-03	GO:0030514	negative regulation of BMP signaling pathway	BP
30	162	0.884679152802	-	1.57e-04	GO:0007568	aging	BP
5	27	0.884679152802	-	5.26e-02	GO:0030534	adult behavior	BP
5	27	0.884679152802	-	5.26e-02	GO:0031069	hair follicle morphogenesis	BP
5	27	0.884679152802	-	7.37e-02	GO:0016358	dendrite development	BP
5	27	0.884679152802	-	9.88e-02	GO:0001662	behavioral fear response	BP
5	27	0.884679152802	-	1.85e-01	GO:0043278	response to morphine	BP
14	76	0.877065968692	-	8.42e-03	GO:0008286	insulin receptor signaling pathway	BP
7	38	0.877065968692	-	7.60e-02	GO:0009790	embryo development	BP
7	38	0.877065968692	-	9.17e-02	GO:0007346	regulation of mitotic cell cycle	BP
7	38	0.877065968692	-	9.86e-02	GO:0033683	nucleotide-excision repair, DNA incision	BP
234	1271	0.876254964657	-	2.73e-10	GO:0006355	regulation of transcription, DNA-templated	BP
20	109	0.871382330189	-	1.74e-03	GO:0071356	cellular response to tumor necrosis factor	BP
11	60	0.870179583107	-	4.56e-02	GO:0007059	chromosome segregation	BP
13	71	0.868331158714	-	2.59e-02	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
30	165	0.858206941441	-	1.13e-04	GO:0007507	heart development	BP
12	66	0.858206941441	-	1.34e-02	GO:0009749	response to glucose	BP
8	44	0.858206941441	-	2.02e-02	GO:0006342	chromatin silencing	BP
8	44	0.858206941441	-	6.61e-02	GO:0032760	positive regulation of tumor necrosis factor production	BP
4	22	0.858206941441	-	9.89e-02	GO:0048741	skeletal muscle fiber development	BP
4	22	0.858206941441	-	1.16e-01	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
4	22	0.858206941441	-	1.16e-01	GO:0001816	cytokine production	BP
4	22	0.858206941441	-	1.16e-01	GO:0015914	phospholipid transport	BP
4	22	0.858206941441	-	1.34e-01	GO:1904886	beta-catenin destruction complex disassembly	BP
2	11	0.858206941441	-	1.50e-01	GO:0008406	gonad development	BP
4	22	0.858206941441	-	1.53e-01	GO:0005978	glycogen biosynthetic process	BP
4	22	0.858206941441	-	1.53e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
2	11	0.858206941441	-	1.88e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
2	11	0.858206941441	-	1.88e-01	GO:0001655	urogenital system development	BP
2	11	0.858206941441	-	1.88e-01	GO:0015918	sterol transport	BP
2	11	0.858206941441	-	1.88e-01	GO:0003323	type B pancreatic cell development	BP
2	11	0.858206941441	-	1.88e-01	GO:0033690	positive regulation of osteoblast proliferation	BP
2	11	0.858206941441	-	2.26e-01	GO:0070365	hepatocyte differentiation	BP
2	11	0.858206941441	-	2.26e-01	GO:0019371	cyclooxygenase pathway	BP
2	11	0.858206941441	-	2.65e-01	GO:0030833	regulation of actin filament polymerization	BP
2	11	0.858206941441	-	2.65e-01	GO:0032206	positive regulation of telomere maintenance	BP
2	11	0.858206941441	-	2.65e-01	GO:0008610	lipid biosynthetic process	BP
2	11	0.858206941441	-	2.65e-01	GO:0060081	membrane hyperpolarization	BP
2	11	0.858206941441	-	2.65e-01	GO:0019068	virion assembly	BP
2	11	0.858206941441	-	2.65e-01	GO:0035413	positive regulation of catenin import into nucleus	BP
2	11	0.858206941441	-	2.65e-01	GO:0048333	mesodermal cell differentiation	BP
2	11	0.858206941441	-	2.65e-01	GO:0000002	mitochondrial genome maintenance	BP
2	11	0.858206941441	-	2.65e-01	GO:0061045	negative regulation of wound healing	BP
2	11	0.858206941441	-	2.65e-01	GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator	BP
4	22	0.858206941441	-	2.71e-01	GO:0048568	embryonic organ development	BP
2	11	0.858206941441	-	3.04e-01	GO:0050927	positive regulation of positive chemotaxis	BP
2	11	0.858206941441	-	3.04e-01	GO:0070914	UV-damage excision repair	BP
2	11	0.858206941441	-	3.04e-01	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	BP
2	11	0.858206941441	-	3.04e-01	GO:0010955	negative regulation of protein processing	BP
2	11	0.858206941441	-	3.04e-01	GO:0032700	negative regulation of interleukin-17 production	BP
2	11	0.858206941441	-	3.04e-01	GO:0045806	negative regulation of endocytosis	BP
2	11	0.858206941441	-	3.04e-01	GO:0030238	male sex determination	BP
2	11	0.858206941441	-	3.04e-01	GO:1904357	negative regulation of telomere maintenance via telomere lengthening	BP
2	11	0.858206941441	-	3.04e-01	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
2	11	0.858206941441	-	3.04e-01	GO:0042511	positive regulation of tyrosine phosphorylation of Stat1 protein	BP
2	11	0.858206941441	-	3.04e-01	GO:0071481	cellular response to X-ray	BP
2	11	0.858206941441	-	3.04e-01	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
2	11	0.858206941441	-	1.50e-01	GO:0016175	superoxide-generating NADPH oxidase activity	MF
4	22	0.858206941441	-	1.53e-01	GO:0004683	calmodulin-dependent protein kinase activity	MF
2	11	0.858206941441	-	2.65e-01	GO:0042054	histone methyltransferase activity	MF
2	11	0.858206941441	-	3.04e-01	GO:0043522	leucine zipper domain binding	MF
10	55	0.858206941441	-	3.59e-02	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
33	183	0.846332841152	-	4.29e-05	GO:0042981	regulation of apoptotic process	BP
9	50	0.843707371746	-	3.30e-02	GO:0071277	cellular response to calcium ion	BP
9	50	0.843707371746	-	5.29e-02	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
198	1102	0.841086671587	-	2.41e-10	GO:0008270	zinc ion binding	MF
7	39	0.839591263273	-	9.17e-02	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
7	39	0.839591263273	-	2.18e-02	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	MF
5	28	0.832211732908	-	1.77e-01	GO:0007528	neuromuscular junction development	BP
5	28	0.832211732908	-	1.85e-01	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
5	28	0.832211732908	-	1.85e-01	GO:0090004	positive regulation of establishment of protein localization to plasma membrane	BP
5	28	0.832211732908	-	1.95e-01	GO:0032008	positive regulation of TOR signaling	BP
8	45	0.825785463748	-	7.18e-02	GO:0010595	positive regulation of endothelial cell migration	BP
19	107	0.824099087121	-	7.27e-03	GO:0000187	activation of MAPK activity	BP
17	96	0.820138900607	-	5.06e-03	GO:0042593	glucose homeostasis	BP
35	198	0.817564956943	-	1.52e-04	GO:0006281	DNA repair	BP
15	85	0.815138219549	-	1.15e-03	GO:1903955	positive regulation of protein targeting to mitochondrion	BP
3	17	0.815138219549	-	9.01e-02	GO:0042310	vasoconstriction	BP
3	17	0.815138219549	-	1.35e-01	GO:0048514	blood vessel morphogenesis	BP
3	17	0.815138219549	-	1.35e-01	GO:0048663	neuron fate commitment	BP
3	17	0.815138219549	-	1.59e-01	GO:0030902	hindbrain development	BP
3	17	0.815138219549	-	1.59e-01	GO:0007043	cell-cell junction assembly	BP
3	17	0.815138219549	-	1.59e-01	GO:0030301	cholesterol transport	BP
3	17	0.815138219549	-	1.59e-01	GO:0045582	positive regulation of T cell differentiation	BP
3	17	0.815138219549	-	1.59e-01	GO:0042462	eye photoreceptor cell development	BP
3	17	0.815138219549	-	1.59e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
3	17	0.815138219549	-	1.85e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
3	17	0.815138219549	-	1.85e-01	GO:0048488	synaptic vesicle endocytosis	BP
3	17	0.815138219549	-	1.85e-01	GO:0043691	reverse cholesterol transport	BP
3	17	0.815138219549	-	2.12e-01	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
3	17	0.815138219549	-	2.12e-01	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
3	17	0.815138219549	-	2.12e-01	GO:0048814	regulation of dendrite morphogenesis	BP
3	17	0.815138219549	-	2.12e-01	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
3	17	0.815138219549	-	2.40e-01	GO:0031333	negative regulation of protein complex assembly	BP
3	17	0.815138219549	-	2.40e-01	GO:0044257	cellular protein catabolic process	BP
3	17	0.815138219549	-	1.35e-01	GO:0017049	GTP-Rho binding	MF
10	57	0.806676640801	-	7.37e-03	GO:0060395	SMAD protein signal transduction	BP
35	200	0.803065387248	-	3.59e-04	GO:0032403	protein complex binding	MF
7	40	0.803065387248	-	9.17e-02	GO:0097191	extrinsic apoptotic signaling pathway	BP
11	63	0.799790255215	-	2.20e-02	GO:0009611	response to wounding	BP
15	86	0.798264400985	-	4.55e-03	GO:0007517	muscle organ development	BP
8	46	0.794076604021	-	5.68e-02	GO:0010506	regulation of autophagy	BP
8	46	0.794076604021	-	6.11e-02	GO:0071230	cellular response to amino acid stimulus	BP
4	23	0.794076604021	-	2.71e-01	GO:0003009	skeletal muscle contraction	BP
4	23	0.794076604021	-	2.82e-01	GO:0031593	polyubiquitin binding	MF
5	29	0.781585659838	-	1.85e-01	GO:0045765	regulation of angiogenesis	BP
5	29	0.781585659838	-	1.85e-01	GO:0034198	cellular response to amino acid starvation	BP
11	64	0.777070178715	-	1.82e-02	GO:0060337	type I interferon signaling pathway	BP
6	35	0.773318043854	-	4.75e-02	GO:0035094	response to nicotine	BP
6	35	0.773318043854	-	1.37e-01	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
7	41	0.767441477518	-	1.81e-02	GO:0022008	neurogenesis	BP
7	41	0.767441477518	-	8.03e-02	GO:0043010	camera-type eye development	BP
7	41	0.767441477518	-	9.86e-02	GO:0014823	response to activity	BP
7	41	0.767441477518	-	1.06e-01	GO:0031072	heat shock protein binding	MF
7	41	0.767441477518	-	1.06e-01	GO:0032947	protein complex scaffold	MF
29	171	0.75776704032	-	4.50e-04	GO:0042127	regulation of cell proliferation	BP
10	59	0.756923605604	-	3.26e-02	GO:0050727	regulation of inflammatory response	BP
10	59	0.756923605604	-	6.60e-02	GO:0001933	negative regulation of protein phosphorylation	BP
28	166	0.749954050789	-	5.64e-03	GO:0046777	protein autophosphorylation	BP
76	453	0.742198833475	-	7.18e-09	GO:0008284	positive regulation of cell proliferation	BP
13	78	0.732676059357	-	5.02e-02	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
19	114	0.732676059357	-	1.46e-02	GO:0006461	protein complex assembly	BP
9	54	0.732676059357	-	4.08e-02	GO:0000902	cell morphogenesis	BP
10	60	0.732676059357	-	6.92e-02	GO:0009967	positive regulation of signal transduction	BP
7	42	0.732676059357	-	7.60e-02	GO:0001541	ovarian follicle development	BP
4	24	0.732676059357	-	9.89e-02	GO:0090102	cochlea development	BP
7	42	0.732676059357	-	1.06e-01	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
3	18	0.732676059357	-	1.12e-01	GO:0010460	positive regulation of heart rate	BP
2	12	0.732676059357	-	1.15e-01	GO:0042738	exogenous drug catabolic process	BP
6	36	0.732676059357	-	1.47e-01	GO:0051402	neuron apoptotic process	BP
6	36	0.732676059357	-	1.47e-01	GO:0042517	positive regulation of tyrosine phosphorylation of Stat3 protein	BP
4	24	0.732676059357	-	1.53e-01	GO:0033344	cholesterol efflux	BP
6	36	0.732676059357	-	1.57e-01	GO:0006953	acute-phase response	BP
5	30	0.732676059357	-	1.85e-01	GO:0007616	long-term memory	BP
3	18	0.732676059357	-	1.85e-01	GO:0006970	response to osmotic stress	BP
3	18	0.732676059357	-	1.85e-01	GO:0007263	nitric oxide mediated signal transduction	BP
3	18	0.732676059357	-	1.85e-01	GO:0061436	establishment of skin barrier	BP
2	12	0.732676059357	-	1.88e-01	GO:0032026	response to magnesium ion	BP
2	12	0.732676059357	-	1.88e-01	GO:0046889	positive regulation of lipid biosynthetic process	BP
1	6	0.732676059357	-	1.91e-01	GO:0030540	female genitalia development	BP
1	6	0.732676059357	-	1.91e-01	GO:2000253	positive regulation of feeding behavior	BP
1	6	0.732676059357	-	1.91e-01	GO:0034755	iron ion transmembrane transport	BP
1	6	0.732676059357	-	1.91e-01	GO:2000272	negative regulation of receptor activity	BP
5	30	0.732676059357	-	1.95e-01	GO:0042177	negative regulation of protein catabolic process	BP
3	18	0.732676059357	-	2.12e-01	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
2	12	0.732676059357	-	2.26e-01	GO:0033700	phospholipid efflux	BP
3	18	0.732676059357	-	2.40e-01	GO:2000249	regulation of actin cytoskeleton reorganization	BP
3	18	0.732676059357	-	2.40e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
2	12	0.732676059357	-	2.65e-01	GO:0060416	response to growth hormone	BP
2	12	0.732676059357	-	2.65e-01	GO:0097028	dendritic cell differentiation	BP
2	12	0.732676059357	-	2.65e-01	GO:0061158	3'-UTR-mediated mRNA destabilization	BP
2	12	0.732676059357	-	2.65e-01	GO:0021846	cell proliferation in forebrain	BP
2	12	0.732676059357	-	2.65e-01	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
2	12	0.732676059357	-	2.65e-01	GO:0008206	bile acid metabolic process	BP
2	12	0.732676059357	-	2.65e-01	GO:0035641	locomotory exploration behavior	BP
2	12	0.732676059357	-	2.65e-01	GO:0002690	positive regulation of leukocyte chemotaxis	BP
2	12	0.732676059357	-	2.65e-01	GO:0007600	sensory perception	BP
2	12	0.732676059357	-	2.65e-01	GO:0045995	regulation of embryonic development	BP
4	24	0.732676059357	-	2.71e-01	GO:0051602	response to electrical stimulus	BP
1	6	0.732676059357	-	2.72e-01	GO:0042737	drug catabolic process	BP
1	6	0.732676059357	-	2.72e-01	GO:0070383	DNA cytosine deamination	BP
1	6	0.732676059357	-	2.72e-01	GO:0045143	homologous chromosome segregation	BP
1	6	0.732676059357	-	2.72e-01	GO:0007635	chemosensory behavior	BP
1	6	0.732676059357	-	2.72e-01	GO:0051552	flavone metabolic process	BP
1	6	0.732676059357	-	2.72e-01	GO:0046483	heterocycle metabolic process	BP
1	6	0.732676059357	-	2.72e-01	GO:0032964	collagen biosynthetic process	BP
1	6	0.732676059357	-	2.72e-01	GO:0006880	intracellular sequestering of iron ion	BP
1	6	0.732676059357	-	2.72e-01	GO:0048856	anatomical structure development	BP
1	6	0.732676059357	-	2.72e-01	GO:0016098	monoterpenoid metabolic process	BP
4	24	0.732676059357	-	2.82e-01	GO:0007088	regulation of mitotic nuclear division	BP
4	24	0.732676059357	-	2.95e-01	GO:0016239	positive regulation of macroautophagy	BP
4	24	0.732676059357	-	2.95e-01	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
2	12	0.732676059357	-	3.04e-01	GO:0001736	establishment of planar polarity	BP
2	12	0.732676059357	-	3.04e-01	GO:0045060	negative thymic T cell selection	BP
2	12	0.732676059357	-	3.04e-01	GO:0021670	lateral ventricle development	BP
2	12	0.732676059357	-	3.04e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
2	12	0.732676059357	-	3.04e-01	GO:0006107	oxaloacetate metabolic process	BP
2	12	0.732676059357	-	3.04e-01	GO:0086004	regulation of cardiac muscle cell contraction	BP
2	12	0.732676059357	-	3.42e-01	GO:0047496	vesicle transport along microtubule	BP
2	12	0.732676059357	-	3.42e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
2	12	0.732676059357	-	3.42e-01	GO:0046902	regulation of mitochondrial membrane permeability	BP
2	12	0.732676059357	-	3.42e-01	GO:0035278	miRNA mediated inhibition of translation	BP
2	12	0.732676059357	-	3.42e-01	GO:0046688	response to copper ion	BP
2	12	0.732676059357	-	3.42e-01	GO:0006301	postreplication repair	BP
2	12	0.732676059357	-	3.42e-01	GO:0032801	receptor catabolic process	BP
2	12	0.732676059357	-	3.42e-01	GO:0090656	t-circle formation	BP
1	6	0.732676059357	-	3.45e-01	GO:0007341	penetration of zona pellucida	BP
1	6	0.732676059357	-	3.45e-01	GO:0086015	SA node cell action potential	BP
1	6	0.732676059357	-	3.45e-01	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	0.732676059357	-	3.45e-01	GO:0021853	cerebral cortex GABAergic interneuron migration	BP
1	6	0.732676059357	-	3.45e-01	GO:0032367	intracellular cholesterol transport	BP
1	6	0.732676059357	-	3.45e-01	GO:0018230	peptidyl-L-cysteine S-palmitoylation	BP
1	6	0.732676059357	-	3.45e-01	GO:0003416	endochondral bone growth	BP
1	6	0.732676059357	-	3.45e-01	GO:0051798	positive regulation of hair follicle development	BP
1	6	0.732676059357	-	3.45e-01	GO:0048793	pronephros development	BP
1	6	0.732676059357	-	3.45e-01	GO:0070508	cholesterol import	BP
1	6	0.732676059357	-	3.45e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	0.732676059357	-	3.45e-01	GO:0071774	response to fibroblast growth factor	BP
1	6	0.732676059357	-	3.45e-01	GO:1900116	extracellular negative regulation of signal transduction	BP
1	6	0.732676059357	-	3.45e-01	GO:0010172	embryonic body morphogenesis	BP
1	6	0.732676059357	-	3.45e-01	GO:0055123	digestive system development	BP
1	6	0.732676059357	-	3.45e-01	GO:0007530	sex determination	BP
1	6	0.732676059357	-	3.45e-01	GO:0061000	negative regulation of dendritic spine development	BP
1	6	0.732676059357	-	3.45e-01	GO:0060710	chorio-allantoic fusion	BP
1	6	0.732676059357	-	4.11e-01	GO:0090344	negative regulation of cell aging	BP
1	6	0.732676059357	-	4.11e-01	GO:0006497	protein lipidation	BP
1	6	0.732676059357	-	4.11e-01	GO:0003179	heart valve morphogenesis	BP
1	6	0.732676059357	-	4.11e-01	GO:0032364	oxygen homeostasis	BP
1	6	0.732676059357	-	4.11e-01	GO:0060415	muscle tissue morphogenesis	BP
1	6	0.732676059357	-	4.11e-01	GO:0035864	response to potassium ion	BP
1	6	0.732676059357	-	4.11e-01	GO:0017196	N-terminal peptidyl-methionine acetylation	BP
1	6	0.732676059357	-	4.11e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
1	6	0.732676059357	-	4.11e-01	GO:0045602	negative regulation of endothelial cell differentiation	BP
1	6	0.732676059357	-	4.11e-01	GO:0032914	positive regulation of transforming growth factor beta1 production	BP
1	6	0.732676059357	-	4.11e-01	GO:0048524	positive regulation of viral process	BP
1	6	0.732676059357	-	4.11e-01	GO:0031960	response to corticosteroid	BP
1	6	0.732676059357	-	4.11e-01	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
1	6	0.732676059357	-	4.11e-01	GO:0048806	genitalia development	BP
1	6	0.732676059357	-	4.11e-01	GO:0061180	mammary gland epithelium development	BP
1	6	0.732676059357	-	4.11e-01	GO:0048845	venous blood vessel morphogenesis	BP
1	6	0.732676059357	-	4.11e-01	GO:0002639	positive regulation of immunoglobulin production	BP
1	6	0.732676059357	-	4.11e-01	GO:0042693	muscle cell fate commitment	BP
1	6	0.732676059357	-	4.11e-01	GO:0070257	positive regulation of mucus secretion	BP
1	6	0.732676059357	-	4.11e-01	GO:0042796	snRNA transcription from RNA polymerase III promoter	BP
1	6	0.732676059357	-	4.11e-01	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	0.732676059357	-	4.11e-01	GO:0032717	negative regulation of interleukin-8 production	BP
1	6	0.732676059357	-	4.11e-01	GO:0071287	cellular response to manganese ion	BP
1	6	0.732676059357	-	4.11e-01	GO:0042048	olfactory behavior	BP
1	6	0.732676059357	-	4.11e-01	GO:0044806	G-quadruplex DNA unwinding	BP
1	6	0.732676059357	-	4.11e-01	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
1	6	0.732676059357	-	4.11e-01	GO:0060056	mammary gland involution	BP
1	6	0.732676059357	-	4.11e-01	GO:0031987	locomotion involved in locomotory behavior	BP
1	6	0.732676059357	-	4.11e-01	GO:0072719	cellular response to cisplatin	BP
1	6	0.732676059357	-	4.11e-01	GO:0042421	norepinephrine biosynthetic process	BP
1	6	0.732676059357	-	4.11e-01	GO:0010960	magnesium ion homeostasis	BP
3	18	0.732676059357	-	4.17e-01	GO:0006913	nucleocytoplasmic transport	BP
3	18	0.732676059357	-	4.17e-01	GO:0043523	regulation of neuron apoptotic process	BP
3	18	0.732676059357	-	4.17e-01	GO:1901741	positive regulation of myoblast fusion	BP
3	18	0.732676059357	-	4.17e-01	GO:0045807	positive regulation of endocytosis	BP
1	6	0.732676059357	-	4.70e-01	GO:0042092	type 2 immune response	BP
1	6	0.732676059357	-	4.70e-01	GO:0006323	DNA packaging	BP
1	6	0.732676059357	-	4.70e-01	GO:1901990	regulation of mitotic cell cycle phase transition	BP
1	6	0.732676059357	-	4.70e-01	GO:0031584	activation of phospholipase D activity	BP
1	6	0.732676059357	-	4.70e-01	GO:0014910	regulation of smooth muscle cell migration	BP
1	6	0.732676059357	-	4.70e-01	GO:0012501	programmed cell death	BP
1	6	0.732676059357	-	4.70e-01	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
1	6	0.732676059357	-	4.70e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	0.732676059357	-	4.70e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
1	6	0.732676059357	-	4.70e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
1	6	0.732676059357	-	4.70e-01	GO:0097062	dendritic spine maintenance	BP
1	6	0.732676059357	-	4.70e-01	GO:0090160	Golgi to lysosome transport	BP
1	6	0.732676059357	-	4.70e-01	GO:0043486	histone exchange	BP
1	6	0.732676059357	-	4.70e-01	GO:0036465	synaptic vesicle recycling	BP
1	6	0.732676059357	-	4.70e-01	GO:0055013	cardiac muscle cell development	BP
1	6	0.732676059357	-	4.70e-01	GO:0050671	positive regulation of lymphocyte proliferation	BP
1	6	0.732676059357	-	4.70e-01	GO:1902065	response to L-glutamate	BP
1	6	0.732676059357	-	4.70e-01	GO:1903715	regulation of aerobic respiration	BP
1	6	0.732676059357	-	4.70e-01	GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation	BP
1	6	0.732676059357	-	4.70e-01	GO:0051902	negative regulation of mitochondrial depolarization	BP
1	6	0.732676059357	-	4.70e-01	GO:2001046	positive regulation of integrin-mediated signaling pathway	BP
1	6	0.732676059357	-	4.70e-01	GO:0097755	positive regulation of blood vessel diameter	BP
1	6	0.732676059357	-	4.70e-01	GO:0030031	cell projection assembly	BP
1	6	0.732676059357	-	4.70e-01	GO:1904417	positive regulation of xenophagy	BP
1	6	0.732676059357	-	4.70e-01	GO:0002819	regulation of adaptive immune response	BP
1	6	0.732676059357	-	4.70e-01	GO:0044794	positive regulation by host of viral process	BP
1	6	0.732676059357	-	4.70e-01	GO:0042487	regulation of odontogenesis of dentin-containing tooth	BP
1	6	0.732676059357	-	4.70e-01	GO:0032025	response to cobalt ion	BP
1	6	0.732676059357	-	4.70e-01	GO:0031442	positive regulation of mRNA 3'-end processing	BP
1	6	0.732676059357	-	4.70e-01	GO:0007044	cell-substrate junction assembly	BP
1	6	0.732676059357	-	4.70e-01	GO:0036289	peptidyl-serine autophosphorylation	BP
1	6	0.732676059357	-	4.70e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
1	6	0.732676059357	-	4.70e-01	GO:0006101	citrate metabolic process	BP
1	6	0.732676059357	-	4.70e-01	GO:0014842	regulation of skeletal muscle satellite cell proliferation	BP
1	6	0.732676059357	-	4.70e-01	GO:2000318	positive regulation of T-helper 17 type immune response	BP
1	6	0.732676059357	-	4.70e-01	GO:0006531	aspartate metabolic process	BP
1	6	0.732676059357	-	4.70e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
1	6	0.732676059357	-	4.70e-01	GO:0042797	tRNA transcription from RNA polymerase III promoter	BP
1	6	0.732676059357	-	4.70e-01	GO:0042791	5S class rRNA transcription from RNA polymerase III type 1 promoter	BP
1	6	0.732676059357	-	4.70e-01	GO:0070585	protein localization to mitochondrion	BP
1	6	0.732676059357	-	4.70e-01	GO:0051353	positive regulation of oxidoreductase activity	BP
1	6	0.732676059357	-	4.70e-01	GO:0010042	response to manganese ion	BP
1	6	0.732676059357	-	4.70e-01	GO:0071474	cellular hyperosmotic response	BP
1	6	0.732676059357	-	4.70e-01	GO:0000018	regulation of DNA recombination	BP
1	6	0.732676059357	-	4.70e-01	GO:1901018	positive regulation of potassium ion transmembrane transporter activity	BP
1	6	0.732676059357	-	4.70e-01	GO:0032754	positive regulation of interleukin-5 production	BP
1	6	0.732676059357	-	4.70e-01	GO:0035520	monoubiquitinated protein deubiquitination	BP
1	6	0.732676059357	-	4.70e-01	GO:0060087	relaxation of vascular smooth muscle	BP
1	6	0.732676059357	-	4.70e-01	GO:0045830	positive regulation of isotype switching	BP
1	6	0.732676059357	-	4.70e-01	GO:0001553	luteinization	BP
1	6	0.732676059357	-	4.70e-01	GO:0048743	positive regulation of skeletal muscle fiber development	BP
1	6	0.732676059357	-	4.70e-01	GO:0035965	cardiolipin acyl-chain remodeling	BP
1	6	0.732676059357	-	4.70e-01	GO:0046599	regulation of centriole replication	BP
1	6	0.732676059357	-	4.70e-01	GO:0090279	regulation of calcium ion import	BP
1	6	0.732676059357	-	4.70e-01	GO:1990000	amyloid fibril formation	BP
1	6	0.732676059357	-	4.70e-01	GO:0061299	retina vasculature morphogenesis in camera-type eye	BP
1	6	0.732676059357	-	4.70e-01	GO:0033194	response to hydroperoxide	BP
1	6	0.732676059357	-	4.70e-01	GO:0071870	cellular response to catecholamine stimulus	BP
1	6	0.732676059357	-	4.70e-01	GO:0006282	regulation of DNA repair	BP
1	6	0.732676059357	-	4.70e-01	GO:0097527	necroptotic signaling pathway	BP
1	6	0.732676059357	-	4.70e-01	GO:0007435	salivary gland morphogenesis	BP
1	6	0.732676059357	-	4.70e-01	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
1	6	0.732676059357	-	4.70e-01	GO:0042423	catecholamine biosynthetic process	BP
7	42	0.732676059357	-	9.86e-02	GO:0048365	Rac GTPase binding	MF
4	24	0.732676059357	-	1.53e-01	GO:0005246	calcium channel regulator activity	MF
3	18	0.732676059357	-	1.59e-01	GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	MF
3	18	0.732676059357	-	1.85e-01	GO:0005319	lipid transporter activity	MF
3	18	0.732676059357	-	2.40e-01	GO:0070530	K63-linked polyubiquitin binding	MF
1	6	0.732676059357	-	2.72e-01	GO:0004322	ferroxidase activity	MF
1	6	0.732676059357	-	2.72e-01	GO:0045545	syndecan binding	MF
1	6	0.732676059357	-	2.72e-01	GO:0005381	iron ion transmembrane transporter activity	MF
2	12	0.732676059357	-	3.42e-01	GO:0097200	cysteine-type endopeptidase activity involved in execution phase of apoptosis	MF
1	6	0.732676059357	-	3.45e-01	GO:0008504	monoamine transmembrane transporter activity	MF
1	6	0.732676059357	-	3.45e-01	GO:0004630	phospholipase D activity	MF
1	6	0.732676059357	-	3.45e-01	GO:0004983	neuropeptide Y receptor activity	MF
1	6	0.732676059357	-	3.45e-01	GO:0004969	histamine receptor activity	MF
1	6	0.732676059357	-	3.45e-01	GO:0048019	receptor antagonist activity	MF
1	6	0.732676059357	-	4.11e-01	GO:0008420	CTD phosphatase activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0003958	NADPH-hemoprotein reductase activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0003910	DNA ligase (ATP) activity	MF
1	6	0.732676059357	-	4.70e-01	GO:1990782	protein tyrosine kinase binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0045182	translation regulator activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0043140	ATP-dependent 3'-5' DNA helicase activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0017108	5'-flap endonuclease activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0030275	LRR domain binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0031730	CCR5 chemokine receptor binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0034618	arginine binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0032050	clathrin heavy chain binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0036402	proteasome-activating ATPase activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0043559	insulin binding	MF
1	6	0.732676059357	-	4.70e-01	GO:0019784	NEDD8-specific protease activity	MF
1	6	0.732676059357	-	4.70e-01	GO:0010997	anaphase-promoting complex binding	MF
20	121	0.720703417691	-	1.16e-02	GO:0004713	protein tyrosine kinase activity	MF
18	110	0.706203847996	-	1.04e-02	GO:0030168	platelet activation	BP
9	55	0.706203847996	-	9.95e-02	GO:0007173	epidermal growth factor receptor signaling pathway	BP
21	129	0.698728727434	-	1.37e-02	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
7	43	0.698728727434	-	9.17e-02	GO:0034605	cellular response to heat	BP
6	37	0.69314769517	-	2.63e-01	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	BP
6	37	0.69314769517	-	2.63e-01	GO:0031623	receptor internalization	BP
16	99	0.688281939998	-	1.64e-02	GO:0001764	neuron migration	BP
5	31	0.685370344579	-	8.58e-02	GO:0048565	digestive tract development	BP
5	31	0.685370344579	-	1.95e-01	GO:0032007	negative regulation of TOR signaling	BP
5	31	0.685370344579	-	2.32e-01	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
4	25	0.673782370303	-	1.16e-01	GO:0032689	negative regulation of interferon-gamma production	BP
4	25	0.673782370303	-	1.34e-01	GO:0050715	positive regulation of cytokine secretion	BP
4	25	0.673782370303	-	2.82e-01	GO:0043542	endothelial cell migration	BP
4	25	0.673782370303	-	2.95e-01	GO:0032757	positive regulation of interleukin-8 production	BP
4	25	0.673782370303	-	3.09e-01	GO:0032735	positive regulation of interleukin-12 production	BP
11	69	0.668545721937	-	9.52e-02	GO:0097190	apoptotic signaling pathway	BP
11	69	0.668545721937	-	1.02e-01	GO:0043130	ubiquitin binding	MF
7	44	0.665561863498	-	8.03e-02	GO:0042552	myelination	BP
56	354	0.657387932053	-	5.26e-05	GO:0008283	cell proliferation	BP
34	215	0.656908551739	-	5.03e-04	GO:0001525	angiogenesis	BP
6	38	0.654673547356	-	2.79e-02	GO:0009409	response to cold	BP
9	57	0.654673547356	-	3.30e-02	GO:0006959	humoral immune response	BP
6	38	0.654673547356	-	1.16e-01	GO:0001942	hair follicle development	BP
3	19	0.654673547356	-	1.35e-01	GO:0033280	response to vitamin D	BP
3	19	0.654673547356	-	2.40e-01	GO:0008589	regulation of smoothened signaling pathway	BP
3	19	0.654673547356	-	2.40e-01	GO:0071385	cellular response to glucocorticoid stimulus	BP
3	19	0.654673547356	-	2.40e-01	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
3	19	0.654673547356	-	2.40e-01	GO:0002230	positive regulation of defense response to virus by host	BP
3	19	0.654673547356	-	4.17e-01	GO:0045453	bone resorption	BP
6	38	0.654673547356	-	2.79e-02	GO:0004519	endonuclease activity	MF
6	38	0.654673547356	-	4.02e-02	GO:0005245	voltage-gated calcium channel activity	MF
3	19	0.654673547356	-	4.17e-01	GO:0001965	G-protein alpha-subunit binding	MF
11	70	0.64778716177	-	4.36e-02	GO:0009791	post-embryonic development	BP
8	51	0.645213218107	-	1.37e-01	GO:0040008	regulation of growth	BP
5	32	0.639566654965	-	6.26e-02	GO:0042100	B cell proliferation	BP
5	32	0.639566654965	-	1.95e-01	GO:0040018	positive regulation of multicellular organism growth	BP
5	32	0.639566654965	-	1.95e-01	GO:0006298	mismatch repair	BP
5	32	0.639566654965	-	1.95e-01	GO:0002027	regulation of heart rate	BP
5	32	0.639566654965	-	2.47e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
22	141	0.637518826317	-	1.84e-02	GO:0006260	DNA replication	BP
12	77	0.635814520104	-	3.14e-02	GO:0031295	T cell costimulation	BP
7	45	0.633140385806	-	8.55e-02	GO:0008015	blood circulation	BP
7	45	0.633140385806	-	2.11e-01	GO:0000186	activation of MAPKK activity	BP
11	71	0.627323059211	-	1.02e-01	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
6	39	0.617198841937	-	1.37e-01	GO:0090002	establishment of protein localization to plasma membrane	BP
8	52	0.617198841937	-	1.49e-01	GO:0006417	regulation of translation	BP
4	26	0.617198841937	-	1.53e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
2	13	0.617198841937	-	1.88e-01	GO:0006693	prostaglandin metabolic process	BP
2	13	0.617198841937	-	2.26e-01	GO:0001516	prostaglandin biosynthetic process	BP
2	13	0.617198841937	-	2.26e-01	GO:0072001	renal system development	BP
2	13	0.617198841937	-	2.26e-01	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
2	13	0.617198841937	-	2.26e-01	GO:0071318	cellular response to ATP	BP
2	13	0.617198841937	-	2.65e-01	GO:0042554	superoxide anion generation	BP
2	13	0.617198841937	-	2.65e-01	GO:0071397	cellular response to cholesterol	BP
2	13	0.617198841937	-	2.65e-01	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
4	26	0.617198841937	-	2.82e-01	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
2	13	0.617198841937	-	3.04e-01	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
2	13	0.617198841937	-	3.04e-01	GO:0051926	negative regulation of calcium ion transport	BP
4	26	0.617198841937	-	3.25e-01	GO:0045070	positive regulation of viral genome replication	BP
2	13	0.617198841937	-	3.42e-01	GO:0006622	protein targeting to lysosome	BP
2	13	0.617198841937	-	3.42e-01	GO:0007096	regulation of exit from mitosis	BP
2	13	0.617198841937	-	3.42e-01	GO:0046685	response to arsenic-containing substance	BP
2	13	0.617198841937	-	3.42e-01	GO:0019725	cellular homeostasis	BP
2	13	0.617198841937	-	3.42e-01	GO:0045778	positive regulation of ossification	BP
2	13	0.617198841937	-	3.42e-01	GO:0006883	cellular sodium ion homeostasis	BP
2	13	0.617198841937	-	3.42e-01	GO:0045780	positive regulation of bone resorption	BP
2	13	0.617198841937	-	3.42e-01	GO:0010952	positive regulation of peptidase activity	BP
2	13	0.617198841937	-	3.42e-01	GO:0002526	acute inflammatory response	BP
2	13	0.617198841937	-	3.80e-01	GO:0045579	positive regulation of B cell differentiation	BP
2	13	0.617198841937	-	3.80e-01	GO:0097284	hepatocyte apoptotic process	BP
2	13	0.617198841937	-	3.80e-01	GO:0045821	positive regulation of glycolytic process	BP
6	39	0.617198841937	-	5.55e-02	GO:0015459	potassium channel regulator activity	MF
2	13	0.617198841937	-	1.50e-01	GO:0019841	retinol binding	MF
2	13	0.617198841937	-	2.65e-01	GO:0004467	long-chain fatty acid-CoA ligase activity	MF
2	13	0.617198841937	-	3.80e-01	GO:0051787	misfolded protein binding	MF
2	13	0.617198841937	-	3.80e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
2	13	0.617198841937	-	3.80e-01	GO:0017160	Ral GTPase binding	MF
9	59	0.604920512159	-	8.86e-02	GO:0050679	positive regulation of epithelial cell proliferation	BP
7	46	0.601431526079	-	1.89e-01	GO:0008542	visual learning	BP
5	33	0.595172535607	-	6.26e-02	GO:0006656	phosphatidylcholine biosynthetic process	BP
5	33	0.595172535607	-	1.95e-01	GO:0042130	negative regulation of T cell proliferation	BP
5	33	0.595172535607	-	2.06e-01	GO:0002931	response to ischemia	BP
5	33	0.595172535607	-	2.32e-01	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
5	33	0.595172535607	-	2.32e-01	GO:0032480	negative regulation of type I interferon production	BP
5	33	0.595172535607	-	2.47e-01	GO:0043491	protein kinase B signaling	BP
80	529	0.592442742851	-	2.35e-06	GO:0006915	apoptotic process	BP
8	53	0.589718105515	-	1.70e-02	GO:0042472	inner ear morphogenesis	BP
30	199	0.587904535143	-	6.21e-03	GO:0007049	cell cycle	BP
11	73	0.587245619835	-	5.38e-02	GO:0008144	drug binding	MF
17	113	0.584922438913	-	6.94e-03	GO:0007417	central nervous system development	BP
40	266	0.584284219464	-	3.97e-03	GO:0000165	MAPK cascade	BP
9	60	0.580672965912	-	9.52e-02	GO:0051291	protein heterooligomerization	BP
9	60	0.580672965912	-	1.78e-01	GO:0021987	cerebral cortex development	BP
9	60	0.580672965912	-	8.86e-02	GO:0005518	collagen binding	MF
3	20	0.580672965912	-	1.59e-01	GO:0001659	temperature homeostasis	BP
3	20	0.580672965912	-	2.12e-01	GO:0006801	superoxide metabolic process	BP
6	40	0.580672965912	-	2.87e-01	GO:0010508	positive regulation of autophagy	BP
3	20	0.580672965912	-	4.17e-01	GO:0042346	positive regulation of NF-kappaB import into nucleus	BP
3	20	0.580672965912	-	4.17e-01	GO:0071276	cellular response to cadmium ion	BP
3	20	0.580672965912	-	4.17e-01	GO:0045862	positive regulation of proteolysis	BP
3	20	0.580672965912	-	4.17e-01	GO:0071310	cellular response to organic substance	BP
3	20	0.580672965912	-	4.30e-01	GO:0007051	spindle organization	BP
3	20	0.580672965912	-	4.45e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
3	20	0.580672965912	-	2.40e-01	GO:0051018	protein kinase A binding	MF
3	20	0.580672965912	-	4.30e-01	GO:0000175	3'-5'-exoribonuclease activity	MF
28	187	0.578099022248	-	2.87e-03	GO:0007420	brain development	BP
7	47	0.570404630458	-	2.11e-01	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
50	337	0.564889968671	-	2.50e-04	GO:0004842	ubiquitin-protein transferase activity	MF
12	81	0.562751057915	-	1.82e-02	GO:0030509	BMP signaling pathway	BP
4	27	0.562751057915	-	2.71e-01	GO:0042476	odontogenesis	BP
4	27	0.562751057915	-	3.09e-01	GO:0040014	regulation of multicellular organism growth	BP
4	27	0.562751057915	-	1.34e-01	GO:0017046	peptide hormone binding	MF
9	61	0.556826223958	-	1.75e-01	GO:0006006	glucose metabolic process	BP
5	34	0.552103813715	-	2.06e-01	GO:0048813	dendrite morphogenesis	BP
5	34	0.552103813715	-	2.19e-01	GO:0033574	response to testosterone	BP
11	75	0.548251488219	-	2.43e-02	GO:0001503	ossification	BP
60	410	0.545049056181	-	7.94e-05	GO:0016567	protein ubiquitination	BP
12	82	0.545049056181	-	1.24e-01	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
6	41	0.545049056181	-	1.29e-01	GO:0048839	inner ear development	BP
6	41	0.545049056181	-	2.63e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
7	48	0.540030981415	-	2.11e-01	GO:0010977	negative regulation of neuron projection development	BP
7	48	0.540030981415	-	3.24e-01	GO:0042542	response to hydrogen peroxide	BP
8	55	0.536278846553	-	1.43e-01	GO:0050680	negative regulation of epithelial cell proliferation	BP
9	62	0.533367251134	-	1.78e-01	GO:0051384	response to glucocorticoid	BP
9	62	0.533367251134	-	1.83e-01	GO:0046330	positive regulation of JNK cascade	BP
30	208	0.524089437546	-	8.99e-03	GO:0004871	signal transducer activity	MF
9	63	0.51028363802	-	1.05e-01	GO:0008203	cholesterol metabolic process	BP
9	63	0.51028363802	-	1.10e-01	GO:0032868	response to insulin	BP
3	21	0.51028363802	-	1.35e-01	GO:0007369	gastrulation	BP
5	35	0.51028363802	-	1.85e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
3	21	0.51028363802	-	1.85e-01	GO:0045333	cellular respiration	BP
5	35	0.51028363802	-	1.95e-01	GO:0001890	placenta development	BP
5	35	0.51028363802	-	2.47e-01	GO:0006641	triglyceride metabolic process	BP
6	42	0.51028363802	-	2.97e-01	GO:0000302	response to reactive oxygen species	BP
3	21	0.51028363802	-	4.45e-01	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
3	21	0.51028363802	-	4.45e-01	GO:0090103	cochlea morphogenesis	BP
3	21	0.51028363802	-	2.12e-01	GO:0031210	phosphatidylcholine binding	MF
3	21	0.51028363802	-	4.45e-01	GO:0004298	threonine-type endopeptidase activity	MF
1	7	0.51028363802	-	1.00e-01	GO:0006766	vitamin metabolic process	BP
2	14	0.51028363802	-	1.50e-01	GO:0051481	negative regulation of cytosolic calcium ion concentration	BP
2	14	0.51028363802	-	1.50e-01	GO:0048149	behavioral response to ethanol	BP
8	56	0.51028363802	-	1.56e-01	GO:0006950	response to stress	BP
2	14	0.51028363802	-	2.26e-01	GO:0051604	protein maturation	BP
8	56	0.51028363802	-	2.46e-01	GO:0051259	protein oligomerization	BP
2	14	0.51028363802	-	2.65e-01	GO:0031103	axon regeneration	BP
2	14	0.51028363802	-	2.65e-01	GO:0002063	chondrocyte development	BP
4	28	0.51028363802	-	2.71e-01	GO:0007628	adult walking behavior	BP
1	7	0.51028363802	-	2.72e-01	GO:0000160	phosphorelay signal transduction system	BP
4	28	0.51028363802	-	2.82e-01	GO:0097193	intrinsic apoptotic signaling pathway	BP
2	14	0.51028363802	-	3.04e-01	GO:0030207	chondroitin sulfate catabolic process	BP
2	14	0.51028363802	-	3.04e-01	GO:0043303	mast cell degranulation	BP
2	14	0.51028363802	-	3.04e-01	GO:0010812	negative regulation of cell-substrate adhesion	BP
4	28	0.51028363802	-	3.09e-01	GO:0005977	glycogen metabolic process	BP
4	28	0.51028363802	-	3.09e-01	GO:0001937	negative regulation of endothelial cell proliferation	BP
4	28	0.51028363802	-	3.09e-01	GO:2000145	regulation of cell motility	BP
4	28	0.51028363802	-	3.41e-01	GO:0019058	viral life cycle	BP
2	14	0.51028363802	-	3.42e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
2	14	0.51028363802	-	3.42e-01	GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway	BP
2	14	0.51028363802	-	3.42e-01	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
2	14	0.51028363802	-	3.42e-01	GO:0030517	negative regulation of axon extension	BP
1	7	0.51028363802	-	3.45e-01	GO:0021520	spinal cord motor neuron cell fate specification	BP
1	7	0.51028363802	-	3.45e-01	GO:0001945	lymph vessel development	BP
1	7	0.51028363802	-	3.45e-01	GO:0048066	developmental pigmentation	BP
1	7	0.51028363802	-	3.45e-01	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
1	7	0.51028363802	-	3.45e-01	GO:0071467	cellular response to pH	BP
1	7	0.51028363802	-	3.45e-01	GO:0051782	negative regulation of cell division	BP
1	7	0.51028363802	-	3.45e-01	GO:2000543	positive regulation of gastrulation	BP
1	7	0.51028363802	-	3.45e-01	GO:0048771	tissue remodeling	BP
2	14	0.51028363802	-	3.80e-01	GO:0072657	protein localization to membrane	BP
2	14	0.51028363802	-	3.80e-01	GO:0001817	regulation of cytokine production	BP
2	14	0.51028363802	-	3.80e-01	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	14	0.51028363802	-	3.80e-01	GO:1901673	regulation of mitotic spindle assembly	BP
2	14	0.51028363802	-	3.80e-01	GO:0050892	intestinal absorption	BP
1	7	0.51028363802	-	4.11e-01	GO:0003209	cardiac atrium morphogenesis	BP
1	7	0.51028363802	-	4.11e-01	GO:0009620	response to fungus	BP
1	7	0.51028363802	-	4.11e-01	GO:1903546	protein localization to photoreceptor outer segment	BP
1	7	0.51028363802	-	4.11e-01	GO:0002281	macrophage activation involved in immune response	BP
1	7	0.51028363802	-	4.11e-01	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
1	7	0.51028363802	-	4.11e-01	GO:2001259	positive regulation of cation channel activity	BP
1	7	0.51028363802	-	4.11e-01	GO:0060463	lung lobe morphogenesis	BP
1	7	0.51028363802	-	4.11e-01	GO:0035878	nail development	BP
1	7	0.51028363802	-	4.11e-01	GO:0009950	dorsal/ventral axis specification	BP
1	7	0.51028363802	-	4.11e-01	GO:0045577	regulation of B cell differentiation	BP
1	7	0.51028363802	-	4.11e-01	GO:0042756	drinking behavior	BP
1	7	0.51028363802	-	4.11e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	0.51028363802	-	4.11e-01	GO:0006657	CDP-choline pathway	BP
1	7	0.51028363802	-	4.11e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
1	7	0.51028363802	-	4.11e-01	GO:0070613	regulation of protein processing	BP
1	7	0.51028363802	-	4.11e-01	GO:0003360	brainstem development	BP
1	7	0.51028363802	-	4.11e-01	GO:0030213	hyaluronan biosynthetic process	BP
1	7	0.51028363802	-	4.11e-01	GO:0042420	dopamine catabolic process	BP
1	7	0.51028363802	-	4.70e-01	GO:0048539	bone marrow development	BP
1	7	0.51028363802	-	4.70e-01	GO:0034138	toll-like receptor 3 signaling pathway	BP
1	7	0.51028363802	-	4.70e-01	GO:0006527	arginine catabolic process	BP
1	7	0.51028363802	-	4.70e-01	GO:0015872	dopamine transport	BP
1	7	0.51028363802	-	4.70e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	0.51028363802	-	4.70e-01	GO:1902260	negative regulation of delayed rectifier potassium channel activity	BP
1	7	0.51028363802	-	4.70e-01	GO:0007256	activation of JNKK activity	BP
1	7	0.51028363802	-	4.70e-01	GO:0014037	Schwann cell differentiation	BP
1	7	0.51028363802	-	4.70e-01	GO:0022612	gland morphogenesis	BP
1	7	0.51028363802	-	4.70e-01	GO:0000578	embryonic axis specification	BP
1	7	0.51028363802	-	4.70e-01	GO:0043576	regulation of respiratory gaseous exchange	BP
1	7	0.51028363802	-	4.70e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	0.51028363802	-	4.70e-01	GO:0006475	internal protein amino acid acetylation	BP
1	7	0.51028363802	-	4.70e-01	GO:0021707	cerebellar granule cell differentiation	BP
1	7	0.51028363802	-	4.70e-01	GO:0061384	heart trabecula morphogenesis	BP
1	7	0.51028363802	-	4.70e-01	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
1	7	0.51028363802	-	4.70e-01	GO:2000121	regulation of removal of superoxide radicals	BP
1	7	0.51028363802	-	4.70e-01	GO:0030814	regulation of cAMP metabolic process	BP
1	7	0.51028363802	-	4.70e-01	GO:0032691	negative regulation of interleukin-1 beta production	BP
1	7	0.51028363802	-	4.70e-01	GO:0035095	behavioral response to nicotine	BP
1	7	0.51028363802	-	4.70e-01	GO:0019054	modulation by virus of host process	BP
1	7	0.51028363802	-	4.70e-01	GO:0097237	cellular response to toxic substance	BP
1	7	0.51028363802	-	4.70e-01	GO:0060042	retina morphogenesis in camera-type eye	BP
1	7	0.51028363802	-	4.70e-01	GO:0071281	cellular response to iron ion	BP
1	7	0.51028363802	-	4.70e-01	GO:0055075	potassium ion homeostasis	BP
1	7	0.51028363802	-	4.70e-01	GO:0070050	neuron cellular homeostasis	BP
1	7	0.51028363802	-	4.70e-01	GO:0009649	entrainment of circadian clock	BP
1	7	0.51028363802	-	4.70e-01	GO:0044539	long-chain fatty acid import	BP
1	7	0.51028363802	-	4.70e-01	GO:0007379	segment specification	BP
1	7	0.51028363802	-	4.70e-01	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
1	7	0.51028363802	-	4.70e-01	GO:0050869	negative regulation of B cell activation	BP
1	7	0.51028363802	-	4.70e-01	GO:0061298	retina vasculature development in camera-type eye	BP
1	7	0.51028363802	-	4.70e-01	GO:0017121	phospholipid scrambling	BP
1	7	0.51028363802	-	4.70e-01	GO:0072205	metanephric collecting duct development	BP
1	7	0.51028363802	-	4.70e-01	GO:0060840	artery development	BP
1	7	0.51028363802	-	4.70e-01	GO:0003084	positive regulation of systemic arterial blood pressure	BP
1	7	0.51028363802	-	4.70e-01	GO:0034372	very-low-density lipoprotein particle remodeling	BP
1	7	0.51028363802	-	4.70e-01	GO:0060449	bud elongation involved in lung branching	BP
1	7	0.51028363802	-	4.70e-01	GO:2000271	positive regulation of fibroblast apoptotic process	BP
1	7	0.51028363802	-	4.70e-01	GO:0042297	vocal learning	BP
1	7	0.51028363802	-	4.70e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	0.51028363802	-	4.70e-01	GO:0060017	parathyroid gland development	BP
1	7	0.51028363802	-	4.70e-01	GO:0072711	cellular response to hydroxyurea	BP
1	7	0.51028363802	-	4.70e-01	GO:0042129	regulation of T cell proliferation	BP
1	7	0.51028363802	-	4.70e-01	GO:0014824	artery smooth muscle contraction	BP
1	7	0.51028363802	-	5.23e-01	GO:0045650	negative regulation of macrophage differentiation	BP
1	7	0.51028363802	-	5.23e-01	GO:0045657	positive regulation of monocyte differentiation	BP
1	7	0.51028363802	-	5.23e-01	GO:0050810	regulation of steroid biosynthetic process	BP
1	7	0.51028363802	-	5.23e-01	GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint	BP
1	7	0.51028363802	-	5.23e-01	GO:0032736	positive regulation of interleukin-13 production	BP
1	7	0.51028363802	-	5.23e-01	GO:0033622	integrin activation	BP
1	7	0.51028363802	-	5.23e-01	GO:0010886	positive regulation of cholesterol storage	BP
1	7	0.51028363802	-	5.23e-01	GO:0031848	protection from non-homologous end joining at telomere	BP
1	7	0.51028363802	-	5.23e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
1	7	0.51028363802	-	5.23e-01	GO:0060706	cell differentiation involved in embryonic placenta development	BP
1	7	0.51028363802	-	5.23e-01	GO:0050805	negative regulation of synaptic transmission	BP
1	7	0.51028363802	-	5.23e-01	GO:0038166	angiotensin-activated signaling pathway	BP
1	7	0.51028363802	-	5.23e-01	GO:0006020	inositol metabolic process	BP
1	7	0.51028363802	-	5.23e-01	GO:0042148	strand invasion	BP
1	7	0.51028363802	-	5.23e-01	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
1	7	0.51028363802	-	5.23e-01	GO:0030916	otic vesicle formation	BP
1	7	0.51028363802	-	5.23e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
1	7	0.51028363802	-	5.23e-01	GO:0014808	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
1	7	0.51028363802	-	5.23e-01	GO:1901841	regulation of high voltage-gated calcium channel activity	BP
1	7	0.51028363802	-	5.23e-01	GO:0071169	establishment of protein localization to chromatin	BP
1	7	0.51028363802	-	5.23e-01	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
1	7	0.51028363802	-	5.23e-01	GO:0014883	transition between fast and slow fiber	BP
1	7	0.51028363802	-	5.23e-01	GO:0071639	positive regulation of monocyte chemotactic protein-1 production	BP
1	7	0.51028363802	-	5.23e-01	GO:0061157	mRNA destabilization	BP
1	7	0.51028363802	-	5.23e-01	GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway	BP
1	7	0.51028363802	-	5.23e-01	GO:0032308	positive regulation of prostaglandin secretion	BP
1	7	0.51028363802	-	5.23e-01	GO:0016070	RNA metabolic process	BP
1	7	0.51028363802	-	5.23e-01	GO:0051932	synaptic transmission, GABAergic	BP
1	7	0.51028363802	-	5.23e-01	GO:0042178	xenobiotic catabolic process	BP
1	7	0.51028363802	-	5.23e-01	GO:0035194	posttranscriptional gene silencing by RNA	BP
1	7	0.51028363802	-	5.23e-01	GO:0032057	negative regulation of translational initiation in response to stress	BP
1	7	0.51028363802	-	5.23e-01	GO:0023052	signaling	BP
1	7	0.51028363802	-	5.23e-01	GO:0007270	neuron-neuron synaptic transmission	BP
1	7	0.51028363802	-	5.23e-01	GO:0051683	establishment of Golgi localization	BP
1	7	0.51028363802	-	5.23e-01	GO:0048820	hair follicle maturation	BP
1	7	0.51028363802	-	5.23e-01	GO:2000270	negative regulation of fibroblast apoptotic process	BP
1	7	0.51028363802	-	5.23e-01	GO:1902715	positive regulation of interferon-gamma secretion	BP
1	7	0.51028363802	-	5.23e-01	GO:0050764	regulation of phagocytosis	BP
1	7	0.51028363802	-	5.23e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
2	14	0.51028363802	-	6.45e-01	GO:0001774	microglial cell activation	BP
2	14	0.51028363802	-	6.45e-01	GO:0031116	positive regulation of microtubule polymerization	BP
2	14	0.51028363802	-	6.45e-01	GO:0043069	negative regulation of programmed cell death	BP
2	14	0.51028363802	-	6.45e-01	GO:0042953	lipoprotein transport	BP
2	14	0.51028363802	-	6.45e-01	GO:0000380	alternative mRNA splicing, via spliceosome	BP
2	14	0.51028363802	-	6.45e-01	GO:0043508	negative regulation of JUN kinase activity	BP
2	14	0.51028363802	-	6.45e-01	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
2	14	0.51028363802	-	6.45e-01	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	BP
2	14	0.51028363802	-	6.45e-01	GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
2	14	0.51028363802	-	6.45e-01	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
2	14	0.51028363802	-	1.15e-01	GO:0008188	neuropeptide receptor activity	MF
1	7	0.51028363802	-	1.91e-01	GO:0004875	complement receptor activity	MF
1	7	0.51028363802	-	2.72e-01	GO:0015645	fatty acid ligase activity	MF
1	7	0.51028363802	-	2.72e-01	GO:0004321	fatty-acyl-CoA synthase activity	MF
2	14	0.51028363802	-	3.04e-01	GO:0005523	tropomyosin binding	MF
2	14	0.51028363802	-	3.42e-01	GO:0005504	fatty acid binding	MF
2	14	0.51028363802	-	3.42e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
1	7	0.51028363802	-	3.45e-01	GO:0016798	hydrolase activity, acting on glycosyl bonds	MF
1	7	0.51028363802	-	4.70e-01	GO:0035612	AP-2 adaptor complex binding	MF
1	7	0.51028363802	-	4.70e-01	GO:0019208	phosphatase regulator activity	MF
1	7	0.51028363802	-	4.70e-01	GO:0043023	ribosomal large subunit binding	MF
1	7	0.51028363802	-	4.70e-01	GO:0000405	bubble DNA binding	MF
1	7	0.51028363802	-	4.70e-01	GO:0016853	isomerase activity	MF
1	7	0.51028363802	-	4.70e-01	GO:0004415	hyalurononglucosaminidase activity	MF
4	28	0.51028363802	-	5.21e-01	GO:0017048	Rho GTPase binding	MF
1	7	0.51028363802	-	5.23e-01	GO:0008432	JUN kinase binding	MF
1	7	0.51028363802	-	5.23e-01	GO:0030274	LIM domain binding	MF
1	7	0.51028363802	-	5.23e-01	GO:0031406	carboxylic acid binding	MF
1	7	0.51028363802	-	5.23e-01	GO:0005078	MAP-kinase scaffold activity	MF
1	7	0.51028363802	-	5.23e-01	GO:0019787	ubiquitin-like protein transferase activity	MF
2	14	0.51028363802	-	6.45e-01	GO:0031432	titin binding	MF
2	14	0.51028363802	-	6.45e-01	GO:0034185	apolipoprotein binding	MF
2	14	0.51028363802	-	6.45e-01	GO:0032794	GTPase activating protein binding	MF
2	14	0.51028363802	-	6.45e-01	GO:0031996	thioesterase binding	MF
2	14	0.51028363802	-	6.45e-01	GO:0005528	FK506 binding	MF
23	162	0.50135051325	-	2.27e-02	GO:0032496	response to lipopolysaccharide	BP
18	127	0.498878874748	-	6.04e-02	GO:0001934	positive regulation of protein phosphorylation	BP
10	71	0.489819535461	-	1.47e-01	GO:0071347	cellular response to interleukin-1	BP
9	64	0.48756356152	-	1.95e-01	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
8	57	0.484748545913	-	6.11e-02	GO:0007338	single fertilization	BP
8	57	0.484748545913	-	2.51e-01	GO:0005070	SH3/SH2 adaptor activity	MF
19	136	0.478103232271	-	1.53e-02	GO:0001501	skeletal system development	BP
18	129	0.476336306097	-	6.42e-02	GO:0043524	negative regulation of neuron apoptotic process	BP
5	36	0.469641653523	-	1.95e-01	GO:0045859	regulation of protein kinase activity	BP
5	36	0.469641653523	-	2.32e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
9	65	0.465195748492	-	1.75e-01	GO:0050796	regulation of insulin secretion	BP
4	29	0.459657564951	-	1.16e-01	GO:0048477	oogenesis	BP
4	29	0.459657564951	-	1.53e-01	GO:0030163	protein catabolic process	BP
8	58	0.459657564951	-	2.66e-01	GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	BP
4	29	0.459657564951	-	2.71e-01	GO:0002088	lens development in camera-type eye	BP
4	29	0.459657564951	-	2.95e-01	GO:0060325	face morphogenesis	BP
4	29	0.459657564951	-	2.95e-01	GO:0048167	regulation of synaptic plasticity	BP
4	29	0.459657564951	-	3.09e-01	GO:0045595	regulation of cell differentiation	BP
4	29	0.459657564951	-	5.21e-01	GO:0042169	SH2 domain binding	MF
11	80	0.455142083828	-	1.72e-01	GO:0030307	positive regulation of cell growth	BP
18	131	0.454140559983	-	1.43e-01	GO:0000086	G2/M transition of mitotic cell cycle	BP
21	153	0.452568140164	-	6.84e-02	GO:0018108	peptidyl-tyrosine phosphorylation	BP
7	51	0.452568140164	-	3.29e-01	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
6	44	0.443169442162	-	4.39e-01	GO:0032147	activation of protein kinase activity	BP
6	44	0.443169442162	-	4.45e-01	GO:0007077	mitotic nuclear envelope disassembly	BP
3	22	0.443169442162	-	4.62e-01	GO:0002092	positive regulation of receptor internalization	BP
3	22	0.443169442162	-	4.79e-01	GO:0016050	vesicle organization	BP
3	22	0.443169442162	-	4.79e-01	GO:0001954	positive regulation of cell-matrix adhesion	BP
3	22	0.443169442162	-	4.79e-01	GO:2001235	positive regulation of apoptotic signaling pathway	BP
5	37	0.430113289336	-	1.95e-01	GO:0007588	excretion	BP
5	37	0.430113289336	-	2.19e-01	GO:0001786	phosphatidylserine binding	MF
14	104	0.424553763995	-	1.69e-01	GO:0045471	response to ethanol	BP
7	52	0.424553763995	-	1.96e-01	GO:0008344	adult locomotory behavior	BP
95	706	0.423969795138	-	1.21e-05	GO:0042803	protein homodimerization activity	MF
2	15	0.41074796447	-	2.26e-01	GO:0080111	DNA demethylation	BP
4	30	0.41074796447	-	2.82e-01	GO:0030073	insulin secretion	BP
2	15	0.41074796447	-	3.42e-01	GO:0008585	female gonad development	BP
2	15	0.41074796447	-	3.42e-01	GO:0010765	positive regulation of sodium ion transport	BP
2	15	0.41074796447	-	3.42e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
2	15	0.41074796447	-	3.80e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	0.41074796447	-	3.80e-01	GO:0070542	response to fatty acid	BP
2	15	0.41074796447	-	3.80e-01	GO:0034375	high-density lipoprotein particle remodeling	BP
4	30	0.41074796447	-	5.28e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
4	30	0.41074796447	-	5.28e-01	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
2	15	0.41074796447	-	6.45e-01	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
2	15	0.41074796447	-	6.45e-01	GO:0010288	response to lead ion	BP
2	15	0.41074796447	-	6.45e-01	GO:0035458	cellular response to interferon-beta	BP
2	15	0.41074796447	-	6.57e-01	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
2	15	0.41074796447	-	6.57e-01	GO:0036503	ERAD pathway	BP
2	15	0.41074796447	-	6.57e-01	GO:1903543	positive regulation of exosomal secretion	BP
2	15	0.41074796447	-	6.57e-01	GO:1902187	negative regulation of viral release from host cell	BP
2	15	0.41074796447	-	6.57e-01	GO:0045190	isotype switching	BP
2	15	0.41074796447	-	6.57e-01	GO:0001935	endothelial cell proliferation	BP
12	90	0.41074796447	-	2.00e-01	GO:0002020	protease binding	MF
2	15	0.41074796447	-	3.80e-01	GO:0017091	AU-rich element binding	MF
4	30	0.41074796447	-	5.28e-01	GO:0005164	tumor necrosis factor receptor binding	MF
2	15	0.41074796447	-	6.45e-01	GO:0097602	cullin family protein binding	MF
2	15	0.41074796447	-	6.57e-01	GO:0005123	death receptor binding	MF
2	15	0.41074796447	-	6.57e-01	GO:0005521	lamin binding	MF
63	476	0.40010072027	-	2.94e-06	GO:0030154	cell differentiation	BP
23	174	0.398257020286	-	3.73e-02	GO:0007411	axon guidance	BP
7	53	0.397073027572	-	2.03e-01	GO:0007612	learning	BP
7	53	0.397073027572	-	2.11e-01	GO:0019233	sensory perception of pain	BP
10	76	0.391639141522	-	3.33e-01	GO:1900034	regulation of cellular response to heat	BP
5	38	0.391639141522	-	4.14e-01	GO:0030155	regulation of cell adhesion	BP
5	38	0.391639141522	-	4.14e-01	GO:0006289	nucleotide-excision repair	BP
5	38	0.391639141522	-	4.14e-01	GO:0097194	execution phase of apoptosis	BP
99	756	0.384752755937	-	8.52e-04	GO:0042802	identical protein binding	MF
3	23	0.379039104742	-	4.17e-01	GO:0001819	positive regulation of cytokine production	BP
3	23	0.379039104742	-	4.62e-01	GO:0048754	branching morphogenesis of an epithelial tube	BP
3	23	0.379039104742	-	4.62e-01	GO:0048675	axon extension	BP
3	23	0.379039104742	-	4.62e-01	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
3	23	0.379039104742	-	4.98e-01	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
3	23	0.379039104742	-	4.98e-01	GO:0030295	protein kinase activator activity	MF
3	23	0.379039104742	-	4.98e-01	GO:0043548	phosphatidylinositol 3-kinase binding	MF
10	77	0.372780114271	-	2.25e-01	GO:0030674	protein binding, bridging	MF
7	54	0.370105979972	-	3.42e-01	GO:0051592	response to calcium ion	BP
7	54	0.370105979972	-	2.61e-02	GO:0008168	methyltransferase activity	MF
8	62	0.363442249691	-	2.74e-01	GO:0035690	cellular response to drug	BP
4	31	0.363442249691	-	2.95e-01	GO:0045907	positive regulation of vasoconstriction	BP
4	31	0.363442249691	-	3.09e-01	GO:0048286	lung alveolus development	BP
4	31	0.363442249691	-	5.21e-01	GO:0021510	spinal cord development	BP
5	39	0.354164436103	-	3.92e-01	GO:0043434	response to peptide hormone	BP
7	55	0.343633768611	-	3.42e-01	GO:0008104	protein localization	BP
7	55	0.343633768611	-	3.50e-01	GO:0045727	positive regulation of translation	BP
22	175	0.325859066883	-	5.40e-02	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
3	24	0.317638560078	-	2.12e-01	GO:0019369	arachidonic acid metabolic process	BP
15	120	0.317638560078	-	2.74e-01	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
9	72	0.317638560078	-	3.12e-01	GO:0043410	positive regulation of MAPK cascade	BP
9	72	0.317638560078	-	4.22e-01	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	BP
6	48	0.317638560078	-	4.39e-01	GO:0009408	response to heat	BP
3	24	0.317638560078	-	4.79e-01	GO:0042113	B cell activation	BP
3	24	0.317638560078	-	4.79e-01	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
3	24	0.317638560078	-	4.79e-01	GO:0002040	sprouting angiogenesis	BP
3	24	0.317638560078	-	4.79e-01	GO:0042327	positive regulation of phosphorylation	BP
3	24	0.317638560078	-	7.28e-01	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
15	120	0.317638560078	-	2.68e-01	GO:0017124	SH3 domain binding	MF
3	24	0.317638560078	-	7.28e-01	GO:0051020	GTPase binding	MF
1	8	0.317638560078	-	1.91e-01	GO:0061303	cornea development in camera-type eye	BP
4	32	0.317638560078	-	2.82e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
2	16	0.317638560078	-	3.04e-01	GO:0097009	energy homeostasis	BP
2	16	0.317638560078	-	3.04e-01	GO:0086002	cardiac muscle cell action potential involved in contraction	BP
4	32	0.317638560078	-	3.25e-01	GO:0008016	regulation of heart contraction	BP
2	16	0.317638560078	-	3.42e-01	GO:0019372	lipoxygenase pathway	BP
2	16	0.317638560078	-	3.80e-01	GO:0010975	regulation of neuron projection development	BP
5	40	0.317638560078	-	3.92e-01	GO:0060291	long-term synaptic potentiation	BP
1	8	0.317638560078	-	4.11e-01	GO:0007506	gonadal mesoderm development	BP
1	8	0.317638560078	-	4.11e-01	GO:0035865	cellular response to potassium ion	BP
1	8	0.317638560078	-	4.11e-01	GO:0007210	serotonin receptor signaling pathway	BP
1	8	0.317638560078	-	4.11e-01	GO:0035988	chondrocyte proliferation	BP
1	8	0.317638560078	-	4.11e-01	GO:0046512	sphingosine biosynthetic process	BP
1	8	0.317638560078	-	4.70e-01	GO:0034380	high-density lipoprotein particle assembly	BP
1	8	0.317638560078	-	4.70e-01	GO:0051896	regulation of protein kinase B signaling	BP
1	8	0.317638560078	-	4.70e-01	GO:0006704	glucocorticoid biosynthetic process	BP
1	8	0.317638560078	-	4.70e-01	GO:0046324	regulation of glucose import	BP
1	8	0.317638560078	-	4.70e-01	GO:0035137	hindlimb morphogenesis	BP
1	8	0.317638560078	-	4.70e-01	GO:0060137	maternal process involved in parturition	BP
1	8	0.317638560078	-	4.70e-01	GO:0032963	collagen metabolic process	BP
1	8	0.317638560078	-	4.70e-01	GO:0045056	transcytosis	BP
1	8	0.317638560078	-	4.70e-01	GO:1900165	negative regulation of interleukin-6 secretion	BP
1	8	0.317638560078	-	4.70e-01	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	BP
1	8	0.317638560078	-	4.70e-01	GO:0002827	positive regulation of T-helper 1 type immune response	BP
1	8	0.317638560078	-	4.70e-01	GO:0060259	regulation of feeding behavior	BP
1	8	0.317638560078	-	4.70e-01	GO:0032099	negative regulation of appetite	BP
1	8	0.317638560078	-	4.70e-01	GO:0035767	endothelial cell chemotaxis	BP
1	8	0.317638560078	-	5.23e-01	GO:0002456	T cell mediated immunity	BP
1	8	0.317638560078	-	5.23e-01	GO:0006972	hyperosmotic response	BP
1	8	0.317638560078	-	5.23e-01	GO:0030836	positive regulation of actin filament depolymerization	BP
1	8	0.317638560078	-	5.23e-01	GO:0035265	organ growth	BP
1	8	0.317638560078	-	5.23e-01	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
1	8	0.317638560078	-	5.23e-01	GO:0060452	positive regulation of cardiac muscle contraction	BP
1	8	0.317638560078	-	5.23e-01	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
1	8	0.317638560078	-	5.23e-01	GO:0060993	kidney morphogenesis	BP
1	8	0.317638560078	-	5.23e-01	GO:0048103	somatic stem cell division	BP
1	8	0.317638560078	-	5.23e-01	GO:0005979	regulation of glycogen biosynthetic process	BP
1	8	0.317638560078	-	5.23e-01	GO:0051451	myoblast migration	BP
1	8	0.317638560078	-	5.23e-01	GO:0038003	opioid receptor signaling pathway	BP
1	8	0.317638560078	-	5.23e-01	GO:0010470	regulation of gastrulation	BP
1	8	0.317638560078	-	5.23e-01	GO:0072091	regulation of stem cell proliferation	BP
1	8	0.317638560078	-	5.23e-01	GO:0045059	positive thymic T cell selection	BP
1	8	0.317638560078	-	5.23e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	8	0.317638560078	-	5.23e-01	GO:0006729	tetrahydrobiopterin biosynthetic process	BP
1	8	0.317638560078	-	5.23e-01	GO:0001841	neural tube formation	BP
1	8	0.317638560078	-	5.23e-01	GO:0021799	cerebral cortex radially oriented cell migration	BP
1	8	0.317638560078	-	5.23e-01	GO:0060155	platelet dense granule organization	BP
1	8	0.317638560078	-	5.23e-01	GO:0001766	membrane raft polarization	BP
1	8	0.317638560078	-	5.23e-01	GO:0042255	ribosome assembly	BP
1	8	0.317638560078	-	5.23e-01	GO:0051963	regulation of synapse assembly	BP
1	8	0.317638560078	-	5.23e-01	GO:0009651	response to salt stress	BP
4	32	0.317638560078	-	5.28e-01	GO:0070830	bicellular tight junction assembly	BP
4	32	0.317638560078	-	5.46e-01	GO:0042594	response to starvation	BP
1	8	0.317638560078	-	5.71e-01	GO:0048739	cardiac muscle fiber development	BP
1	8	0.317638560078	-	5.71e-01	GO:0070723	response to cholesterol	BP
1	8	0.317638560078	-	5.71e-01	GO:0047497	mitochondrion transport along microtubule	BP
1	8	0.317638560078	-	5.71e-01	GO:0007097	nuclear migration	BP
1	8	0.317638560078	-	5.71e-01	GO:0001825	blastocyst formation	BP
1	8	0.317638560078	-	5.71e-01	GO:0044387	negative regulation of protein kinase activity by regulation of protein phosphorylation	BP
1	8	0.317638560078	-	5.71e-01	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	BP
1	8	0.317638560078	-	5.71e-01	GO:0006012	galactose metabolic process	BP
1	8	0.317638560078	-	5.71e-01	GO:0035148	tube formation	BP
1	8	0.317638560078	-	5.71e-01	GO:0006782	protoporphyrinogen IX biosynthetic process	BP
1	8	0.317638560078	-	5.71e-01	GO:0010888	negative regulation of lipid storage	BP
1	8	0.317638560078	-	5.71e-01	GO:0072321	chaperone-mediated protein transport	BP
1	8	0.317638560078	-	5.71e-01	GO:0001955	blood vessel maturation	BP
1	8	0.317638560078	-	5.71e-01	GO:0006264	mitochondrial DNA replication	BP
1	8	0.317638560078	-	5.71e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	0.317638560078	-	5.71e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
1	8	0.317638560078	-	5.71e-01	GO:0042035	regulation of cytokine biosynthetic process	BP
1	8	0.317638560078	-	5.71e-01	GO:0019934	cGMP-mediated signaling	BP
1	8	0.317638560078	-	5.71e-01	GO:0010544	negative regulation of platelet activation	BP
1	8	0.317638560078	-	5.71e-01	GO:0007289	spermatid nucleus differentiation	BP
1	8	0.317638560078	-	5.71e-01	GO:0032790	ribosome disassembly	BP
1	8	0.317638560078	-	5.71e-01	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
1	8	0.317638560078	-	5.71e-01	GO:0007172	signal complex assembly	BP
1	8	0.317638560078	-	5.71e-01	GO:0035196	production of miRNAs involved in gene silencing by miRNA	BP
1	8	0.317638560078	-	5.71e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
1	8	0.317638560078	-	5.71e-01	GO:0035457	cellular response to interferon-alpha	BP
1	8	0.317638560078	-	5.71e-01	GO:0070206	protein trimerization	BP
1	8	0.317638560078	-	5.71e-01	GO:0002262	myeloid cell homeostasis	BP
1	8	0.317638560078	-	5.71e-01	GO:0006613	cotranslational protein targeting to membrane	BP
1	8	0.317638560078	-	5.71e-01	GO:0014909	smooth muscle cell migration	BP
1	8	0.317638560078	-	5.71e-01	GO:0060712	spongiotrophoblast layer development	BP
1	8	0.317638560078	-	5.71e-01	GO:0051646	mitochondrion localization	BP
2	16	0.317638560078	-	6.45e-01	GO:0060292	long term synaptic depression	BP
2	16	0.317638560078	-	6.45e-01	GO:0090026	positive regulation of monocyte chemotaxis	BP
2	16	0.317638560078	-	6.57e-01	GO:0061136	regulation of proteasomal protein catabolic process	BP
2	16	0.317638560078	-	6.71e-01	GO:0042523	positive regulation of tyrosine phosphorylation of Stat5 protein	BP
2	16	0.317638560078	-	6.71e-01	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
1	8	0.317638560078	-	3.45e-01	GO:0003996	acyl-CoA ligase activity	MF
1	8	0.317638560078	-	3.45e-01	GO:0047760	butyrate-CoA ligase activity	MF
1	8	0.317638560078	-	3.45e-01	GO:0038036	sphingosine-1-phosphate receptor activity	MF
1	8	0.317638560078	-	4.11e-01	GO:0004126	cytidine deaminase activity	MF
1	8	0.317638560078	-	4.70e-01	GO:0047498	calcium-dependent phospholipase A2 activity	MF
1	8	0.317638560078	-	4.70e-01	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
1	8	0.317638560078	-	5.23e-01	GO:0035613	RNA stem-loop binding	MF
1	8	0.317638560078	-	5.23e-01	GO:0017110	nucleoside-diphosphatase activity	MF
1	8	0.317638560078	-	5.23e-01	GO:0008430	selenium binding	MF
1	8	0.317638560078	-	5.23e-01	GO:0036310	annealing helicase activity	MF
4	32	0.317638560078	-	5.28e-01	GO:0016791	phosphatase activity	MF
1	8	0.317638560078	-	5.71e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	0.317638560078	-	5.71e-01	GO:0008026	ATP-dependent helicase activity	MF
1	8	0.317638560078	-	5.71e-01	GO:0031748	D1 dopamine receptor binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0019215	intermediate filament binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0050700	CARD domain binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0001849	complement component C1q binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	MF
1	8	0.317638560078	-	5.71e-01	GO:0031995	insulin-like growth factor II binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0035197	siRNA binding	MF
1	8	0.317638560078	-	5.71e-01	GO:0035591	signaling adaptor activity	MF
2	16	0.317638560078	-	6.45e-01	GO:0043274	phospholipase binding	MF
2	16	0.317638560078	-	6.45e-01	GO:0071949	FAD binding	MF
2	16	0.317638560078	-	6.57e-01	GO:0005159	insulin-like growth factor receptor binding	MF
2	16	0.317638560078	-	6.71e-01	GO:0008266	poly(U) RNA binding	MF
2	16	0.317638560078	-	6.71e-01	GO:0050998	nitric-oxide synthase binding	MF
27	217	0.310974829797	-	1.27e-01	GO:0000209	protein polyubiquitination	BP
9	73	0.29773900264	-	4.08e-02	GO:0030216	keratinocyte differentiation	BP
6	49	0.287891216684	-	4.59e-01	GO:0043621	protein self-association	MF
8	66	0.27324444072	-	2.58e-01	GO:0007224	smoothened signaling pathway	BP
4	33	0.27324444072	-	5.57e-01	GO:0008219	cell death	BP
7	58	0.267012487008	-	3.50e-01	GO:0016525	negative regulation of angiogenesis	BP
7	58	0.267012487008	-	4.91e-01	GO:0017148	negative regulation of translation	BP
7	58	0.267012487008	-	2.11e-01	GO:0050660	flavin adenine dinucleotide binding	MF
20	166	0.264527223619	-	1.67e-01	GO:0016477	cell migration	BP
3	25	0.258744871025	-	1.85e-01	GO:0009880	embryonic pattern specification	BP
12	100	0.258744871025	-	2.79e-01	GO:0006979	response to oxidative stress	BP
3	25	0.258744871025	-	4.30e-01	GO:0045880	positive regulation of smoothened signaling pathway	BP
3	25	0.258744871025	-	7.28e-01	GO:0048678	response to axon injury	BP
3	25	0.258744871025	-	7.34e-01	GO:0046875	ephrin receptor binding	MF
3	25	0.258744871025	-	7.34e-01	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	MF
13	109	0.249893953442	-	3.05e-01	GO:0044325	ion channel binding	MF
20	168	0.247249232187	-	2.29e-01	GO:0030335	positive regulation of cell migration	BP
5	42	0.247249232187	-	3.75e-01	GO:0050885	neuromuscular process controlling balance	BP
5	42	0.247249232187	-	3.75e-01	GO:0015485	cholesterol binding	MF
7	59	0.242350432774	-	4.97e-01	GO:0001948	glycoprotein binding	MF
46	389	0.237574171149	-	1.46e-03	GO:0007283	spermatogenesis	BP
4	34	0.230175718828	-	2.71e-01	GO:0043330	response to exogenous dsRNA	BP
4	34	0.230175718828	-	2.71e-01	GO:0045747	positive regulation of Notch signaling pathway	BP
2	17	0.230175718828	-	3.04e-01	GO:0007276	gamete generation	BP
8	68	0.230175718828	-	3.99e-01	GO:0034976	response to endoplasmic reticulum stress	BP
4	34	0.230175718828	-	5.21e-01	GO:0030501	positive regulation of bone mineralization	BP
2	17	0.230175718828	-	6.45e-01	GO:0043651	linoleic acid metabolic process	BP
2	17	0.230175718828	-	6.45e-01	GO:0050804	modulation of synaptic transmission	BP
2	17	0.230175718828	-	6.45e-01	GO:0021537	telencephalon development	BP
2	17	0.230175718828	-	6.45e-01	GO:0006471	protein ADP-ribosylation	BP
2	17	0.230175718828	-	6.57e-01	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
2	17	0.230175718828	-	6.57e-01	GO:0034199	activation of protein kinase A activity	BP
2	17	0.230175718828	-	6.57e-01	GO:0046427	positive regulation of JAK-STAT cascade	BP
2	17	0.230175718828	-	6.71e-01	GO:0032418	lysosome localization	BP
2	17	0.230175718828	-	6.71e-01	GO:0061003	positive regulation of dendritic spine morphogenesis	BP
2	17	0.230175718828	-	6.86e-01	GO:0014002	astrocyte development	BP
2	17	0.230175718828	-	3.80e-01	GO:0048018	receptor agonist activity	MF
2	17	0.230175718828	-	6.86e-01	GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	MF
129	1106	0.217730145267	-	1.85e-06	GO:0007165	signal transduction	BP
10	86	0.213301900263	-	7.29e-02	GO:0006805	xenobiotic metabolic process	BP
5	43	0.213301900263	-	6.01e-01	GO:0034260	negative regulation of GTPase activity	BP
8	69	0.2091141033	-	2.51e-01	GO:0060079	excitatory postsynaptic potential	BP
8	69	0.2091141033	-	5.48e-01	GO:0006369	termination of RNA polymerase II transcription	BP
1029	8884	0.207672149425	-	6.08e-10	GO:0005515	protein binding	MF
15	130	0.202161342658	-	5.71e-03	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
6	52	0.202161342658	-	2.97e-01	GO:0042157	lipoprotein metabolic process	BP
3	26	0.202161342658	-	4.98e-01	GO:0030010	establishment of cell polarity	BP
3	26	0.202161342658	-	7.41e-01	GO:0051225	spindle assembly	BP
3	26	0.202161342658	-	4.62e-01	GO:0003785	actin monomer binding	MF
3	26	0.202161342658	-	4.62e-01	GO:0019838	growth factor binding	MF
4	35	0.188355543133	-	3.41e-01	GO:0051321	meiotic cell cycle	BP
4	35	0.188355543133	-	7.75e-01	GO:0043407	negative regulation of MAP kinase activity	BP
5	44	0.180135036328	-	2.47e-01	GO:0061337	cardiac conduction	BP
5	44	0.180135036328	-	3.75e-01	GO:0006879	cellular iron ion homeostasis	BP
5	44	0.180135036328	-	3.83e-01	GO:0006631	fatty acid metabolic process	BP
5	44	0.180135036328	-	6.01e-01	GO:0006094	gluconeogenesis	BP
6	53	0.174680606236	-	6.39e-01	GO:0050729	positive regulation of inflammatory response	BP
9	80	0.165635466633	-	4.22e-01	GO:0007229	integrin-mediated signaling pathway	BP
26	234	0.147713558636	-	3.69e-01	GO:0007067	mitotic nuclear division	BP
3	27	0.147713558636	-	2.12e-01	GO:0007389	pattern specification process	BP
11	99	0.147713558636	-	2.61e-01	GO:0016310	phosphorylation	BP
2	18	0.147713558636	-	3.42e-01	GO:0007141	male meiosis I	BP
2	18	0.147713558636	-	3.42e-01	GO:0036342	post-anal tail morphogenesis	BP
1	9	0.147713558636	-	3.45e-01	GO:0043266	regulation of potassium ion transport	BP
1	9	0.147713558636	-	3.45e-01	GO:0090181	regulation of cholesterol metabolic process	BP
5	45	0.147713558636	-	3.83e-01	GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	BP
1	9	0.147713558636	-	4.11e-01	GO:0097186	amelogenesis	BP
1	9	0.147713558636	-	4.11e-01	GO:0051205	protein insertion into membrane	BP
1	9	0.147713558636	-	4.11e-01	GO:0043583	ear development	BP
1	9	0.147713558636	-	4.11e-01	GO:0070286	axonemal dynein complex assembly	BP
1	9	0.147713558636	-	4.11e-01	GO:0045580	regulation of T cell differentiation	BP
3	27	0.147713558636	-	4.30e-01	GO:0009755	hormone-mediated signaling pathway	BP
1	9	0.147713558636	-	4.70e-01	GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry	BP
1	9	0.147713558636	-	4.70e-01	GO:0060586	multicellular organismal iron ion homeostasis	BP
1	9	0.147713558636	-	4.70e-01	GO:0071435	potassium ion export	BP
1	9	0.147713558636	-	4.70e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	0.147713558636	-	4.70e-01	GO:0070989	oxidative demethylation	BP
1	9	0.147713558636	-	4.70e-01	GO:0009972	cytidine deamination	BP
1	9	0.147713558636	-	4.70e-01	GO:0022010	central nervous system myelination	BP
11	99	0.147713558636	-	4.80e-01	GO:0031175	neuron projection development	BP
1	9	0.147713558636	-	5.23e-01	GO:0086014	atrial cardiac muscle cell action potential	BP
1	9	0.147713558636	-	5.23e-01	GO:0044342	type B pancreatic cell proliferation	BP
1	9	0.147713558636	-	5.23e-01	GO:2001223	negative regulation of neuron migration	BP
1	9	0.147713558636	-	5.23e-01	GO:0061549	sympathetic ganglion development	BP
1	9	0.147713558636	-	5.23e-01	GO:0003374	dynamin family protein polymerization involved in mitochondrial fission	BP
1	9	0.147713558636	-	5.23e-01	GO:0010838	positive regulation of keratinocyte proliferation	BP
1	9	0.147713558636	-	5.23e-01	GO:0008347	glial cell migration	BP
1	9	0.147713558636	-	5.23e-01	GO:0042698	ovulation cycle	BP
1	9	0.147713558636	-	5.23e-01	GO:0035845	photoreceptor cell outer segment organization	BP
1	9	0.147713558636	-	5.23e-01	GO:0045124	regulation of bone resorption	BP
1	9	0.147713558636	-	5.23e-01	GO:0045741	positive regulation of epidermal growth factor-activated receptor activity	BP
1	9	0.147713558636	-	5.23e-01	GO:0035313	wound healing, spreading of epidermal cells	BP
1	9	0.147713558636	-	5.23e-01	GO:0010917	negative regulation of mitochondrial membrane potential	BP
1	9	0.147713558636	-	5.23e-01	GO:0046620	regulation of organ growth	BP
1	9	0.147713558636	-	5.23e-01	GO:1900017	positive regulation of cytokine production involved in inflammatory response	BP
1	9	0.147713558636	-	5.23e-01	GO:0055086	nucleobase-containing small molecule metabolic process	BP
1	9	0.147713558636	-	5.23e-01	GO:0002237	response to molecule of bacterial origin	BP
4	36	0.147713558636	-	5.37e-01	GO:0015758	glucose transport	BP
1	9	0.147713558636	-	5.71e-01	GO:0034383	low-density lipoprotein particle clearance	BP
1	9	0.147713558636	-	5.71e-01	GO:0046638	positive regulation of alpha-beta T cell differentiation	BP
1	9	0.147713558636	-	5.71e-01	GO:2001224	positive regulation of neuron migration	BP
1	9	0.147713558636	-	5.71e-01	GO:0090197	positive regulation of chemokine secretion	BP
1	9	0.147713558636	-	5.71e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	0.147713558636	-	5.71e-01	GO:0060340	positive regulation of type I interferon-mediated signaling pathway	BP
1	9	0.147713558636	-	5.71e-01	GO:0060068	vagina development	BP
1	9	0.147713558636	-	5.71e-01	GO:0048193	Golgi vesicle transport	BP
1	9	0.147713558636	-	5.71e-01	GO:0060231	mesenchymal to epithelial transition	BP
1	9	0.147713558636	-	5.71e-01	GO:0051983	regulation of chromosome segregation	BP
1	9	0.147713558636	-	5.71e-01	GO:0006105	succinate metabolic process	BP
1	9	0.147713558636	-	5.71e-01	GO:0006111	regulation of gluconeogenesis	BP
1	9	0.147713558636	-	5.71e-01	GO:0006930	substrate-dependent cell migration, cell extension	BP
1	9	0.147713558636	-	5.71e-01	GO:0071243	cellular response to arsenic-containing substance	BP
1	9	0.147713558636	-	5.71e-01	GO:0031915	positive regulation of synaptic plasticity	BP
1	9	0.147713558636	-	5.71e-01	GO:0042908	xenobiotic transport	BP
1	9	0.147713558636	-	5.71e-01	GO:0007034	vacuolar transport	BP
1	9	0.147713558636	-	5.71e-01	GO:0072089	stem cell proliferation	BP
1	9	0.147713558636	-	5.71e-01	GO:0032835	glomerulus development	BP
5	45	0.147713558636	-	5.88e-01	GO:0060048	cardiac muscle contraction	BP
5	45	0.147713558636	-	6.01e-01	GO:0006909	phagocytosis	BP
2	18	0.147713558636	-	6.45e-01	GO:0045216	cell-cell junction organization	BP
2	18	0.147713558636	-	6.45e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
2	18	0.147713558636	-	6.45e-01	GO:0035249	synaptic transmission, glutamatergic	BP
2	18	0.147713558636	-	6.45e-01	GO:0071294	cellular response to zinc ion	BP
2	18	0.147713558636	-	6.57e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
2	18	0.147713558636	-	6.86e-01	GO:0046579	positive regulation of Ras protein signal transduction	BP
2	18	0.147713558636	-	6.86e-01	GO:0045664	regulation of neuron differentiation	BP
2	18	0.147713558636	-	6.86e-01	GO:0008045	motor neuron axon guidance	BP
2	18	0.147713558636	-	6.86e-01	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
2	18	0.147713558636	-	7.01e-01	GO:0042098	T cell proliferation	BP
2	18	0.147713558636	-	7.01e-01	GO:0010824	regulation of centrosome duplication	BP
2	18	0.147713558636	-	7.01e-01	GO:1904380	endoplasmic reticulum mannose trimming	BP
3	27	0.147713558636	-	7.28e-01	GO:0035987	endodermal cell differentiation	BP
3	27	0.147713558636	-	7.41e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
1	9	0.147713558636	-	1.00e+00	GO:0001771	immunological synapse formation	BP
1	9	0.147713558636	-	1.00e+00	GO:0043030	regulation of macrophage activation	BP
1	9	0.147713558636	-	1.00e+00	GO:0048489	synaptic vesicle transport	BP
1	9	0.147713558636	-	1.00e+00	GO:0034063	stress granule assembly	BP
1	9	0.147713558636	-	1.00e+00	GO:0098779	positive regulation of macromitophagy in response to mitochondrial depolarization	BP
1	9	0.147713558636	-	1.00e+00	GO:0010761	fibroblast migration	BP
1	9	0.147713558636	-	1.00e+00	GO:0006390	transcription from mitochondrial promoter	BP
1	9	0.147713558636	-	1.00e+00	GO:0035372	protein localization to microtubule	BP
1	9	0.147713558636	-	1.00e+00	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	BP
1	9	0.147713558636	-	1.00e+00	GO:0031115	negative regulation of microtubule polymerization	BP
1	9	0.147713558636	-	1.00e+00	GO:0032780	negative regulation of ATPase activity	BP
1	9	0.147713558636	-	1.00e+00	GO:0034629	cellular protein complex localization	BP
1	9	0.147713558636	-	1.00e+00	GO:0006000	fructose metabolic process	BP
1	9	0.147713558636	-	1.00e+00	GO:2000008	regulation of protein localization to cell surface	BP
1	9	0.147713558636	-	1.00e+00	GO:0034501	protein localization to kinetochore	BP
1	9	0.147713558636	-	1.00e+00	GO:0010863	positive regulation of phospholipase C activity	BP
1	9	0.147713558636	-	1.00e+00	GO:0000075	cell cycle checkpoint	BP
1	9	0.147713558636	-	1.00e+00	GO:0051315	attachment of mitotic spindle microtubules to kinetochore	BP
1	9	0.147713558636	-	1.00e+00	GO:0070198	protein localization to chromosome, telomeric region	BP
1	9	0.147713558636	-	1.00e+00	GO:0033689	negative regulation of osteoblast proliferation	BP
1	9	0.147713558636	-	1.00e+00	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
1	9	0.147713558636	-	1.00e+00	GO:0060711	labyrinthine layer development	BP
1	9	0.147713558636	-	1.00e+00	GO:0048012	hepatocyte growth factor receptor signaling pathway	BP
2	18	0.147713558636	-	2.65e-01	GO:0016409	palmitoyltransferase activity	MF
2	18	0.147713558636	-	3.42e-01	GO:0016746	transferase activity, transferring acyl groups	MF
2	18	0.147713558636	-	3.80e-01	GO:0031267	small GTPase binding	MF
5	45	0.147713558636	-	4.03e-01	GO:0008047	enzyme activator activity	MF
1	9	0.147713558636	-	4.11e-01	GO:0055056	D-glucose transmembrane transporter activity	MF
3	27	0.147713558636	-	4.62e-01	GO:0004435	phosphatidylinositol phospholipase C activity	MF
3	27	0.147713558636	-	4.98e-01	GO:0004857	enzyme inhibitor activity	MF
1	9	0.147713558636	-	5.23e-01	GO:0017111	nucleoside-triphosphatase activity	MF
1	9	0.147713558636	-	5.71e-01	GO:0052659	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	MF
1	9	0.147713558636	-	5.71e-01	GO:0045236	CXCR chemokine receptor binding	MF
5	45	0.147713558636	-	5.88e-01	GO:0003730	mRNA 3'-UTR binding	MF
5	45	0.147713558636	-	6.01e-01	GO:0019902	phosphatase binding	MF
6	54	0.147713558636	-	6.39e-01	GO:0004197	cysteine-type endopeptidase activity	MF
2	18	0.147713558636	-	6.45e-01	GO:0016209	antioxidant activity	MF
1	9	0.147713558636	-	1.00e+00	GO:0016595	glutamate binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0048027	mRNA 5'-UTR binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0005522	profilin binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0008821	crossover junction endodeoxyribonuclease activity	MF
1	9	0.147713558636	-	1.00e+00	GO:0017081	chloride channel regulator activity	MF
1	9	0.147713558636	-	1.00e+00	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
1	9	0.147713558636	-	1.00e+00	GO:0045505	dynein intermediate chain binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0032357	oxidized purine DNA binding	MF
1	9	0.147713558636	-	1.00e+00	GO:0061578	Lys63-specific deubiquitinase activity	MF
18	163	0.138835407289	-	1.40e-01	GO:0051607	defense response to virus	BP
9	82	0.130011556902	-	5.58e-01	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
6	55	0.121241347275	-	8.19e-01	GO:0031124	mRNA 3'-end processing	BP
5	46	0.116004698908	-	8.05e-01	GO:0016241	regulation of macroautophagy	BP
15	138	0.116004698908	-	3.66e-01	GO:0051015	actin filament binding	MF
13	120	0.111187682611	-	5.32e-01	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
17	157	0.110480652437	-	2.37e-01	GO:0006511	ubiquitin-dependent protein catabolic process	BP
12	111	0.108185194449	-	5.02e-01	GO:0048015	phosphatidylinositol-mediated signaling	BP
4	37	0.108185194449	-	5.57e-01	GO:0045184	establishment of protein localization	BP
4	37	0.108185194449	-	5.68e-01	GO:0051898	negative regulation of protein kinase B signaling	BP
4	37	0.108185194449	-	5.68e-01	GO:0007611	learning or memory	BP
4	37	0.108185194449	-	7.75e-01	GO:0071364	cellular response to epidermal growth factor stimulus	BP
8	74	0.108185194449	-	2.74e-01	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
11	102	0.104644836744	-	7.37e-01	GO:0043488	regulation of mRNA stability	BP
10	93	0.100407843857	-	5.82e-01	GO:0030336	negative regulation of cell migration	BP
3	28	0.0952461387416	-	4.45e-01	GO:0007194	negative regulation of adenylate cyclase activity	BP
3	28	0.0952461387416	-	4.62e-01	GO:0030449	regulation of complement activation	BP
6	56	0.0952461387416	-	6.50e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
3	28	0.0952461387416	-	7.41e-01	GO:0051491	positive regulation of filopodium assembly	BP
3	28	0.0952461387416	-	7.56e-01	GO:0014047	glutamate secretion	BP
3	28	0.0952461387416	-	4.98e-01	GO:0008139	nuclear localization sequence binding	MF
6	56	0.0952461387416	-	6.34e-01	GO:0004722	protein serine/threonine phosphatase activity	MF
3	28	0.0952461387416	-	7.41e-01	GO:0004003	ATP-dependent DNA helicase activity	MF
3	28	0.0952461387416	-	7.56e-01	GO:0043021	ribonucleoprotein complex binding	MF
39	366	0.0873409406563	-	7.68e-02	GO:0006954	inflammatory response	BP
49	460	0.0868583532489	-	1.00e-02	GO:0007275	multicellular organism development	BP
5	47	0.0849778032878	-	7.99e-01	GO:0031532	actin cytoskeleton reorganization	BP
5	47	0.0849778032878	-	8.05e-01	GO:0036297	interstrand cross-link repair	BP
2	19	0.0697110466345	-	3.04e-01	GO:0018345	protein palmitoylation	BP
2	19	0.0697110466345	-	6.57e-01	GO:0048545	response to steroid hormone	BP
2	19	0.0697110466345	-	6.57e-01	GO:0060384	innervation	BP
2	19	0.0697110466345	-	6.86e-01	GO:0031290	retinal ganglion cell axon guidance	BP
2	19	0.0697110466345	-	7.01e-01	GO:0046716	muscle cell cellular homeostasis	BP
2	19	0.0697110466345	-	7.01e-01	GO:0046597	negative regulation of viral entry into host cell	BP
4	38	0.0697110466345	-	7.72e-01	GO:0045214	sarcomere organization	BP
4	38	0.0697110466345	-	7.89e-01	GO:0030049	muscle filament sliding	BP
2	19	0.0697110466345	-	1.00e+00	GO:0070987	error-free translesion synthesis	BP
2	19	0.0697110466345	-	3.04e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
6	57	0.0697110466345	-	3.08e-01	GO:0001664	G-protein coupled receptor binding	MF
8	76	0.0697110466345	-	6.86e-01	GO:0051117	ATPase binding	MF
35	333	0.0675432099518	-	5.06e-01	GO:0051301	cell division	BP
33	314	0.0674119305449	-	3.33e-02	GO:0007399	nervous system development	BP
154	1469	0.0638064202167	-	1.25e-02	GO:0005524	ATP binding	MF
5	48	0.0546041542443	-	8.12e-01	GO:0010467	gene expression	BP
5	48	0.0546041542443	-	5.88e-01	GO:0030145	manganese ion binding	MF
8	77	0.0508520193832	-	8.48e-01	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
6	58	0.0446200656717	-	4.52e-01	GO:0006952	defense response	BP
3	29	0.0446200656717	-	4.62e-01	GO:0048706	embryonic skeletal system development	BP
3	29	0.0446200656717	-	4.98e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
6	58	0.0446200656717	-	6.30e-01	GO:0043087	regulation of GTPase activity	BP
6	58	0.0446200656717	-	6.34e-01	GO:0042102	positive regulation of T cell proliferation	BP
3	29	0.0446200656717	-	7.41e-01	GO:0021915	neural tube development	BP
3	29	0.0446200656717	-	1.00e+00	GO:0090307	mitotic spindle assembly	BP
15	146	0.0347045968066	-	4.53e-01	GO:0016887	ATPase activity	MF
8	78	0.0322363412158	-	3.80e-01	GO:0008544	epidermis development	BP
4	39	0.0322363412158	-	5.37e-01	GO:0050890	cognition	BP
4	39	0.0322363412158	-	5.68e-01	GO:0045071	negative regulation of viral genome replication	BP
39	382	0.0256119509046	-	2.66e-01	GO:0035556	intracellular signal transduction	BP
12	118	0.0199580114374	-	6.26e-01	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
9	89	0.011830130554	-	3.05e-01	GO:0007160	cell-matrix adhesion	BP
19	189	0.0033236493006	-	5.18e-01	GO:0005516	calmodulin binding	MF
3	30	-0.00428953480928	-	4.62e-01	GO:0046676	negative regulation of insulin secretion	BP
6	60	-0.00428953480928	-	8.25e-01	GO:0030334	regulation of cell migration	BP
3	30	-0.00428953480928	-	1.00e+00	GO:0007052	mitotic spindle organization	BP
4	40	-0.00428953480928	-	3.41e-01	GO:0060348	bone development	BP
2	20	-0.00428953480928	-	3.42e-01	GO:0055074	calcium ion homeostasis	BP
1	10	-0.00428953480928	-	4.11e-01	GO:0007195	adenylate cyclase-inhibiting dopamine receptor signaling pathway	BP
1	10	-0.00428953480928	-	4.70e-01	GO:0001775	cell activation	BP
1	10	-0.00428953480928	-	4.70e-01	GO:0007168	receptor guanylyl cyclase signaling pathway	BP
1	10	-0.00428953480928	-	4.70e-01	GO:0045730	respiratory burst	BP
1	10	-0.00428953480928	-	4.70e-01	GO:0060322	head development	BP
1	10	-0.00428953480928	-	4.70e-01	GO:0007567	parturition	BP
1	10	-0.00428953480928	-	5.23e-01	GO:0060306	regulation of membrane repolarization	BP
1	10	-0.00428953480928	-	5.23e-01	GO:0071305	cellular response to vitamin D	BP
1	10	-0.00428953480928	-	5.23e-01	GO:0042359	vitamin D metabolic process	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0046325	negative regulation of glucose import	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0033674	positive regulation of kinase activity	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0022038	corpus callosum development	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0048745	smooth muscle tissue development	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0016322	neuron remodeling	BP
1	10	-0.00428953480928	-	5.71e-01	GO:0048853	forebrain morphogenesis	BP
2	20	-0.00428953480928	-	6.71e-01	GO:0034314	Arp2/3 complex-mediated actin nucleation	BP
2	20	-0.00428953480928	-	7.01e-01	GO:0006783	heme biosynthetic process	BP
2	20	-0.00428953480928	-	7.01e-01	GO:0051493	regulation of cytoskeleton organization	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0007191	adenylate cyclase-activating dopamine receptor signaling pathway	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0071803	positive regulation of podosome assembly	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0051918	negative regulation of fibrinolysis	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0010226	response to lithium ion	BP
2	20	-0.00428953480928	-	1.00e+00	GO:0039702	viral budding via host ESCRT complex	BP
1	10	-0.00428953480928	-	1.00e+00	GO:2001214	positive regulation of vasculogenesis	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0014894	response to denervation involved in regulation of muscle adaptation	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0001952	regulation of cell-matrix adhesion	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0003149	membranous septum morphogenesis	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0050848	regulation of calcium-mediated signaling	BP
1	10	-0.00428953480928	-	1.00e+00	GO:1904903	ESCRT III complex disassembly	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0046007	negative regulation of activated T cell proliferation	BP
2	20	-0.00428953480928	-	1.00e+00	GO:0042276	error-prone translesion synthesis	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0051901	positive regulation of mitochondrial depolarization	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0051492	regulation of stress fiber assembly	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0007084	mitotic nuclear envelope reassembly	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0030071	regulation of mitotic metaphase/anaphase transition	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0014075	response to amine	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0043114	regulation of vascular permeability	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0090136	epithelial cell-cell adhesion	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0090129	positive regulation of synapse maturation	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0001759	organ induction	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0071985	multivesicular body sorting pathway	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0016075	rRNA catabolic process	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0010820	positive regulation of T cell chemotaxis	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0003014	renal system process	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0051639	actin filament network formation	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0060394	negative regulation of pathway-restricted SMAD protein phosphorylation	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0045475	locomotor rhythm	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0046415	urate metabolic process	BP
1	10	-0.00428953480928	-	1.00e+00	GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0010038	response to metal ion	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0016064	immunoglobulin mediated immune response	BP
1	10	-0.00428953480928	-	1.00e+00	GO:2000772	regulation of cellular senescence	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0071688	striated muscle myosin thick filament assembly	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0045792	negative regulation of cell size	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0032940	secretion by cell	BP
1	10	-0.00428953480928	-	1.00e+00	GO:0051024	positive regulation of immunoglobulin secretion	BP
1	10	-0.00428953480928	-	1.00e+00	GO:2000146	negative regulation of cell motility	BP
1	10	-0.00428953480928	-	2.72e-01	GO:0008081	phosphoric diester hydrolase activity	MF
1	10	-0.00428953480928	-	3.45e-01	GO:0008509	anion transmembrane transporter activity	MF
1	10	-0.00428953480928	-	3.45e-01	GO:0008970	phosphatidylcholine 1-acylhydrolase activity	MF
1	10	-0.00428953480928	-	3.45e-01	GO:0008395	steroid hydroxylase activity	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0008199	ferric iron binding	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0005272	sodium channel activity	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0017128	phospholipid scramblase activity	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0004791	thioredoxin-disulfide reductase activity	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0030215	semaphorin receptor binding	MF
1	10	-0.00428953480928	-	4.70e-01	GO:0000900	translation repressor activity, nucleic acid binding	MF
1	10	-0.00428953480928	-	5.23e-01	GO:0031957	very long-chain fatty acid-CoA ligase activity	MF
1	10	-0.00428953480928	-	5.71e-01	GO:0004596	peptide alpha-N-acetyltransferase activity	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0043142	single-stranded DNA-dependent ATPase activity	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0031702	type 1 angiotensin receptor binding	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0045294	alpha-catenin binding	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0003724	RNA helicase activity	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0051428	peptide hormone receptor binding	MF
1	10	-0.00428953480928	-	1.00e+00	GO:0017166	vinculin binding	MF
8	81	-0.0222114428065	-	5.48e-01	GO:0007626	locomotory behavior	BP
5	51	-0.032858687006	-	8.02e-01	GO:0045860	positive regulation of protein kinase activity	BP
7	72	-0.0449315193066	-	8.55e-02	GO:0050853	B cell receptor signaling pathway	BP
7	72	-0.0449315193066	-	6.68e-01	GO:0006816	calcium ion transport	BP
19	196	-0.0491437705935	-	2.74e-01	GO:0004872	receptor activity	MF
3	31	-0.0515952495876	-	7.41e-01	GO:0009953	dorsal/ventral pattern formation	BP
3	31	-0.0515952495876	-	7.41e-01	GO:0019882	antigen processing and presentation	BP
3	31	-0.0515952495876	-	7.56e-01	GO:0043200	response to amino acid	BP
6	62	-0.0515952495876	-	8.21e-01	GO:0051289	protein homotetramerization	BP
3	31	-0.0515952495876	-	1.00e+00	GO:0005158	insulin receptor binding	MF
2	21	-0.0746788627007	-	3.42e-01	GO:0036150	phosphatidylserine acyl-chain remodeling	BP
2	21	-0.0746788627007	-	6.45e-01	GO:0014059	regulation of dopamine secretion	BP
2	21	-0.0746788627007	-	6.86e-01	GO:0000266	mitochondrial fission	BP
2	21	-0.0746788627007	-	7.01e-01	GO:0001676	long-chain fatty acid metabolic process	BP
2	21	-0.0746788627007	-	1.00e+00	GO:0060828	regulation of canonical Wnt signaling pathway	BP
2	21	-0.0746788627007	-	1.00e+00	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
4	42	-0.0746788627007	-	1.00e+00	GO:0045785	positive regulation of cell adhesion	BP
2	21	-0.0746788627007	-	1.00e+00	GO:0070207	protein homotrimerization	BP
2	21	-0.0746788627007	-	1.00e+00	GO:0007029	endoplasmic reticulum organization	BP
2	21	-0.0746788627007	-	1.00e+00	GO:0035307	positive regulation of protein dephosphorylation	BP
2	21	-0.0746788627007	-	6.71e-01	GO:0001530	lipopolysaccharide binding	MF
8	85	-0.0917523760596	-	6.88e-01	GO:0007565	female pregnancy	BP
8	85	-0.0917523760596	-	1.00e+00	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
3	32	-0.0973989392008	-	7.34e-01	GO:0007498	mesoderm development	BP
3	32	-0.0973989392008	-	1.00e+00	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
6	64	-0.0973989392008	-	1.00e+00	GO:0000226	microtubule cytoskeleton organization	BP
4	43	-0.108626194624	-	7.84e-01	GO:0032880	regulation of protein localization	BP
4	43	-0.108626194624	-	7.89e-01	GO:0042110	T cell activation	BP
4	43	-0.108626194624	-	1.00e+00	GO:0051496	positive regulation of stress fiber assembly	BP
4	43	-0.108626194624	-	1.00e+00	GO:0021762	substantia nigra development	BP
4	43	-0.108626194624	-	7.89e-01	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
4	43	-0.108626194624	-	1.00e+00	GO:0030971	receptor tyrosine kinase binding	MF
40	434	-0.121984577479	-	6.35e-02	GO:0045087	innate immune response	BP
7	76	-0.122934031308	-	6.77e-01	GO:0043085	positive regulation of catalytic activity	BP
125	1364	-0.130205084284	-	8.07e-01	GO:0003723	RNA binding	MF
2	22	-0.141793058559	-	8.19e-02	GO:0098664	G-protein coupled serotonin receptor signaling pathway	BP
1	11	-0.141793058559	-	2.72e-01	GO:0060285	cilium-dependent cell motility	BP
1	11	-0.141793058559	-	3.45e-01	GO:0006071	glycerol metabolic process	BP
1	11	-0.141793058559	-	4.11e-01	GO:0006590	thyroid hormone generation	BP
1	11	-0.141793058559	-	4.11e-01	GO:0010529	negative regulation of transposition	BP
1	11	-0.141793058559	-	5.23e-01	GO:0006702	androgen biosynthetic process	BP
1	11	-0.141793058559	-	5.23e-01	GO:0006636	unsaturated fatty acid biosynthetic process	BP
1	11	-0.141793058559	-	5.23e-01	GO:0048703	embryonic viscerocranium morphogenesis	BP
1	11	-0.141793058559	-	5.23e-01	GO:0031284	positive regulation of guanylate cyclase activity	BP
1	11	-0.141793058559	-	5.71e-01	GO:0000050	urea cycle	BP
1	11	-0.141793058559	-	5.71e-01	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
1	11	-0.141793058559	-	5.71e-01	GO:0006707	cholesterol catabolic process	BP
1	11	-0.141793058559	-	5.71e-01	GO:0045446	endothelial cell differentiation	BP
1	11	-0.141793058559	-	5.71e-01	GO:0060294	cilium movement involved in cell motility	BP
1	11	-0.141793058559	-	5.71e-01	GO:0035108	limb morphogenesis	BP
2	22	-0.141793058559	-	6.71e-01	GO:0019915	lipid storage	BP
2	22	-0.141793058559	-	6.71e-01	GO:0034113	heterotypic cell-cell adhesion	BP
3	33	-0.141793058559	-	7.56e-01	GO:0050808	synapse organization	BP
1	11	-0.141793058559	-	1.00e+00	GO:0051279	regulation of release of sequestered calcium ion into cytosol	BP
3	33	-0.141793058559	-	1.00e+00	GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	BP
1	11	-0.141793058559	-	1.00e+00	GO:0001944	vasculature development	BP
1	11	-0.141793058559	-	1.00e+00	GO:0033628	regulation of cell adhesion mediated by integrin	BP
1	11	-0.141793058559	-	1.00e+00	GO:0050921	positive regulation of chemotaxis	BP
1	11	-0.141793058559	-	1.00e+00	GO:1900273	positive regulation of long-term synaptic potentiation	BP
1	11	-0.141793058559	-	1.00e+00	GO:0034067	protein localization to Golgi apparatus	BP
1	11	-0.141793058559	-	1.00e+00	GO:0090161	Golgi ribbon formation	BP
1	11	-0.141793058559	-	1.00e+00	GO:0030431	sleep	BP
6	66	-0.141793058559	-	1.00e+00	GO:0006396	RNA processing	BP
1	11	-0.141793058559	-	1.00e+00	GO:0006937	regulation of muscle contraction	BP
1	11	-0.141793058559	-	1.00e+00	GO:0006312	mitotic recombination	BP
1	11	-0.141793058559	-	1.00e+00	GO:0032786	positive regulation of DNA-templated transcription, elongation	BP
1	11	-0.141793058559	-	1.00e+00	GO:0030033	microvillus assembly	BP
1	11	-0.141793058559	-	1.00e+00	GO:0051085	chaperone mediated protein folding requiring cofactor	BP
1	11	-0.141793058559	-	1.00e+00	GO:0006600	creatine metabolic process	BP
3	33	-0.141793058559	-	1.00e+00	GO:0030100	regulation of endocytosis	BP
2	22	-0.141793058559	-	1.00e+00	GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	BP
1	11	-0.141793058559	-	1.00e+00	GO:0032695	negative regulation of interleukin-12 production	BP
2	22	-0.141793058559	-	1.00e+00	GO:0031954	positive regulation of protein autophosphorylation	BP
1	11	-0.141793058559	-	1.00e+00	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
2	22	-0.141793058559	-	1.00e+00	GO:0048278	vesicle docking	BP
1	11	-0.141793058559	-	1.00e+00	GO:0070935	3'-UTR-mediated mRNA stabilization	BP
1	11	-0.141793058559	-	1.00e+00	GO:0021756	striatum development	BP
1	11	-0.141793058559	-	1.00e+00	GO:0042417	dopamine metabolic process	BP
1	11	-0.141793058559	-	1.00e+00	GO:0009117	nucleotide metabolic process	BP
1	11	-0.141793058559	-	1.00e+00	GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity	BP
1	11	-0.141793058559	-	1.00e+00	GO:0044319	wound healing, spreading of cells	BP
1	11	-0.141793058559	-	1.00e+00	GO:0002523	leukocyte migration involved in inflammatory response	BP
1	11	-0.141793058559	-	1.00e+00	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
1	11	-0.141793058559	-	1.00e+00	GO:0071257	cellular response to electrical stimulus	BP
2	22	-0.141793058559	-	1.00e+00	GO:0051924	regulation of calcium ion transport	BP
1	11	-0.141793058559	-	1.00e+00	GO:2000279	negative regulation of DNA biosynthetic process	BP
1	11	-0.141793058559	-	1.00e+00	GO:0032211	negative regulation of telomere maintenance via telomerase	BP
1	11	-0.141793058559	-	1.00e+00	GO:0061001	regulation of dendritic spine morphogenesis	BP
1	11	-0.141793058559	-	1.00e+00	GO:0051382	kinetochore assembly	BP
1	11	-0.141793058559	-	1.00e+00	GO:1903364	positive regulation of cellular protein catabolic process	BP
1	11	-0.141793058559	-	4.11e-01	GO:0008028	monocarboxylic acid transmembrane transporter activity	MF
1	11	-0.141793058559	-	4.70e-01	GO:0051378	serotonin binding	MF
1	11	-0.141793058559	-	4.70e-01	GO:0004523	RNA-DNA hybrid ribonuclease activity	MF
1	11	-0.141793058559	-	5.23e-01	GO:0015278	calcium-release channel activity	MF
1	11	-0.141793058559	-	5.71e-01	GO:0042301	phosphate ion binding	MF
1	11	-0.141793058559	-	5.71e-01	GO:0043394	proteoglycan binding	MF
7	77	-0.141793058559	-	8.34e-01	GO:0005543	phospholipid binding	MF
1	11	-0.141793058559	-	1.00e+00	GO:0035615	clathrin adaptor activity	MF
1	11	-0.141793058559	-	1.00e+00	GO:0048407	platelet-derived growth factor binding	MF
1	11	-0.141793058559	-	1.00e+00	GO:0005068	transmembrane receptor protein tyrosine kinase adaptor activity	MF
1	11	-0.141793058559	-	1.00e+00	GO:0030371	translation repressor activity	MF
6	66	-0.141793058559	-	1.00e+00	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
3	33	-0.141793058559	-	1.00e+00	GO:0051219	phosphoprotein binding	MF
1	11	-0.141793058559	-	1.00e+00	GO:0043225	ATPase-coupled anion transmembrane transporter activity	MF
2	22	-0.141793058559	-	1.00e+00	GO:0000993	RNA polymerase II core binding	MF
1	11	-0.141793058559	-	1.00e+00	GO:0043295	glutathione binding	MF
1	11	-0.141793058559	-	1.00e+00	GO:0017154	semaphorin receptor activity	MF
2	22	-0.141793058559	-	1.00e+00	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	MF
5	55	-0.141793058559	-	5.94e-01	GO:0007368	determination of left/right symmetry	BP
5	55	-0.141793058559	-	3.92e-01	GO:0003824	catalytic activity	MF
176	1943	-0.14700000687	-	9.97e-04	GO:0046872	metal ion binding	MF
11	122	-0.153667158848	-	4.80e-01	GO:0006629	lipid metabolic process	BP
9	100	-0.156292628254	-	7.10e-01	GO:0005178	integrin binding	MF
7	78	-0.160408736727	-	4.97e-01	GO:0090305	nucleic acid phosphodiester bond hydrolysis	BP
7	78	-0.160408736727	-	6.61e-01	GO:0035023	regulation of Rho protein signal transduction	BP
7	78	-0.160408736727	-	1.00e+00	GO:0000724	double-strand break repair via homologous recombination	BP
16	179	-0.166177217186	-	1.55e-01	GO:0003676	nucleic acid binding	MF
4	45	-0.174214536252	-	5.68e-01	GO:0006633	fatty acid biosynthetic process	BP
8	90	-0.174214536252	-	1.00e+00	GO:0010976	positive regulation of neuron projection development	BP
4	45	-0.174214536252	-	1.00e+00	GO:0014070	response to organic cyclic compound	BP
3	34	-0.184861780451	-	1.00e+00	GO:0007080	mitotic metaphase plate congression	BP
12	136	-0.184861780451	-	1.00e+00	GO:0008360	regulation of cell shape	BP
3	34	-0.184861780451	-	7.28e-01	GO:0017080	sodium channel regulator activity	MF
3	34	-0.184861780451	-	1.00e+00	GO:0048487	beta-tubulin binding	MF
18	207	-0.205923395979	-	1.00e+00	GO:0008017	microtubule binding	MF
2	23	-0.205923395979	-	7.01e-01	GO:0032967	positive regulation of collagen biosynthetic process	BP
2	23	-0.205923395979	-	1.00e+00	GO:0006297	nucleotide-excision repair, DNA gap filling	BP
2	23	-0.205923395979	-	1.00e+00	GO:0006259	DNA metabolic process	BP
14	161	-0.205923395979	-	1.00e+00	GO:0006397	mRNA processing	BP
2	23	-0.205923395979	-	1.00e+00	GO:0034394	protein localization to cell surface	BP
2	23	-0.205923395979	-	1.00e+00	GO:0030866	cortical actin cytoskeleton organization	BP
4	46	-0.205923395979	-	5.37e-01	GO:0005044	scavenger receptor activity	MF
2	23	-0.205923395979	-	1.00e+00	GO:0017134	fibroblast growth factor binding	MF
7	81	-0.214856520749	-	8.52e-01	GO:0031145	anaphase-promoting complex-dependent catabolic process	BP
7	81	-0.214856520749	-	4.97e-01	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
5	58	-0.218414340162	-	1.00e+00	GO:0050839	cell adhesion molecule binding	MF
6	70	-0.226681956146	-	2.97e-01	GO:0042391	regulation of membrane potential	BP
6	70	-0.226681956146	-	8.25e-01	GO:0001558	regulation of cell growth	BP
3	35	-0.226681956146	-	1.00e+00	GO:0005057	signal transducer activity, downstream of receptor	MF
16	187	-0.22925589981	-	1.00e+00	GO:0000287	magnesium ion binding	MF
7	82	-0.232558522482	-	1.00e+00	GO:0051897	positive regulation of protein kinase B signaling	BP
11	129	-0.234157076708	-	4.87e-01	GO:0007605	sensory perception of sound	BP
4	47	-0.2369502916	-	7.72e-01	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
4	47	-0.2369502916	-	1.00e+00	GO:0051781	positive regulation of cell division	BP
4	47	-0.2369502916	-	1.00e+00	GO:0048812	neuron projection morphogenesis	BP
4	47	-0.2369502916	-	7.72e-01	GO:0005544	calcium-dependent phospholipid binding	MF
5	59	-0.243076394396	-	4.14e-01	GO:0016266	O-glycan processing	BP
6	71	-0.247146058705	-	1.00e+00	GO:0007584	response to nutrient	BP
7	83	-0.250045949211	-	8.52e-01	GO:0006928	movement of cell or subcellular component	BP
1	12	-0.267323940643	-	4.70e-01	GO:0003376	sphingosine-1-phosphate signaling pathway	BP
1	12	-0.267323940643	-	5.23e-01	GO:0086012	membrane depolarization during cardiac muscle cell action potential	BP
1	12	-0.267323940643	-	5.23e-01	GO:0046323	glucose import	BP
1	12	-0.267323940643	-	5.23e-01	GO:0042574	retinal metabolic process	BP
1	12	-0.267323940643	-	5.71e-01	GO:0030208	dermatan sulfate biosynthetic process	BP
1	12	-0.267323940643	-	5.71e-01	GO:0034374	low-density lipoprotein particle remodeling	BP
3	36	-0.267323940643	-	7.48e-01	GO:0032467	positive regulation of cytokinesis	BP
6	72	-0.267323940643	-	8.43e-01	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
1	12	-0.267323940643	-	1.00e+00	GO:0055003	cardiac myofibril assembly	BP
1	12	-0.267323940643	-	1.00e+00	GO:0010759	positive regulation of macrophage chemotaxis	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
1	12	-0.267323940643	-	1.00e+00	GO:0010717	regulation of epithelial to mesenchymal transition	BP
1	12	-0.267323940643	-	1.00e+00	GO:0001946	lymphangiogenesis	BP
1	12	-0.267323940643	-	1.00e+00	GO:0001779	natural killer cell differentiation	BP
1	12	-0.267323940643	-	1.00e+00	GO:0043032	positive regulation of macrophage activation	BP
1	12	-0.267323940643	-	1.00e+00	GO:0016242	negative regulation of macroautophagy	BP
2	24	-0.267323940643	-	1.00e+00	GO:0007159	leukocyte cell-cell adhesion	BP
7	84	-0.267323940643	-	1.00e+00	GO:0001822	kidney development	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045724	positive regulation of cilium assembly	BP
2	24	-0.267323940643	-	1.00e+00	GO:0001578	microtubule bundle formation	BP
1	12	-0.267323940643	-	1.00e+00	GO:0010447	response to acidic pH	BP
1	12	-0.267323940643	-	1.00e+00	GO:0050777	negative regulation of immune response	BP
1	12	-0.267323940643	-	1.00e+00	GO:0090162	establishment of epithelial cell polarity	BP
1	12	-0.267323940643	-	1.00e+00	GO:0048024	regulation of mRNA splicing, via spliceosome	BP
1	12	-0.267323940643	-	1.00e+00	GO:0019430	removal of superoxide radicals	BP
1	12	-0.267323940643	-	1.00e+00	GO:0046834	lipid phosphorylation	BP
2	24	-0.267323940643	-	1.00e+00	GO:0046686	response to cadmium ion	BP
1	12	-0.267323940643	-	1.00e+00	GO:0008340	determination of adult lifespan	BP
1	12	-0.267323940643	-	1.00e+00	GO:0030277	maintenance of gastrointestinal epithelium	BP
1	12	-0.267323940643	-	1.00e+00	GO:0002009	morphogenesis of an epithelium	BP
1	12	-0.267323940643	-	1.00e+00	GO:0016540	protein autoprocessing	BP
2	24	-0.267323940643	-	1.00e+00	GO:0030030	cell projection organization	BP
3	36	-0.267323940643	-	1.00e+00	GO:0006479	protein methylation	BP
2	24	-0.267323940643	-	1.00e+00	GO:0008306	associative learning	BP
1	12	-0.267323940643	-	1.00e+00	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
1	12	-0.267323940643	-	1.00e+00	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
1	12	-0.267323940643	-	1.00e+00	GO:0007041	lysosomal transport	BP
1	12	-0.267323940643	-	1.00e+00	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
3	36	-0.267323940643	-	1.00e+00	GO:0030819	positive regulation of cAMP biosynthetic process	BP
1	12	-0.267323940643	-	1.00e+00	GO:0032693	negative regulation of interleukin-10 production	BP
1	12	-0.267323940643	-	1.00e+00	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
1	12	-0.267323940643	-	1.00e+00	GO:0009303	rRNA transcription	BP
2	24	-0.267323940643	-	1.00e+00	GO:0006182	cGMP biosynthetic process	BP
1	12	-0.267323940643	-	1.00e+00	GO:0006885	regulation of pH	BP
3	36	-0.267323940643	-	1.00e+00	GO:0000381	regulation of alternative mRNA splicing, via spliceosome	BP
1	12	-0.267323940643	-	1.00e+00	GO:0051310	metaphase plate congression	BP
1	12	-0.267323940643	-	1.00e+00	GO:0046710	GDP metabolic process	BP
1	12	-0.267323940643	-	1.00e+00	GO:2000010	positive regulation of protein localization to cell surface	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	BP
1	12	-0.267323940643	-	1.00e+00	GO:0050710	negative regulation of cytokine secretion	BP
1	12	-0.267323940643	-	1.00e+00	GO:0097320	plasma membrane tubulation	BP
1	12	-0.267323940643	-	1.00e+00	GO:0030516	regulation of axon extension	BP
1	12	-0.267323940643	-	1.00e+00	GO:0048747	muscle fiber development	BP
3	36	-0.267323940643	-	1.00e+00	GO:0000723	telomere maintenance	BP
2	24	-0.267323940643	-	1.00e+00	GO:0048041	focal adhesion assembly	BP
1	12	-0.267323940643	-	1.00e+00	GO:0034122	negative regulation of toll-like receptor signaling pathway	BP
1	12	-0.267323940643	-	1.00e+00	GO:0071360	cellular response to exogenous dsRNA	BP
1	12	-0.267323940643	-	1.00e+00	GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045086	positive regulation of interleukin-2 biosynthetic process	BP
2	24	-0.267323940643	-	1.00e+00	GO:0051928	positive regulation of calcium ion transport	BP
1	12	-0.267323940643	-	1.00e+00	GO:0040007	growth	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045717	negative regulation of fatty acid biosynthetic process	BP
3	36	-0.267323940643	-	1.00e+00	GO:0006605	protein targeting	BP
1	12	-0.267323940643	-	1.00e+00	GO:0045199	maintenance of epithelial cell apical/basal polarity	BP
1	12	-0.267323940643	-	4.11e-01	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	MF
1	12	-0.267323940643	-	5.23e-01	GO:0004065	arylsulfatase activity	MF
1	12	-0.267323940643	-	1.00e+00	GO:0097493	structural molecule activity conferring elasticity	MF
3	36	-0.267323940643	-	1.00e+00	GO:0051287	NAD binding	MF
1	12	-0.267323940643	-	1.00e+00	GO:0008143	poly(A) binding	MF
1	12	-0.267323940643	-	1.00e+00	GO:0003688	DNA replication origin binding	MF
1	12	-0.267323940643	-	1.00e+00	GO:0008179	adenylate cyclase binding	MF
1	12	-0.267323940643	-	1.00e+00	GO:0031994	insulin-like growth factor I binding	MF
2	24	-0.267323940643	-	1.00e+00	GO:0005031	tumor necrosis factor-activated receptor activity	MF
6	73	-0.287223498081	-	1.00e+00	GO:0045454	cell redox homeostasis	BP
5	61	-0.291170682597	-	1.00e+00	GO:0007613	memory	BP
3	37	-0.30685230483	-	1.00e+00	GO:0034446	substrate adhesion-dependent cell spreading	BP
3	37	-0.30685230483	-	1.00e+00	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
3	37	-0.30685230483	-	1.00e+00	GO:0019894	kinesin binding	MF
6	74	-0.30685230483	-	1.00e+00	GO:0035091	phosphatidylinositol binding	MF
17	210	-0.309144116338	-	6.85e-01	GO:0007268	chemical synaptic transmission	BP
5	62	-0.314629655421	-	6.01e-01	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	BP
5	62	-0.314629655421	-	1.00e+00	GO:0030593	neutrophil chemotaxis	BP
14	174	-0.317950013713	-	1.00e+00	GO:0051260	protein homooligomerization	BP
2	25	-0.326217629697	-	6.45e-01	GO:0007602	phototransduction	BP
4	50	-0.326217629697	-	1.00e+00	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	BP
2	25	-0.326217629697	-	1.00e+00	GO:0043484	regulation of RNA splicing	BP
4	50	-0.326217629697	-	1.00e+00	GO:0006091	generation of precursor metabolites and energy	BP
4	50	-0.326217629697	-	1.00e+00	GO:0006906	vesicle fusion	BP
2	25	-0.326217629697	-	1.00e+00	GO:0043473	pigmentation	BP
2	25	-0.326217629697	-	1.88e-01	GO:0030594	neurotransmitter receptor activity	MF
2	25	-0.326217629697	-	1.00e+00	GO:0043014	alpha-tubulin binding	MF
7	88	-0.334438136502	-	8.41e-01	GO:0016311	dephosphorylation	BP
5	63	-0.337713268534	-	8.31e-01	GO:0016197	endosomal transport	BP
8	101	-0.340572922674	-	7.34e-01	GO:0007062	sister chromatid cohesion	BP
3	38	-0.345326452644	-	4.98e-01	GO:0048468	cell development	BP
6	76	-0.345326452644	-	8.43e-01	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	BP
3	38	-0.345326452644	-	1.00e+00	GO:0030199	collagen fibril organization	BP
16	203	-0.347697357107	-	3.78e-01	GO:0050900	leukocyte migration	BP
4	51	-0.354786781893	-	8.15e-01	GO:0075733	intracellular transport of virus	BP
4	51	-0.354786781893	-	1.00e+00	GO:0060326	cell chemotaxis	BP
5	64	-0.360433345035	-	1.00e+00	GO:0008217	regulation of blood pressure	BP
6	77	-0.364185479896	-	8.44e-01	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
3	39	-0.382801158063	-	4.98e-01	GO:0007631	feeding behavior	BP
1	13	-0.382801158063	-	5.23e-01	GO:0007342	fusion of sperm to egg plasma membrane	BP
1	13	-0.382801158063	-	5.71e-01	GO:0048599	oocyte development	BP
1	13	-0.382801158063	-	5.71e-01	GO:0006957	complement activation, alternative pathway	BP
2	26	-0.382801158063	-	6.71e-01	GO:0035025	positive regulation of Rho protein signal transduction	BP
2	26	-0.382801158063	-	6.86e-01	GO:0019432	triglyceride biosynthetic process	BP
5	65	-0.382801158063	-	8.30e-01	GO:0007015	actin filament organization	BP
5	65	-0.382801158063	-	8.30e-01	GO:0050790	regulation of catalytic activity	BP
1	13	-0.382801158063	-	1.00e+00	GO:0030837	negative regulation of actin filament polymerization	BP
1	13	-0.382801158063	-	1.00e+00	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	-0.382801158063	-	1.00e+00	GO:0072488	ammonium transmembrane transport	BP
2	26	-0.382801158063	-	1.00e+00	GO:0031297	replication fork processing	BP
1	13	-0.382801158063	-	1.00e+00	GO:0060996	dendritic spine development	BP
1	13	-0.382801158063	-	1.00e+00	GO:0033962	cytoplasmic mRNA processing body assembly	BP
1	13	-0.382801158063	-	1.00e+00	GO:0060134	prepulse inhibition	BP
1	13	-0.382801158063	-	1.00e+00	GO:0050806	positive regulation of synaptic transmission	BP
2	26	-0.382801158063	-	1.00e+00	GO:0032148	activation of protein kinase B activity	BP
1	13	-0.382801158063	-	1.00e+00	GO:0032784	regulation of DNA-templated transcription, elongation	BP
1	13	-0.382801158063	-	1.00e+00	GO:0045116	protein neddylation	BP
2	26	-0.382801158063	-	1.00e+00	GO:0042104	positive regulation of activated T cell proliferation	BP
2	26	-0.382801158063	-	1.00e+00	GO:0046487	glyoxylate metabolic process	BP
1	13	-0.382801158063	-	1.00e+00	GO:0032230	positive regulation of synaptic transmission, GABAergic	BP
1	13	-0.382801158063	-	1.00e+00	GO:0001967	suckling behavior	BP
1	13	-0.382801158063	-	1.00e+00	GO:0016226	iron-sulfur cluster assembly	BP
1	13	-0.382801158063	-	1.00e+00	GO:0010821	regulation of mitochondrion organization	BP
1	13	-0.382801158063	-	1.00e+00	GO:0031274	positive regulation of pseudopodium assembly	BP
1	13	-0.382801158063	-	1.00e+00	GO:0000038	very long-chain fatty acid metabolic process	BP
1	13	-0.382801158063	-	1.00e+00	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
1	13	-0.382801158063	-	1.00e+00	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
3	39	-0.382801158063	-	1.00e+00	GO:0009968	negative regulation of signal transduction	BP
1	13	-0.382801158063	-	1.00e+00	GO:0042136	neurotransmitter biosynthetic process	BP
1	13	-0.382801158063	-	1.00e+00	GO:0071280	cellular response to copper ion	BP
1	13	-0.382801158063	-	1.00e+00	GO:0036109	alpha-linolenic acid metabolic process	BP
2	26	-0.382801158063	-	1.00e+00	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
1	13	-0.382801158063	-	1.00e+00	GO:0009395	phospholipid catabolic process	BP
1	13	-0.382801158063	-	1.00e+00	GO:0035418	protein localization to synapse	BP
1	13	-0.382801158063	-	1.00e+00	GO:0035640	exploration behavior	BP
3	39	-0.382801158063	-	1.00e+00	GO:0070527	platelet aggregation	BP
1	13	-0.382801158063	-	5.23e-01	GO:0008195	phosphatidate phosphatase activity	MF
1	13	-0.382801158063	-	5.71e-01	GO:0035240	dopamine binding	MF
2	26	-0.382801158063	-	6.86e-01	GO:0042605	peptide antigen binding	MF
1	13	-0.382801158063	-	1.00e+00	GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0008757	S-adenosylmethionine-dependent methyltransferase activity	MF
2	26	-0.382801158063	-	1.00e+00	GO:0042056	chemoattractant activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0004089	carbonate dehydratase activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0003995	acyl-CoA dehydrogenase activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0016829	lyase activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0004527	exonuclease activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0005041	low-density lipoprotein receptor activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0015464	acetylcholine receptor activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0004385	guanylate kinase activity	MF
1	13	-0.382801158063	-	1.00e+00	GO:0031005	filamin binding	MF
1	13	-0.382801158063	-	1.00e+00	GO:0004518	nuclease activity	MF
22	286	-0.382801158063	-	2.30e-01	GO:0045296	cadherin binding	MF
7	92	-0.398568473921	-	1.00e+00	GO:0016337	single organismal cell-cell adhesion	BP
5	66	-0.404827464393	-	1.00e+00	GO:0072659	protein localization to plasma membrane	BP
5	66	-0.404827464393	-	1.00e+00	GO:0030855	epithelial cell differentiation	BP
9	119	-0.407254201788	-	1.00e+00	GO:0006935	chemotaxis	BP
7	93	-0.414165328972	-	7.18e-01	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	BP
9	120	-0.419327034088	-	7.45e-01	GO:0030036	actin cytoskeleton organization	BP
6	81	-0.437248942085	-	4.52e-01	GO:0035725	sodium ion transmembrane transport	BP
2	27	-0.437248942085	-	6.71e-01	GO:0007154	cell communication	BP
2	27	-0.437248942085	-	7.01e-01	GO:0042755	eating behavior	BP
2	27	-0.437248942085	-	1.00e+00	GO:0043029	T cell homeostasis	BP
4	54	-0.437248942085	-	1.00e+00	GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic	BP
2	27	-0.437248942085	-	1.00e+00	GO:0035329	hippo signaling	BP
2	27	-0.437248942085	-	1.00e+00	GO:0007131	reciprocal meiotic recombination	BP
2	27	-0.437248942085	-	1.00e+00	GO:0001656	metanephros development	BP
2	27	-0.437248942085	-	1.00e+00	GO:0070979	protein K11-linked ubiquitination	BP
2	27	-0.437248942085	-	1.00e+00	GO:0001975	response to amphetamine	BP
2	27	-0.437248942085	-	6.57e-01	GO:0019706	protein-cysteine S-palmitoyltransferase activity	MF
2	27	-0.437248942085	-	1.00e+00	GO:0001968	fibronectin binding	MF
17	230	-0.440388649616	-	3.59e-01	GO:0061024	membrane organization	BP
3	41	-0.454950943819	-	7.94e-01	GO:0034613	cellular protein localization	BP
4	55	-0.463721153447	-	1.00e+00	GO:1903779	regulation of cardiac conduction	BP
9	125	-0.478220723142	-	5.33e-01	GO:0006897	endocytosis	BP
25	349	-0.485588476357	-	4.33e-01	GO:0005102	receptor binding	MF
3	42	-0.48971636198	-	7.48e-01	GO:0046426	negative regulation of JAK-STAT cascade	BP
3	42	-0.48971636198	-	7.94e-01	GO:0006986	response to unfolded protein	BP
3	42	-0.48971636198	-	1.00e+00	GO:0030148	sphingolipid biosynthetic process	BP
3	42	-0.48971636198	-	1.00e+00	GO:0015631	tubulin binding	MF
1	14	-0.48971636198	-	4.70e-01	GO:0015074	DNA integration	BP
1	14	-0.48971636198	-	4.70e-01	GO:0006790	sulfur compound metabolic process	BP
1	14	-0.48971636198	-	4.70e-01	GO:0052695	cellular glucuronidation	BP
1	14	-0.48971636198	-	5.23e-01	GO:0006646	phosphatidylethanolamine biosynthetic process	BP
1	14	-0.48971636198	-	5.71e-01	GO:0042633	hair cycle	BP
1	14	-0.48971636198	-	5.71e-01	GO:0046928	regulation of neurotransmitter secretion	BP
1	14	-0.48971636198	-	5.71e-01	GO:0051967	negative regulation of synaptic transmission, glutamatergic	BP
1	14	-0.48971636198	-	1.00e+00	GO:0006122	mitochondrial electron transport, ubiquinol to cytochrome c	BP
2	28	-0.48971636198	-	1.00e+00	GO:0000422	mitophagy	BP
1	14	-0.48971636198	-	1.00e+00	GO:0044130	negative regulation of growth of symbiont in host	BP
1	14	-0.48971636198	-	1.00e+00	GO:0006940	regulation of smooth muscle contraction	BP
1	14	-0.48971636198	-	1.00e+00	GO:0022408	negative regulation of cell-cell adhesion	BP
1	14	-0.48971636198	-	1.00e+00	GO:0043403	skeletal muscle tissue regeneration	BP
1	14	-0.48971636198	-	1.00e+00	GO:0042026	protein refolding	BP
1	14	-0.48971636198	-	1.00e+00	GO:0032461	positive regulation of protein oligomerization	BP
1	14	-0.48971636198	-	1.00e+00	GO:1901185	negative regulation of ERBB signaling pathway	BP
1	14	-0.48971636198	-	1.00e+00	GO:2000045	regulation of G1/S transition of mitotic cell cycle	BP
1	14	-0.48971636198	-	1.00e+00	GO:0045055	regulated exocytosis	BP
1	14	-0.48971636198	-	1.00e+00	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
1	14	-0.48971636198	-	1.00e+00	GO:0007625	grooming behavior	BP
1	14	-0.48971636198	-	1.00e+00	GO:0060122	inner ear receptor stereocilium organization	BP
1	14	-0.48971636198	-	1.00e+00	GO:0022904	respiratory electron transport chain	BP
1	14	-0.48971636198	-	1.00e+00	GO:1901381	positive regulation of potassium ion transmembrane transport	BP
1	14	-0.48971636198	-	1.00e+00	GO:0048172	regulation of short-term neuronal synaptic plasticity	BP
1	14	-0.48971636198	-	1.00e+00	GO:1900006	positive regulation of dendrite development	BP
1	14	-0.48971636198	-	1.00e+00	GO:0021591	ventricular system development	BP
1	14	-0.48971636198	-	1.00e+00	GO:0006402	mRNA catabolic process	BP
1	14	-0.48971636198	-	1.00e+00	GO:0021794	thalamus development	BP
1	14	-0.48971636198	-	1.00e+00	GO:0045947	negative regulation of translational initiation	BP
2	28	-0.48971636198	-	1.00e+00	GO:0006520	cellular amino acid metabolic process	BP
1	14	-0.48971636198	-	1.00e+00	GO:0030194	positive regulation of blood coagulation	BP
1	14	-0.48971636198	-	1.00e+00	GO:0090303	positive regulation of wound healing	BP
1	14	-0.48971636198	-	1.00e+00	GO:0000712	resolution of meiotic recombination intermediates	BP
1	14	-0.48971636198	-	1.00e+00	GO:0032006	regulation of TOR signaling	BP
1	14	-0.48971636198	-	1.00e+00	GO:0051642	centrosome localization	BP
2	28	-0.48971636198	-	2.26e-01	GO:0004993	G-protein coupled serotonin receptor activity	MF
1	14	-0.48971636198	-	5.23e-01	GO:0005355	glucose transmembrane transporter activity	MF
1	14	-0.48971636198	-	5.71e-01	GO:0030955	potassium ion binding	MF
1	14	-0.48971636198	-	5.71e-01	GO:0008499	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity	MF
1	14	-0.48971636198	-	1.00e+00	GO:0050811	GABA receptor binding	MF
1	14	-0.48971636198	-	1.00e+00	GO:0030169	low-density lipoprotein particle binding	MF
1	14	-0.48971636198	-	1.00e+00	GO:1990381	ubiquitin-specific protease binding	MF
1	14	-0.48971636198	-	1.00e+00	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
1	14	-0.48971636198	-	1.00e+00	GO:0030553	cGMP binding	MF
1	14	-0.48971636198	-	1.00e+00	GO:0005149	interleukin-1 receptor binding	MF
9	127	-0.501121125252	-	1.00e+00	GO:0007204	positive regulation of cytosolic calcium ion concentration	BP
7	99	-0.504363137944	-	8.53e-01	GO:0006469	negative regulation of protein kinase activity	BP
6	85	-0.506789875338	-	8.43e-01	GO:0006874	cellular calcium ion homeostasis	BP
5	71	-0.510180464539	-	1.00e+00	GO:0098869	cellular oxidant detoxification	BP
14	199	-0.511631138408	-	6.55e-01	GO:0007601	visual perception	BP
6	86	-0.523663693903	-	5.80e-01	GO:0048013	ephrin receptor signaling pathway	BP
8	115	-0.527851490866	-	6.18e-01	GO:0005085	guanyl-nucleotide exchange factor activity	MF
2	29	-0.540342435049	-	6.86e-01	GO:0060078	regulation of postsynaptic membrane potential	BP
2	29	-0.540342435049	-	7.64e-01	GO:0000281	mitotic cytokinesis	BP
2	29	-0.540342435049	-	7.64e-01	GO:0000387	spliceosomal snRNP assembly	BP
2	29	-0.540342435049	-	1.00e+00	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
2	29	-0.540342435049	-	1.00e+00	GO:0030203	glycosaminoglycan metabolic process	BP
4	58	-0.540342435049	-	1.00e+00	GO:0002244	hematopoietic progenitor cell differentiation	BP
2	29	-0.540342435049	-	1.00e+00	GO:0055072	iron ion homeostasis	BP
2	29	-0.540342435049	-	1.00e+00	GO:0045776	negative regulation of blood pressure	BP
2	29	-0.540342435049	-	1.00e+00	GO:0019933	cAMP-mediated signaling	BP
2	29	-0.540342435049	-	1.00e+00	GO:0051017	actin filament bundle assembly	BP
2	29	-0.540342435049	-	6.57e-01	GO:0005184	neuropeptide hormone activity	MF
2	29	-0.540342435049	-	1.00e+00	GO:0008234	cysteine-type peptidase activity	MF
3	44	-0.556830557838	-	7.96e-01	GO:0002224	toll-like receptor signaling pathway	BP
27	402	-0.578525628937	-	8.34e-01	GO:0006955	immune response	BP
7	105	-0.58925203553	-	7.20e-01	GO:0006914	autophagy	BP
2	30	-0.58925203553	-	7.64e-01	GO:0051297	centrosome organization	BP
2	30	-0.58925203553	-	7.64e-01	GO:0036258	multivesicular body assembly	BP
3	45	-0.58925203553	-	7.97e-01	GO:0010501	RNA secondary structure unwinding	BP
1	15	-0.58925203553	-	1.00e+00	GO:0048738	cardiac muscle tissue development	BP
1	15	-0.58925203553	-	1.00e+00	GO:0007340	acrosome reaction	BP
1	15	-0.58925203553	-	1.00e+00	GO:0051895	negative regulation of focal adhesion assembly	BP
1	15	-0.58925203553	-	1.00e+00	GO:0010569	regulation of double-strand break repair via homologous recombination	BP
1	15	-0.58925203553	-	1.00e+00	GO:0007099	centriole replication	BP
1	15	-0.58925203553	-	1.00e+00	GO:0060997	dendritic spine morphogenesis	BP
1	15	-0.58925203553	-	1.00e+00	GO:0048026	positive regulation of mRNA splicing, via spliceosome	BP
1	15	-0.58925203553	-	1.00e+00	GO:0035082	axoneme assembly	BP
1	15	-0.58925203553	-	1.00e+00	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
1	15	-0.58925203553	-	1.00e+00	GO:0000028	ribosomal small subunit assembly	BP
3	45	-0.58925203553	-	1.00e+00	GO:0019722	calcium-mediated signaling	BP
1	15	-0.58925203553	-	1.00e+00	GO:0034587	piRNA metabolic process	BP
1	15	-0.58925203553	-	1.00e+00	GO:1904874	positive regulation of telomerase RNA localization to Cajal body	BP
1	15	-0.58925203553	-	1.00e+00	GO:0006112	energy reserve metabolic process	BP
1	15	-0.58925203553	-	1.00e+00	GO:0001963	synaptic transmission, dopaminergic	BP
1	15	-0.58925203553	-	1.00e+00	GO:2000311	regulation of AMPA receptor activity	BP
1	15	-0.58925203553	-	1.00e+00	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
1	15	-0.58925203553	-	1.00e+00	GO:0030490	maturation of SSU-rRNA	BP
1	15	-0.58925203553	-	1.00e+00	GO:0061053	somite development	BP
1	15	-0.58925203553	-	1.00e+00	GO:0090141	positive regulation of mitochondrial fission	BP
1	15	-0.58925203553	-	1.00e+00	GO:0006376	mRNA splice site selection	BP
4	60	-0.58925203553	-	1.00e+00	GO:0006968	cellular defense response	BP
1	15	-0.58925203553	-	1.00e+00	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	BP
1	15	-0.58925203553	-	1.00e+00	GO:0048168	regulation of neuronal synaptic plasticity	BP
1	15	-0.58925203553	-	1.00e+00	GO:0006750	glutathione biosynthetic process	BP
1	15	-0.58925203553	-	1.00e+00	GO:0030214	hyaluronan catabolic process	BP
1	15	-0.58925203553	-	1.00e+00	GO:0015671	oxygen transport	BP
1	15	-0.58925203553	-	1.00e+00	GO:2000147	positive regulation of cell motility	BP
1	15	-0.58925203553	-	1.00e+00	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
38	571	-0.591780861841	-	9.21e-02	GO:0043547	positive regulation of GTPase activity	BP
4	61	-0.613098777485	-	1.00e+00	GO:0006869	lipid transport	BP
4	61	-0.613098777485	-	1.00e+00	GO:0050896	response to stimulus	BP
3	46	-0.620960895258	-	6.22e-01	GO:0000910	cytokinesis	BP
3	46	-0.620960895258	-	7.94e-01	GO:0032956	regulation of actin cytoskeleton organization	BP
3	46	-0.620960895258	-	6.20e-01	GO:0008307	structural constituent of muscle	MF
5	77	-0.627219885729	-	1.00e+00	GO:0007286	spermatid development	BP
20	310	-0.636557750309	-	1.82e-01	GO:0000166	nucleotide binding	MF
4	62	-0.636557750309	-	1.00e+00	GO:0007416	synapse assembly	BP
2	31	-0.636557750309	-	7.64e-01	GO:0008536	Ran GTPase binding	MF
4	62	-0.636557750309	-	1.00e+00	GO:0008237	metallopeptidase activity	MF
5	78	-0.645835563897	-	5.51e-01	GO:0046718	viral entry into host cell	BP
8	125	-0.648145724584	-	3.48e-01	GO:0006470	protein dephosphorylation	BP
3	47	-0.651987790878	-	7.96e-01	GO:0003774	motor activity	MF
8	126	-0.659641363422	-	3.48e-01	GO:0002576	platelet degranulation	BP
4	63	-0.659641363422	-	8.15e-01	GO:0016740	transferase activity	MF
8	127	-0.671046126694	-	1.00e+00	GO:0019221	cytokine-mediated signaling pathway	BP
8	127	-0.671046126694	-	6.17e-01	GO:0008289	lipid binding	MF
8	127	-0.671046126694	-	1.00e+00	GO:0020037	heme binding	MF
3	48	-0.682361439922	-	7.94e-01	GO:0035176	social behavior	BP
3	48	-0.682361439922	-	7.94e-01	GO:0071320	cellular response to cAMP	BP
1	16	-0.682361439922	-	5.23e-01	GO:0030500	regulation of bone mineralization	BP
1	16	-0.682361439922	-	5.71e-01	GO:0036149	phosphatidylinositol acyl-chain remodeling	BP
2	32	-0.682361439922	-	7.66e-01	GO:0000722	telomere maintenance via recombination	BP
1	16	-0.682361439922	-	1.00e+00	GO:0048535	lymph node development	BP
1	16	-0.682361439922	-	1.00e+00	GO:0051893	regulation of focal adhesion assembly	BP
1	16	-0.682361439922	-	1.00e+00	GO:0046037	GMP metabolic process	BP
1	16	-0.682361439922	-	1.00e+00	GO:0048255	mRNA stabilization	BP
1	16	-0.682361439922	-	1.00e+00	GO:0007094	mitotic spindle assembly checkpoint	BP
1	16	-0.682361439922	-	1.00e+00	GO:0050770	regulation of axonogenesis	BP
1	16	-0.682361439922	-	1.00e+00	GO:0048265	response to pain	BP
1	16	-0.682361439922	-	1.00e+00	GO:0061028	establishment of endothelial barrier	BP
1	16	-0.682361439922	-	1.00e+00	GO:0006103	2-oxoglutarate metabolic process	BP
1	16	-0.682361439922	-	1.00e+00	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
1	16	-0.682361439922	-	1.00e+00	GO:0006882	cellular zinc ion homeostasis	BP
2	32	-0.682361439922	-	1.00e+00	GO:0043588	skin development	BP
2	32	-0.682361439922	-	1.00e+00	GO:0003091	renal water homeostasis	BP
1	16	-0.682361439922	-	1.00e+00	GO:0000132	establishment of mitotic spindle orientation	BP
1	16	-0.682361439922	-	1.00e+00	GO:0006275	regulation of DNA replication	BP
1	16	-0.682361439922	-	1.00e+00	GO:0048240	sperm capacitation	BP
1	16	-0.682361439922	-	1.00e+00	GO:0007020	microtubule nucleation	BP
2	32	-0.682361439922	-	7.64e-01	GO:0005154	epidermal growth factor receptor binding	MF
1	16	-0.682361439922	-	1.00e+00	GO:0005216	ion channel activity	MF
1	16	-0.682361439922	-	1.00e+00	GO:0050431	transforming growth factor beta binding	MF
1	16	-0.682361439922	-	1.00e+00	GO:0008574	ATP-dependent microtubule motor activity, plus-end-directed	MF
1	16	-0.682361439922	-	1.00e+00	GO:0023026	MHC class II protein complex binding	MF
2	32	-0.682361439922	-	1.00e+00	GO:0050661	NADP binding	MF
1	16	-0.682361439922	-	1.00e+00	GO:0010181	FMN binding	MF
6	97	-0.697311781388	-	2.38e-01	GO:0097711	ciliary basal body docking	BP
4	65	-0.70472925295	-	8.15e-01	GO:0030574	collagen catabolic process	BP
3	49	-0.712108783316	-	1.00e+00	GO:0065009	regulation of molecular function	BP
6	99	-0.72675555928	-	4.69e-01	GO:0046854	phosphatidylinositol phosphorylation	BP
2	33	-0.72675555928	-	1.00e+00	GO:0051262	protein tetramerization	BP
4	66	-0.72675555928	-	8.15e-01	GO:0003777	microtubule motor activity	MF
3	50	-0.741255128975	-	1.00e+00	GO:0006644	phospholipid metabolic process	BP
3	50	-0.741255128975	-	6.22e-01	GO:0008092	cytoskeletal protein binding	MF
6	101	-0.755610421953	-	8.21e-01	GO:0007218	neuropeptide signaling pathway	BP
12	203	-0.762734856386	-	5.79e-01	GO:0034220	ion transmembrane transport	BP
14	237	-0.763749766763	-	4.57e-02	GO:0000398	mRNA splicing, via spliceosome	BP
1	17	-0.769824281172	-	5.71e-01	GO:0050908	detection of light stimulus involved in visual perception	BP
1	17	-0.769824281172	-	1.00e+00	GO:0031589	cell-substrate adhesion	BP
1	17	-0.769824281172	-	1.00e+00	GO:0070266	necroptotic process	BP
1	17	-0.769824281172	-	1.00e+00	GO:0007292	female gamete generation	BP
1	17	-0.769824281172	-	1.00e+00	GO:0006261	DNA-dependent DNA replication	BP
1	17	-0.769824281172	-	1.00e+00	GO:0000920	cell separation after cytokinesis	BP
1	17	-0.769824281172	-	1.00e+00	GO:0001556	oocyte maturation	BP
1	17	-0.769824281172	-	1.00e+00	GO:0071539	protein localization to centrosome	BP
1	17	-0.769824281172	-	1.00e+00	GO:0002407	dendritic cell chemotaxis	BP
1	17	-0.769824281172	-	1.00e+00	GO:2000114	regulation of establishment of cell polarity	BP
1	17	-0.769824281172	-	1.00e+00	GO:0036148	phosphatidylglycerol acyl-chain remodeling	BP
1	17	-0.769824281172	-	1.00e+00	GO:0006939	smooth muscle contraction	BP
2	34	-0.769824281172	-	1.00e+00	GO:0030282	bone mineralization	BP
1	17	-0.769824281172	-	1.00e+00	GO:0015012	heparan sulfate proteoglycan biosynthetic process	BP
1	17	-0.769824281172	-	1.00e+00	GO:0010592	positive regulation of lamellipodium assembly	BP
1	17	-0.769824281172	-	1.00e+00	GO:0032722	positive regulation of chemokine production	BP
1	17	-0.769824281172	-	1.00e+00	GO:0007026	negative regulation of microtubule depolymerization	BP
5	85	-0.769824281172	-	3.48e-01	GO:0051087	chaperone binding	MF
3	51	-0.769824281172	-	4.79e-01	GO:0003743	translation initiation factor activity	MF
1	17	-0.769824281172	-	1.00e+00	GO:0030234	enzyme regulator activity	MF
1	17	-0.769824281172	-	1.00e+00	GO:0031489	myosin V binding	MF
1	17	-0.769824281172	-	1.00e+00	GO:0004521	endoribonuclease activity	MF
4	68	-0.769824281172	-	1.00e+00	GO:0005262	calcium channel activity	MF
16	273	-0.775118580842	-	8.29e-02	GO:0003779	actin binding	MF
11	188	-0.777518672962	-	4.04e-01	GO:0030198	extracellular matrix organization	BP
8	137	-0.780393522882	-	1.00e+00	GO:0005506	iron ion binding	MF
34	587	-0.792115291782	-	2.44e-01	GO:0055114	oxidation-reduction process	BP
10	174	-0.803376840883	-	1.00e+00	GO:0002250	adaptive immune response	BP
9	157	-0.807057187371	-	4.28e-01	GO:0042742	defense response to bacterium	BP
2	35	-0.811644456867	-	5.75e-01	GO:0019985	translesion synthesis	BP
2	35	-0.811644456867	-	7.64e-01	GO:1901998	toxin transport	BP
2	35	-0.811644456867	-	7.69e-01	GO:0050918	positive chemotaxis	BP
8	141	-0.821912792321	-	2.83e-01	GO:0051056	regulation of small GTPase mediated signal transduction	BP
3	53	-0.825319393764	-	1.00e+00	GO:0030317	flagellated sperm motility	BP
5	89	-0.836166776001	-	2.74e-01	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
3	54	-0.852286441364	-	6.27e-01	GO:0043406	positive regulation of MAP kinase activity	BP
10	180	-0.852286441364	-	7.26e-01	GO:0050776	regulation of immune response	BP
1	18	-0.852286441364	-	1.00e+00	GO:0042267	natural killer cell mediated cytotoxicity	BP
1	18	-0.852286441364	-	1.00e+00	GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	BP
1	18	-0.852286441364	-	1.00e+00	GO:0098609	cell-cell adhesion	BP
3	54	-0.852286441364	-	1.00e+00	GO:0019730	antimicrobial humoral response	BP
1	18	-0.852286441364	-	1.00e+00	GO:0006541	glutamine metabolic process	BP
1	18	-0.852286441364	-	1.00e+00	GO:0008637	apoptotic mitochondrial changes	BP
1	18	-0.852286441364	-	1.00e+00	GO:0007413	axonal fasciculation	BP
1	18	-0.852286441364	-	1.00e+00	GO:0016079	synaptic vesicle exocytosis	BP
1	18	-0.852286441364	-	1.00e+00	GO:0019229	regulation of vasoconstriction	BP
2	36	-0.852286441364	-	1.00e+00	GO:0006654	phosphatidic acid biosynthetic process	BP
1	18	-0.852286441364	-	1.00e+00	GO:0045089	positive regulation of innate immune response	BP
2	36	-0.852286441364	-	1.00e+00	GO:0010811	positive regulation of cell-substrate adhesion	BP
1	18	-0.852286441364	-	1.00e+00	GO:0010596	negative regulation of endothelial cell migration	BP
1	18	-0.852286441364	-	1.00e+00	GO:0002026	regulation of the force of heart contraction	BP
1	18	-0.852286441364	-	5.71e-01	GO:0004745	retinol dehydrogenase activity	MF
2	36	-0.852286441364	-	6.71e-01	GO:0004497	monooxygenase activity	MF
2	36	-0.852286441364	-	7.66e-01	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
3	54	-0.852286441364	-	7.94e-01	GO:0004860	protein kinase inhibitor activity	MF
1	18	-0.852286441364	-	1.00e+00	GO:0051371	muscle alpha-actinin binding	MF
1	18	-0.852286441364	-	1.00e+00	GO:0008157	protein phosphatase 1 binding	MF
1	18	-0.852286441364	-	1.00e+00	GO:0005545	1-phosphatidylinositol binding	MF
1	18	-0.852286441364	-	1.00e+00	GO:0005520	insulin-like growth factor binding	MF
2	36	-0.852286441364	-	1.00e+00	GO:0008138	protein tyrosine/serine/threonine phosphatase activity	MF
1	18	-0.852286441364	-	1.00e+00	GO:0043395	heparan sulfate proteoglycan binding	MF
1	18	-0.852286441364	-	1.00e+00	GO:0005539	glycosaminoglycan binding	MF
1	18	-0.852286441364	-	1.00e+00	GO:0098641	cadherin binding involved in cell-cell adhesion	MF
13	235	-0.858438668346	-	3.09e-01	GO:0007166	cell surface receptor signaling pathway	BP
25	456	-0.871395264312	-	2.20e-01	GO:0007155	cell adhesion	BP
9	165	-0.878758652725	-	1.28e-01	GO:0006457	protein folding	BP
2	37	-0.891814805551	-	7.66e-01	GO:0034332	adherens junction organization	BP
2	37	-0.891814805551	-	7.69e-01	GO:0031122	cytoplasmic microtubule organization	BP
2	37	-0.891814805551	-	1.00e+00	GO:0008202	steroid metabolic process	BP
3	56	-0.904753861258	-	3.65e-01	GO:0003725	double-stranded RNA binding	MF
3	56	-0.904753861258	-	6.20e-01	GO:0042277	peptide binding	MF
15	281	-0.909897164534	-	9.38e-02	GO:0005096	GTPase activator activity	MF
1	19	-0.930288953366	-	7.15e-01	GO:0051298	centrosome duplication	BP
1	19	-0.930288953366	-	1.00e+00	GO:0033141	positive regulation of peptidyl-serine phosphorylation of STAT protein	BP
1	19	-0.930288953366	-	1.00e+00	GO:0030539	male genitalia development	BP
1	19	-0.930288953366	-	1.00e+00	GO:0006892	post-Golgi vesicle-mediated transport	BP
1	19	-0.930288953366	-	1.00e+00	GO:0032502	developmental process	BP
1	19	-0.930288953366	-	1.00e+00	GO:0008156	negative regulation of DNA replication	BP
1	19	-0.930288953366	-	1.00e+00	GO:0009083	branched-chain amino acid catabolic process	BP
1	19	-0.930288953366	-	1.00e+00	GO:0048148	behavioral response to cocaine	BP
2	38	-0.930288953366	-	1.00e+00	GO:0006839	mitochondrial transport	BP
1	19	-0.930288953366	-	1.00e+00	GO:0072583	clathrin-dependent endocytosis	BP
1	19	-0.930288953366	-	1.00e+00	GO:0042246	tissue regeneration	BP
1	19	-0.930288953366	-	1.00e+00	GO:0019226	transmission of nerve impulse	BP
1	19	-0.930288953366	-	1.00e+00	GO:0033198	response to ATP	BP
1	19	-0.930288953366	-	1.00e+00	GO:0002028	regulation of sodium ion transport	BP
1	19	-0.930288953366	-	1.00e+00	GO:0042311	vasodilation	BP
4	76	-0.930288953366	-	6.54e-01	GO:0008233	peptidase activity	MF
1	19	-0.930288953366	-	7.15e-01	GO:0017022	myosin binding	MF
5	95	-0.930288953366	-	8.31e-01	GO:0004867	serine-type endopeptidase inhibitor activity	MF
1	19	-0.930288953366	-	1.00e+00	GO:0019955	cytokine binding	MF
1	19	-0.930288953366	-	1.00e+00	GO:0016597	amino acid binding	MF
1	19	-0.930288953366	-	1.00e+00	GO:0017075	syntaxin-1 binding	MF
7	134	-0.941095708322	-	5.99e-01	GO:0010951	negative regulation of endopeptidase activity	BP
6	115	-0.942888990145	-	1.48e-01	GO:0003729	mRNA binding	MF
7	135	-0.951822114915	-	8.53e-01	GO:0005975	carbohydrate metabolic process	BP
3	58	-0.955379934328	-	6.27e-01	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
2	39	-0.967763658784	-	5.75e-01	GO:0007162	negative regulation of cell adhesion	BP
2	39	-0.967763658784	-	5.80e-01	GO:0071377	cellular response to glucagon stimulus	BP
2	39	-0.967763658784	-	5.80e-01	GO:0008333	endosome to lysosome transport	BP
2	39	-0.967763658784	-	7.66e-01	GO:0007190	activation of adenylate cyclase activity	BP
2	39	-0.967763658784	-	7.66e-01	GO:0050829	defense response to Gram-negative bacterium	BP
11	215	-0.971122670874	-	6.42e-02	GO:0007264	small GTPase mediated signal transduction	BP
15	295	-0.980041988563	-	2.00e-01	GO:0007267	cell-cell signaling	BP
5	99	-0.989789965114	-	1.26e-01	GO:0016236	macroautophagy	BP
3	60	-1.00428953481	-	3.65e-01	GO:0048306	calcium-dependent protein binding	MF
1	20	-1.00428953481	-	7.15e-01	GO:0016601	Rac protein signal transduction	BP
1	20	-1.00428953481	-	7.15e-01	GO:0001836	release of cytochrome c from mitochondria	BP
1	20	-1.00428953481	-	1.00e+00	GO:0042474	middle ear morphogenesis	BP
1	20	-1.00428953481	-	1.00e+00	GO:0043687	post-translational protein modification	BP
1	20	-1.00428953481	-	1.00e+00	GO:0030101	natural killer cell activation	BP
1	20	-1.00428953481	-	1.00e+00	GO:0006401	RNA catabolic process	BP
2	40	-1.00428953481	-	1.00e+00	GO:0043408	regulation of MAPK cascade	BP
1	20	-1.00428953481	-	7.15e-01	GO:0004896	cytokine receptor activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0005251	delayed rectifier potassium channel activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0042923	neuropeptide binding	MF
1	20	-1.00428953481	-	1.00e+00	GO:0043539	protein serine/threonine kinase activator activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0070840	dynein complex binding	MF
1	20	-1.00428953481	-	1.00e+00	GO:0004601	peroxidase activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0004602	glutathione peroxidase activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0004198	calcium-dependent cysteine-type endopeptidase activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0004520	endodeoxyribonuclease activity	MF
1	20	-1.00428953481	-	1.00e+00	GO:0004622	lysophospholipase activity	MF
4	81	-1.02221144281	-	1.85e-01	GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	BP
3	61	-1.02813627676	-	7.97e-01	GO:0051965	positive regulation of synapse assembly	BP
5	102	-1.03285868701	-	1.28e-01	GO:0006406	mRNA export from nucleus	BP
8	164	-1.03991344454	-	9.07e-02	GO:0060271	cilium assembly	BP
14	287	-1.03991344454	-	1.58e-01	GO:0006810	transport	BP
6	123	-1.03991344454	-	5.78e-01	GO:0070588	calcium ion transmembrane transport	BP
2	41	-1.03991344454	-	1.00e+00	GO:0005160	transforming growth factor beta receptor binding	MF
1	21	-1.0746788627	-	7.15e-01	GO:0042730	fibrinolysis	BP
1	21	-1.0746788627	-	7.15e-01	GO:0060999	positive regulation of dendritic spine development	BP
1	21	-1.0746788627	-	7.15e-01	GO:0045921	positive regulation of exocytosis	BP
1	21	-1.0746788627	-	7.15e-01	GO:0032402	melanosome transport	BP
1	21	-1.0746788627	-	7.16e-01	GO:0007004	telomere maintenance via telomerase	BP
1	21	-1.0746788627	-	7.16e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
1	21	-1.0746788627	-	1.00e+00	GO:0030162	regulation of proteolysis	BP
1	21	-1.0746788627	-	1.00e+00	GO:1904659	glucose transmembrane transport	BP
1	21	-1.0746788627	-	1.00e+00	GO:0006637	acyl-CoA metabolic process	BP
2	42	-1.0746788627	-	4.27e-01	GO:0003727	single-stranded RNA binding	MF
1	21	-1.0746788627	-	7.16e-01	GO:0031369	translation initiation factor binding	MF
2	43	-1.10862619462	-	5.83e-01	GO:0032755	positive regulation of interleukin-6 production	BP
7	151	-1.11341125719	-	2.09e-01	GO:0008201	heparin binding	MF
22	481	-1.13282290505	-	7.96e-04	GO:0043312	neutrophil degranulation	BP
2	44	-1.14179305856	-	4.27e-01	GO:0030838	positive regulation of actin filament polymerization	BP
2	44	-1.14179305856	-	5.75e-01	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
2	44	-1.14179305856	-	5.77e-01	GO:0032729	positive regulation of interferon-gamma production	BP
2	44	-1.14179305856	-	5.83e-01	GO:0023014	signal transduction by protein phosphorylation	BP
1	22	-1.14179305856	-	7.15e-01	GO:0006090	pyruvate metabolic process	BP
1	22	-1.14179305856	-	7.15e-01	GO:0006941	striated muscle contraction	BP
1	22	-1.14179305856	-	7.15e-01	GO:0008652	cellular amino acid biosynthetic process	BP
1	22	-1.14179305856	-	7.16e-01	GO:0046835	carbohydrate phosphorylation	BP
1	22	-1.14179305856	-	7.16e-01	GO:0000070	mitotic sister chromatid segregation	BP
1	22	-1.14179305856	-	7.19e-01	GO:0051894	positive regulation of focal adhesion assembly	BP
1	22	-1.14179305856	-	7.19e-01	GO:0032465	regulation of cytokinesis	BP
2	44	-1.14179305856	-	7.69e-01	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	BP
1	22	-1.14179305856	-	1.00e+00	GO:0017158	regulation of calcium ion-dependent exocytosis	BP
1	22	-1.14179305856	-	1.00e+00	GO:0017157	regulation of exocytosis	BP
1	22	-1.14179305856	-	1.00e+00	GO:0002286	T cell activation involved in immune response	BP
1	22	-1.14179305856	-	1.00e+00	GO:0002227	innate immune response in mucosa	BP
1	22	-1.14179305856	-	1.00e+00	GO:0045332	phospholipid translocation	BP
1	22	-1.14179305856	-	1.00e+00	GO:0006855	drug transmembrane transport	BP
4	88	-1.14179305856	-	1.40e-01	GO:0003697	single-stranded DNA binding	MF
3	66	-1.14179305856	-	2.81e-01	GO:0004004	ATP-dependent RNA helicase activity	MF
1	22	-1.14179305856	-	7.15e-01	GO:0015035	protein disulfide oxidoreductase activity	MF
1	22	-1.14179305856	-	7.16e-01	GO:0035255	ionotropic glutamate receptor binding	MF
1	22	-1.14179305856	-	1.00e+00	GO:0005248	voltage-gated sodium channel activity	MF
3	67	-1.16348812966	-	2.78e-01	GO:0001618	virus receptor activity	MF
11	247	-1.17129705287	-	1.89e-01	GO:0055085	transmembrane transport	BP
2	45	-1.17421453625	-	7.66e-01	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	BP
5	113	-1.18061230745	-	9.61e-02	GO:0051082	unfolded protein binding	MF
9	204	-1.18486178045	-	4.46e-01	GO:0006898	receptor-mediated endocytosis	BP
4	92	-1.20592339598	-	1.43e-01	GO:0019886	antigen processing and presentation of exogenous peptide antigen via MHC class II	BP
1	23	-1.20592339598	-	7.15e-01	GO:0032733	positive regulation of interleukin-10 production	BP
1	23	-1.20592339598	-	7.16e-01	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
1	23	-1.20592339598	-	7.19e-01	GO:0007422	peripheral nervous system development	BP
1	23	-1.20592339598	-	7.19e-01	GO:0043001	Golgi to plasma membrane protein transport	BP
1	23	-1.20592339598	-	1.00e+00	GO:0017144	drug metabolic process	BP
1	23	-1.20592339598	-	1.00e+00	GO:0009617	response to bacterium	BP
1	23	-1.20592339598	-	1.00e+00	GO:0008037	cell recognition	BP
1	23	-1.20592339598	-	1.00e+00	GO:0046856	phosphatidylinositol dephosphorylation	BP
1	23	-1.20592339598	-	1.00e+00	GO:0007140	male meiosis	BP
1	23	-1.20592339598	-	7.19e-01	GO:0042162	telomeric DNA binding	MF
1	23	-1.20592339598	-	1.00e+00	GO:0003950	NAD+ ADP-ribosyltransferase activity	MF
1	23	-1.20592339598	-	1.00e+00	GO:0050840	extracellular matrix binding	MF
1	23	-1.20592339598	-	1.00e+00	GO:0070330	aromatase activity	MF
30	694	-1.21426269689	-	1.35e-02	GO:0005509	calcium ion binding	MF
7	162	-1.21485652075	-	1.31e-01	GO:0008083	growth factor activity	MF
4	93	-1.22152025103	-	1.85e-01	GO:0006464	cellular protein modification process	BP
2	47	-1.2369502916	-	4.35e-01	GO:0061077	chaperone-mediated protein folding	BP
7	165	-1.24132873211	-	2.09e-02	GO:0008380	RNA splicing	BP
3	72	-1.26732394064	-	2.07e-01	GO:0006661	phosphatidylinositol biosynthetic process	BP
2	48	-1.26732394064	-	4.31e-01	GO:0043647	inositol phosphate metabolic process	BP
1	24	-1.26732394064	-	5.06e-01	GO:0070536	protein K63-linked deubiquitination	BP
1	24	-1.26732394064	-	5.06e-01	GO:0072661	protein targeting to plasma membrane	BP
2	48	-1.26732394064	-	5.80e-01	GO:0006687	glycosphingolipid metabolic process	BP
1	24	-1.26732394064	-	7.15e-01	GO:0014003	oligodendrocyte development	BP
1	24	-1.26732394064	-	7.15e-01	GO:0007214	gamma-aminobutyric acid signaling pathway	BP
1	24	-1.26732394064	-	7.15e-01	GO:0060135	maternal process involved in female pregnancy	BP
1	24	-1.26732394064	-	7.16e-01	GO:0007126	meiotic nuclear division	BP
1	24	-1.26732394064	-	7.23e-01	GO:0097352	autophagosome maturation	BP
1	24	-1.26732394064	-	1.00e+00	GO:0002376	immune system process	BP
1	24	-1.26732394064	-	1.00e+00	GO:0008654	phospholipid biosynthetic process	BP
1	24	-1.26732394064	-	1.00e+00	GO:0050482	arachidonic acid secretion	BP
4	96	-1.26732394064	-	4.11e-01	GO:0016491	oxidoreductase activity	MF
1	24	-1.26732394064	-	7.15e-01	GO:0043236	laminin binding	MF
3	73	-1.28722349808	-	1.00e+00	GO:0016042	lipid catabolic process	BP
2	49	-1.29707128404	-	2.30e-01	GO:0007266	Rho protein signal transduction	BP
2	49	-1.29707128404	-	3.15e-01	GO:0006606	protein import into nucleus	BP
7	173	-1.3096347455	-	1.65e-01	GO:0005125	cytokine activity	MF
3	75	-1.3262176297	-	2.07e-01	GO:0043086	negative regulation of catalytic activity	BP
2	50	-1.3262176297	-	3.20e-01	GO:0007269	neurotransmitter secretion	BP
1	25	-1.3262176297	-	5.06e-01	GO:0006096	glycolytic process	BP
1	25	-1.3262176297	-	5.06e-01	GO:0006446	regulation of translational initiation	BP
1	25	-1.3262176297	-	5.07e-01	GO:0000375	RNA splicing, via transesterification reactions	BP
1	25	-1.3262176297	-	7.15e-01	GO:0019433	triglyceride catabolic process	BP
1	25	-1.3262176297	-	7.19e-01	GO:0046580	negative regulation of Ras protein signal transduction	BP
1	25	-1.3262176297	-	7.19e-01	GO:0045840	positive regulation of mitotic nuclear division	BP
1	25	-1.3262176297	-	7.23e-01	GO:0022604	regulation of cell morphogenesis	BP
1	25	-1.3262176297	-	1.00e+00	GO:0030206	chondroitin sulfate biosynthetic process	BP
1	25	-1.3262176297	-	1.00e+00	GO:0098656	anion transmembrane transport	BP
3	76	-1.34532645264	-	1.14e-01	GO:0007030	Golgi organization	BP
7	178	-1.35073994883	-	2.08e-01	GO:0030246	carbohydrate binding	MF
2	52	-1.38280115806	-	2.36e-01	GO:0006521	regulation of cellular amino acid metabolic process	BP
1	26	-1.38280115806	-	5.07e-01	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
1	26	-1.38280115806	-	5.07e-01	GO:0008089	anterograde axonal transport	BP
1	26	-1.38280115806	-	5.10e-01	GO:0007017	microtubule-based process	BP
1	26	-1.38280115806	-	5.10e-01	GO:0061621	canonical glycolysis	BP
1	26	-1.38280115806	-	7.19e-01	GO:0051930	regulation of sensory perception of pain	BP
1	26	-1.38280115806	-	1.00e+00	GO:0036152	phosphatidylethanolamine acyl-chain remodeling	BP
19	497	-1.39153596804	-	5.79e-02	GO:0006508	proteolysis	BP
3	79	-1.40117968738	-	3.69e-01	GO:0006813	potassium ion transport	BP
3	79	-1.40117968738	-	7.96e-01	GO:0006814	sodium ion transport	BP
1	27	-1.43724894209	-	5.06e-01	GO:0090023	positive regulation of neutrophil chemotaxis	BP
1	27	-1.43724894209	-	5.06e-01	GO:0050766	positive regulation of phagocytosis	BP
1	27	-1.43724894209	-	5.07e-01	GO:0006611	protein export from nucleus	BP
1	27	-1.43724894209	-	5.10e-01	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
1	27	-1.43724894209	-	5.10e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
1	27	-1.43724894209	-	5.15e-01	GO:0050690	regulation of defense response to virus by virus	BP
1	27	-1.43724894209	-	7.15e-01	GO:0006699	bile acid biosynthetic process	BP
1	27	-1.43724894209	-	7.19e-01	GO:0006612	protein targeting to membrane	BP
1	27	-1.43724894209	-	1.00e+00	GO:0036151	phosphatidylcholine acyl-chain remodeling	BP
1	27	-1.43724894209	-	1.00e+00	GO:0050832	defense response to fungus	BP
2	54	-1.43724894209	-	3.15e-01	GO:0005507	copper ion binding	MF
1	27	-1.43724894209	-	5.06e-01	GO:0008135	translation factor activity, RNA binding	MF
1	27	-1.43724894209	-	7.16e-01	GO:0005244	voltage-gated ion channel activity	MF
2	55	-1.46372115345	-	5.77e-01	GO:0005254	chloride channel activity	MF
3	83	-1.47243837055	-	2.08e-01	GO:0007409	axonogenesis	BP
2	56	-1.48971636198	-	3.15e-01	GO:0016485	protein processing	BP
1	28	-1.48971636198	-	7.15e-01	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
1	28	-1.48971636198	-	1.00e+00	GO:0086010	membrane depolarization during action potential	BP
1	28	-1.48971636198	-	1.00e+00	GO:0051482	positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway	BP
2	56	-1.48971636198	-	2.30e-01	GO:0004175	endopeptidase activity	MF
1	28	-1.48971636198	-	1.00e+00	GO:0015020	glucuronosyltransferase activity	MF
5	141	-1.49998469743	-	9.61e-02	GO:0005215	transporter activity	MF
3	85	-1.50678987534	-	6.16e-02	GO:0030165	PDZ domain binding	MF
1	29	-1.54034243505	-	3.57e-01	GO:0007093	mitotic cell cycle checkpoint	BP
1	29	-1.54034243505	-	3.57e-01	GO:0030032	lamellipodium assembly	BP
1	29	-1.54034243505	-	5.07e-01	GO:0090200	positive regulation of release of cytochrome c from mitochondria	BP
1	29	-1.54034243505	-	5.07e-01	GO:0051881	regulation of mitochondrial membrane potential	BP
1	29	-1.54034243505	-	5.10e-01	GO:0006400	tRNA modification	BP
1	29	-1.54034243505	-	7.15e-01	GO:0006730	one-carbon metabolic process	BP
1	29	-1.54034243505	-	1.00e+00	GO:0042572	retinol metabolic process	BP
1	29	-1.54034243505	-	1.00e+00	GO:0019228	neuronal action potential	BP
1	29	-1.54034243505	-	1.00e+00	GO:0018146	keratan sulfate biosynthetic process	BP
1	29	-1.54034243505	-	3.57e-01	GO:0061631	ubiquitin conjugating enzyme activity	MF
1	29	-1.54034243505	-	1.00e+00	GO:0004623	phospholipase A2 activity	MF
3	89	-1.57313237017	-	7.56e-01	GO:0006956	complement activation	BP
1	30	-1.58925203553	-	5.06e-01	GO:0099132	ATP hydrolysis coupled cation transmembrane transport	BP
1	30	-1.58925203553	-	3.57e-01	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
1	30	-1.58925203553	-	5.15e-01	GO:0032266	phosphatidylinositol-3-phosphate binding	MF
1	30	-1.58925203553	-	7.15e-01	GO:0004864	protein phosphatase inhibitor activity	MF
8	247	-1.63072867151	-	2.28e-01	GO:0004252	serine-type endopeptidase activity	MF
5	156	-1.6458355639	-	9.48e-03	GO:0007010	cytoskeleton organization	BP
2	63	-1.65964136342	-	4.27e-01	GO:0007586	digestion	BP
7	224	-1.68236143992	-	5.86e-04	GO:0003924	GTPase activity	MF
1	32	-1.68236143992	-	5.15e-01	GO:0006139	nucleobase-containing compound metabolic process	BP
2	65	-1.70472925295	-	1.67e-01	GO:0050830	defense response to Gram-positive bacterium	BP
3	99	-1.72675555928	-	3.24e-02	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
1	33	-1.72675555928	-	3.57e-01	GO:0072593	reactive oxygen species metabolic process	BP
1	33	-1.72675555928	-	3.68e-01	GO:0010827	regulation of glucose transport	BP
1	33	-1.72675555928	-	3.68e-01	GO:0006270	DNA replication initiation	BP
1	33	-1.72675555928	-	3.63e-01	GO:0019843	rRNA binding	MF
1	33	-1.72675555928	-	5.10e-01	GO:0004866	endopeptidase inhibitor activity	MF
6	201	-1.74845063038	-	4.04e-04	GO:0006364	rRNA processing	BP
2	68	-1.76982428117	-	9.01e-02	GO:0008565	protein transporter activity	MF
1	34	-1.76982428117	-	5.07e-01	GO:0015276	ligand-gated ion channel activity	MF
2	69	-1.7908858967	-	8.65e-02	GO:0006887	exocytosis	BP
2	69	-1.7908858967	-	1.20e-01	GO:0019905	syntaxin binding	MF
10	350	-1.81164445687	-	1.15e-05	GO:0015031	protein transport	BP
1	35	-1.81164445687	-	2.54e-01	GO:0032781	positive regulation of ATPase activity	BP
1	35	-1.81164445687	-	3.63e-01	GO:0007040	lysosome organization	BP
1	35	-1.81164445687	-	5.06e-01	GO:0045494	photoreceptor cell maintenance	BP
1	36	-1.85228644136	-	2.51e-01	GO:0061025	membrane fusion	BP
1	36	-1.85228644136	-	5.15e-01	GO:0019731	antibacterial humoral response	BP
2	73	-1.8721859988	-	5.75e-01	GO:0006501	C-terminal protein lipidation	BP
2	74	-1.89181480555	-	8.65e-02	GO:0022617	extracellular matrix disassembly	BP
1	37	-1.89181480555	-	7.19e-01	GO:0009566	fertilization	BP
10	370	-1.89181480555	-	6.13e-06	GO:0005525	GTP binding	MF
2	76	-1.93028895337	-	8.83e-02	GO:0007018	microtubule-based movement	BP
1	38	-1.93028895337	-	2.54e-01	GO:0004721	phosphoprotein phosphatase activity	MF
3	115	-1.94288899015	-	4.42e-03	GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	BP
3	116	-1.95537993433	-	8.44e-02	GO:0034765	regulation of ion transmembrane transport	BP
4	156	-1.96776365878	-	1.86e-01	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	BP
1	39	-1.96776365878	-	2.50e-01	GO:0000413	protein peptidyl-prolyl isomerization	BP
1	39	-1.96776365878	-	2.51e-01	GO:0006695	cholesterol biosynthetic process	BP
1	39	-1.96776365878	-	2.50e-01	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	MF
1	39	-1.96776365878	-	5.06e-01	GO:0022857	transmembrane transporter activity	MF
3	120	-2.00428953481	-	1.00e+00	GO:0006958	complement activation, classical pathway	BP
1	40	-2.00428953481	-	2.58e-01	GO:0008277	regulation of G-protein coupled receptor protein signaling pathway	BP
1	40	-2.00428953481	-	5.15e-01	GO:0001895	retina homeostasis	BP
1	40	-2.00428953481	-	3.68e-01	GO:0051539	4 iron, 4 sulfur cluster binding	MF
1	40	-2.00428953481	-	1.00e+00	GO:0015293	symporter activity	MF
5	201	-2.01148503621	-	2.12e-01	GO:0004888	transmembrane signaling receptor activity	MF
1	41	-2.03991344454	-	5.06e-01	GO:0006024	glycosaminoglycan biosynthetic process	BP
1	42	-2.0746788627	-	1.77e-01	GO:0051028	mRNA transport	BP
5	212	-2.0883537996	-	1.34e-04	GO:0006886	intracellular protein transport	BP
5	212	-2.0883537996	-	2.66e-03	GO:0005198	structural molecule activity	MF
3	128	-2.0973989392	-	8.44e-02	GO:0071805	potassium ion transmembrane transport	BP
1	43	-2.10862619462	-	1.77e-01	GO:0006635	fatty acid beta-oxidation	BP
2	86	-2.10862619462	-	1.67e-01	GO:0016787	hydrolase activity	MF
1	43	-2.10862619462	-	1.74e-01	GO:0043022	ribosome binding	MF
20	861	-2.11030277243	-	1.53e-01	GO:0007186	G-protein coupled receptor signaling pathway	BP
4	174	-2.12530493577	-	6.76e-04	GO:0006412	translation	BP
2	87	-2.12530493577	-	2.27e-02	GO:0070126	mitochondrial translational termination	BP
2	87	-2.12530493577	-	6.30e-02	GO:0090630	activation of GTPase activity	BP
15	655	-2.13082194074	-	1.43e-01	GO:0004930	G-protein coupled receptor activity	MF
3	132	-2.14179305856	-	1.10e-03	GO:0006413	translational initiation	BP
1	44	-2.14179305856	-	5.06e-01	GO:0015701	bicarbonate transport	BP
1	44	-2.14179305856	-	1.80e-01	GO:0000149	SNARE binding	MF
1	44	-2.14179305856	-	2.51e-01	GO:0030276	clathrin binding	MF
1	44	-2.14179305856	-	5.10e-01	GO:0019825	oxygen binding	MF
2	89	-2.15809487089	-	2.27e-02	GO:0004725	protein tyrosine phosphatase activity	MF
1	45	-2.17421453625	-	1.00e+00	GO:0050871	positive regulation of B cell activation	BP
1	45	-2.17421453625	-	1.00e+00	GO:0034987	immunoglobulin receptor binding	MF
2	92	-2.20592339598	-	8.65e-02	GO:1902476	chloride transmembrane transport	BP
1	47	-2.2369502916	-	3.57e-01	GO:0008152	metabolic process	BP
1	47	-2.2369502916	-	7.19e-01	GO:0018149	peptide cross-linking	BP
2	94	-2.2369502916	-	1.21e-01	GO:0005179	hormone activity	MF
1	47	-2.2369502916	-	1.77e-01	GO:0017112	Rab guanyl-nucleotide exchange factor activity	MF
2	95	-2.25221704825	-	1.09e-02	GO:0016192	vesicle-mediated transport	BP
2	96	-2.26732394064	-	1.55e-02	GO:0006936	muscle contraction	BP
1	49	-2.29707128404	-	2.50e-01	GO:0015992	proton transport	BP
1	49	-2.29707128404	-	1.00e+00	GO:0002377	immunoglobulin production	BP
1	51	-2.35478678189	-	2.54e-01	GO:0010923	negative regulation of phosphatase activity	BP
3	156	-2.38280115806	-	4.30e-01	GO:0007608	sensory perception of smell	BP
1	52	-2.38280115806	-	8.38e-02	GO:0030170	pyridoxal phosphate binding	MF
2	106	-2.41028189449	-	3.81e-03	GO:0005200	structural constituent of cytoskeleton	MF
1	54	-2.43724894209	-	5.95e-02	GO:0016049	cell growth	BP
1	54	-2.43724894209	-	1.00e+00	GO:0006911	phagocytosis, engulfment	BP
1	54	-2.43724894209	-	6.11e-02	GO:0019003	GDP binding	MF
1	56	-2.48971636198	-	8.47e-02	GO:0032981	mitochondrial respiratory chain complex I assembly	BP
1	61	-2.61309877748	-	4.21e-02	GO:0048208	COPII vesicle coating	BP
1	61	-2.61309877748	-	1.74e-01	GO:0001523	retinoid metabolic process	BP
1	62	-2.63655775031	-	2.74e-02	GO:0030433	ubiquitin-dependent ERAD pathway	BP
1	62	-2.63655775031	-	1.80e-01	GO:0005201	extracellular matrix structural constituent	MF
1	64	-2.68236143992	-	1.21e-01	GO:0008236	serine-type peptidase activity	MF
1	70	-2.81164445687	-	4.09e-02	GO:0009055	electron carrier activity	MF
1	74	-2.89181480555	-	1.25e-01	GO:0032259	methylation	BP
1	85	-3.09175237606	-	5.84e-02	GO:0006486	protein glycosylation	BP
1	86	-3.10862619462	-	4.12e-03	GO:0070125	mitochondrial translational elongation	BP
1	90	-3.17421453625	-	1.29e-03	GO:0006614	SRP-dependent cotranslational protein targeting to membrane	BP
2	180	-3.17421453625	-	5.63e-03	GO:0031424	keratinization	BP
1	93	-3.22152025103	-	2.72e-01	GO:0005549	odorant binding	MF
1	108	-3.43724894209	-	2.80e-04	GO:0019083	viral transcription	BP
1	115	-3.52785149087	-	6.00e-03	GO:0004222	metalloendopeptidase activity	MF
1	138	-3.7908858967	-	1.25e-04	GO:0017137	Rab GTPase binding	MF
1	148	-3.89181480555	-	1.89e-05	GO:0006888	ER to Golgi vesicle-mediated transport	BP
1	151	-3.92076617925	-	3.68e-01	GO:0003823	antigen binding	MF
1	159	-3.99524439521	-	5.40e-06	GO:0003735	structural constituent of ribosome	MF
1	426	-5.41707106015	-	1.00e+00	GO:0050911	detection of chemical stimulus involved in sensory perception of smell	BP
1	426	-5.41707106015	-	1.00e+00	GO:0004984	olfactory receptor activity	MF
